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Summary
SUMMARY.
After primary infection, herpes simplex virus type 1 (HSV-1) remains latent in 
neurons of the host. To facilitate studies on HSV-1 latency, models of latency have been 
developed in tissue culture.
The HSV-1 protein Vmw65 is an essential structural component of the virus 
tegument. Following fusion of the virus envelope with the cell membrane Vmw65 is 
released into the cell and forms a complex with cellular factors which bind to 
TAATGARAT (where R is a purine) elements upstream of the viral immediate early (EE) 
genes. Once the complex has bound to DNA, the acidic carboxy-terminal domain of 
Vmw65 stimulates transcription by recruiting components of the RNA polymerase H 
transcription initiation complex to the promoter.
The mutant ml814 has a 4 amino acid insertion in Vmw65 which disrupts its ability 
to form the transactivation complex, as a consequence levels of EE transcription are 
reduced. During infection of cells with m l814 at low multiplicity of infection (MOI), only 
a minor proportion of infecting viruses undergo replication, whereas the majority of viral 
genomes enter a quiescent state. These quiescent genomes can be reactivated by 
expression within the cell of the HSV-1 encoded protein Vmwl 10 and probably by other 
herpesvirus proteins functionally equivalent to Vmwl 10. At high MOI ml814 replicates 
as efficiently as wild type virus.
To perform structural and functional studies on the quiescent ml814 genomes, it is 
necessary to permit infection of cultured cells at high MOI. An in vitro latency system has 
been developed by D.R.S. Jamieson and C.M. Preston using two modifications which 
further reduce the expression of viral EE proteins, thereby enabling infection of human 
foetal lung (HFL) cells with ml814 at high MOI without extensive cell destruction. 
Firstly, the regulatory region controlling transcription of the gene encoding the EE protein 
Vmwl 10 has been replaced by the Moloney murine leukaemia virus (MMLV) enhancer. 
Since the MMLV enhancer is a relatively inefficient promoter in HFL cells the resulting 
mutant, named m l820, exhibits a phenotype equivalent to that of a Vmwl 10 deletion 
mutant of ml 814 when titrated on HFL cells. Another modification is pretreatment of the 
cells with human interferon a  (IFNa). Treatment of cells with EFNa results in an 
antiviral state against HSV-1 which has been attributed to reduced viral EE gene 
expression.
Previous studies demonstrated that infection of IFNoc-treated HIT, cells with 
m l820 at high MOI results in high efficiency retention of viral genomes in a 
transcriptionally repressed state. The purpose of the study reported here was to extend 
previous analysis by D.R.S. Jamieson on the structure of the m l820 genome during 
latency in vitro, and to characterise early events in the establishment of latency.
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Initial experiments confirmed previous data showing that the m l820 genome is 
nonlinear in the in vitro latency system, as was reported to occur in neurons in vivo. 
Quantification of Southern blots revealed that after an initial input MOI of 120 particles of 
m l820 per cell, approximately 84% of the total nuclear viral DNA was nonlinear and that 
on average each cell retained approximately 12 viral genomes.
Upon reactivation of latent m l820 by superinfection of latently infected HFL cells 
in the presence of an inhibitor of DNA replication, the reactivated genomes remained 
nonlinear, demonstrating that a change from a nonlinear to a linear form is not a 
requirement for reactivation. The configuration of the linear genomes also remained 
unchanged upon reactivation.
During in vitro latency, the nonlinear viral genomes were more sensitive to 
nucleases than the linear genomes. Linearity and resistance to nucleases is indicative of 
genomes which are not uncoated and are thus unable to circularise. Comparison of rates 
of uncoating after infection of BHK, HeLa, CV-1 and HFL cells revealed that uncoating 
appeared significantly slower in HFL cells than in the other cell types tested.
Latent HSV-1 DNA in the brainstems of mice is associated with nucleosomes in a 
chromatin structure. Previous studies examining the structure of in 1820 in the in vitro 
latency system showed that the thymidine kinase (TK) gene is not bound by nucleosomes 
with regular spacing. The study reported here also showed the absence of a regular 
chromatin structure oil the TK gene and furthermore that the nature of the inhibitor of 
DNA replication used to prevent the spread of nonlatent virus was not a significant 
variable. Fascinatingly, the LAT / Vmwl 10 encoding region, the only region 
transcriptionally active during latency in vivo, was in a regular chromatin structure in the 
in vitro latency system. However, when the LAT / Vmwl 10 encoding region and the TK 
gene were examined in a parallel experiment, both regions exhibited a possible regular 
nucleosomal structure suggesting that a regular nucleosomal structure exists on the entire 
genome and is not confined to the LAT / Vmwl 10 region. Thus the previous inability to 
detect chromatin on the TK gene may have been caused by differences in the arrangement 
of nucleosome between experiments or experimental differences in the ability to detect 
nucleosome-associated DNA.
Infection of HFL cells with light particles (L-particles) or virions of m l814 which 
have been inactivated by irradiation with ultraviolet (UV) light, made the cells less 
permissive for plaque initiation upon subsequent infection with m l853 (m l853 is ml814 
with the Escherichia coli lac Z marker gene recombined into the TK locus).
Infection of HFL cells with UV-irradiated ml814 L-particles had no detectable 
effect on adsorption, penetration and uncoating of m l853, indicating an inhibition of viral 
gene expression similar to that caused by the action of IFNa. However, the release of a
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soluble factor into the culture medium by HFL cells infected with UV irradiated viral 
particles could not be detected.
Northern blot analysis showed reduced levels of viral IE mRNAs after infection of 
HFL cells previously infected with UV irradiated ml814 L-particles. The reduction in 
levels of the viral IE mRNAs did not require protein synthesis, implying that UV 
irradiated particles were activating previously existing factors rather than inducing 
transcription of cell genes. In addition, it was demonstrated that the virion-host shutoff 
factor present in the UV inactivated viral particles was not responsible for their inhibitory 
effect on plaque initiation.
The ability of m l814 to establish latency in vitro with high efficiency is reflected in 
its high particle / PFU ratio. The particle / PFU ratio of in 1814 varies between cell types 
and is particularly high in HFL cells. An investigation was undertaken to determine 
whether slow uncoating was the cause of the high particle / PFU ratio observed in HFL 
cells and hence an important property in the establishment of in vitro latency. Slow 
uncoating of the virus might give more time for components of the virion to modify the 
cellular environment before release of the viral DNA into the cell nucleus. During natural 
HSV-1 infection in vivo virus particles fuse with nerve endings at the periphery and the 
nucleocapsids travel along the nerve axon to release the viral genomes into the cell 
nucleus. The relatively long distance between the peripheral nerve ending and the 
neuronal cell body causes a delay between infection at the cell surface and release of the 
viral DNA into the nucleus. The inhibition of m l853 plaque initiation in HFL cells 
previously infected with UV inactivated ml814 may be interpreted as supporting the 
hypothesis that viral proteins modify the cell, predisposing the cell to being latently 
infected.
In order to control uncoating of ml814, a temperature sensitive uncoating defect 
was cloned from the HSV-1 mutant ts 1213 and recombined into the m l814 genome, 
yielding a virus named ml815 which did not release viral DNA into the nuclei of cells 
infected at 39.5°. Uncoating of in 1815 was controlled by temperature shift.
One important characteristic of latency of ml814 in HFL cells is unresponsiveness 
of the viral genome to activators of transcription such as N,N'-hexamethylene-bis- 
acetamide (HMBA). HMBA overcomes the defect in ml814 based viruses if applied early 
in infection. However, during the first 7 hours of infection the virus gradually enters a 
latent state which is unresponsive to HMBA.
Infecting HFL cells with ml814 or ml815 and maintaining at 39.5° for 7 hours, 
followed by the addition of HMBA and downshift to 31°, showed that unlike m l814, 
ml815 did not become unresponsive to HMBA at 39.5°. The rate of silencing of the 
ml815 genome after downshift to 31° was not greater after 7 hours at 39.5° than after 1 
hour at 39.5°, indicating that the factors responsible for silencing the viral genome did not
Summary
accumulate to higher levels at 39.5°. No evidence was found to suggest that slow 
uncoating causes increased efficiency of establishment of latency.
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Introduction
1. INTRODUCTION.
1.1. THE HERPESVIRUSES.
1.1.1. Characteristics of the herpesviruses.
The herpesviruses produce a variety of diseases in humans and are widespread in 
other vertebrates (Minson, 1989). However, each herpesvirus is usually limited to a 
single host species in nature. They are united by their structural architecture and mode of 
replication. Structurally, a herpesvirus virion is 120-300 nm in diameter and consists of a 
single dsDNA genome ranging from 125-240 kbp in size surrounded by an icosahedral 
nucleocapsid. The entire virion is surrounded by a lipid envelope and between the 
envelope and the capsid exists amorphous material which constitutes the tegument (figure
1.3.).
The mode of replication of the herpesviruses exhibits several unifying 
characteristics: 1) viral DNA synthesis and nucleocapsid assembly occur in the nucleus of 
the infected cell. 2) Enzymes for viral nucleic acid metabolism are encoded by the virus. 
3) Lytic infection results in the death of the cell. 3) Latent infections can be established.
The genes encoded by the herpesviruses include about 40 ‘core’ genes which show 
amino acid sequence homology between all of the herpesviruses and are believed to result 
from a common evolutionary progenitor (table 1.1.; Figure 1.4.; Davison, 1993). The 
core genes encode the structural proteins and proteins involved in virion morphogenesis, 
nucleotide metabolism and DNA packaging. Presumably it is the remaining genes which 
result in the individual characteristics of each virus.
The herpesviruses have been divided into three subfamilies, alpha, beta and gamma, 
depending mainly upon their biological characteristics (Minson, 1989).
Alphaherpesviruses are distinguished by their ability to infect a wide range of tissue 
culture cells in vitro, their rapid growth cycle, and their ability to establish latency in 
nervous tissues. Humans are natural hosts for 3 alphaherpesviruses: herpes simplex virus 
types 1 and 2 (HSV-1 and HSV-2) and varicella-zoster virus (VZV).
The betaherpesviruses grow less rapidly in tissue culture and in vivo and are limited 
by the cell types which they are capable of infecting. The betaherpesviruses known to 
naturally infect humans are human cytomegalovirus (HCMV), and human herpesviruses 6 
and 7 (HHV-6 and HHV-7). The cytomegaloviruses gain their name from the 
characteristic cytopathic effect (CPE) which they induce, since infected cells become 
extremely large and round. The sites at which the betaherpesviruses establish latency has
1
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been difficult to identify, however the observation that HCMV is transmitted by blood 
products suggests that latency may occur in a circulatory cell type. Latency of HCMV has 
been observed in cultured granulocyte-macrophage progenitor cells (Kondo et al., 1994), 
and in addition, the major population of virally infected cells in the blood of mice infected 
with murine cytomegalovirus are mononuclear phagocytes (Stoddart et a l , 1994), thus 
macrophages and their progenitor cells have been implicated as sites of betaherpesvirus 
latency (Sinclair and Sissons, 1994).
Gammaherpesviruses are distinguished by their ability to replicate and establish 
latency in lymphoid cells. The gammaherpesviruses infecting humans are Epstein-Barr 
virus (EBV) and possibly human herpesvirus 8 (HHV-8).
1.1.2. The role of herpesviruses in human disease.
HSV.
Initial infection with HSV occurs via the mucous membranes of the mouth, genitals, 
throat or eyes (Minson, 1989; Ginsberg, 1990). Replication ensues at the site of entry and 
virus spreads to the local lymph nodes. Replication is usually localised to the site of 
infection, however viraemia occurs occasionally, resulting in replication in distant organs. 
Infection usually occurs during the first 6-18 months of life and is most often inapparent, 
however 10-15% of those infected develop herpetic gingivostomatitis (vesicles on the oral 
mucous membranes or mucocutaneous border).
During the primary infection, virus is taken up by nerve endings and travels to the 
nerve cell bodies in the sensory ganglia (predominantly the trigeminal ganglia in oral 
gingivostomatitis), where it establishes a latent infection for the lifetime of the host despite 
the presence of circulating anti-HSV antibodies. Reactivation can be triggered later in life 
by a variety of stimuli including trauma, hormonal changes or illness, thereby resulting in 
viral replication at the site of the primary infection.
Two serotypes of HSV exist: HSV-1 is primarily associated with oral infections 
while HSV-2 is predominantly associated with genital infections. However, both 
serotypes are capable of replication and latency at either anatomical location but recurrent 
reactivation of HSV-1 is favoured in the trigeminal ganglia and HSV-2 reactivation is 
favoured in the spinal ganglia innervating the genitals, thus the two HSV serotypes appear 
to have evolved to optimise their spread at separate anatomical sites.
Complication with HSV infections include fatal encephalitis in neonates and 
immuno-compromised patients, and blindness resulting from primary infection in the eye.
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vzv.
The primary disease caused by VZV is called chickenpox or varicella. Virus enters 
by the respiratory tract and replicates in the local lymph nodes (Minson, 1989; Ginsberg, 
1990). Viraemia results, and after an incubation period of 14-15 days a fever ensues and 
vesicles appear on the skin. The primary disease can be particularly severe in adults, 
however infection is so common that most people are infected before the age of 20.
During primary infection, VZV establishes latency in sensory ganglia of the spinal 
or cranial nerves where it persists for the lifetime of the host in the presence of 
neutralising antibodies. As with HSV, trauma and immune suppression can trigger 
reactivation. Reactivation leads to shingles (also called herpes-zoster), which is 
manifested as vesicles and severe pain at the distribution of the infected nerve.
HCM V.
HCMV is the most common cause of severe intra-uterine infections (Pass, 1985; 
Minson, 1989; Ginsberg, 1990; Borucki and Pollard, 1994). Although 0.5-2.4% of 
newborn babies are infected with HCMV (in the USA), clinical symptoms only occurs in 
approximately 5-10% of those infected. Severity of clinically apparent HCMV infections 
vary from mild to severe, however approximately one third suffer permanent neurological 
damage.
It is common for asymtomatic adults to secrete virus, thus HCMV establishes latent 
infections. There is mounting evidence that macrophage progenitor cells and macrophages 
are the sites of HCMV latency (Sinclair and Sissons, 1994).
EBV.
Infection with EBV occurs via the oral route, after which it replicates in the 
epithelium of the mouth and salivary gland ducts (Rickinson eta l., 1985; Minson, 1989; 
Ginsberg, 1990). It is believed that EBV infects B-lymphocytes associated with the 
oropharangeal epithelial tissues and that the infected B-lymphocytes circulate around the 
body and provide a source of latent infection.
Infection usually occurs within the first five years of life and produces subclinical 
disease, however increased hygiene in recent years has caused infection of a greater 
proportion of the population to be delayed until adolescence. When EBV infection occurs 
at ages above 15 years, approximately 50% of patients exhibit the clinical manifestations 
of the disease known as infectious mononucleosis (IM) or glandular fever. Symptoms of
3
Introduction
IM include enlarged lymph nodes and spleen, abnormal lymphocytes in the blood and 
fatigue which can last for months. IM patients secrete EBV for weeks after the primary 
infection.
EBV can immortalise B-lymphocytes in vitro, and in addition EBV-infected 
immortalised B-lymphocytes can be isolated from the blood of EBV-infected individuals, 
thus the B-lymphocyte is a major site of EBV latency. EBV sequences are commonly 
found in at least 2 types of tumours, Burkitt’s lymphoma and nasopharangeal carcinoma, 
thus the immortalisation functions of EBV can facilitate the development of certain 
tumours.
HHV-6 and HHV-7.
HHV-6 was first isolated from the blood of patients with lymphoproliferative 
disorders or AIDS (Salahuddin et al., 1986). Up to 90% of the population are 
asymptomatically infected with HHV-6, however infection in infants sometimes causes a 
mild skin rash termed exanthum subitum (Yamanishi et a l, 1988; Okuna et al., 1989), 
and acute febrile illness in young children (Pruksananonda et al., 1992; Hall et al., 1994). 
HHV-6 can replicate in CD4+ T-lymphocytes, and there is evidence that the monocyte is a 
site of latency. Despite its lymphotropism HHV-6 has been classified as a 
betaherpesvirus, since it shares amino acid sequence similarities and overall gene 
organisation with HCMV, and infects a wide range of cell types other than lymphocytes 
(Lawrence etal., 1990; Neipel etal., 1991; Nicholas and Martin, 1994).
HHV-7 shares a number of common features with HHV-6, including replication in 
T-lymphocytes (Frenkel etal., 1990; Bememan etal., 1992; Lusso etal., 1994), a similar 
genome organisation (Lindquester and Pellett, 1991; Gompels et al., 1995; Secchiero et 
al., 1995) and 50-60% nucleotide identity in the genomic regions which have been 
examined (Berneman et a l, 1992). HHV-7 has also been isolated from the blood and 
saliva of immunosuppressed and healthy subjects (Frenkel et al., 1990; Wyatt and 
Frenkel, 1992). Although the association of HHV-7 with any disease has yet to be 
resolved, there is evidence that HHV-7 may be associated with some cases of exanthum 
subitum (Portolani etal., 1995).
HHV-8.
Recent attempts to identify infectious agents associated with the Kaposi’s sarcoma 
(KS) lesions suffered by AIDS patients have demonstrated the existence of unique viral 
DNA sequences with close homology to regions of the EBV genome (Memar et al.,
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1995). Sequences of the new herpesvirus, termed HHV-8, are present in all AIDS-related 
and sporadic forms of KS and have been demonstrated in peripheral blood mononuclear 
cells of KS+ patients, thus the presence of HHV-8 DNA appears essential for the 
aetiology of KS. HHV-8 has yet to be isolated or demonstrated to have immortalising or 
transforming ability.
1.1.3. Human herpesvirus genomes.
Herpesviruses possess large single dsDNA genomes which vary in size, G+C 
content and in the arrangment of their major repeat regions (figure 1.1.; McGeoch, 1989).
The genome of HSV-1 is approximately 152 kbp, with a G+C content of 68.3% 
(McGeoch et al., 1985, 1986, 1988a; Perry and McGeoch, 1988). It consists of 2 
covalently joined segments termed the long (L) and short (S) regions, representing 82% 
and 18% of the genome respectively. Both the L and S regions are divided into a unique 
region (Ul or U s) flanked by repeats in opposite orientation to each other. The internal 
repeat in the L region is termed IRl and the terminal repeat is termed TRl , likewise the 
internal and terminal repeats of the S region are termed IRs and TRs respectively. At each 
of the termini there is an approximately 250-350 bp direct repeat termed the a sequence, 
which is present in variable numbers at the L-terminus and one copy at the S-terminus 
(Wilkie, 1976; Wagner and Summers, 1978; Roizman, 1979; Davison and Wilkie, 1981). 
There is also at least one copy of the a sequence in the joint between the L and S regions 
which is in opposite orientation to that of the terminal a sequences. Both of the genomic 
termini possess an overhanging residue leaving a 3' hydroxyl group free (Mocarski and 
Roizman, 1982).
The L and S regions can invert relative to each other so that virion DNA consists of 
equimolar proportions of 4 isomers (figure 1.2.; Hayward et al., 1975; Morse et al., 
1977; Roizman, 1979), one of which has been assigned as the prototype to facilitate 
mapping (Roizman, 1979; McGeoch e ta l,  1988a). Since the genes in the repeat regions 
are diploid, the internal inverted repeats can be deleted and the virus remains viable in 
tissue culture, however the resulting deletion mutants produce progeny whose L and S 
segments cannot invert relative to each other (Poffenberger et a l , 1983; Poffenberger and 
Roizman, 1985; Jenkins and Roizman, 1986). Deletion mutants have been constructed 
which are fixed in one of all the 4 isomeric forms. Recombination between the a 
sequences is the mechanism which generates the 4 isomers (Mocarski and Roizman, 
1982; Chou and Roizman, 1985).
Since a small proportion of virion DNA is circular and circularisation of linear viral 
genomes occurs rapidly after entry into the nucleus, it is likely that the termini of the 
genome are in close proximity or possibly held together in the virion (Poffenberger and
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Figure 1.1. Sizes and structures of human herpesvirus genomes. Repeat regions are 
represented by open rectangles- with the orientation of the repeats indicated by arrows. 
Unique regions are represented by horizontal lines.
Abbreviations are as follows :
UL unique long.
Us unique short.
T/ERl terminal / internal long repeat.
T/IRs terminal /  internal short repeat.
Dl direct repeat left.
D r direct repeat right.
MIR major internal repeat.
Adapted from Anderson (1991).
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Figure 1.2. Gross structure of the HSV genome showing a sequences and possible 
isomeric forms. (A) The HSV genome displaying the positions and orientations of the 
repeated sequences, b ’ and c' are identical to b and c, but in inverse orientation, a ’ and a 
are repeat elements in inverse orientation and variable in copy number. There are 1-5 a 
sequences at the L-terminus and the joint between the L and S segments, whereas there 
is only 1 a sequence at the S-terminus. (B) The 4 possible isomeric forms resulting from 
different orientations of the U l and Us regions. The larger arrows represent the 
orientations of the U l segments and the smaller arrows represent the orientations of the 
Us segments.
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Roizman, 1985; Roizman and Sears, 1993). Virion DNA is also reported to contain nicks 
and gaps (Frenkel and Roizman, 1972; Wilkie, 1973).
The genomes of HSV-1 and HSV-2 are closely related and colinear. Coding 
sequences of HSV-1 and HSV-2 show 70-80% similarity (McGeoch et al., 1987), 
whereas the noncoding regions are more greatly diverged (Davison and Wilkie, 1981; 
Whitton and Clements, 1984; McGeoch et al., 1991). HSV-2 also contains a slightly 
higher G+C content, 69%, compared to 68.3% in HSV-1 (McGeoch et al., 1988a). A 
major difference between the 2 viruses has been noted in their Us4 genes, which encodes 
gG (McGeoch et a l, 1987). The HSV-2 Us4 is 1460 bp larger than its HSV-1 
counterpart, encoding 2 additional domains in the gG protein.
The VZV genome is approximately 125 kbp with a G+C content of 46.0% (Davison 
and Scott, 1986). The gross VZV genome structure is similar to that of HSV only the 
inverted repeats flanking the U l segment are only 88 bp compared to the 9.2 kbp repeats 
of HSV, in addition the VZV genome is not terminally redundant (Davison, 1984). As 
with HSV, both termini end in a 1 nt 3' overhang. Four isomers of the VZV genome 
exist, however, approximately 95% of virion genomes contain 1 orientation of U l.
The genome of EBV strain B95-8 is approximately 172 bp with a G+C content of 
59.5%, however these values are not accurate since strain B95-8 has acquired a 
spontaneous deletion. Taking the deletion into account the size is likely to be around 186 
kbp (Raab-Traub etal., 1980; Baer et al., 1984; Laux et a l, 1985). The genomic termini 
consist of several directly repeated copies of a 540 bp sequence. Several repeat elements 
are located internally in the EBV genome, these include D l  and D r  which are 1 kbp direct 
repeats at the extremities of the U l segment, and the major internal repeat (MIR), which is 
a tandemly reiterated 3072 bp sequence separating the U l and Us segments.
The HCMV genome has a very similar structure to the HSV genome but is much 
larger, with a size of 230 kbp and G+C content of 56% (Weststrate et al., 1983; Chee et 
al., 1990). Four isomers of HCMV are possible, and the genome contains an element 
equivalent to the a sequence (Spaete and Mocarski, 1985).
The HHV-6 genome is 159 kbp with a G+C content of 43% (Gompels et a l,  
1995). The HHV-6 genome consists of a 143 kbp unique segment flanked by 8 kbp direct 
repeats. The terminal direct repeats are themselves flanked by 350 bp elements with 
similar structure to human telomeres. The HHV-7 genome has a very similar structure to 
the genome of HHV-6, with 50-60% sequence identity (Bememan e ta l,  1992; Secchiero 
e ta l ,  1995).
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1.1.4. The HSV-1 a sequence.
The HSV-1 a sequence is highly conserved but contains variable numbers of repeat 
elements. The a sequence is tandemly reiterated 1-5 times at the L-terminus, but only one 
copy exists at the S-terminus (Wilkie, 1976; Wagner and Summers, 1978). The HSV-1 
strain F a sequence has been analysed in some detail, and consists of the following 
elements: a 20 bp direct repeat (DR1), a 65 bp unique sequence (Ub), 19-23 copies of a 
12 bp direct repeat (DR2), 2-3 copies of a 37 bp direct repeat, and a 58 bp unique 
sequence (Uc) followed by another DR1 (Mocarski and Roizman, 1981). The a sequence 
can therefore be represented as:
DRl-Ub-DR2n-DR4m-Uc-DRl
Adjacent a sequences share the intervening DR1 (Mocarski and Roizman, 1981). 
The size of the a sequence varies from strain to strain and is partly determined by the 
numbers of copies of DR2 and DR4. Since the terminal a sequence of the L component 
contains a truncated DR1 consisting of 18 bp and a one nucleotide 3' overhang, whereas 
the a sequence of the S-terminus ends with a DR1 consisting of only 1 bp and one 3' 
overhang, a complete DR1 is formed upon circularisation (Mocarski and Roizman, 1982). 
The a sequence contains dj-acting signals for circularisation, cleavage of concatemers 
into single unit length molecules, and encapsidation (Mocarski and Roizman, 1982; 
Vlazny et a l , 1982; Varmuza and Smiley, 1985). In addition, it contains the promoter for 
ICP34.5 (Chou and Roizman, 1986).
1.1.5. HSV virion structure.
The HSV virion is approximately 120-300 nm in diameter and consists of 3 distinct 
structures, namely capsid, tegument and envelope (figure 1.3.; Rixon, 1993; Beers et al.,
1994). The capsid is an icosahedral structure in the centre of the virion, in which the viral 
genome resides. The tegument is an apparently amorphous layer surrounding the capsid. 
Surrounding the tegument is the external lipid envelope with protruding glycoprotein 
spikes. Over half of the over 70 proteins encoded by HSV-1 are believed to be present in 
the virion or involved in virion assembly.
The 100-110 nm diameter icosahedral capsid is composed of 162 capsomeres 
(Schrag et a l , 1989). Three types of capsid can be isolated from cells infected with HSV 
(Gibson and Roizman, 1972). Type A capsids are empty capsids, type B capsids lack 
DNA but contain a core of proteinacious material, whereas type C capsids contain the 
viral DNA. Since the three capsid types represent different stages of nucleocapsid
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Capsid
Tegum ent
Envelope
Glycoproteins
Figure 1.3. The HSV virion. A cryo-electron micrograph of the HSV virion is 
shown with the positions of the capsid, tegument, envelope and glycoprotein spikes 
indicated by arrows. The virion is magnified approximately 230, 000-fold. Photograph 
supplied by F.J. Rixon.
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maturation and DNA packaging, their analysis has shed some light on these processes. 
Type A capsids are believed to be the result of abortive attempts to package DNA 
(Newcomb and Brown, 1989; Newcomb et al., 1989; Newcomb and Brown, 1991). 
Type A capsids consist of 5 viral structural proteins, namely VP5 (encoded by U l1 9 )  
which is the capsomer protein (Heine et al., 1974; Vernon et al., 1981; Shrag et al., 
1989), VP 19c (Ul 38) which binds to DNA (Braun et al., 1984), VP23 (UL18) which 
possibly connects adjacent capsomeres (Schrag et al., 1989), VP24 (U l26) which is 
believed to be a remnant of the scaffold proteins which are necessary for capsid assembly 
and lost upon packaging of the DNA (Davison et al., 1992), and VP26 (U l35) which is 
required for mechanical stability (Newcomb and Brown, 1991). Type B capsids differ in 
protein content from the type A capsids in that they contain VP22a (U l26 .5 ) and small 
amounts of VP21 (U l26), and these 2 proteins form the scaffold which is transiently 
associated with the capsids prior to packaging of the DNA (Rixon et al., 1988; Sherman 
and Bachenheimer, 1988; Newcomb and Brown, 1989; Schrag et al., 1989; Newcomb 
and Brown, 1991). Type C capsids contain the viral DNA, since the scaffold proteins are 
lost after packaging, the polypeptide content of type C capsids is similar to that of the type 
A capsids (Gibson and Roizman, 1974; Rixon et al., 1988; Sherman and Bachenheimer, 
1988; Newcomb and Brown, 1989).
The tegument lies between the capsid and envelope and often appears variable in 
size and shape upon examination under the electron microscope, however, the variable 
appearance may be a product of sample preparation (Rixon, 1993). The tegument is 
probably not as chaotic as was previously thought, since specific interactions of various 
tegument components have recently been uncovered (Smibert et al., 1994; Elliott et al., 
1995). The tegument contains many viral factors whose direct introduction into the cell by 
virus-cell fusion facilitates the process of infection. Examples include Vmw65 (Ace et al., 
1988, 1989), the virion host shutoff factor (Kwong et al., 1988), and possibly the IE 
proteins Vmwl75 and VmwllO (Yao and Courtney, 1989, 1992; Yang and Courtney, 
1995). There are probably many other viral gene products in the tegument which are 
nonessential but play important qualitative roles in replication, examples of which include 
protein kinases (Coulter e t a l ,  1993). Vmw65 plays an important qualitative role in 
stimulating IE transcription and also has an essential structural role (Ace et al ,  1988, 
1989; Weinheimer et al., 1992).
At least 11 virally-encoded glycoproteins reside in the virion envelope (Spear,
1993). The glycoproteins are involved in adsorption, penetration, membrane fusion, 
envelopment, prevention of superinfection and egress. In addition, the glycoproteins are 
important targets for the immune response. Three glycoproteins, gB, gD and gH are 
indispensable for growth in tissue culture. It is likely that the glycoproteins function in 
envelopment by specifically interacting with virus tegument proteins (Zhu and Courtney,
1994).
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1.2. THE LYTIC CYCLE OF HSV.
1.2.1. Early stages of infection.
The early stages of HSV infection can be summarised as follows (Roizman and 
Sears, 1993; Spear, 1993). The HSV virion binds to a specific receptor on the cell 
surface. Binding is followed by fusion of the viral membrane with the cell plasma 
envelope, thereby releasing the contents of the tegument and the nucleocapsid containing 
the DNA into the cytoplasm. The virion core migrates to the nucleus where the viral 
genome is released into a nuclear pore. Components of the tegument play an important 
qualitative role in modifying the cell and in stimulating viral gene expression, thus 
enabling efficient viral replication.
Attachment occurs by specific binding of the virion glycoproteins to receptors on 
the cell surface (Spear, 1993). There are 11 HSV-1 glycoproteins (gB, gC, gD, gE, gG, 
gH, gl, gJ, gK, gL and gM), of which 6 are dispensable for infection of most tissue 
culture cells (gC, gE, gG, gl, gJ and gM). A characteristic feature of HSV attachment is 
that several glycoprotein-receptor interactions can be utilised in tissue culture. A possible 
reason for the redundancy of the majority of the viral glycoproteins in tissue culture is that 
HSV encounters a wide range of cell types in vivo, some of which are highly polarised 
and might express only a limited subset of HSV receptors, thus the glycoproteins 
dispensable in tissue culture might be crucial for infection of particular cell types in vivo 
(Roizman and Sears, 1993).
Heparin sulphate has been identified as a major cellular receptor for HSV-1 by 
interacting with the viral gC, however weak binding is still observed with gC mutants. 
Binding via heparin can also occur in the absence of gC by at least one other glycoprotein, 
gB.
Penetration involves fusion of the viral and cellular surface membranes. Viral 
glycoproteins gB, gD and gH are essential for the fusion process (Spear, 1991). Once 
inside the cytoplasm, the viral core containing the DNA is transported to the nucleus by 
the cellular cytoskeleton (Kristensson et al., 1986).
Very little is known about the molecular events involved in uncoating and release of 
the viral genome into the nuclear pore. The major tegument protein Vmw273 plays an 
essential role in uncoating, since the uncoating mutation in the strain HFEM mutant tsB l 
maps to this protein (Batterson et al., 1983). In cells infected with tsB l at the non- 
permissive temperature (NPT), DNA-containing nucleocapsids can be observed 
accumulating at the nuclear pores and when the cells are shifted to a permissive 
temperature the DNA is extruded from the nucleocapsids into the nuclei.
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Once released into the nucleus, the viral genome is converted to a nonlinear form by 
pre-existing factors (Poffenberger and Roizman, 1985).
1.2.2. Regulation of viral gene expression.
Since the initial sequence analysis of the HSV-1 genome, several further open 
reading frames (ORFs) have been identified. Thus the total number of known HSV-1 
genes is well in excess of 70 and gradually increasing (table 1.1.; figure 1.4.). HSV 
genes are transcribed by the host RNA polymerase II in discrete subnuclear compartments 
(Roizman and Sears, 1993; Rice et al., 1994). Recent data suggests that the large subunit 
of RNA polymerase II exhibits an unusual pattern of phosphorylation in HSV infected 
cells (Rice et al., 1994), and that Vmw68 is required for this modification (Rice et a l, 
1995). The significance of RNA pol II phosphorylation in the regulation of HSV gene 
expression has yet to be determined, however it is important to note that Vmw68 is 
required for the normal viral transcription pattern (Rice et al., 1995). HSV transcripts are 
similar to those of the host, thus they are capped at the 5' end, polyadenylated at the 3' 
end, and methylated internally. Only 5 HSV transcription units are known to yield spliced 
products, namely DEI (encoding VmwllO), IE4 (Vmw68), IE5 (Vmwl2), Ul15 and the 
latency-associated transcript (LAT). Translation of viral mRNA takes place in the 
cytoplasm.
HSV gene expression is regulated temporally via cw-acting regulatory sequences in 
the 5' proximal regions of the genes and also by 3'-end mRNA processing (Roizman and 
Sears, 1993; Beers et a l, 1994). On the basis of their time of transcription, dependence 
upon viral regulatory proteins and viral DNA replication, the HSV genes are divided into 
three major classes: immediate early (IE), early (E) and late (L).
The 5 IE genes are the first viral genes to be transcribed. IE transcription is 
stimulated by pre-existing factors, thus they are the only genes expressed in the presence 
of inhibitors of protein synthesis. With the exception of Vmwl2, the IE genes are 
regulators of subsequent viral gene expression. The IE proteins Vmwl75, Vmwl 10 and 
Vmw63 perform an autoregulatory function by downregulating IE gene expression.
The E genes are dependent upon the IE genes for their expression but do not require 
viral DNA replication. The E gene products are predominantly involved in nucleic acid 
metabolism and DNA synthesis; examples include thymidine kinase (TK), ribonucleotide 
reductase, deoxyuridine triphosphatase (dUTPase) and the DNA polymerase.
The L genes can be divided into 2 groups, Li genes are only partially inhibited by 
inhibitors of viral DNA synthesis (examples are gB, gD and ICP34.5) whereas L2 genes 
are wholly dependent on DNA synthesis (gC, for example). The L proteins are mainly 
virion structural proteins or factors involved in virion formation.
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Table 1.1. Designation, function and status of HSV-1 strain  17 genes. Genes 
marked in bold and underlined are conserved in all 3 herpesvirus subfamilies. The 
positions of the origins of replication are shown, as are the nucleotide positions of the 
genomic segments and central a sequence. The status of each gene in cell culture is 
indicated as follows: E = essential; NE= non-essential; E? = probably essential; NE? = 
probably nonessential; (E) = mutants are viable but severely disabled; E/NE = essential 
under certain conditions. Compiled by A J. Davison and C.A. MacLean.
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GENE FUNCTION OF PROTEIN STATUS
RL1 Neurovirulence factor (ICP34.5) NE
RL2 (3 exons) IE protein; regulator of gene expression (VmwllO, ICPO) NE
LAT Latency-associated transcript; probably not protein coding NE
(UL starts at 9213)
UL1 Glycoprotein L; complexes with glycoprotein H (UL22) E
UL2 Uracil-DNA glycosylase NE
UL3 Function unknown NE
UL4 Function unknown NE
UL5 Component of DNA helicase-primase complex; possesses E
helicase motifs
UL6 Minor capsid protein E
UL7 Function unknown E?
UL8 Component of DNA helicase-primase complex E
UL9 Ori-binding protein essential for DNA replication E
UL10 Virion surface glycoprotein M NE
UL11 Myrisylated tegument protein; role in virion envelopment NE
UL12 Deoxyribonuclease; role in maturation /  packaging of DNA (E)
UL13 Tegument protein; probable protein kinase NE
UL14 Function unknown E
UL15 (2 exons) Role in DNA packaging; putative terminase component E
UL16 Function unknown NE
UL17 Function unknown E
UL18 Capsid protein (VP23); component of intercapsomeric E
triplex
UL19 Major capsid protein (VP5); forms hexons and pen tons E
UL20 Integral membrane protein; role in egress of nascent E/NE
virions; host range phenotype; syn locus 
UL21 tegument protein NE
ITT.22 Virion surface glycoprotein H; complexes with E
glycoprotein L (UL1); role in cell entry 
UL23 Thymidine kinase NE
UL24 Function unknown; syn locus NE
IJT.25 Capsid-associated tegument protein E
UL26 Protease; acts in virion maturation; N-terminal portion is E
capsid protein (VP24)
UL26.5 Internal protein of immature capsids (VP22a); processed (E)
by UL26 protease
UL27 Virion surface glycoprotein B; role in cell entry; syn locus E
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UL28 Role in DNA packaging E
UL29 Single-stranded DNA-binding protein E
(centre of oriL is at 62473 /  62474)
UL30 Catalytic subunit of replicative DNA polymerase; E
complexes with UL42 protein 
UL31 Function unknown E
UL32 Function unknown E?
UL33 Role in DNA packaging E
UL34 Membrane-associated phosphoprotein; substrate for US3 E?
protein kinase
UL35 Capsid protein (VP26); located on tips of hexons E?
UL36 Very large tegument protein; role in uncoating E
UL37 Tegument protein E?
UL38 Capsid protein (VP19c); component of intercapsomeric E
triplex
UL39 Ribonucleotide reductase large subunit (Vmwl36, ICP6, E/NE
RI)
UL40 Ribonucleotide reductase small subunit (Vmw38, R2) E/NE
UL41 Tegument protein; host-shutoff factor NE
UL42 Subunit of replicative DNA polymerase; increases E
processivity; complexes with UL30 protein 
UL43 Function unknown; probable integral membrane protein NE
UL44 Virion surface glycoprotein C; role in cell entry NE
UL45 Tegument /  envelope protein NE
UL46 Tegument protein; modulates IE transactivation by UL48 NE
protein
UL47 Tegument protein; modulates IE transactivation by UL48 NE
protein
UL48 Tegument protein; transactivates IE genes (Vmw65, E
VP16, a-TIF)
UL49 Tegument protein NE?
UL49A Envelope protein disulphide-linked to tegument NE?
UL50 Deoxyuridine triphosphatase NE
UL51 Function unknown (E)
UL52 Component of DNA helicase primase complex E
UL53 Glycoprotein K (E)
UL54 IE protein; post-transcriptional regulator of gene E
expression (Vmw63, ICP27)
UL55 Function unknown NE
UL56 Function unknown NE
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(IRL starts at 117158)
LAT Latency-associated transcript; probably not protein NE
coding
RL2 (3 exons) IE protein; regulator of gene expression (VmwllO, ICPO) NE
RL1 Neurovirulence factor (ICP34.5) NE
(Left hand of a sequence is at 125970)
(Internal c sequence starts at 126371)
RSI IE protein; transcriptional regulator (Vmwl 75, ICP4) E
(Centre of oriS is at 131997)
(US starts at 132603)
US1 IE protein; required for virally-induced phosphorylation E/NE
of RNA pol II; host range phenotype (Vmw68, ICP22)
US2 Function unknown NE
US3 Protein kinase; phosphorylates UL34 protein NE
US4 Virion surface glycoprotein G NE
US5 Proposed glycoprotein J NE
US6 Virion surface glycoprotein D; role in cell entry E
US7 Virion surfacer glycoprotein I; complexed with NE
glycoprotein E (US8) in Fc receptor 
US8 Virion surface glycoprotein E; complexed with NE
glycoprotein I (US7) in Fc receptor 
US8A Function unknown NE
US9 Tegument protein NE
US10 Virion protein NE
US11 Virion protein; ribosome-associated in infected cells NE
US12 IE protein, interferes vith antigen presentation (Vmwl2, ICP47) NE
(TRS starts at 145583)
(Centre of oriS is at 146233)
RSI IE protein; transcriptional regulator (Vmwl75, ICP4) E
(Last nucleotide is 152259)
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Figure 1.4. HSV-1 gene organisation. The genome is divided into 6 panels 25 
kbp long, with the exception of the 6th panel which is longer. The repeat segments are 
depicted as wider than the unique segments. Protein coding regions are represented by 
shaded horizontal arrows with the direction of transcription indicated by the direction of 
the arrow. LAT transcription is indicated by a plain horizontal arrow. The vertical 
arrows show the positions of polyadenylation sites within the appropriate strand. The 
positions of the 3 replication origins are also depicted. Adapted from Davison (1993).
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I.2.2.I. Regulation of IE transcription.
The HSV IE genes are defined as the only viral genes transcribed in the presence of 
cycloheximide (Everett, 1987). It follows that IE transcription is regulated by pre-existing 
viral and cellular factors rather than by viral transactivator proteins synthesised de novo 
after infection, as are the E and L genes. Another crucial characteristic of the IE genes is 
their ability to be transactivated by the tegument protein Vmw65 (O’Hare, 1993; Spector 
et a l , 1993). After fusion of the viral particle with the cell, Vmw65 is transported to the 
nucleus where it complexes with 2 cellular factors, thereby forming the IE transactivation 
complex (IETC). IETC binds c/s-acting sequences upstream of all of the viral IE genes. 
Once IETC is bound to DNA, the acidic carboxy-terminal domain of Vmw65 increases 
the rate of transcription by interacting with components of the basal transcriptional 
apparatus assembled around the TATA-box.
In early studies it was observed that infection of cell lines stably transfected with the 
Vmwl75 promoter controlling the TK gene led to a stimulation of TK expression, even in 
the presence of cycloheximide (Post et al,  1981). The ability of UV-inactivated virus to 
induce TK expression and the ability of the temperature sensitive uncoating mutant tsBl 
to induce TK at the NPT strongly indicated that components of the virus particles were 
stimulating gene expression (Batterson and Roizman, 1983; Batterson et al,  1983). The 
consensus dy-acting sequence necessary for induction by the virion factor was identified 
as TAATGARAT (where R is a purine; Mackem and Roizman, 1982a, b, c; Kristie and 
Roizman, 1984; Preston et al,  1984; Gaffney et a l,  1985; Bzik and Preston, 1986; 
O’Hare and Goding, 1988; Preston et a l,  1988). In addition to the TAATGARAT 
elements, G+C-rich elements responsible for the basal levels of IE transcription were 
identified (Kristie and Roizman, 1984). The G+C-rich elements are binding sites for the 
transcription factor Spl.
The ORF which encodes the protein capable of stimulating IE transcription was 
identified by cotransfecting an IE-TK construct with HSV DNA fragments (Campbell et 
al ,  1984). The virion transactivator protein is the gene product of U l4 8 , named Vmw65 
(Dalrymple et al,  1985; Pellett et al,  1985). Vmw65 is present in the virion tegument at 
an abundance of about 500-1000 copies per virion (Spear and Roizman, 1972; Heine et 
a l ,  1974).
It was apparent that Vmw65 transactivated IE genes via a complex with cellular 
factors (McKnight et al.,. 1987; Gerster and Roeder, 1988; O’Hare et a l ,  1988; O’Hare 
and Goding, 1988; Preston et al,  1988; Triezenberg et al,  1988; Spector et al,  1990). 
The cellular factor Oct-1 and another previously unknown cell factor termed host cell 
factor (HCF) are essential components of IETC.
Oct-1 is a homeobox protein which interacts with the octamer elements upstream of 
many ubiquitously expressed genes involved in morphology, polarity and differentiation,
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the consensus octamer element being ATGCAAAT (Herr, 1992). Binding sites for Oct-1 
are also found in the immunoglobulin promoters and promoters of other viruses such as 
SV40, adenovirus and the IE promoters of most other alphaherpesviruses. The 
transcription factor Oct-2 is expressed in B-lymphocytes and activates transcription via the 
octamer elements upstream of the immunoglobulin genes, however Oct-2 is incapable of 
forming a complex with Vmw65 (Stem et a l, 1989). Oct-1 and Oct-2 belong to a family 
of homeobox proteins termed POU proteins, which share a 150-160 amino acid sequence 
called the POU domain. The POU domain can be divided into 2 subdomains, the POU- 
homeo subdomain and the POU-specific subdomain. The POU-homeo subdomain 
contacts the TAAT portion of the octamer element. The POU-homeo subdomain is 
important for DNA binding and for complex assembly with Vmw65. The POU-specific 
subdomain has no intrinsic DNA binding activity, but when linked to the POU-homeo 
subdomain contacts ATGC in the octamer element and provides sequence specificity. The 
GARAT motif is not necessary for Oct-1 to bind to DNA by itself. However, since 
GARAT is very highly conserved in the HSV IE gene promoters it seems probable that 
Vmw65 makes contact with GARAT when in IETC, but that binding is extremely weak in 
the absence of Oct-1 and HCF. Evidence for Vmw65 binding to DNA has been reported 
(Kristie and Sharp, 1990; Stem and Herr, 1991). Oct-1 binding to the HSV IE gene 
promoters alone has only a small effect on transcription (O’Hare and Goding, 1988), thus 
the Vmw65 component of IETC is crucial for stimulating transcription.
Several lines of evidence have implied that the highly acidic carboxy-terminal 
domain of Vmw65 is the region of IETC important for stimulating transcription. (1) 
When the carboxy-terminal domain of Vmw65 was fused to the DNA-binding domain of 
the yeast transcription factor GAL4, an extremely potent activator was produced 
(Sadowski et al., 1988). (2) A Vmw65 protein lacking the carboxy-terminal domain was 
capable of complex formation but not of transactivation (Greaves and O’Hare, 1989). (3) 
The carboxy-terminal domain of Vmw65 interacts specifically with components of the 
basal transcription initiation apparatus (Stringer etal., 1990; Lin and Green, 1991; Walker 
et al., 1993). (4) The acidic domain has amino acid sequence similarities to other 
transcriptional activators (Cress and Triezenberg, 1991).
The third component of the IETC, HCF, was previously unidentified and has 
therefore only been investigated relatively recently. HCF is unable to bind the octamer 
element, but binds to Vmw65. The HCF-Vmw65 complex can only bind to Oct-1 which 
is already bound to DNA, thus the sequential order of complex formation has been 
determined. The initial step is Oct-1 binding to the octamer elements upstream of the viral 
IE genes, Vmw65 complexed with HCF then associates with the DNA-bound Oct-1, 
thereby forming IETC. A cDNA encoding HCF has been cloned (Wilson et al., 1993), 
and it is encoded by a single gene located on the X chromosome (Wilson et al., 1995a). 
The function of HCF in uninfected cells is unknown and the protein shows no homology
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to any other protein. When the cDNA is expressed in human cells the resulting products 
comprise a series of proteins with molecular weights ranging from 110-300 kDa, thus it 
appears that the smaller products arise by processing of the larger 300 kDa protein. The 
HCF amino acid sequence reveals a highly conserved 26-amino acid sequence repeated 6 
times in the HCF precursor protein. The repeat alone is sufficient to induce cleavage of a 
heterologous protein (Wilson e t a l , 1995b). Alternative splicing of the HCF mRNA and 
cleavage of the precursor protein is likely to be important for regulation of HCF activity. 
HCF is expressed most abundantly in foetal and placental tissues and in tissue culture 
cells, suggesting that it has a role in cell proliferation (Wilson et a l , 1995b). In adults 
HCF is most abundant in the kidney, however it is not abundant in the brain, a site of 
HSV latency.
The finding that the HSV IE genes are dependent upon viral and cellular factors for 
high levels of expression has raised important questions as to the role of Vmw65, octamer 
binding proteins and HCF in the HSV life cycle, latency in particular. Since it seems 
likely that insufficient IE gene expression leads to latency, loss of Vmw65, lack of HCF 
or Oct-1, or the binding of transcriptional repressors to the octamer elements upstream of 
the HSV IE genes are all possible determinants of the outcome of HSV infection (section 
1.3.5.).
The construction of the HSV-1 mutant ml814, which has a 4 amino-acid insertion 
in Vmw65 rendering it unable to interact with other components of IETC and thereby 
unable to transactivate IE genes, has enabled an assessment of the role of Vmw65 in the 
virus life cycle to be made (Ace et al ,  1988, 1989). The insertion in ml814 leads to an 
approximately 10-fold reduction in viral IE gene expression (Ace et al., 1989). In tissue 
culture, ml814 is impaired in its ability to initiate plaque formation at low multiplicities of 
infection (MOIs), resulting in a high particle / PFU ratio. Preston and co-workers have 
undertaken to investigate the genomes which do not undergo replication in the belief that 
they enter a latent state at least partially resembling that in vivo (Harris and Preston, 1991; 
Jamieson et al., 1995). At high MOIs, the defect in ml814 is overcome and replication 
ensues normally, presumably due to residual IE gene expression. 7«1814 replicates with 
reduced efficiency in vivo but establishes latency and reactivates normally (Steiner et al,  
1990; Ecob-Prince et al., 1993a), thus both in vivo and in vitro, loss of IETC results in 
an increased propensity to establish a latent rather than lytic infection.
1.2.2.2. The IE proteins.
There are 5 HSV IE proteins, namely Vmwl75 (encoded by IE3, named ICP4 in 
American terminology), VmwllO (IE1, ICP0), Vmw63 (IE2, ICP27), Vmw68 (IE4, 
ICP22) and Vmwl2 (IE5, ICP47).
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V m w l7 5 .
Vmwl75 is an essential viral polypeptide required for expression of the E genes and 
repression of the IE genes, thus it is capable of transactivation or repressing RNA 
polymerase II-mediated transcription. The essential regulatory function of Vmwl75 is 
clearly demonstrated by the HSV-1 mutant taK which overproduces IE polypeptides at the 
NPT and is unable to enter into the E phase of lytic infection (Preston, 1979a, 1979b). 
Mutant taK has a single amino acid substitution in the DNA-binding domain of Vmwl75 
which completely abolishes transactivation activity at the NPT (Davison et al., 1984).
The mechanism by which Vmwl75 activates or represses transcription involves 
binding to DNA (Faber and Wilcox, 1986; Kristie and Roizman, 1986; Everett et al., 
1991a; Pizer et al,  1991). The consensus sequence for binding is RTCGTCNNYNYSG 
(where R is a purine, Y is a pyrimidine, S is C or G and N is any base; Faber and 
Wilcox, 1986; DiDonato et al., 1991; Everett et al,  1991a; Pizer et al., 1991), however 
this sequence is highly degenerate and nonspecific interactions with DNA suffice for 
transcriptional activation (Smiley etal., 1992; Gu andDeLuca, 1994). Site-specific DNA 
binding near the transcription initiation site is required for repression, however (Roberts 
et al., 1988; Gu eta l ,  1993; Michael and Roizman, 1993).
Vmwl75 is a target for phosphorylation and ADP-ribosylation (Preston and 
Notarianni, 1983; Xia et al., 1996). It has been demonstrated that different electrophoretic 
forms of Vmwl75 differ in the ability to bind to DNA (Michaeli et al,  1988) and possibly 
in the ability to form cell factor-DNA complexes (Papavassiliou et al,  1991). In infected 
cells, Vmwl75 normally exists as a 350 kDa dimer (Metzler and Wilcox, 1985; Shepard 
etal.,  1990).
The genes repressed by Vmwl75 include LAT (Batchelor and O’Hare, 1994), 
ORF-P (Bohenzky et al., 1993; Yeh and Shaffer, 1993; Lagunoff and Roizman, 1994,
1995) and IE3 itself (DeLuca and Schaffer, 1985; O’Hare and Hayward, 1985b). 
Removal of the Vmwl75 binding site induces changes in the pattern of expression of the 
gene, such as expression earlier during infection and loss of dependence on DNA 
synthesis (Koop e ta l ,  1993; Rivera-Gonzalez e ta l ,  1994).
Vmwl75 acts in concert with, and physically interacts with Vmwl 10 to stimulate 
transcription (Everett, 1984b; Yao and Shaffer, 1994). In addition, Vmwl75 activity is 
modulated by Vmw63 since Vmwl75 synthesised in the absence of Vmw63 is impaired 
in its ability to repress transcription from the ORF-P promoter and exhibits impaired 
ability to bind to DNA (Samaniego et al,  1995). The distribution of Vmwl75 within the 
infected cell is also altered by Vmw63 (Zhu and Schaffer, 1995), thus there is mounting 
evidence that the IE proteins act synergistically and regulate one-another’s activity.
Vmwl75 on the IE3 binding site forms a complex with the TATA-binding protein 
(TBP) and TFIIB, suggesting that this complex is responsible for repression of
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transcription (Smith et al., 1993; Kuddus et al., 1995). The mechanism by which the 
tripartite complex inhibits transcription has yet to be determined.
VmwllO.
DEI, the gene encoding Vmwl 10, is located entirely within the R l regions of the 
genome and is therefore diploid (Perry et al., 1986). Unusually for an HSV gene, IE1 
contains 2 introns. A virus devoid of both introns has been constructed but a resulting 
phenotype has not yet been demonstrated (Everett, 1991; Natarajan et al., 1991), thus a 
function of Vmwl 10 mRNA splicing has never been demonstrated.
Vmwl 10 is a nuclear phosphoprotein which binds to calf-thymus DNA-cellulose 
columns in crude nuclear extracts (Pereira et al., 1977; Hay and Hay, 1980; Ackerman et 
al., 1984; Everett et al,  1991b). A crucial feature of VmwllO is that it is capable of 
transactivating all of the 3 classes of HSV genes, and also many cellular genes (Everett, 
1984b, 1986, 1988; Gelman and Silverstein, 1985; O’Hare and Hayward, 1985a, b; 
Quinlan and Knipe, 1985; Gelman and Silverstein, 1986; Cai and Schaffer, 1989, 1992; 
Jang et al., 1991). Vmwl 10 and Vmwl75 act synergistically to activate the E and L viral 
genes (Everett, 1984b, 1986, 1988; O’Hare and Hayward, 1985a, b; Gelman and 
Silverstein, 1986). The synergistic action of Vmwl 10 and Vmwl75 might be via a direct 
interaction of the two proteins (Yao and Schaffer, 1994).
Although not essential for virus replication, VmwllO mutants exhibit increased 
particle / PFU ratios after infection of tissue culture cells at low MOI (Everett, 1986; Stow 
and Stow, 1986, 1989). In addition to its replication-enhancing function, Vmwl 10 is the 
sole requirement for reactivation of HSV in in vitro latency systems (Russell and Preston, 
1986; Harris et al., 1989; Harris and Preston, 1991). Mutants of VmwllO are also 
impaired in their ability to reactivate from latency in animal models (Clements and Stow, 
1989; Leib et al,  1989; Cai et al., 1993), thus in addition to facilitating replication, 
Vmwl 10 plays a specific qualitative role in reactivation from latency. The observation that 
VmwllO mutants are capable of reactivation, albeit at reduced efficiency, and that 
Vmwl 10 mutants replicate with similar abilities to wild type virus in the U20S cell line 
(Yao and Schaffer, 1995), suggests that cell factors can substitute functionally for the 
Vmwl 10 reactivation function.
VmwllO belongs to a class of viral and cellular proteins which contain a 
characteristic C3HC4 arrangement of cysteines and histidines which binds zinc ions, the 
‘RING’ finger. The RING finger is essential for the full function of Vmwl 10 (Everett, 
1986, 1988, 1989; Harris et al., 1989; Everett et al., 1995a). All of the 
alphaherpes viruses examined to date encode a protein containing the RING finger motif, 
and a few of them have been demonstrated to be interchangeable between viruses
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(Moriuchi et a l, 1994; Everett et a l, 1995b). The exact function or mechanism of action 
of the RING finger is unknown.
Vmwl 10 binds strongly and specifically to a 135 kDa cellular protein in infected 
cells (Meredith et a l, 1994, 1995). Micro-sequencing of peptides from the 135 kDa 
protein, followed by hybridisation screening of cDNA librarys with ‘guessmer’ probes 
derived from the amino acid sequence, has recently enabled cloning of the entire cDNA 
encoding the 135 kDa protein (R.D. Everett and M.R. Meredith, unpublished data). The 
135 kDa protein has 2 regions of homology to the ubiquitin-specific protease family of 
enzymes, a family of proteases which de-ubiquitinise proteins. The precise role of the 135 
kDa protein in virus infection has yet to be determined, however it is possible that by 
interating with the 135 kDa protein, Vmwl 10 inactivates a protein whose normal function 
is to remove ubiquitin from a protein targeted for proteolysis. The function of the 135 kDa 
protein might also be related to the interaction of Vmwl 10 with ND10 domains (section 
1.3.8.4.). Identification of the targets of the 135 kDa protein should facilitate our 
understanding of the role of Vmwl 10 in virus infection.
Vm w63.
Vmw63 is an essential regulatory protein which is required for the switch from E to 
L viral gene expression and for efficient DNA replication (Sacks et a l, 1985; Sekulovich 
et a l, 1988; McCarthy et a l, 1989; Su and Knipe, 1989; McMahan and Schaffer, 1990; 
Rice and Knipe, 1990; Curtin and Knipe, 1993). Vmw63 acts synergistically with 
Vmwl75 and Vmwl 10 to stimulate or repress gene expression (Everett, 1986; Rice and 
Knipe, 1988; Sekulovich et a l, 1988; Hardwicke et a l, 1989; Su and Knipe, 1989), but 
has also been demonstrated to be capable of transactivating the gB promoter in the 
absence of other viral gene products and therefore possesses some transactivation 
capability by itself (Rice and Knipe, 1988).
A crucial activity of Vmw63 is its effects on mRNA 3' processing and stability. 
Vmw63 is responsible for the selective usage of L viral poly(A) sites in infected cells 
(McLauchlan et a l, 1989, 1992). In addition, it has been demonstrated that Vmw63 
stabilises labile cellular mRNAs by a mechanism that is dependent on the 3' end 
processing and poly (A) signals (Mosca et a l, 1987, 1992; Brown et a l,  1995). The 
observation that Vmw63 is capable of binding to the 3' mRNA processing signals of 
labile mRNAs (Brown e ta l,  1995), suggests that Vmw63 modulates gene expression by 
selectively targeting and stabilising mRNA.
Vmw63 is believed to contribute to the overall shutoff of host gene expression by 
virtue of its ability to inhibit pre-mRNA splicing. Since spliced genes are widespread in 
the cell genome but scarce in the HSV genome, the inhibition of splicing by Vmw63
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might enable the selective expression of viral RNA over host RNA. HSV infection leads 
to inhibition of host cell splicing (Schroder et a l , 1989; Sandri-Goldin and Mendoza, 
1992; Hardwicke and Sandri-Goldin, 1994; Hardy and Sandri-Goldin, 1994). In 
addition, infection with wild type virus but not Vmw63 mutants leads to the redistribution 
of components of the spliceosome termed small nuclear ribonucleoprotein particles 
(snRNPs), from their diffuse speckled pattern in the nuclei of uninfected cells to discrete 
clusters on the nuclear periphery (Martin et al., 1987; Phelan et a l , 1993). Vmw63 is 
required for the inhibition of host cell splicing and localises in the redistributed snRNP- 
containing nuclear structures (Sandri-Goldin and Mendoza, 1992; Phelan et al., 1993; 
Hardy and Sandri-Goldin, 1994), thus it was proposed that the redistribution of snRNPs 
by Vmw63 is related to the inhibition of host cell splicing during HSV infection. In a 
recent study a ts viral Vmw63 mutant was observed to redistribute snRNPs without 
inhibiting host cell splicing (Sandri-Goldin e ta l ,  1995), thus redistribution of snRNPs is 
not sufficient for inhibition of splicing per se and another Vmw63-induced function is 
required.
V m w 68.
Vmw68 is a nuclear protein which is phosphorylated by the Ul13 gene product in 
infected cells (Purves etal., 1992, 1993). Vmw68 mutants are highly attenuated in vivo 
(Meingner et al., 1988; Poffenberger et al., 1994), and exhibit cell-type dependent defects 
in tissue culture (Sears eta l ,  1985; Poffenberger etal., 1993; Rice etal. , 1995). Vmw68 
mutants grow well in Vero cells, but in nonpermissive cell types such as human foetal 
lung (HFL) cells expression of the E proteins is delayed and expression of the L proteins 
is delayed and reduced, whereas DNA replication is unaffected.
In a recent study it was demonstrated that Vmw68 is required for the accumulation 
of an unusually phosphorylated form of the RNA pol II large subunit (RNAPII), named 
Hi (Rice et al., 1995). It is possible that Hi has altered promoter specificity that is crucial 
for transcriptional regulation HSV genes. In HFL cells infected with Vmw68-  mutants 
transcription of the L genes is greatly reduced, however the viral transcription pattern in 
Vero cells infected with Vmw68-  mutants is normal even though Hi is not produced, thus 
it appears that the requirement for Hi is dependent upon other host cell factors.
V m w l 2.
Unlike the other HSV IE proteins, Vmwl2 is located in the cytoplasm of infected 
cells and is not phosphorylated (Preston, 1979b; Hay and Hay, 1980; Marsden et al.,
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1982). Virus mutants defective in Vmwl2 grow normally in tissue culture (Mavromaro- 
Nazos et a l, 1986), suggesting that Vmwl2 plays a specific role in pathogenesis in vivo. 
Consistent with a role for Vmwl2 in vivo, it was recently reported that Vmwl2 prevents 
antigen presentation to CD8+ T-lymphocytes (York et a l, 1994).
1.2.2.3. Regulation of earlv gene expression.
Early studies on the regulation of E gene promoters employed the use of 
transformed cells stably transfected with the HSV TK gene controlled by its native 5' 
promoter sequences (Everett, 1987). TK was expressed at low levels in the cell genome, 
but was strongly stimulated upon infection with HSV by a mechanism which involved the 
IE proteins (Leiden e ta l,  1976), especially Vmwl75 (Kit e ta l,  1978). Expression from 
the 8-globin promoter controlling TK was also stimulated by HSV, thus the stimulation 
also appeared to act on non-viral promoters (Everett, 1985). Microinjection of various 
deletion constructs of the TK promoter gene into Xenopus oocytes was subsequently 
used to identify the regulatory sequences important for TK activity. A 110 bp region 
upstream of the TK mRNA cap site, consisting of a TATA box, a CAAT motif and two 
Spl binding sites were important for full TK expression (McKnight et a l,  1981; 
McKnight and Kingsbury, 1982; Jones et a l, 1985). The use of transient transfection 
techniques were employed to examine the regions of the gD promoter sufficient for full 
induction by the HSV IE genes. Two Spl sites and a TATA box were identified in an 83 
bp region of the gD promoter necessary for full activity, however no single region was 
demonstrated as crucial for inducibility (Everett, 1983, 1984). The validity of the 
transfection experiments was confirmed by the construction of viruses with modified TK 
promoters. The TK gene was regulated with similar characteristics in the context of the 
viral genome as it was after transfection (Coen et a l, 1986). Thus Vmwl75 is essential 
for activation of the E genes (Everett, 1983; O’Hare and Hayward, 1984; Eisenberg et a l, 
1985; ElKareh et a l, 1985), and in addition VmwllO is also capable of apparently 
nonspecific activation (Everett, 1984b; Gelman and Silverstein, 1985; O’Hare and 
Hayward, 1985a; Quinlan and Knipe, 1985). Some investigators have reported that 
Vmwl75 and VmwllO are capable of efficient activation by themselves (Gelman and 
Silverstein, 1985; O’Hare and Hayward, 1985), while in other studies Vmwl75 and 
Vmwl 10 exhibited low activity by themselves, but acted synergistically to give strong 
activation when together (Everett, 1984b, 1986).
18
Introduction
I.2.2.4. Regulation of late gene expression.
The L genes of HSV encode components of the virion, and factors required for 
virion assembly, DNA packaging and egress. The L genes can be divided into 2 classes 
depending upon their expression in the presence of inhibitors of viral DNA synthesis: 
leaky L genes (Li) are expressed at low levels in the presence of inhibitors of viral DNA 
synthesis, whereas expression of the true L genes (L2) is undetectable in the absence of 
DNA synthesis (Spector etal., 1993).
Experiments in which the HSV TK gene was fused to the VP5 promoter (an Li 
gene; Dennis and Smiley, 1984) or Ul49.5 promoter (an L2 gene; Silver and Roizman, 
1985) and used to stably transfect TK-  cells demonstrated that basal expression of an L 
gene in the cell genome is lower than that of an E gene (the TK promoter), and that like an 
E gene, the VP5 promoter is stimulated upon infection with TK-  HSV. However both of 
the viral L promoters were still expressed after infection with HSV in the presence of the 
viral DNA replication inhibitor phosphonoacetic acid (PAA), thus the L genes were 
regulated as E genes when in the cell genome (Silver and Roizman, 1985). Clearly L 
genes are regulated differently in the context of the viral genome than in the cell genome.
The mechanism of repression of the L genes prior to, and activation after the onset 
of DNA synthesis is unknown at present. Evidence has been reported which suggests that 
ICP8, the ssDNA binding protein essential for viral DNA synthesis, may be a negative 
regulator of L gene expression, since the ICP8 ts mutant KOS1.1 te l8 exhibited low level 
expression of the L2 gC gene at the NPT in the presence of inhibitors of DNA synthesis 
(Godowski and Knipe, 1985).
Like the E genes, the HSV L genes are not expressed in cells infected with ts 
Vmwl75 mutants at the NPT (Preston, 1979a). Vmwl 10 can transactivate all classes of 
genes, including L genes, in addition, the IE protein Vmw63 can activate an Li gene 
(VP5) in concert with Vmwl75 or Vmwl 10, but does not cause activation on its own and 
actually represses an L2 gene (gC), when expressed with Vmwl75 or VmwllO 
(Sekulovich eta l., 1988).
The L gene promoters are the simplest of all the classes of HSV genes, at a 
superficial level seeming to consist solely of a TATA-box (Johnson and Everett, 1986; 
Homa et al., 1988; Flanagan etal., 1991). However, the transcribed, untranslated leader 
sequences may contain elements necessary for high level expression (Mavromara-Nazos 
and Roizman, 1989; Godowski eta l., 1994). Godowski etal. identified an element 
common to the nontranslated leader sequences of many L genes which was capable of 
binding a 35 kDa cellular protein and conferring transcriptional activation (Godowski et 
a l,  1994).
Huang et al. observed a 40 kDa protein bind to the -6  to +8 region of the U l 19 
promoter (Huang et al., 1996), and Mills et al. have identified binding sites for the factor
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YY1 in the upstream regions of many Li genes (Mills et a l , 1994). Although the L gene 
promoters contain binding sites for cellular transcription factors, the mechanism by which 
the virus modulates expression of the L genes during viral replication remains unknown.
1.2.3. Alterations of host metabolism.
HSV infection is known to alter the host cellular metabolism in a number of ways. 
O verall shutoff of host gene expression.
Infection with HSV leads to the overall inhibition of cellular DNA, RNA and 
protein synthesis (Roizman et al., 1965; Fenwick, 1984). The ‘shutoff’ of cellular 
metabolism by HSV can been divided into 2 stages, that which is mediated by a virion 
component and occurs very early in infection (early shutoff), and that which is mediated 
by a viral protein synthesised de novo (delayed shutoff; Fenwick and Clarke, 1982). The 
observations that UV-irradiated virus induces the early shutoff of cellular protein 
synthesis (Fenwick and Walker, 1978; Fenwick and Clarke, 1982; Fenwick and 
McMenamin, 1984), and that the shutoff occurs when de novo viral gene expression is 
prevented by chemical inhibitors (Schek and Bachenheimer, 1985; Storm and Frenkel, 
1987), demonstrated that the early shutoff is caused by components of the virus particle. 
The virion host shutoff (vhs) function induces the degradation within the cytoplasm of 
host as well as viral mRNAs (Fenwick and McMenamin, 1984; Schek and Bachenheimer, 
1985; Storm and Frenkel, 1987), thereby causing rapid mRNA turnover and facilitating 
the changes in expression of the kinetic classes of viral genes. A functional Ul41 gene of 
HSV-1 is necessary for vhs activity (Kwong et al., 1988; Fenwick and Everett, 1990a, b; 
Smibert and Smiley, 1990; Read et al., 1993), and was demonstrated to be the only viral 
gene product required to induce the degradation of CAT mRNA expressed from a 
transfected reporter construct (Pak et a l , 1995).
Actinomycin D chase experiments in which the in vivo v/w-induced degradation of 
an mRNA was followed using RNase protection employing probes to protect 5' or 3' 
regions of the reporter mRNA demonstrated that the 5' portion was preferentially 
degraded (Karr and Read, abstract 202, 20th International Herpesvirus Workshop, 
Groningen, The Netherlands, 1995). Moreover, in an in vitro translation system vhs was 
demonstrated to induce a single endonucleolytic cleavage at one of several sites located 
30-60 nt from the 5' end of the mRNA, thus removing the 5' cap structure (Elgadi et a l , 
abstract 201, 20th International Herpesvirus Workshop, Groningen, The Netherlands,
1995). The cleavage event occurred much less efficiently on an uncapped RNA and was
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inhibited by cap analogues, indicating that the cap structure was important for vhs 
activity. Evidence was found to suggest that the cap-dependent cleavage event was a 
primary event in the degradation process, and that vhs also induces cleavage in the target 
RNA at apparently random sites by a cap-independent process. It remains to be 
determined whether the vhs factor has its own RNase activity or whether it functions via a 
cellular RNase.
The ULl3-encoded protein kinase contributes to mRNA instability in infected cells 
(Overton et al., 1994). Since phosphorylation of vhs was unaffected in lysates of virions 
from a Ul13 mutant, the Ul13 product does not appear to induce mRNA instability by 
phosphorylating vhs.
Vmw63 contributes to the shutoff of host gene expression by inhibiting the 
processing of pre-mRNAs (section 1.2.2.3.; Hardwicke and Sandri-Goldin, 1994).
Cellular genes activated bv HSV.
Although HSV infection causes the overall inhibition of cellular gene expression, 
the expression of a proportion of cellular genes remains unaffected and some are 
stimulated (Smiley et al., 1991). The cellular stress proteins are induced in response to 
HSV infection (Notarianni and Preston, 1982; LaThangue et al., 1984; Latchman et al., 
1987; Russell et al., 1987a). A comparison of the abilities of adenovirus 5, HSV-1, SV40 
and vaccinia virus to induce 3 species of the 70 kDa heat shock protein (hsp) family 
revealed that only adenovirus 5 and HSV-1 were capable of induction, and only one of 
the 70 kDa hsp ’s were induced, suggesting that the induction was not a general response 
to viral infection but was specific (Phillips etal., 1991). Induction of the 70 kDa hsp by 
HSV-1 was transient, and was followed by repression. It has been noted that temperature 
sensitive HSV-1 Vmwl75 mutants which overproduce IE proteins induce high levels of 
stress proteins at the NPT (Notarianni and Preston, 1982). An HSV-1 mutant encoding a 
truncated Vmwl75 failed to induce the stress response, therefore the abnormal form of 
Vmwl75 expressed by the ts mutants was responsible for the induction (Russell et al., 
1987a). The HSV IE proteins are capable of specifically inducing cellular genes, thus 
Vmwl75 induces ubiquitin B but not ubiquitin A or C (Latchman et al., 1987; Kemp and 
Latchman, 1988b), Vmwl 10 induces c-jun and the AP-1 transcription factor (Jang et al., 
1991), Vmw63 is required for the accumulation of a protein termed p40 which is 
expressed in transformed cells (Estridge et al., 1989). In addition to the IE proteins, 
Vmw65 is capable of transactivating cellular genes controlled by octamer elements which 
resemble a viral TAATGARAT regulatory sequence, for example the gene encoding the 
U3 snRNA is transactivated by Vmw65, but not the genes encoding the U l or U2 
snRNAs (Kemp and Latchman, 1988a; Latchman, 1991). Cellular gene induction can
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occur in the absence of protein synthesis (Kemp et al., 1986), not only via transinduction 
by Vmw65 but also by binding to a specific receptor on the cell surface (Preston, 1990).
The Alu repeats are the most abundant family of mobile short interspersed elements 
(SINEs) in the human genome. There are nearly 106 copies of the Alu repeats per 
genome, compromising approximately 5% of the total DNA, each repeat being 
approximately 300 nt in length. Alu elements transpose via an RNA intermediate 
transcribed by RNA pol ID, however, the majority are transcriptionally silent due to the 
absence of the necessary cis-acting regulatory sequences. RNA pol IE transcription of the 
Alu repeats is stimulated by infection with adenovirus 5 or HSV-1 (Jang and Latchman, 
1989; Panning and Smiley, 1994; 1995), thus activation of Alu transcription might be a 
normal cellular response to viral infection. Induction by HSV-1 requires de novo viral 
gene expression and occurs when transcription is limited to the IE genes (Panning and 
Smiley, 1994). Deletions which inactivated each of the five IE genes had no effect on Alu 
induction, therefore 2 or more HSV IE proteins suffice to stimulate Alu transcription. In 
contrast to a previous finding (Jang and Latchman, 1992), Vmw63 was not required for 
induction (Panning and Smiley, 1994). The exact mechanism of stimulation of Alu  
transcription is unknown, however transactivation might be due to the direct action of 
viral transactivators, alterations of cell chromatin or methylation, or alteration of the cell 
growth signalling pathways. The role of the Alu SINEs in the life cycle of both cells and 
virus is unknown, however, it has been reported that expression of Alu  elements 
transfected into HeLa cells inhibits proliferation (Sakamoto et al., 1991), hence it was 
suggested that one role of the Alu elements is to alter the cell cycle, reduce cell growth and 
limit viral replication (Panning and Smiley, 1995).
IC P 34 .5 .
Mutants of HSV-1 defective in ICP34.5 have an LD50 increased by approximately 
105-fold in rodents (Whitley et al., 1993). The requirement for ICP34.5 varies between 
cell types, but ICP34.5 is crucial for efficient replication in neurons, hence its importance 
in virulence. In human SK-N-SH neuroblastoma cells infected with ICP34.5-  mutants the 
onset of viral DNA replication triggers premature shutoff of protein synthesis and 
inhibition of viral replication, whereas wild type virus does not trigger the shutoff (Chou 
and Roizman, 1992). It was proposed that ICP34.5 functions by preventing the viral 
infection-induced stress response which leads to inhibition of protein synthesis. In non- 
neuronal cells such as Vero cells, premature shutoff is not induced by HSV infection and 
ICP34.5 is not required. The carboxy-terminal domain of ICP34.5 has homology to the 
carboxy-terminal domains of the murine protein MyDl 16, a protein expressed in myeloid 
leukaemia cells induced to differentiate by IL-6, and the hamster protein GADD34, which
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is expressed in response to growth arrest and DNA damage (Chou and Roizman, 1994). 
The carboxy-terminal domain of ICP34.5 is required to preclude the premature shutoff in 
infected cells, and the carboxy-terminal domain of the murine M y d ll6 protein can 
substitute functionally for its viral counterpart (Chou and Roizman, 1994; He et al.,
1996), thus ICP34.5 appears to mimic the action of Mydl 16.
The translation initiation factor eIF-2a is phosphorylated, and hence inactivated, in 
cells infected with ICP34.5-  mutants, in contrast to cells infected with wild type virus or 
mock-infected cells where it is not phosphorylated (Chou et al., 1995). In cells infected 
with ICP34.5-  mutants the dsRNA-dependent interferon (IFN)-induced protein kinase 
(PKR; section 1.5.) was found to associate with a 90 kDa protein, whereas in wild type 
infected cells association with the 90 kDa protein occurred only at very low levels. Since 
activated PKR shuts-off protein synthesis by phosphorylating eIF-2a, it was proposed 
that in the absence of ICP34.5, PKR complexes with p90 and shuts-off protein synthesis 
by phosphorylating eIF-2a.
Modification of RNA polymerase II.
Infection with HSV leads to an unusually phosphorylated form of the RNA pol II 
large subunit (RNAPII) and its recruitment to subnuclear viral replication compartments 
(Rice et al., 1994). It was suggested that the unusually phosphorylated form of RNAP II 
could account for the differences between regulation of genes in the cell genome and in 
the context of the viral genome. Thus, a cellular gene is inactive when in the cell genome 
during viral infection, but remains active in the context of the viral genome. It was 
demonstrated that the IE protein Vmw68 is required for the modification of RNAP II and 
establishment of the normal viral transcription program (Rice et al., 1995).
1.2.4. DNA Replication.
HSV DNA replication occurs in approximately 200 discrete compartments in the cell 
nucleus. The formation of the replication compartments is dependent on the U l29 gene 
product, ICP8 (De Bryn Kops and Knipe, 1988). DNA replication occurs by a rolling 
circle mechanism and results in the production of large head-to-tail concatemers (Jacob 
and Roizman, 1977; Jacob etal., 1979; Jongeneel and Bachenheimer, 1981).
There are 3 palindromic origins of DNA replication in the HSV-1 genome which are 
capable of binding the U l9 gene product (figure 1.4.; Vlazny and Frenkel, 1981; Stow, 
1982; Stow and McMonagle, 1983; Quinn and McGeoch, 1985; Weller et al., 1985;
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HSV gene Function Reference
Ul 30 DNA polymerase. Coen et a l,  1984.
Ul 29 ssDNA-binding protein; anchors the polymerase to the replication complex. Boehmer and Lehman, 1993.
Ul 9 On-binding protein. Boehmer et a l, 1993.
Ul 42 DsDNA binding protein; increases processivity of DNA replication. Digard e ta l ,  1993.
Ul 8, Ul 5 and 
UL52
Form the helicase-primase complex in 
equimolar amounts.
Crate e ta l,  1989; 
Calder et a l, 1992.
Table 1.2. HSV genes essential for replication of viral DNA and their 
proposed functions.
Lockshon and Galloway, 1986). There is one copy of oris *n ea°h of the S segment 
repeats, which directs unidirectional DNA replication. Another replication origin, ori^, is 
located in the U l segment and directs bidirectional replication. O h'l or one of the oris 
origins can be deleted without affecting virus viability.
There are 7 viral genes which are essential for viral DNA replication in tissue 
culture. The genes essential for DNA replication were identified by cotransfecting 
plasmids containing a viral replication origin with cloned fragments of the HSV genome 
and assessing the ability of the viral genes to replicate the origin-containing plasmid 
(Challberg, 1986; McGeoch et a l, 1988b; Wu et a l, 1988). The viral genes necessary for 
efficient DNA replication in the assay and their proposed functions are presented in table
1.2 .
There are many virally encoded enzymes involved in nucleotide metabolism which 
are necessary for efficient virus replication in vivo, but not essential for replication in 
tissue culture cells. The virally-encoded enzymes involved in nucleotide metabolism are 
especially important for replication in neurons which are non-dividing and therefore have 
low natural pools of the cellular enzymes with equivalent functions.
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The alkaline DNase (U l12) complexes with the U l2 9  gene product and cleaves the 
a sequence during packaging (Weller et a l , 1990; Thomas et al., 1992). The uracil DNA- 
glycosylase (U l2) is involved in DNA repair and proof reading (Caradonna et a l ,  1987; 
Pyles and Thompson, 1994). This enzyme removes dUTP residues and deaminated 
cytosine residues in DNA and is presumably of importance since the HSV genome 
contains a high G+C content. The viral ribonucleotide reductase consists of 4 subunits, 2 
from U l3 9  and 2 from U l4 0 , and converts ribonucleotides to deoxyribonucleotides 
thereby producing sufficient deoxyribonucleotides for viral DNA synthesis (Ingemarson 
and Lankinen, 1987; Idowu et al,  1992). TK (U l23) phosphorylates thymidine to TMP 
(Jamieson and Subak-Sharpe, 1974; Efstathiou et al,  1989), TMP is then converted to 
dTTP by cellular enzymes and the viral ribonucleotide reductase. The viral dUTPase 
(U l5 0 ; Preston and Fisher, 1984; Fisher and Preston, 1986; Pyles et a l ,  1992), 
hydrolyses dUTP to dUMP, thereby preventing incorporation of dUTP into DNA and 
providing a pool of dUMP for conversion to dTMP by thymidylate synthase.
1.2.5. Cleavage and packaging of DNA.
Capsid assembly and packaging of the viral DNA occurs in the nucleus. Viral DNA 
is packaged into type B capsids which contain the ‘scaffold’ proteins: the U l26 and 
U l2 6 .5  gene products and the self-cleavage products of U l2 6  (Rixon et al,  1988; Liu 
and Roizman, 1991a, b, 1992; Davison et al,  1992; Dilanni e ta l ,  1993).
Viral DNA lacking free ends, such as circular or head-to-tail concatemeric DNA, is 
cleaved into unit length virion genomes and packaged into pre-formed capsids by a tightly 
coupled mechanism involving amplification of a sequences (Deiss and Frenkel, 1986). 
The ultimate result is the production of a packaged viral genome with a free S-terminus 
containing a DR1 consisting of a single bp and a 1 nt 3' extension, and an L-terminus 
consisting of 1-5 copies of the a sequence ending in a DR1 containing 18 bp and a 1 nt 3' 
extension, such that a single DR1 is produced when the ends are joined together 
(Mocarski and Roizman, 1982).
Stow et al  noted that the ability of a plasmid containing a viral oris to be packaged 
by a helper virus required the presence of a sequences in the plasmid (Stow et al,  1983). 
Subsequently Deiss et al  identified 2 regions in the Ub and Uc regions of the a sequence, 
termed pacl  and pac2 respectively, which were important for packaging and are 
conserved among several herpesviruses (Deiss et al ,  1986). Deiss et a l  proposed a 
model for the packaging and cleavage process (Deiss et al,  1986; Roizman and Sears, 
1993). The model proposes that a protein binds to an a sequence and in turn binds to a 
site on the capsid, the DNA is then extruded into the capsid until another a sequence in 
identical orientation comes to be packaged, whereupon 1 of the juxtaposed a sequences is
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cleaved. The cleaved a sequence is then repaired and duplicated by the double-strand 
break and gap repair mechanism proposed by Szostak et al. (Szostak et al., 1983). 
Following duplication, cleavage occurs within the shared DR1 sites of the a sequences. 
The model predicts that the region of DNA packaged is predicted by the distance between 
2 direct repeats of the a sequence, consistent with the finding that the internal a sequences 
can be deleted without fully inhibiting packaging (Poffenberger et al., 1983; Poffenberger 
and Roizman, 1985; Jenkins and Roizman, 1986). However, defectives containing over 
17 direct repeats of the a sequence can be detected in virions from defective viruses 
(Frenkel et a l , 1976), in addition there is some evidence that shorter than full-length 
DNAs are packaged but not enveloped (Vlazny et a l , 1982), thus it has been suggested 
that complete filling of the capsid is required for correct cleavage and maturation to occur.
Viral mutants unable to cleave and encapsidate DNA typically accumulate type B 
capsids and concatemeric viral DNA under nonpermissive conditions. The full array of 
viral gene products required for cleavage and encapsidation and their exact functions are 
unknown, however genes required include U l6 , U l1 5 , U l2 5 , U l2 6 , U l2 8 , U l3 2  and 
U l3 3  (Preston et al,  1983; Addison et al,  1984, 1990; Sherman and Bachenheimer, 
1987, 1988; Al-Kobaisi eta l ,  1991; Poon and Roizman, 1993; Baines e ta l ,  1994; Patel 
et al,  1996). Chou and Roizman have identified 2 viral proteins which can specifically 
bind to the p a d  element of the a sequence (Chou and Roizman, 1989), and in addition, 
the capsid protein VP 19c is capable of binding to DNA (Braun et al,  1984), thus these 
viral proteins might play important roles in the cleavage and encapsidation process.
The capsid is enveloped by budding through patches of tegument proteins and 
immature glycoproteins on the inner nuclear membrane. The virion reaches the Golgi 
where the glycoproteins are glycosylated to their mature form (Darlington and Moss, 
1969; Schwartz and Roizman, 1969; Johnson and Spear, 1982). It remains unclear 
whether the envelope present on released virions is derived from the inner nuclear 
membrane or derived from the Golgi membrane, since two possible pathways of 
envelopment can be envisaged (Rixon, 1993). The first pathway predicts that after 
budding through the inner nuclear membrane the envelope is lost by fusion with the outer 
nuclear membrane and that the virion envelope is formed by fusion with the Golgi 
membrane. In the second pathway, after gaining the envelope from the inner nuclear 
membrane the nucleocapsid enters a vesicle derived from the outer nuclear membrane. 
The vesicle-enclosed virion fuses with the Golgi membrane thereby releasing the virion 
into the Golgi and preserving the envelope derived from the inner nuclear membrane.
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1.3. HSV LATENCY
Introduction
1.3.1. General aspects of latency.
HSV remains in a latent state within neurons innervating the site of primary infection 
(Stevens and Cook, 1971; Nesbum et a l, 1972; Stevens et al., 1972; Walz e ta l ,  1974). 
In many individuals, reactivation occurs spontaneously in latently infected neurons and 
virus returns to the periphery to produce clinical lesions, thereby augmenting the spread 
of the virus to other individuals. During primary infection, HSV adsorbs to sensory nerve 
endings at the peripheral site of replication and the nucleocapsid is released into the nerve 
axon via fusion of the viral and cell membranes. The nucleocapsid is transported to the 
nerve cell body in the ganglia by axonal transport (Cook and Stevens, 1973). When in the 
cell body the viral genome is uncoated, released into the neuronal nucleus and converted 
to a nonlinear form (Rock and Fraser, 1983, 1985; Efstathiou et a l,  1986). The time 
between infection at the neuronal cell surface and entry of the nucleocapsid into the 
nucleus after infection of the mouse via the footpad was estimated to be approximately 20- 
24 hours (Cook and Stevens, 1973). Once in the nucleus, the viral genome is either 
converted to the latent state and stably retained for the life span of the host, or enters into 
the lytic cycle of replication. During latency, transcription of the genome is confined to the 
LAT region, thus the viral IE promoters, which are characterised by their strong activities 
in the absence of protein synthesis, are repressed.
1.3.2. Sites of latency.
I.3.2.I. Neuronal sites of latency.
In 1929, Goodpasture wrote “It seems to me probable from experimental and clinical 
facts that herpetic virus does reside in a latent state within the human body and specifically 
in the nervous tissues, perhaps primarily within nerve cells of the ganglia; and that 
neuronal disturbances are frequently the basis of subsequent outbreaks.” Goodpasteur 
made an intelligent deduction from the observation that the major proportions of human 
herpetic eruptions occur from the peripheral distribution of the fifth cranial nerve, and that 
injury to nerves (Cushing, 1905), as well as stress, illness and administration of toxic 
substances caused reactivation.
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More direct evidence that nerve ganglia harbour latent HSV came in 1971 when 
Stevens and Cook reactivated HSV-1 from the spinal ganglia of mice months after 
inoculation into the footpad (Stevens and Cook, 1971). Latently infected murine ganglia 
were explanted and cocultivated with permissive tissue culture cells. Explantation caused 
reactivation of HSV-1 from the ganglia leading to destruction of the cultured cells. Virus 
could not be detected in ganglia which were homogenised and assayed for infectious virus 
immediately after explantation from latently infected mice, and in addition, ultrastructural 
and immunofluorescence analyses failed to detect virus-specific products in latently 
infected ganglia. A novel latent state was therefore occurring rather than a low level of 
replication. Later, Stevens and co-workers demonstrated the presence of latent HSV in the 
trigeminal ganglia of rabbits after inoculation in the eye (Nesbum et a l, 1972; Stevens et 
a l, 1972). Using the cocultivation technique on human ganglia obtained post mortem, 
numerous groups have demonstrated the presence of latent HSV-1 in humans (Bastian et 
al., 1972; Baringer and Swoveland, 1973; Plummer, 1973; Warren et al., 1977; Warren 
et a l, 1978; Lonsdale et a l, 1979). Baringer isolated HSV-2 from three separate human 
sacral ganglion isolates, consistent with the observation that HSV-2 reactivations occur 
predominately at the genital mucosa, and in one subject HSV-1 and HSV-2 were 
recovered from the trigeminal and sacral ganglia respectively (Baringer, 1974). HSV-1 
has been reactivated from the peripheral ANS of mice (Price et a l, 1975) and humans 
(Warren et a l,  1978), therefore latency is not restricted to the sensory ganglia. HSV-1 
has also been reactivated from the trigeminal nerve roots taken from human cadavers 
(Warren et a l, 1982), suggesting that clinically latent HSV may not be confined to the 
ganglia. Latency is established in ganglia innervating the site of inoculation (Walz et a l, 
1974), and after replication in the local sensory ganglia the virus travels to the CNS via 
the nerve axons (Cook and Stevens, 1973). Inoculation of HSV-1 into the cornea 
(Baringer and Griffith, 1970), brain (Tanaka et a l, 1994) or induction of viraemia (Cook 
and Stevens, 1976) leads to a severe productive infection in the CNS of mice, after which 
latent virus can be detected in multiple neuronal tissues (Cook and Stevens, 1976; Tanaka 
et a l, 1994). It seems likely that latency can be established in virtually any nervous tissue 
that is exposed to an adequate concentration of virus. The trigeminal and spinal ganglia 
are the most frequent sites of reactivation in humans, producing lesions at the peripheral 
mucosae thereby facilitating the spread of the virus.
HSV-1 has been reactivated from CNS tissue from only a very small fraction of 
inoculated mice (Knotts et a l, 1973; Cook and Stevens, 1976; Cabrera et a l, 1980). In 
the study by Cabrera et a l, 90% of mice had a productive infection in the brain after 
inoculation of HSV-1 into the cornea (Cabrera et a l,  1980). Reactivation after explant / 
cocultivation occurred in trigeminal ganglia from 95% of the mice that had recovered from 
the acute infection but reactivation occurred in CNS tissue from only 5%. However,
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HSV-1 DNA was detected in the CNS tissues from 30% of the recovered mice, 
suggesting that latency was readily established in the CNS but reactivation was less 
efficient than in trigeminal ganglia. HSV-1 DNA has also been detected in human brain 
tissue (Sequiera et al., 1979; Fraser et a l, 1981). Reactivation from human CNS tissue 
has never been demonstrated, making it difficult to assess the significance of latency in 
the CNS in human disease.
The cell type(s) within latently infected ganglia which harbour the HSV genome is an 
important issue. Cook et al. examined explanted ganglia of mice by immunofluoresence 
labelling with HSV-1-specific antibodies (Cook et al., 1974). After explantation to induce 
reactivation, HSV-1 antigens appeared initially in neurons and at later times in the 
surrounding cells. When rabbit anti-HSV-1 antibodies were present in the culture medium 
of explanted ganglia, virus was restricted to the neurons, implying that reactivation 
occurred solely in the neurons. After explantation and cocultivation in medium containing 
[^H]-thymidine, incorporation of ^H occurred at above background levels only in 
neurons. Neurons do not replicate their own DNA, therefore the incorporation must have 
been due to HSV-1 DNA replication. After the [^H]-thymidine had been removed and 
replaced with unlabelled thymidine, the radioactive label moved into the surrounding 
cells. It was deduced that the neurons were the sole site of reactivation after explantation 
of the ganglia. McLennan and Darby infected mice in the footpad with ts mutants of HSV- 
1 and allowed the infections to proceed to latency (McLennan and Darby, 1980). The 
nerves of cervical ganglia were severed in order to induce reactivation in vivo and three 
days later the ganglia were removed and immunohistochemically stained for HSV-1 
antigen. The body temperature of mice was nonpermissive for the mutants, therefore the 
reactivated virus was not expected to spread from the site of latency. Staining occurred 
only in neurons, supporting the data of Cook et al. (Cook et a l,  1974). The data of 
McLennan and Darby should be interpreted with caution for two reasons: first, the ts 
mutants did not replicate in the ganglia as would occur in a natural infection with wild- 
type virus, and as it had previously been shown that HSV-1 reaches ganglia via the nerve 
axons and not the blood or lymph (Cook and Stevens, 1973), virus would have been 
unable to reach the non-neuronal cells and establish latency; and, second, the latent HSV- 
1 was reactivated by nerve section, a treatment which selectively affects neurons and not 
the non-neuronal supporting cells. Although the methods used by McLennan and Darby 
can be brought into question, it should be stated that work by others has proved that the 
final interpretation that latency in sensory ganglia occurs solely in neurons was probably 
correct. Kennedy et a l observed that reactivation of HSV-1 and HSV-2 occurred initially 
in neurons after explantation and dissociation of the DRG of latently infected mice 
(Kennedy et al., 1983). Neurons were unambiguously identified with a neuron-specific 
antibody. Detection of LAT by in situ hybridisation has facilitated the detection of cells
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latently infected with HSV-1 (Stroop et a l, 1984; Deatly et al., 1988) or HSV-2 (Tenser 
et al., 1991). LAT expression is largely confined to neurons but some studies have 
reported hybridisation to LAT occurring in non-neuronal cells of the nervous system 
(Deatly etal., 1988; Tenser etal., 1991).
I.3.2.2. Non-neuronal sites of latency.
There is evidence that HSV can establish latency in cell types other than neurons. 
Extra-neuronal sites of latency have been identified by their ability to produce virus after 
explantation / cocultivation. However, this technique does not distinguish latency from 
persistent low-grade virus replication and a number of criteria have therefore been used 
which a virus-tissue interaction must exhibit in order to be considered a latent interaction. 
1) During a latent infection, infectious virus is not detectable in cell-free homogenates 
prepared immediately after explantation (Stevens and Cook, 1971). 2) Virus appears 
immediately after cocultivation of persistently infected tissue, whereas in latently infected 
tissue there is a prolonged delay between explantation and the release of virus (Scriba, 
1981). 3) Persistent infections are cleared by exposure to an inhibitor of viral DNA 
replication in the culture medium during cocultivation (Scriba, 1981), whereas the rate of 
reactivation from latently infected tissue is unaffected after removal of the inhibitor 
(Scriba, 1981; Cook and Brown, 1987; Al-Saadi etal., 1988)
HSV-1 or HSV-2 was induced to reactivate from the explanted footpads of mice 
months after inoculation at that site (Al-Saadi et al., 1983; Subak-Sharpe et a l, 1984a, b). 
As with latently infected ganglia, infectious virus was not detectable in the footpads 
homogenised and assayed for infectivity immediately after explantation, but was 
reactivated after culturing. When mice were administered acycloguanosine (ACG) for 
prolonged periods before explant, reactivation was not precluded (Clements and Subak- 
Sharpe, 1988). Treatment of explanted footpads in vitro with ACG or PAA in the culture 
medium also failed to affect the appearance of vims after the inhibitors were removed (Al- 
Saadi et a l,  1988), thus a novel latent state was occurring rather than a persistent low 
level of replication. Footpads of mice do not contain neuronal cell bodies, therefore 
latency must have been in non-neuronal cells. The cellular foci of reactivation in the 
mouse footpad were identified by in situ hybridisation to viral RNA in sections taken 
from cultured footpads (Clements and Jamieson, 1989). HSV-1-specific RNA first 
appeared in basal cells of hair follicles, cells of the hair root sheath, epithelial cells of 
sebaceous glands and in cells of the epidermis.
HSV-1 and HSV-2 have been recovered from the footpads of guinea pigs during the 
latent phase of infection (Scriba, 1977). However, reactivation from the guinea pig 
footpad differs from that which occurs in the mouse footpad as HSV-2 clearly persists as
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a replicative rather than latent infection (Scriba, 1981). Analyses of reactivation from the 
guinea pig footpad suggested persistent replication in all three of the criteria listed above 
(Scriba, 1981).
Another possible non-neuronal site of HSV latency is the cornea (Shimeld et a l, 1982; 
Cook et a l, 1987; Claoue e ta l,  1990; Cook et a l, 1991b). Interestingly, several groups 
have reported transcripts antisense to Vmwl 10 mRNA in the corneas of latently infected 
animals (Cook et a l, 1991a; Abghari et a l, 1992). In addition, regions of the LAT 
promoter which stimulate transcription specifically in neuronal cells are also active in 
corneal cells (Perng et a l, 1994b), thus transcription of the LAT may be regulated with 
similar characteristics in comeal cells as it is in neurons.
When IE transcription of HSV-1 is inhibited, the genome is stably retained in cultured 
non-neuronal cells in a form resembling latency (Harris and Preston, 1991; Jamieson et 
a l,  1995; this thesis). The presence of VZV transcripts in satellite cells of latently infected 
human sensory ganglia suggests that VZV can establish latency in non-neuronal cells, 
thus giving credibility to the hypothesis that HSV is capable of latency in non-neuronal 
cells (Croen et a l, 1988; Croen and Straus, 1991).
1.3.3. Animal models.
The animals most frequently used to study HSV latency are mice, rabbits and guinea 
pigs, although no single model mimics the situation in the natural human host exactly. 
Any finding concerning latency which is suggested by in vitro experimentation ultimately 
requires confirmation in animal models.
After inoculation of animals with HSV, latency was established in the nervous tissue 
innervating the site of inoculation (Stevens and Cook, 1971; Stevens et a l,  1972; Cook 
and Stevens, 1973; Walz et a l, 1974). Surviving animals continued to harbour latent 
vims which was reactivated by cocultivation of the ganglia with permissive tissue culture 
cells. Cocultivation of ganglia has proved an invaluable technique for assessing the 
latency-competence of viruses and for identifying sites of latency. However, the relevance 
of molecular events following cocultivation to reactivation in vivo is dubious. The models 
of in vivo reactivation described below are valuable methods of examining the host-virus 
interaction, but explantation / cocultivation of mouse ganglia is a better model for 
molecular studies.
Inoculation of mice in the ear led to a latent infection in the cervical dorsal root ganglia 
(Hill et a l, 1975). A small proportion of latently infected mice exhibited spontaneous 
recurrence leading to erythryma or vesicles at the site of inoculation. A greater proportion 
of latently infected mice could be induced to reactivate by exposing the ear to stimuli such
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as UV light, ice or cellophane stripping (Blyth et al., 1976; Hill et al., 1978; Harbour et 
a l , 1983).
Sawtell and Thompson used transient hyperthermia to reactivate HSV-1 from 
trigeminal and lumbosacral ganglia of mice latently infected after inoculation at one of 
several sites (Sawtell and Thompson, 1992a). Hyperthermia caused rapid in vivo 
reactivation, but reactivation occurred from only a very small proportion of neurons in the 
ganglia. The hyperthermia-induced reactivation technique showed that a LAT-  mutant 
reactivated less frequently from the trigeminal ganglia than a LAT+ virus (Sawtell and 
Thompson, 1992b). The difference in reactivation frequencies was attributed to a 
difference in the abilities to establish latency rather than a difference in reactivation abilies 
per se.
The administration of CdSC>4 led to reactivation of HSV-1 from the trigeminal ganglia 
of latently infected mice (Fawl and Roizman, 1993). Reactivation was not induced by 
zinc, nickel or manganese, indicating that reactivation was not caused by the 
metallothioneins and might be caused by CdSC>4 specifically inhibiting the factors which
maintain the vims in the latent state.
The proportion of mice which survived inoculation in the eye was increased by passive 
immunisation 24 hours prior to infection (Shimeld et al., 1989). Treatment with the 
immune-suppressors cyclophosphamide and dexamethasone resulted in ocular shedding 
in 50% of the animals.
After inoculation in the eye and establishment of latency, reactivation was induced in 
the trigeminal ganglia of rabbits by iontophoresis of epinephrine (Kwon et al., 1981) or 
treatment with cyclophosphamide and dexamethasone (Haruta et al., 1989). The rabbit 
eye model has been useful in demonstrating the role of LAT in efficient reactivation (Hill 
et al., 1990; Farrell et a l, 1993; Bloom et al., 1994).
The guinea pig has been used in a model for genital herpes. Inoculation in the vagina 
or urethra resulted in a self-limiting primary infection with replication in the lumbosacral 
ganglia leading to latency in the dorsal root ganglia (Stanberry et al., 1982, 1985). 
Symptomatic and asymptomatic occurrences occurred after the primary infection and the 
frequency of such occurrences decreased with time. The primary infection was similar 
after inoculation with HSV-1 or HSV-2, however spontaneous reactivation occurred more 
frequently with HSV-2 and the guinea pig model thus apparently mimicked genital herpes 
in humans.
While in vivo models have provided important information on the pathogenesis of 
HSV infection and the role of viral factors in latency, their use in the dissection of the 
molecular mechanisms controlling latency is limited because of the complexity of the 
contribution of host factors and the immune system to latency, they are expensive and 
only a small proportion of neurons are induced to reactivate simultaneously. An in vitro 
latency system in which all of the latent genomes can be induced to reactivated
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simultaneously is clearly desirable to enable characterisation of establishment, 
maintenance and reactivation of latency at the molecular level. Molecular interactions 
observed in in vitro systems should ideally be confirmed by experimentation in vivo.
1.3.4. In vitro models.
Studies on latency with animal models are hindered by the small amount of latently 
infected tissue available and by experimental inadequacies imposed by the use of animals. 
To facilitate studies on latency, in vitro models have been developed. An in vitro latency 
system should exhibit the following characteristics (1) Viral genomes should persist in 
cell nuclei in the absence of infectious virus. (2) Viral genomes should be nonlinear, as 
they are in vivo. (3) Transcription of the genomes should be repressed or at most limited 
to the LAT region. (4) Latent virus should be capable of reactivation to produce infectious 
virus.
In vitro latency systems can be divided into three types, those that use (1) primary 
cultures from the ganglia of rodents, (2) cell-lines of neuronal origin, or (3) non-neuronal 
tissue culture cells.
I.3.4.I. In vitro models using primary neuronal cultures.
The most significant in vitro system using primary neuronal cultures was developed by 
C.L.Wilcox and co-workers. Cervical ganglia from neonatal rats were treated with 
collagenase, dissociated onto a growth surface and treated with the mitotic inhibitor 
fluorodeoxyuridine to reduce the non-neuronal cell population to less than 5% of the total 
cell population (Wilcox and Johnson, 1987). The cultures were infected with HSV-1 and 
incubated in the presence of anti-HSV-1 antiserum to minimise the number of cultures 
destroyed by viral CPE. The presence of nerve growth factor (NGF) in the culture 
medium was neccesary not only for the survival of the neurons but also to maintain the 
virus in the latent state. Infection with 1 PFU per cell resulted in 63% of the cultures 
surviving the initial infection with 53% of the surviving cultures containing reactivatable 
virus. The application of ACG for 7 days after infection instead of anti-HSV-1 antiserum 
enabled MOIs of up to 5 PFU per cell to be used with 100% of the cultures surviving and 
100% of the surviving cultures retaining reactivatable virus (Wilcox and Johnson, 1988). 
Viral antigens were not detected during the latent phase but appeared in all neurons within 
24 hours after NGF depletion, indicating that all the neurons contained latent virus 
(Wilcox and Johnson, 1988). The 2.0 kb LAT and its 1.5 kb splicing derivative were the 
only viral transcripts detected during the latent phase (Doerig et al., 1991b; Smith et al.,
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1994). An antigen encoded by LAT ORF-2 (section 1.3.9.) was reported to be present 
during latent infection of the neuronal cultures (Doerig et al., 1991a), but as identification 
of ORF-2 products in vivo and further characterisation in neuronal cultures has not been 
forthcoming, definite conclusions about the putative LAT translation products are 
unavailable. Probably the most significant information gathered from the system of 
Wilcox was that depletion of NGF from the culture medium, stimulation of cAMP- 
dependent second messenger pathways or activation of protein kinase C (PKC) resulted 
in reactivation (Wilcox and Johnson, 1987; Wilcox etal., 1990; Smith e ta l ,  1992).
In a system developed by Wigdahl et al., isolated rat foetal dorsal root ganglia were 
pretreated with IFNa and the replication inhibitor (E)-5-(2-bromovinyl)-2'-deoxyuridine 
(BVDU) for 1 day prior to infection with up to 2.5 PFU of HSV-1 per cell (Wigdahl et 
al., 1983). The infected cultures were maintained for 7 days at 37° in the presence of the 
inhibitors, after which time the inhibitors were removed and the cultures shifted to 40.5°. 
The virus remained in an apparently latent state as long as the cultures remained at the 
elevated temperature. Reactivation was triggered by downshift to 37°. Southern blot 
analysis of DNA from the system of Wigdahl et al. revealed that the predominant 
population of viral genomes were linear (Wigdahl et al., 1984a). Further structural and 
biochemical analysis of the system have not been forthcoming.
I.3.4.2. In vitro models using neuron-derived cell lines.
Clone C l300 mouse neuroblastoma cells are nonpermissive for HSV replication 
compared to other mouse cell-types (Vahlne and Lycke, 1978; Wheatley et al., 1990). A 
C l300 clone highly resistant to HSV-1 was obtained by repeatedly exposing C l300 cells 
to progressively higher MOIs of virus (Nilheden etal. 1985a). The highly resistant clone 
was infected with 1 PFU of HSV-1 per cell and passaged in the presence of neutralising 
HSV-1 antibody without cell destruction (Nilheden et al., 1985b). Reactivation of latent 
HSV-1 by superinfection with HSV-2 showed that the latent virus was diluted upon 
passage, indicating that the genomes were retained in a nonreplicating state (Nilheden et 
al., 1985b). The restriction of HSV-1 in C l300 cells is caused by a reduction in viral IE 
transcription dependent on the TAATGARAT elements upstream of the IE genes (Kemp 
et al., 1989, 1990). Transfection of plasmids containing octamer elements relieved the 
restriction of replication in C l300, indicating that the transfected binding sites were 
competing with the TAATGARAT elements in the viral genomes for a transcriptional 
repressor which bound to the viral TAATGARAT elements (Kemp et al., 1990). The 
reduction of viral IE transcription in C l300 cells is probably caused by neuronal forms of 
Oct-2 binding to the TAATGARAT elements and preventing formation of the Vmw65- 
containing transactivation complex, as has been shown in other non-permissive cell lines
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derived from neonatal rat dorsal root ganglia fused to C l300 cells (ND cells; section 
1.3.5.; Lillycrop et a l,  1991; Wheatley et al., 1991; Lillycrop and Latchman, 1992; 
Lillycrop et al., 1994). After infection of ND3 cells with 1 PFU of HSV-1 per cell, 
Vmwl75 was detected in only 1.5% of the cells (Wheatley et a l, 1990). Transcription 
from the five viral IE genes was not detected in nuclear run-on assays but transcripts 
antisense to Vmwl 10 mRNA, not formally identified as LAT, were present at high levels 
(Wheatley et al., 1990). Infection of the neuron-derived cell lines which expressed high 
levels of Oct-2 led to a latent viral state which resembled latency in neurons in vivo. Cell 
lines such as ND3 could be used for in vitro studies on latency, however latency in ND 
cells has not been characterised in detail.
I.3.4.3. In vitro models using non-neuronal tissue culture cells.
O’Neill et al. examined the possibility of HSV-2 entering a latent state in cultured HFL 
cells when virus replication was inhibited with arabinofuranosyl cytosine (Ara-C; O’Neill 
et al., 1972). HFL cells were pretreated with Ara-C for 24 hours, infected with HSV-2 
and maintained at 37° for 7 days in the presence of Ara-C. After removal of the inhibitor, 
infectious virus was undetectable for a 5 to 6 day period, defined as the latent period. 
Latent HSV-2 was not eliminated by prolonged exposure to Ara-C, indicating that a latent 
rather than persistent state was occurring. After latency was established with 1 PFU of 
HSV-2 per cell, 0.025% of the cells produced infectious vims. Later it was found that the 
latent state could be maintained in the absence of Ara-C if the cultures were shifted to 40° 
after removal of the inhibitor (O’Neill, 1977). Latent HSV-2 was reactivated by 
downshift to 37° or by superinfection with HCMV (Colberg-Poley et a l,  1979). After 
superinfection with HCMV of cultures latently infected with 0.2 PFU of HSV-2 per cell, 
1.6 % of the cells contained viral RNA and 0.3% of the cells produced infectious vims 
(Colberg-Poley et a l, 1981). Ts mutants of HCMV defective in DNA replication retained 
the ability to reactivate latent HSV-2 at the NPT, suggesting that an IE or E function of 
HCMV induced reactivation (Colberg-Poley et al., 1981). A closely related system was 
used to establish latency of HSV-1 (Wigdahl etal., 1981). Latent HSV-1 was reactivated 
by incubation at 37°, superinfection with HCMV or superinfection with ts mutants of 
HSV-2 (Wigdahl et a l, 1981, 1982a). The antiviral action of human leukocyte IFNa 
acted synergistically with the HSV-1-specific antiviral BVDU to enable high initial MOIs 
to be used without destmction of cell monolayers (Wigdahl et a l, 1982b). With an MOI 
of 2.5 PFU of HSV-1 per cell, 1-3% of the cells harboured at least one latent genome 
which was induced to reactivate by incubation at 37° or superinfection with HCMV 
(Wigdahl et a l, 1982b). HSV-1 latency was established in cultured rat or human sensory 
neurons using a similar technique to that used to establish latency in HFL cells (Wigdahl
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et al., 1983, 1984b). Analysis of the HSV-1 genome during latency in HFL cells and rat 
sensory neurons revealed a copy number of 0.25-0.5 genomes per haploid cell genome 
equivalent in HFL cells and 8-10 genomes per haploid cell genome equivalent in neurons 
(Wigdahl et al., 1984a). No alteration in size or molarity of the HSV-1 terminal or joint 
DNA fragments was detected compared to virion DNA, suggesting that the latent viral 
genomes were nonintegrated, linear and nonconcatemeric (Wigdahl et al., 1984a). The 
efficiency of establishment of latency was increased to 1-5% of the cells containing 
reactivatable virus by use of ACG in combination with IFNa (Scheck et al., 1986, 1987). 
Superinfection of cultures containing latent HSV-2 with HSV-1 in the presence of 
BVDU, or superinfection of latent HSV-1 with HCMV in the presence of various DNA 
replication inhibitors, did not lead to reactivation, thus at least a subset of early-late gene 
products was required for reactivation (Scheck et al., 1987, 1989). During the latent 
phase, 2% of the cells contained HSV-1-specific RNA (Scheck et al., 1989).
Russell and Preston developed an in vitro latency system which exploited the failure of 
HSV-2 to replicate at 42° (Russell and Preston, 1986). HFL cells were infected at 37° 
with up to 0.03 PFU of HSV-2 per cell, shifted to 42° and incubated for 6 days, after 
which time the cultures were returned to 37° (Russell and Preston, 1986; Preston and 
Russell, 1991). Upon downshift to 37°, the virus remained latent, as defined by the 
absence of viral TK activity, CPE, or infectious virus for up to 6 days (Russell and 
Preston, 1986; Russell et al., 1987b; Russell, 1989; Preston and Russell, 1991). Almost 
all of the initial input inoculum was competent for reactivation by superinfection (Russell 
and Preston, 1986; Preston and Russell, 1991). When HSV-1 insertion and deletion 
mutants were tested for the ability to induce reactivation, the VmwllO deletion mutant 
d l1403 did not induce reactivation (Russell and Preston, 1986; Russell etal., 1987b) and, 
furthermore, it was demonstrated using recombinant adenoviruses that Vmwl 10 was the 
only HSV-1 protein required to induce reactivation (Harris et al., 1989). The finding that 
Vmwl 10 caused reactivation was a revolutionary discovery that implicated Vmwl 10 in 
reactivation from latency in vivo and supported the validity of the in vitro latency system. 
Once established, the latent state was insensitive to activators of transcription other than 
VmwllO, such as Vmwl75 or Vmw65, as demonstrated by the inability of d l1403 or 
UV-inactivated tsK to induce reactivation (Russell and Preston, 1986; Russell et al., 
1987b), thus the viral genomes were in a novel transcriptionally repressed state. In further 
support of the relevance of in vitro latency, and in contrast to the systems described above 
which used inhibitors to induce latency, the viral genomes were retained in a nonlinear 
configuration (Preston and Russell, 1991). Conversion to the nonlinear configuration 
during the establishment of latency in HFL cells was slow, being completed 4 days after 
infection. Virtually 100% of the input PFU of virus was capable of reactivation, 
corresponding to about 10% of the latently infected cells. Quantification of Southern blots 
revealed a viral genome copy number of 4.5 genomes per latently infected cell, thus a
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proportion of the retained genomes were unable to reactivate. Latent virus was diluted 
with the cells upon subculture, hence viral DNA did not replicate with the cell DNA, and 
it was also noted that reactivation could not be induced by treatments which alter the cell 
metabolic state such as application of dimethyl sulphoxide (DMSO), phorbal 12-myristate 
13-acetate (TPA) or ultraviolet (UV) light, thus the viral genomes were stable to 
alterations in the cell metabolic state (Russell and Preston, 1986). A small background of 
spontaneous reactivation was observed, suggesting that under certain conditions the latent 
genomes were induced to reactivate by cell factors or did not establish latency fully.
The system of Russell and Preston exhibits several characteristics which are 
advantageous over the inhibitor-induced systems. (1) The higher temperature of 42° 
negated the requirement for the use of chemical inhibitors. (2) The latent state was stable 
at 37°, whereas in the inhibitor-induced system reactivation occurred rapidly after 
downshift to 37°. (3) A greater proportion of cells harboured a reactivatable virus, 10% 
compared to 1-5% in the systems of Scheck et al. (Scheck et a l , 1986, 1987). (4) The 
latent, reactivatable genomes were nonlinear, in contrast to the inhibitor-induced system 
where the genomes were linear (Wigdahl et a l,  1984a). (5) VmwllO was the sole 
requirement for reactivation, whereas reactivation from inhibitor-induced latency involved 
at least a subset of early-late gene products (Scheck et al., 1987, 1989).
It was hypothesised that two populations of genomes exist in the inhibitor-induced 
systems, one which reactivates upon downshift to 37° and one which reactivates after 
superinfection with HCMV (Shiraki and Rapp, 1986). The number of cells that 
reactivated virus after temperature reduction decreased rapidly with time, whereas the 
number that reactivated by HCMV superinfection was steady (Shiraki and Rapp, 1986). 
Preston and Russell proposed that the latter represented virus latency in the 42°-induced 
system (Preston and Russell, 1991); such a proposal might indicate that latent viral 
genomes in the inhibitor-induced systems which are reactivated by superinfection are 
nonlinear, and that the 37°-reactivatable genomes are linear but present at such a high 
abundance as to swamp-out detection of the nonlinear genomes in Southern blots 
(Wigdahl e ta l ,  1984a).
The HSV-1 mutant ml814 has a 4 amino-acid insertion in Vmw65 which renders it 
unable to stimulate IE transcription but does not impair the structural role of the protein 
(Ace et al., 1989). Transcription of the viral EE genes is reduced approximately 10-fold in 
cells infected with ml814, greatly reducing its cytotoxicity (Ace et a l,  1989). After 
infection of tissue culture cells at low MOI, m l814 exhibits a high particle / PFU ratio 
which is particularly high in HFL cells (Ace et a l, 1989). The particle / PFU ratio of 
in 1814 in HFL cells was 1.7 x 105 particles per PFU compared to 11 particles per PFU 
for wild-type strain 17, thus after infection of cells with ml814, the majority of viruses 
did not form plaques. The mutation in ml814 did not alter the rate of entry of the viral
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genomes into the cell nuclei or the stability of the viral genomes once they had reached the 
nuclei, hence the genomes were retained in the cell nuclei (Ace et a l , 1989).
The low infectivity and cytotoxicity of in 1814 enabled establishment of latency in HFL 
cells after infection at an MOI of 5 particles per cell (Harris and Preston, 1991). 7wl814 
established latency in HFL cells efficiently at 37° and was retained at 1-8 copies per cell in 
a nonlinear form. The presence of a viral replication inhibitor during latency was 
necessary to prevent replication and spread of the small background of nonlatent virus, 
and Ara-C was deemed a suitable inhibitor as it did not affect the reactivation ability or 
configuration of the latent genomes. Viral genes, as exemplified by TK and LAT, were 
repressed during latency in HFL cells, when examined by the highly sensitive polymerase 
chain reaction (PCR) assay (Anderson, 1991). Lack of LAT expression in HFL cells was 
deemed to be because neuronal transcription factors necessary for LAT transcription were 
absent in HFL cells (Anderson, 1991; Harris and Preston, 1991). It was of interest to 
note that incubation of cells infected with 1814R (the revertant of m l814) at 42° inhibited 
plaque formation by 1000-fold, compared to a 4-fold reduction on ml814, suggesting 
incubation at 42° might cause latency by disrupting transactivation by Vmw65 (Harris and 
Preston, 1991).
Several researchers have postulated that latency in neurons is caused by a block to IE 
transcription, possibly via a disruption of transactivation by Vmw65 (Roizman and Sears, 
1987; Kristie and Roizman, 1988; Kemp e ta l , 1990; Lillycrop e ta l , 1991; Sears e ta l , 
1991; Roizman and Sears, 1993; Lillycrop et al., 1994; Hagmann et a l,  1995). It is 
therefore possible that in tissue culture the mutation in ml814 mimics the disruption of 
transactivation in neurons, thereby leading to latency (Ace et a l,  1989; Harris and 
Preston, 1991).
The in vitro latency system using m l814 was limited to low initial MOIs because of 
residual cytotoxicity and IE transcription at high MOI (Harris and Preston, 1991). An in 
vitro system in which the viral DNA could be detected in Southern blots without previous 
banding in CsCl gradients was needed to facilitate molecular studies on the latent 
genomes, hence the in vitro system was modified by incorporating steps which further 
reduced cytotoxicity and IE transcription (Jamieson, 1993; Jamieson et a l, 1995). HFL 
cells were pretreated with IFNa, a treatment which is known to reduce HSV IE 
transcription (Mittnach et a l,  1988; Oberman and Panet, 1989; DeStasio and Taylor,
1990). In addition, m l814 was modified by replacing the promoter controlling 
transcription of IE1 with the MMLV LTR, yielding the virus named m l820. As the 
MMLV LTR is not active under IE conditions in HFL cells, m l820 behaves as if deleted 
for IE1 (Jamieson et a l, 1995). Mutants of Vmwl 10 have a similar phenotype to m l814 
in cell culture (Stow and Stow, 1986; Everett, 1989), hence the plaque-initiation defect in 
ml814 is probably caused by lower expression of VmwllO (Jamieson et a l,  1995).
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Reduced expression of Vmwl 10 from m l820 leads to an exceptionally high particle / 
PFU ratio and low cytotoxicity in HFL cells, thus an increased proportion of virus-cell 
interactions lead to latency (Jamieson, 1993; Jamieson et al., 1995). Latency was 
established by infecting IFNa-treated HFL cells with 1 PFU of m l820 per cell and 
incubating the cultures at 37° for 2 or 3 days in the presence of Ara-C.
Insertion of lacZ under the control of IE promoters into nonessential regions of the 
m l820 genome enabled the retention of the virus to be assessed quantitatively. An 
extrapolation of the number of blue cells formed after reactivation of cultured latently 
infected at low MOIs with the number of genomes detected in Southern blots in cultures 
infected at high MOI enabled the demonstration that most viral genomes were competent 
for reactivation (Jamieson et al., 1995). This was a crucial finding because for the first 
time it could be stated with certainty that the genomes in an in vitro latency system 
detected in Southern blots were templates for reactivation and were thus biologically 
relevant.
After infection with 1 PFU per cell, nonlinear m l820 genomes were retained in HFL 
cells at high enough abundance to be detected in Southern blots without previous banding 
on CsCl gradients (Jamieson, 1993), as was required in previous in vitro latency systems 
using HFL cells (Harris and Preston, 1991; Preston and Russell, 1991), thus molecular 
studies on the structure of the latent genomes were facilitated by use of m l820.
Assessment of the fate of the input m l820 DNA during the course of latency showed 
that the quantity of intracellular nuclear viral genomes fell by 3-fold during the first 3 days 
of infection, but the nonlinear genomes remaining after 2 days infection were stable 
(Jamieson et al., 1995). The input DNA not converted to the nonlinear form could not be 
detected in the cytoplasm or culture medium and presumably was degraded.
Regularly spaced nucleosomes could not be detected on the TK gene of latent m l820 
genomes, as assayed by micrococcal nuclease (MN) digestion and Southern blotting, 
however the viral TK gene was bound by regularly spaced nucleosomes when in the cell 
genome, thus the TK gene does not have an intrinsic property which precludes the 
formation of regularly spaced nucleosomes during latency (Jamieson et al., 1995). The 
nucleosome organisation of the genomes during latency in HFL cells appeared to differ 
fundamentally from the arrangement in vivo where the latent genomes are predominantly 
in a regular structure (Deshmane and Fraser, 1989). It was suggested that the absence of a 
regular nucleosome arrangement on genomes latent in HFL cells could be explained by 
the apparent inefficiency of reactivation from nervous tissue where the number of 
genomes detected in Southern blots far exceeds the number of neurons from which 
reactivation is induced, thus the chromatin-associated genomes may not be competent for 
reactivation and might be biologically irrelevant. The genomes in the in vitro system might 
represent the small proportion of genomes which can be reactivated in vivo.
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7>zl820 genomes became more sensitive to MN as the virus proceeded to latency, as 
compared to shortly after infection and to a virus transcribing in the presence of Ara-C 
(Jamieson, 1993). It was proposed that the increase in sensitivity was due to structural 
changes which occurred as a result of entry into the nonlinear, latent state and that 
transcribing viruses do not have such changes conferred upon them.
1.3.5. Establishment.
The level of IE gene expression during the early stages of infection probably 
determines whether an infection proceeds to the lytic cascade observed in tissue culture 
cells or enters into the latent state (Roizman and Sears, 1987; Kristie and Roizman, 1988; 
Kemp et al., 1990; Roizman and Sears, 1990; Lillycrop et al., 1991; Sears etal., 1991; 
Lillycrop et al., 1994). When IE transcription is below a threshold level, the genome is 
converted to the latent state, whereas if IE transcription is above the threshold, viral 
replication ensues and presumably the neuron is killed, as invariably occurs during 
infection of tissue culture cells. The observation that there is no sensory loss at the site of 
recurrent lesions is difficult to reconcile with neuronal cell killing (Gominak et al., 1990), 
thus it is disputable whether reactivation leads to the death of the neuron.
All virus mutants tested are capable of establishing latency, including m l814 which 
has a 4 amino-acid insertion in Vmw65 preventing transactivation of IE genes (Steiner et 
al., 1990; Harris and Preston, 1991; Ecob-Prince et al., 1993a, b), thus none of the virus 
gene products identified so far are required for establishment of latency. The apparent 
inability of TK, Vmw63, VmwllO and Vmwl75 mutants to establish latency was 
probably caused by defective replication, leading to lower inocula of virus reaching 
sensory ganglia and inefficient replication after reactivation, rather than inability to 
establish latency (Clements and Stow, 1989; Coen et al., 1989; Efstathiou et al., 1989; 
Leib etal., 1989).
Latency can be established in non-neuronal tissue culture cells only after artificial 
manipulation (Wigdahl e ta l,  1981; Russell and Preston, 1986; Harris and Preston, 1991; 
Jamieson et al., 1995), thus, if the natural block is at the IE level, neurons must contain 
factors that inhibit viral IE transcription. Inhibition of IE transcription in vivo might be 
caused by neuronal forms of Oct-2 binding to the TAATGARAT elements upstream of the 
IE genes and repressing transcription, as has been observed in transformed cell lines of 
neuronal origin (Kemp et a l, 1990; Lillycrop et a l,  1991, 1993), or the viral 
transactivator Vmw65 may be lost during passage over the relatively long distance 
between the neuronal cell surface and the neuronal nucleus, so that when the viral genome 
enters the cell nucleus IE transcription is not stimulated by Vmw65 (Roizman and Sears, 
1987).
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HSV-1 transcription was repressed in neuron-derived cell lines in a manner dependent 
on the TAATGARAT elements (Kemp et al., 1990). Repression of the HSV IE promoters 
was mediated by the homeobox protein Oct-2 binding to the TAATGARAT elements and 
inhibiting transactivation by Vmw65 (Lillycrop et a l, 1991, 1993). Oct-2 is present in B- 
cells and in neuronal cells, but the predominant forms in the two cell types differ due to 
alternative splicing of the transcript (Wirth et a l, 1991; Lillycrop and Latchman, 1992; 
Stoykova et a l, 1992). Although all forms can activate a simple octamer element (Wirth et 
a l, 1991), they differ in their effect in the context of the TAATGARAT elements in the 
viral genome (Lillycrop and Latchman, 1992). The B-cell form of Oct-2, named Oct-2.1, 
activates transcription, whereas the neuronal forms, Oct-2.4 and 2.5, cause repression 
(Lillycrop and Latchman, 1992). Recently it was reported that Oct-2 could not be detected 
in sensory neurons, but the factors required for Vmw65-mediated activation, Oct-1 and 
HCF, were detected, suggesting that repression by Oct-2 is not an important mechanism 
of IE gene repression in vivo (Hagmann et a l, 1995). Further clarification of the pattern 
of Oct-2 expression in vivo is required before conclusions can be made about its role in 
latency.
The Vmw65-induced complex formed by extracts of permissive HeLa, 3T3 cells or 
brain can be resolved into 3 distinct bands in DNA-protein complex electrophoretic 
mobility shift assays (Hagmann et a l, 1995). However, electrophoresis of complexes 
formed from extracts of sensory neurons revealed that the lower mobility complex was 
absent (Hagmann et a l, 1995). It was suggested that alternative processing of HCF or the 
absence of a fourth factor in sensory neurons could account for the absence of the lower 
mobility complex, and the different complex could be incapable of transactivation. It is of 
interest to determine the cause of the unusual Vmw65-induced complex in sensory 
neurons, and whether it is capable of transactivation.
If Vmw65 is lost over the distance between the neuronal cell surface and the cell 
nucleus, neurons infected via the periphery, where the distance travelled by the 
nucleocapsid is measured in centimetres, would be more likely to be latently infected than 
neurons infected from adjacent neurons, where the distance between the cell surface and 
the nucleus is a few micrometers. The theory that latency is caused by prevention of 
Vmw65 transactivation would explain why HSV IE genes are stimulated by a complex 
between cell factors and a component of the virion tegument rather than by enhancer 
elements dependent solely upon cellular transcription factors for high levels of expression 
(Roizman and Sears, 1993). An attempt was made to determine whether expression of 
Vmw65 causes reactivation or precludes the establishment of latency. The gene encoding 
Vmw65 was placed under control of the mouse metallothionein promoter and recombined 
into the HSV-1 genome (Sears et a l, 1991). The recombinant virus was inoculated into 
mice and Vmw65 expression induced at various stages of infection by administering 
CdS0 4 - Induction of Vmw65 during latency did not cause reactivation of virus, neither
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did induction at the time of inoculation. Similar results were obtained using transgenic 
mice containing the mouse metallothionein promoter controlling Vmw65. It was 
concluded that the absence of Vmw65 cannot alone account for the establishment of 
latency. The data of Sears et a l  are somewhat confusing given the finding that the 
metallothionein promoter is not expressed during latency (Lokensgard et a l , 1994), and 
that CdSC>4 causes reactivation (Fawl and Roizman, 1993).
The HSV-1 IE genes show a degree of transcriptional activity even in the absence of 
Vmw65, as demonstrated by use of the HSV-1 mutant m l814 which has a 4 amino-acid 
insertion in Vmw65 preventing formation of the transactivation complex (Ace et a l , 
1989). The defect in ml814 is overcome after infection at high MOI, presumably because 
of residual IE transcription, thus MOI might be an important determinant of the outcome 
of infection in neurons in vivo.
1.3.6. Maintenance.
The HSV-1 genome was retained as a nonlinear episome associated with nucleosomes 
during latency (Rock and Fraser, 1983, 1985; Efstathiou et a l , 1986; Mellerick and 
Fraser, 1987; Deshmane and Fraser, 1989). Latent DNA was stable over several months 
in mice (Efstathiou e ta l , 1986), and presumably remains in humans until death. The lack 
of any free ends would prevent degradation by exonucleases, and association with 
nucleosomes might also prevent degradation. In in vitro latency systems, nonlinear DNA 
was preferentially retained and linear DNA not converted to the nonlinear form was 
degraded (Preston and Russell, 1991; Jamieson e t a l , 1995). Thus nonlinearity and 
association with nucleosomes may contribute to DNA stablility during latency.
The number of viral genomes retained per latently infected neuron is unclear at present. 
In trigeminal ganglia harbouring latent virus, there is an estimated 0.1-1 genomes per cell 
(Puga et a l, 1978; Cabrera et a l, 1980; Efstathiou et a l, 1986; Rock and Fraser, 1986). 
This is the copy number for the total number of cells in a ganglion, but as neurons only 
constitute approximately 10% of the total number of cells in a ganglion, there is likely to 
be more than one genome per latently infected neuron. Only 3% of neurons in a latently 
infected ganglion express LAT (Rock et a l, 1987), thus if expression of LAT is taken as 
a marker for latent infection the number of genomes per latently infected neuron is likely 
to be much higher. However, data from studies using in situ PCR indicate that the 
number of latently infected neurons exceeds the number of neurons expressing levels of 
LAT detectable by in situ hybridisation (Gressens and Martin, 1994; Ramakrishnan et a l, 
1994; Mehta et a l, 1995). Until recently, individual cells latently infected with HSV 
could only be identified in situ by hybridisation to LAT RNA or transcripts produced 
from reporter genes linked to the LAT promoter. Attempts to detect latent HSV DNA by
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in situ hybridisation have failed, probably because of the low copy number of HSV 
genomes per latently infected cell, or perhaps because the latent genome is in a structure 
or compartment inaccessible to probes under current conditions of section preparation 
and hybridisation (Stevens, 1989). The inability to detect latent HSV DNA by in situ 
hybridisation left it unclear whether HSV can establish a latent infection without 
expressing LAT. In non-neuronal cells the neuron-specific LAT promoter is unlikely to be 
active during latency (Zwaagstra et al., 1990; Anderson, 1991; Leib et al., 1991; 
Zwaagstra et al., 1991; Batchelor and O’Hare, 1992; Kenny et al., 1994), and detection 
of latently infected cells in non-neuronal tissues in situ is therefore limited to the detection 
of HSV antigens or transcripts after explantation (Clements and Jamieson, 1989). The 
highly sensitive technique of in situ PCR is now being used to identify latently infected 
cells in ganglia irrespective of whether transcripts are detectable (Gressens and Martin, 
1994; Ramakrishnan et a l, 1994; Mehta et a l, 1995). The assay of Mehta et al. was 
sensitive enough to detect a single copy cell gene in 50% of neurons (Mehta et a l, 1995). 
In three separate studies the number of neurons containing a viral genome detected by in 
situ PCR was greater than the number of LAT+ neurons detected by in situ hybridisation 
suggesting that not every latently infected neuron contained LAT (Gressens and Martin, 
1994; Ramakrishnan et a l, 1994; Mehta et al., 1995). However, because of the 
sensitivity of in situ PCR and the relative insensitivity of in situ hybridisation, the 
discrepancy between HSV DNA+ and LAT+ neurons may have been caused by neurons 
containing HSV DNA detectable by in situ PCR but expressing levels of LAT 
undetectable by in situ hybridisation. Dual labelling in situ RT-PCR for the detection of 
LAT and in situ PCR for the detection HSV DNA will determine if neurons contain HSV 
DNA without expressing LAT. In situ PCR will facilitate an accurate assessment of the 
number of viral genomes per latently infected neuron, and in addition it will give greater 
insight into the sites of latency and enable detection of HSV DNA in ganglia infected with 
LAT-  mutants.
Sympathetic and sensory neurons are dependent for growth and survival upon NGF 
synthesised and released by the tissues which they innervate (Thoenen and Barde, 1980; 
Bandtlow et al., 1987). After binding to the nerve cell surface, NGF and its receptor are 
internalised and transported to the nerve cell body leading to induction of expression of 
cell genes (Johnson et al., 1987; Lindsay and Harmar, 1989). It has long been 
documented that damage to the nerve terminals of latently infected neurons causes 
reactivation of HSV (Cushing, 1905; Goodpasteur, 1929; Cook et al., 1974; Walz et a l, 
1974; Hill et a l, 1978; Tenser et a l, 1988), One possible mechanism by which damage 
to nerve terminals causes reactivation is by preventing NGF or possibly other factors 
released by the target tissues from reaching the neuronal cell bodies. The continued 
presence of NGF is necessary for maintenance of latency in sympathetic or sensory
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neurons cultured in vitro (Wilcox and Johnson, 1987, 1988; Wilcox et al. , 1990). 
Depletion of NGF for a little as 1 hour resulted in reactivation from cultured ganglia 
(Wilcox et al., 1990). The species-specific anti-human NGF receptor monoclonal 
antibody Mab-20.4 caused reactivation in human but not rat neuronal cultures, and in 
addition the monoclonal antibody Mab-192 which binds to the rat NGF receptor but does 
not block its function did not cause reactivation from rat ganglia. 6-hydroxydopamine, 
which is toxic for sympathetic nerve terminals, caused reactivation of HSV from latently 
infected cultures via a mechanism which was partially overcome by the addition of higher 
levels of NGF. When levels of 6-hydroxydopamine that cause destruction of the nerve 
terminals were applied, NGF did not overcome the effect, hence 6-hydroxydopamine 
appeared to reactivate latent virus by blocking the transport of NGF. Colchicine, which 
inhibits microtubule polymerisation leading to a blockage of axonal transport (Johnson et 
al., 1987), also induced reactivation. Inhibition of translation for 1 hour was sufficient to 
cause reactivation, indicating that continually synthesised factors keep the viral genome in 
the latent state. Exposure of latently infected cultured ganglia to UV light failed to cause 
reactivation from latency, even at high doses that damaged the cells, however UV 
damaged cultures retained the ability to reactivate virus after NGF deprivation, further 
supporting the concept that reactivation occurred as a result of specific molecular events 
rather than because of the general state of the cells. In summary, NGF specifically causes 
the induction of factors necessary to maintain HSV in a latent state within cultured 
ganglia, and probably in ganglia in vivo. Reactivation by NGF deprivation acts via 
activation of one of several second-messenger pathways that lead to reactivation (Smith et 
al., 1992).
Levels of Oct-2 were increased 3-4-fold in cultured rat sensory neurons in response to 
NGF stimulation, as measured by a DNA electrophoretic mobility shift assay (Wood et 
al., 1992). The increase in Oct-2 DNA binding was paralleled by a 2-fold increase in Oct- 
2 mRNA. Levels of the POU proteins Oct-1 and Bm-3 and the non-POU transcription 
factor TFIIIC were unaffected by NGF, thus NGF appeared to cause a specific 
upregulation of Oct-2. At least one of the mechanisms by which NGF maintains HSV in 
the latent state might be to constantly upregulate levels of Oct-2 transcription. After tissue 
damage at the periphery, insufficient levels of NGF would reach the ganglia and hence 
Oct-2 levels would decrease below levels required to keep the latent genome repressed, 
thus viral IE transcription would ensue and the replicative cycle would begin.
1.3.7. Reactivation.
Latent HSV can be triggered to reactivate in vivo by fever, stress, sunlight, 
administration of toxic substance and local stimulation at the peripheral site innervated by
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latently infected neurons. As discussed in section 1.3.6., NGF deprivation of neurons is 
one possible mechanism by which reactivation can be induced.
Vmw65 is not present during the initial stages of reactivation from latency, thus IE 
transcription is initiated by a change in the pool of cellular transcription factors within the 
latently infected neuron. The ability of m l814 to reactivate from latency after explantation 
clearly demonstrates that transactivation by Vmw65 is not necessary for reactivation 
(Steiner et al., 1990; Ecob-Prince et al., 1993a, b). Induced expression of Vmw65 by 
administration of CdSC>4 to latently infected transgenic mice containing the mouse
metallothionein promoter controlling Vmw65 expression did not cause any difference in 
the recovery of virus (Sears et al., 1991), and in addition the latent genomes in in vitro 
systems are also insensitive to Vmw65 (Russell and Preston, 1986; Harris and Preston,
1991).
VmwllO was the sole requirement for reactivation in in vitro latency systems 
developed by Preston and co-workers (Russell et al., 1987b; Harris et al., 1989; Harris 
and Preston, 1991). In addition a Vmwl 10 deletion mutant entered a latent state in tissue 
culture in a way resembling in vitro latency of ml814 (Stow and Stow, 1989). A role for 
VmwllO in reactivation in vivo is demonstrated by the inefficient capability of IE1 
mutants to reactivate from latently infected ganglia, thus VmwllO is not essential for 
reactivation from latency but facilitates this process (Clements and Stow, 1989; Leib et 
al., 1989; Cai e ta l,  1993). Initial studies examining the latency capabilities of Vmwl 10 
mutants were complicated by the fact that LAT was mutated in addition to Vmwl 10, thus 
a phenotype could not be attributed unequivocally to the mutation in Vmwl 10 (Clements 
and Stow, 1989; Leib et a l, 1989). Insertion of IE1 and its control elements between 
Ul26 and Ul27 of a LAT-  / Vmwl 10-  mutant restored the replication and reactivation 
capability of the virus to half that of wild-type virus, demonstrating that Vmwl 10 plays a 
role in reactivation (Cai et al., 1993). VmwllO facilitates, but is not essential for 
reactivation, thus it seems likely that cell transcription factors can mimic its function. 
Evidence that VmwllO represents a class of transcription factors which mimic its 
reactivation function is manifold. (1) VmwllO mutants can reactivate from latency 
(Clements and Stow, 1989; Leib etal., 1989). (2) The defect in ml814 varies during the 
cell cycle (Daksis and Preston, 1992). (3) The defect of Vmwl 10 mutants varies greatly 
between cell types (Stow and Stow, 1986; Everett, 1989; Yao and Schaffer, 1995). An 
osteosarcoma cell line appears to express a factor that substitutes functionally for 
VmwllO (Yoa and Schaffer, 1995). The isolation and characterisation of such a factor 
will finally test the hypothesis that cell factors related to VmwllO can reactivate HSV 
from latency.
A function encoded by the LAT region plays a role in facilitating reactivation (section 
1.3.9.), the mechanism of action of the LAT on reactivation is unknown.
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The compounds N,N'-hexamethylene-bis-acetamide (HMBA) and DMSO can facilitate 
reactivation in explanted cultures (section 1.3.8.2.; Harbour et a l , 1983; Whitby et al., 
1987; Bernstein and Kappes, 1988; Leib et a l, 1989). These compounds also overcome 
the defect of m l814 in tissue culture by stimulating transcription (section 1.4.; McFarlane 
et a l,  1992), thus one possible mechanism by which they facilitate reactivation is to 
substitute for the lack of Vmw65.
No viral gene product which is essential for the establishment of latency has yet been 
identified. However, any viral factor which is required for efficient replication in neurons 
plays an important role in the pathogenesis of HSV latency. The phenotype of TK 
mutants exemplifies the the role of virus replication in reactivation. TK is specifically 
required for replication in nondividing neuronal cells (Tenser and Dunstan, 1979; Coen et 
al., 1989; Efstathiou et a l, 1989), thus during infection of laboratory animals with TK-  
mutants, virus replication occurs at the periphery and virus reaches the innervating 
neurons. Replication does not occur in ganglia, however, due to the absence of TK, even 
though latency is established. Although activation of the genomes of latent TK-  mutants is 
likely to occur, the neurons are too nonpermissive for a productive infection to ensue 
resulting in the poor reactivation phenotype.
1.3.8. The structure of HSV genomes during latency.
1.3.8.1. Genome configuration.
The predominant population of HSV genomes in virus particles are linear DNA 
molecules (Poffenberger and Roizman, 1985; McGeoch, 1989). Several groups have 
endeavoured to determine the configuration of the genome during latency in neurons. 
There are several possible arrangements including linear, circular, linear concatemeric or 
circular concatememeric episomal DNA, or integration into the cell genome either as a 
single copy or a concatemer (figure 1.5.).
Puga et al. examined the sizes of the terminal restriction endonuclease fragments of 
HSV-1 during latency in mouse trigeminal ganglia (Puga et al., 1984). iscoRI fragments 
fractionated by reverse phase column chromatography and subjected to Southern blotting 
revealed the presence of several sizes of terminal restriction fragments suggesting 
extensive genome rearrangement or integration into the host DNA at a limited number of 
integration sites.
Analysis of HSV-1 DNA in human brain tissue by Southern blotting revealed that in 
some cases the entire genome was present and in others only part of the genome was 
present (Fraser et a l , 1981). Terminal restriction fragments could be detected in some
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Figure 1.5. Possible configurations of HSV genomes during latency. The
predominant population of genomes in HSV virions are linear (Poffenberger and 
Roizman, 1985; McGeoch, 1989). During latency, the joint Bamtil restriction 
fragments are present at double the molarity of the unique fragments (Rock and Fraser, 
1985; Efstathiou et a l , 1986), indicating that the ends are joined together. As the latent 
genomes are episomal (Mellerick and Fraser, 1987), the most likely configurations are 
single or concatemeric circular molecules. Adapted from Anderson (1991).
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cases, suggesting the DNA was in a linear non-integrated form. In contrast Rock and 
Fraser detected most, if not all of the genome in mouse brains, but terminal restriction 
fragments were not detected implying that the genomes were not linear unit length 
molecules (Rock and Fraser, 1983). The molar ratio of restriction fragments from the 
joint region : unique fragments of HSV-1 in murine brains was determined by 
densitometric analysis of Southern blots (Rock and Fraser, 1985). The ratio of joint 
fragments to unique fragments was 1 : 1 for virion DNA, 1.6 : 1 during the acute phase of 
infection and 2 : 1 during latency in trigeminal ganglia. The ratio of 2 : 1 suggests a 
circular, concatemeric, integrated concatemeric or single genomes integrated via the 
unique sequences of the genome.
Efstathiou et a l showed that the HSV-1 genome was present in human trigeminal 
ganglia in an endless form (Efstathiou et a l , 1986). All four isomers were detected in 
murine brainstems and the genome was stably retained over a four month period. The 
genomic termini were detected in mouse brainstems during the acute phase of infection.
The HSV-1 genome was separated from the chromosomal DNA of latently infected 
mouse brains by CsCl buoyant density gradient centrifugation (Mellerick and Fraser, 
1987). CsCl buoyant density gradient centrifugation separates DNA molecules on the 
basis of differences in their G+C contents. EB V DNA was not separated from cell DNA 
from a cell line known to harbour an integrated EBV genome, thus the HSV-1 genome 
was existing in mouse brains in an unintegrated form.
It is now generally accepted that the HSV genome is an endless episomal molecule 
during latency, although it remains unclear whether the genomes are single circular 
molecules or concatemers. The data of Fraser et al. and Puga et al. are difficult to explain 
(Fraser et al., 1981; Puga et al., 1984), however, linear DNA in their latently infected 
samples may have been caused if reactivation had occurred in the latently infected tissues. 
Conversion of the virus genome to the nonlinear configuration occurs during the early 
stages of lytic infection in tissue culture cells and is caused by pre-existing factors 
(Poffenberger and Roizman, 1985). During acute infection there is a mixture of endless 
concatemeric genomes present as replicative intermediates, and linear genomes packaged 
in nucleocapsids.
The retention of nonlinear HSV DNA in in vitro latency models has been reported by 
Preston and co-workers (Harris and Preston, 1991; Preston and Russell, 1991; Jamieson 
et al., 1995) and this is in contrast to the apparently related systems of Wigdahl et al., in 
which the viral DNA was linear (Wigdahl et al., 1984a). In light of the finding that the 
HSV genome is nonlinear during latency in neurons, an in vitro latency system 
representing true latency should contain nonlinear rather than linear DNA.
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1.3.8.2. M ethvlation.
Methylation of DNA plays an important role in the regulation of gene transcription, 
methylation usually correlating with gene inactivity (Razin and Cedar, 1991). Numerous 
studies have sought to identify whether methylation of HSV DNA is a mechanism by 
which transcription of the genome is regulated during latency. Chemicals known to cause 
gross demethylation of the cellular genome, such as 5-azacytidine (Jones and Taylor, 
1980), HMBA, DMSO and L-ethionine (Christman et al., 1980), have been utilised to 
investigate the effect of DNA demethylation on reactivation of HSV from latency 
(Harbour et al., 1983; Whitby et a l, 1987; Bernstein and Kappes, 1988; Leib et a l, 
1989). Application of DMSO to the ears of mice latently infected with HSV-1 after 
inoculation at that site caused reactivation in innervating cervical ganglia (Harbour et al., 
1983). 5-azacytidine and L-ethionine increased the incidence of reactivation of HSV-1 
when added to the culture medium of cultured, dissociated latently infected mouse 
ganglia, and the presence of DMSO and 5-azacytidine caused earlier detection of virus 
(Whitby et al., 1987). HSV-2 was recovered earlier and from a greater percentage of 
latently infected guinea pig dorsal root ganglion and external genital skin cultures when 
HMBA was present in the culture medium (Bernstein and Kappes, 1988). The failure of 
an HSV-1 Vmwl 10 mutant to reactivate from cultured murine ganglia was circumvented 
by DMSO (Leib et a l, 1989). It is probable that these hypomethylating substances have 
additional effects on the cell besides demethylation of DNA (Tamame et al., 1983; Schafer 
and Priest, 1984). Reactivation of HSV could be caused by a change in regulation of cell 
functions rather than demethylation of viral DNA. HMBA overcomes the defect in the 
HSV-1 mutant ml814 if applied early after infection, whereas 5-azacytidine does not 
(McFarlane et a l,  1992). The effect of HMBA on m l814 appears not to be via a 
mechanism involving demethylation of viral DNA, but by a direct stimulation of IE 
transcription (McFarlane et al., 1992; McFarlane, 1993), supporting the view that 
hypomethylating agents may facilitate reactivation by mechanisms not involving 
demethylation of viral DNA.
During the latent phase of infection in an in vitro latency system which utilised a 
persistently infected lymphoblastoid T-cell line, the HSV-1 genome was extensively 
methylated (Youssoufian et a l, 1982), this is in contrast to the productive phase when the 
genome was not methylated. Methylated CG residues were not detected in the in vitro 
latency system of Jamieson et al. when a lacZ gene insertion in the viral genome was 
examined (Jamieson et a l, 1995). Cleavage of DNA extracted from murine brainstems 
with restriction enzymes which fail to cut DNA at methylated sites revealed that the HSV- 
1 genome was not extensively methylated during latency in neurons in vivo (Dressier et 
al., 1987). The three enzymes used by Dressier et al. were estimated to cut at 3% of the 
total CG residues of the viral genome, some of which were at sites likely to be
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preferentially methylated to control transcriptional activity. Methylation at all sites was not 
excluded and the resolution was limited due to the low copy number of viral genomes in 
neuronal tissue. DNA methylation is unlikely to cause the gross transcriptional repression 
of the HSV genome during latency in neurons.
Deamination of 5-methylcytosine in CG dinucleotides produces TG or CA. 
Lymphotropic herpesviruses (EBV and HVS) are deficient in CG and contain excess TG 
and CA, possibly as the result of continuous methylation of their genomes (Honess et al.,
1989). Neurotropic herpesviruses (HSV-1, HSV-2 and VZV) and HCMV contain the 
expected number of CG dinucleotides predicted from the mononucleotide compositions, 
implying that methylation is not important for transcriptional regulation of these viruses, 
at least at the gross level. Retrospective sequence analysis is in agreement with the data of 
Dressier et al., indicating that methylation of CG residues is not an important mechanism 
of gene silencing in HSV (Dressier et al., 1987; Honess et al., 1989). The herpesviruses 
predicted to be regulated by methylation, such as EBV and HVS, establish latency in 
dividing cells where efficient de novo methylation is possible, whereas de novo 
methylation in non-dividing neurons is likely to be inefficient making methylation an 
unlikely cause of transcriptional regulation of HSV during latency (Honess et a l, 1989).
1.3.8.3. Nucleosome organisation.
Eukaryotic cell DNA is wound around nucleosomes (Komberg and Lorch, 1992). 
Regions of DNA organised with nucleosomes can be identified by the use of 
deoxyribonucleases such as MN or staphylococcal nuclease (SN) which cut between 
nucleosomes but are incapable of cleaving DNA wound around nucleosome cores. Partial 
digestion of chromatin with MN or SN yields a series of DNA fragments with sizes 
multiples of approximately 200 bp, thus digestion with MN and SN has proved a useful 
tool for studying nucleosomes binding to viral DNA. The association of viral genomes 
with nucleosomes has also been detected by electron microscopic examination of virus 
nucleoprotein complexes extracted from infected cells (Griffith, 1975; Pignatti and 
Cassai, 1980) and by electrophoretic analysis of polypeptides associated with virus 
nucleoprotein extracts (Pignatti and Cassai, 1980).
The genomes of polyoma virus and SV40 were organised in nucleosomes during lytic 
infection (Griffith, 1975). During productive infection in adenovirus infected cells, 
parental viral genomes were bound by nucleosomes but progeny DNA was non- 
nucleosomal (Daniell et al., 1981). The EBV genome was associated with nucleosomes in 
non-producing cell lines, but after reactivation from latency and in productive cell lines 
only a small proportion was associated with nucleosomes (Shaw etal., 1979). Studies on 
the HSV genome during productive infection have shown that nucleosomes were
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undetectable (Mouttet et a l , 1979; Pagnatti and Cassai, 1980; Lentine and Bachenheimer,
1990) or as with EBV, most DNA was non-nucleosomal with a small background of 
nucleosome-associated DNA (Leinbach and Summers, 1980; Hall et al., 1982; 
Muggeridge and Fraser, 1986). The HSV-1 genome was associated with nucleosomes in 
a chromatin structure during latency in the brainstems of mice (Deshmane and Fraser, 
1989). All regions of the latent HSV-1 genome examined, including the region 
transcriptionally active during latency, were in a structure indistinguishable from cell 
chromatin when analysed by MN digestion. The presence of nucleosomes may be 
required for long term stability of the HSV genome during latency (Efstathiou et a l , 
1986; Deshmane and Fraser, 1989). The fact that nucleosomes are present on the latent 
HSV-1 genome but are absent during lytic infection makes it feasible that nucleosomes 
contribute to silencing the genome during latency. However, a number of promoters 
which are active in the cell genome do not remain active in the viral genome during long 
term latency both in vivo (Lokensgard et a l, 1994) and in in vitro latency systems (Smith 
et a l,  1994; Jamieson et a l, 1995), thus transcriptional silencing during latency may 
involve more than nucleosome-mediated repression.
1.3.8.4. Transcriptional repression.
Gene repression can be caused by the binding of repressor proteins to specific DNA 
sequences (Herschbach and Johnson, 1993). It has been proposed that during the 
establishment of latency IE transcription is repressed by neuronal forms of the octamer- 
binding transcription factor Oct-2 binding to the viral TAATGARAT elements and 
preventing rraws-activation by Vmw65 (Lillycrop e ta l ,  1991; Wood et a l, 1992). Oct-2 
is upregulated in NGF treated neurons, whereas Oct-1 is unaffected (Wood et a l, 1992). 
As NGF is necessary for the maintenance of latency, maintenance of Oct-2 levels may 
provide a mechanism for the action of NGF, inferring that Oct-2 remains bound to the 
genome during latency.
A novel regulatory sequence in the long repeat region of the HSV genome distinct 
from the LAT core promoter can drive expression of LAT or reporter genes over long 
distances during latency and thus contains an element which prevents promoter 
inactivation (section 1.3.9.; Dobson e ta l,  1990; Lokensgard e ta l,  1994). Fascinatingly, 
the MMLV LTR contains an element which is at least partially functionally equivalent to 
the HSV element and can drive long-term expression during latency when placed 
downstream of the neuron-specific LAT core promoter at the gC locus (Lokensgard et a l,
1994) or when placed by itself as far as 500 bp downstream of the LAT polyadenylation 
signal (Dobson et a l,  1990), but when placed alone at the gC locus is repressed 
(Lokensgard et a l, 1994). The HSV-specified element responsible for overcoming
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repression of the genome and its precise location within the HSV long repeat region 
remains to be characterised, although evidence from various studies suggests that it is 
located downstream of the LAT cap site (Lokensgard et al., 1994). The effects on DNA 
structure of the element responsible for maintaining LAT transcription might give clues to 
the mechanism of repression of the viral genome during latency.
The location of the HSV genome within the nucleus might play a crucial role in 
latency. Recently, HSV-1 DNA was found to co-localise with nuclear structure known as 
ND10 domains during the early stages of lytic infection (Maul et a l, abstract 133, 20th 
International Herpesvirus Workshop, Groningen, The Netherlands, 1995; R.D. Everett, 
personal communication). The function of ND10 domains is unknown. One component 
of ND10, named PML, contains a RING finger domain similar to that of VmwllO 
(Goddard et a l , 1991). In promyelocytic leukaemia cells a chromosomal translocation 
fuses the RING finger of PML with the retinoic acid receptor, inferring that PML and 
other components of ND10 play a role in cell differentiation (Kakizuka et al., 1991). 
Treatments which cause reactivation of HSV, such as hyperthermia (Sawtell and 
Thompson, 1992a), administration of CdS0 4  (Fawl and Roizman, 1993) or expression
of Vmwl 10 (Harris et al., 1989; Harris and Preston, 1991; Cai et a l , 1993; Minigawa et 
a l,  1994) all cause disruption of ND10 (Maul et a l, 1993; Maul, 1995; Maul et a l,  
abstract 133, 20th International Herpesvirus Workshop, Groningen, The Netherlands,
1995) whereas treatment of cells with the IFNs, which inhibit the onset of lytic infection, 
causes an increase in the number of ND10 domains (Guldner et a l, 1992; Korioth et a l,
1995). It appears that disruption of ND10 is required for efficient lytic infection and that 
factors present in ND10 and their interaction with Vmwl 10 might play an important role 
in latency and reactivation. It is of interest to know if HSV DNA is located in ND10 
domains during latency.
1.3.9. Viral transcription during latency.
In early studies HSV transcripts were detected in latently infected neurons (Galloway 
et a l, 1979, 1982; Stroop et a l,  1984). Detailed analysis of transcription using in situ 
hybridisation and northern blotting revealed that the only detectable transcripts arose from 
around IE1 and were antisense to VmwllO mRNA (Croen et a l, 1987; Deatly et a l, 
1987; Spivack and Fraser, 1987; Stevens e ta l,  1987; Gordon e ta l,  1988; Krause e ta l,  
1988; Steiner et a l, 1988; Stevens et a l, 1988). The most abundant latency-associated 
transcript (LAT) was around 2 kb in size, and a smaller 1.5 kb molecule was also 
observed at about 50% abundance to the 2 kb LAT (Rock et a l, 1987; Spivack and 
Fraser, 1987; Stevens et a l, 1987; Krause et a l, 1988; Wagner et a l,  1988a, b). Both 
the 2 kb LAT and the 1.5 kb LAT overlapped and were antisense to about 750 residues of
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Figure 1.6. T ranscrip tion  and regulatory elements of the LAT region. (A)
Depiction of the HSV-1 genome. (B) The internal copy of the long repeat region is 
expanded showing the restriction endonuclease sites relevant to the studies in the thesis 
presented here. (C) Transcripts arising from the LAT region and their directions of 
transcription. The 2 kb LAT is believed to be a splicing product from the mLAT, 
however the spliced mLAT exon has not been detected and recent evidence suggests 
that the 2 kb LAT may also arise independently of the mLAT via LAP-2-mediated 
transcription (Chen etal., 1995). The position of ORF-P is also indicated (Bohenzky et 
al., 1993; Lagunoff and Roizman, 1994, 1995). (D) Two regulatory elements 
controlling LAT transcription, LAP-1 and LAP-2. LAP-1 mediates LAT transcription 
during latency and LAP-2 is important for transcription during lytic infection. The 
positions of the p-globin insertion downstream of the LAT TATA box in the 
recombinant virus made by Dobson et al. (1989) and the lacZ insertion downstream of 
LAP-2 in the recombinant virus made by Ho and Mocarski (1989) are indicated.
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the 3' end of Vmwl 10 mRNA (figure 1.6.; Rock et al., 1987; Spivack and Fraser, 1987; 
Stevens et a l, 1987; Krause et a l, 1988; Wagner et a l, 1988a, b; Spivack et a l, 1991). 
The LATs were largely confined to the nuclei of neurons and were poly (A)-  (Rock et a l, 
1987; Stevens et a l, 1987; Wagner et a l, 1988a). The transcription pattern was similar 
during latency in humans (Krause et a l, 1988; Steiner et a l, 1988), mice (Spivack and 
Fraser, 1987; Stevens et a l, 1987) and rabbits (Rock et a l, 1987). In one study virus 
strain and host species affected the relative abundance of the 2 kb and 1.5 kb LATs 
(Wagner et a l, 1988b). During lytic infection in tissue culture or acute infection of animal 
brains the 2 kb LAT was much less abundant than during latency and the 1.5 kb LAT was 
undetectable (Spivack and Fraser, 1987; Krause et a l, 1988; Steiner et a l, 1988; Wagner 
e ta l ,  1988b).
Cloning of partial LAT cDNAs from latently infected trigeminal ganglia enabled the 
identification of a 550 nucleotide sequence spliced from the 2 kb LAT forming the 1.5 kb 
LAT (Spivack et a l, 1991). Interestingly, the splice signals forming the 1.5 kb LAT 
differ from the usual eukaryotic splice signal in that the 5' end of the LAT intron is GC 
instead of GT. It was suggested that the unusual signal accounted for the neuronal 
specificity of the splicing reaction and acted inefficiently during latency, causing the 
greater abundance of the 2 kb LAT over the 1.5 kb LAT. Removal of the intron from the 
2 kb LAT may enable efficient translation of putative downstream ORFs: such ORFs can 
be translated from denatured RNA in vitro but their translation products have yet to be 
demonstrated in vivo.
Several groups have reported hybridisation in latently infected ganglia with probes 
from regions immediately adjacent to both the 5' and 3' ends of the 2 kb LAT, and these 
transcripts were named the minor hybridising LAT (mLAT; Krause et a l, 1988; Wagner 
et al., 1988a; Mitchell et a l, 1990a). The mLAT was detected by in situ hybridisation but 
was present at levels undetectable in northern blots, appearing to be far less stable than the 
major abundance LATs (Krause et al., 1988; Wagner et a l,  1988a; Mitchell et a l, 
1990a). A TATA box-containing promoter located 700 bp upstream of the 5' end of the 
LAT was identified by its ability to drive expression of heterologous genes during latency 
(Dobson et a l,  1989), lytic infection (Dobson et a l, 1989), and in transfection assays 
(Zwaagstra et a l, 1989; Batchelor and O’Hare, 1990; Zwaagstra et a l, 1990). Deletion of 
the promoter 700 bp upstream of the LAT from the HSV genome abolished expression of 
the major LAT and the mLAT (Javier et a l, 1988; Dobson e ta l,  1989; Izumi et a l, 1989; 
Mitchell et a l, 1990b). Transcription from the LAT promoter terminated at the first 
polyadenylation signal located 8.77 kb from the TATA box, thus the mLAT was colinear 
with and overlapped the LAT, antisense to IE1 and ICP34.5, and was poly(A)+ (Dobson 
et a l, 1989; Devi-Rao et a l,  1991). It seemed likely that the mLAT was spliced to 
produce the abundant LAT, however the 6.77 kb derivative of such a splicing event was 
not detected, presumably due to instability (Dobson et al., 1989; Devi-Rao et a l, 1991).
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When a clone of LAT DNA was inserted into the E.coli lacZ gene within a replicating 
eukaryotic expression vector, resulting transcription gave rise to high levels of LAT and 
relatively lower levels of spliced p-galactosidase mRNA (Farrell et al., 1991). 
Sequencing of the spliced product revealed that splicing had occurred at the consensus 
donor and acceptor sites. The LAT appeared to be an unusually stable intron that itself 
contained an intron.
The regulatory region upstream of the mLAT transcription start site is a functional 
transcriptional promoter containing the usual consensus RNA polymerase II elements, 
including a TATA box. Elements controlling transcription from the promoter upstream of 
the mLAT include several Spl sites (Batchelor and O’Hare, 1992), two cAMP response 
elements (Leib et al., 1991; Kenny et al., 1994), a CAAT homology (Batchelor and 
O’Hare, 1992), regions which confer neuronal specificity (Zwaagstra et a l, 1990, 1991; 
Batchelor and O’Hare, 1992), a binding site for an activator protein termed the LAT 
promoter binding factor (LPBF; Zwaagstra et al., 1991), and a repressive Vmwl75 
binding site located on the transcription start site (Batchelor and O’Hare, 1990; Batchelor 
et a l, 1994). The element regulating LAT expression exhibits two crucial characteristics, 
firstly it is capable of overcoming the transcriptional repression which occurs on the rest 
of the genome, and secondly it has neuronal specificity. Fascinatingly, the LAT TATA- 
containing promoter and upstream sequences were only capable of driving expression 
during the early stages of latency but were unable to drive long-term transcription when 
placed away from the LAT region at the gC locus (Lokensgard et a l, 1994). The MMLV 
LTR was unable to drive long-term expression when placed at the gC locus by itself, but 
when paired with the upstream LAT promoter long-term transcription initiated within the 
LTR (Lokensgard et al., 1994). The MMLV LTR was thus able to overcome repression 
of the genome during latency and the upstream LAT promoter provided the required 
neuronal transcription factor binding sites. The LAT region of the HSV-1 genome is 
thought to contain a DNA element functionally equivalent to the MMLV LTR. The 
following evidence suggests that the region of the HSV-1 genome capable of overcoming 
repression is located between the LAT start site and the start of the 2 kb LAT: 1) A virus 
with the rabbit (3-globin gene immediately downstream of the LAT TATA box was able to 
express rabbit P-globin during latency (Dobson et a l, 1989). 2) A virus with the lacZ 
gene downstream of the LAT TATA box with 1.5 kbp of the downstream sequences 
deleted was unable to give long term expression (Margolis et al. 1992), as the entire 
sequences upstream of the LAT TATA box were present the long-term expression element 
cannot be upstream of the TATA box. 3) The MMLV LTR remained active during latency 
when placed by itself 500 bp downstream of the LAT polyadenylation signal (Dobson et 
al., 1990) but was not active when placed by itself at a distance from the LAT region at 
the gC locus (Lokensgard et al., 1994). Clearly proximity to the LAT region conferred 
activity on the MMLV LTR. The region between the mLAT start site and the 2 kb LAT
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start site is a novel TATA-less promoter active during latency in mouse ganglia and in 
transfection assays (Goins e ta l , 1994).
The novel latency-active promoter downstream of the mLAT start site and upstream of 
the 2 kb LAT was named the latency-active promoter-2 (LAP-2) and the TATA-containing 
upstream promoter named LAP-1 (figure 1.6.; Goins et al., 1994). LAP-2 contains 
elements common to eukaryotic housekeeping gene promoters, was downregulated by 
Vmwl75 and Vmwl 10 and was 5-10 fold less active than LAP-1 in transfection assays 
(Goins et a l, 1994). Transcription from LAP-2 started at or near the 5' end of the 2 kb 
LAT, implying that the 2 kb LAT can be transcribed as a single unit independent of LAP- 
1 and the mLAT (Goins et al., 1994). Previous studies have supported transcription 
initiation at the start of the 2 kb LAT: Ho and Mocarski inserted lacZ at +137 relative to 
the start of the 2 kb LAT and found that mRNA initiated near the 5' end of the stable 
LATs rather than at the LAT TATA box (Ho and Mocarski, 1989). The splice sites 
forming the 2 kb LAT in the clones described by Spivack et al. did not correlate with 
consensus splice site usage in that the 5' end was one nucleotide removed from the 
proposed splice donor sequence and the 3' end mapped 79 bp upstream of the splice 
acceptor site (Spivack et a l, 1991). Recent data suggests both LAP-1 and LAP-2 are 
required for maximal LAT expression during latency (Chen et al., 1995). LAP-2 contains 
the elements causing expression during lytic infection, whereas LAP-1 did not contribute 
to expression during lytic infection. LAP-1 was the element most influential on 2 kb LAT 
during latency. LAP-1 and LAP-2 may be independent elements required for expression 
of LAT at different stages of infection. It is of interest that LAP-1 remained active during 
latency in the absence of LAP-2, therefore the element within the LAT region proposed by 
Feldman to drive long-term expression (Lokensgard etal., 1994), must be downstream of 
the region designated as LAP-2 by Glorioso (Goins etal., 1994). Clearly LAP-1 and the 
long-term expression element act in concert to enable long-term transcription during 
latency. Further analysis is required to identify and characterise the long-term expression 
element in HSV functionally equivalent to the MMLV LTR, and to determine how LAT 
expression and splicing is regulated during lytic and latent infection.
Several ORFs have been identified in the LAT DNA sequence, however antibodies 
raised against synthetic peptides from the predicted proteins have never demonstrated the 
presence of a LAT-encoded protein in vivo (Wagner et al., 1988a; Wechsler et al., 1989). 
Doerig et al. reported a LAT antigen expressed in the in vitro latency system of Wilcox 
and co-workers utilising primary neuronal cultures from foetal dorsal-root ganglia treated 
with ACG (Doerig et al., 1991a). Antibodies were raised against a bacterially expressed 
fusion protein consisting of part of the ORF designated by Wagner et al. as ORF-2 
(Wagner et a l, 1988a). The antibody stained latently infected cultures, but although the 
predicted size of the protein was 33 kDa, the antibody recognised an 80 kDa protein. The 
antigen observed by Doerig et al. has never been identified in vivo and until such an
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identification is made should be considered an unfortunate artefact of their experimental 
system.
Two LAT ORFs are conserved between HSV-1 strains F, 17(syn+) and KOS, making 
it feasible that they code for functional proteins (Wechsler et a l, 1989). Translation of 
one ORF has been induced in vitro, although translation occurred only after the transcripts 
had been heat denatured (Spivack et al., 1991). Translation of the two conserved LAT 
ORFs would be inhibited by the secondary structure and AUGs present in the intron of 
the 2 kb LAT. It was proposed that splicing to produce the 1.5 kb LAT regulates 
translation of the LAT ORFs enabling translation during latency, an attractive hypothesis 
because the 1.5 kb LAT has only been demonstrated during latency and is absent during 
lytic infection.
LAT sequences of HSV-1 and HSV-2 are dissimilar except for the promoters and 
regions overlapping IE1 (McGeoch et al., 1991). Previously identified ORFs are not 
conserved between HSV-1 and HSV-2 and both virus strains show no signs of the three 
nucleotide bias in nucleotide composition characteristic of HSV-1 coding sequences. 
Sequence comparison between the LAT regions of HSV-1 and HSV-2 provided evidence 
against a LAT-encoded protein.
The inability to detect a LAT-encoded protein, the nuclear localisation and lack of a 
poly(A) tail of the LAT and the lack of any ORFs conserved between HSV-1 and HSV-2 
argues against a protein encoded by the major abundance LATs, however a LAT-encoded 
protein might be expressed transiently at a specific stage of infection such as during the 
early stages of establishment of or reactivation from latency, hence the protein would be 
undetectable during latency. The possibility of translation from an as yet undetected RNA 
or ORF cannot be discounted.
Lagunoff et a l identified 16 potential ORFs predicted to encode 50 or more codons 
within the mLAT and examined 5 of the ORFs by in-frame insertion of an epitope from an 
HCMV-encoded protein (Lagunoff et a l, 1994). One ORF designated ORF-P (figure 
1.6.), was detected in extracts from lytically infected tissue culture cells using antibodies 
specific for the HCMV epitope. Insertion of a second in-frame epitope into ORF-P 
resulted in the detection of a slower migrating protein, confirming the authenticity of 
ORF-P. In addition, another group has detected an RNA transcript arising from ORF-P, 
and have identified its promoter (Bohenzky et a l, 1993). ORF-P is antisense to and 
comprises almost all of the gene encoding ICP34.5. It is of interest that mutations 
affecting ICP34.5 also disrupt ORF-P and that such mutants exhibit a reduced capacity to 
establish and reactivate from latency (Whitley et a l, 1993), thus ORF-P has raised 
considerable interest as having a potential role in latency. Regulation of ORF-P exibits 
charateristics expected of a latency-active gene, since it is expressed under IE conditions, 
is repressed by Vmwl75 and its promoter contains a potential binding site for Vmw65, 
thus ORF-P is transcriptionally repressed during lytic infection and might be expressed
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during latency (Lagunoff and Roizman, 1994, 1995). Although ORF-P translation 
products have not been detected in latently infected tissue to date, the low level of 
expression observed in tissue culture suggests that expression might be undetectable 
during latency. During late times of infection in tissue culture, the epitope-tagged ORF-P 
was modified to forms which migrated more slowly during electrophoresis and which 
assumed distinct structures in the cell nuclei (Lagunoff and Roizman, 1995).
The main approach used to investigate the function of LAT has been to examine the 
phenotypes of mutants which do not express a stable LAT during latency in animal 
models. In numerous studies, the inability to express a stable LAT during latency did not 
affect the ability to establish and maintain latency (Ho and Mocarski, 1989; Sederati et al., 
1989; Block et al., 1990; Hill et al., 1990; Deshmane et al., 1993; Pemg et al., 1994a). A 
common phenotype observed with many, but not all mutants was impaired reactivation 
(Steiner et al., 1989; Hill et al., 1990; Pemg et al., 1994a). The inability to produce a 
stable LAT during latency did not necessarily correlate with impaired reactivation (Ho and 
Mocarski, 1989; Block et al., 1990; Deshmane et a l, 1993). Regulation of the LAT 
region is complex and is dependent on different regulatory elements during lytic infection 
and latency (Goins et al., 1994; Lokensgard et al., 1994; Chen et a l,  1995). It is of 
interest to note that some LAT mutants unable to express a stable LAT during latency can 
express transcripts from the LAT region during lytic infection (Block et al., 1990), hence 
transcription from the LAT region was not completely disrupted when transcription of a 
stable LAT during latency was prevented, thus it is possible that mutations which 
prevented LAT expression during latency did not all impair the function of the LAT region 
which facilitates reactivation. The region of the LAT transcription unit which facilitates 
reactivation requires further identification and characterisation.
A LAT-  mutant of strain KOS which expresses |3-galactosidase from the LAT 
promoter established 80% fewer p-galactosidase-expressing neurons during latency in the 
trigeminal ganglia of mice when compared to the wild type parent, and reactivated 80% 
less efficiently after the mice were exposed to hyperthermia (Sawtell and Thompson, 
1992b). However, no difference was observed in the establishment or reactivation of 
latency from the lumbrosacral ganglia, indicating that the reactivation impairment of the 
LAT-  mutant was dependent upon the site of latency. Analysis of colocalisation of p- 
galactosidase with HSV antigen during the establishment of latency revealed a higher 
degree of colocalisation in trigeminal but not the lumbrosacral ganglia infected with the 
LAT-  mutant. It was suggested that LAT facilitated repression of viral replication, thus in 
ganglia infected with the LAT-  mutant a greater proportion of cells were lytically infected 
and killed, resulting in a poor ability to establish latency and an impaired ability to 
reactivate. Another group reported that a LAT-  mutant of strain 17(syn+) was delayed in 
reactivation from trigeminal ganglia of mice, but the KOS LAT-  mutant was not impaired
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in reactivation from the lumbosacral ganglia (Devi-Rao et a l, 1994), thus supporting the 
hypothesis that LAT-  mutants have a site-dependent phenotype.
The mechanism by which LAT facilitates reactivation is unknown. LAT might act as a 
functional RNA or might encode an as-yet undetected protein. Early suggestions that LAT 
functions as an antisense molecule by downregulating translation of VmwllO mRNA 
(Stevens et a l, 1987) was disproved by the finding that LAT mutants establish latency 
and are impaired for reactivation rather than biased towards lytic infection. As LAT 
mutants are capable of establishing and maintaining latency, it is clear that LAT plays a 
qualitative rather than essential role in latency.
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1.4. EFFECT OF HMBA ON in 1814.
HMBA is of interest since it dramatically overcomes the defective phenotype of 
m l814 in tissue culture, restoring its particle / PFU ratio close to that of wild type virus 
(McFarlane et a l, 1992, McFarlane, 1993). HMBA also enhances reactivation of HSV 
from explanted ganglia (Bernstein and Kappes, 1988).
HMBA belongs to a class of compounds, including DMSO and hypoxanthine, 
which are united by their ability to induce terminal differentiation of myeloid 
erythroleukaemia cells (MELCs) and certain tumour cell lines (Friend et a l , 1971; Palfrey 
et al., 1977; Collins et al., 1980; Reuben et a l, 1980; Marks et al., 1987). Treatment of 
MELCs with HMBA leads to a dramatic change in gene expression in the cells, ultimately 
resulting in greatly increased expression of the a  and Pmaj-globin genes. The exact 
mechanism by which HMBA initiates the changes in gene expression are not fully 
understood, however HMBA binds to the cell surface and causes a change in the cell- 
surface potential (Arcangeli et al., 1993). Early changes induced by HMBA include a 
decrease in levels of c-myc and c-myb mRNAs, an increase in c-fos mRNA and a 
transient rise in p53 mRNA (Ramsay et al., 1986; Richon et al., 1989). However, these 
early changes in c-myc, c-myb, c-fos and p53 are not sufficient for irreversible 
commitment to differentiation (Richon et a l, 1989). Forced constitutive expression of c- 
myb in MELCs makes the cells unable to differentiate (Copolla and Cole, 1986; 
Dmitrovsky et al., 1986; Clarke et a l,  1988), and dexamethasone, which inhibits 
HMBA-induced differentiation, prevents the early decrease in c-myb induced by HMBA 
(Ramsay et al., 1986), thus the downregulation of c-myb appears necessary for 
differentiation to occur.
Exposure of MELCs to HMBA or DMSO results in extensive demethylation of the 
cell genome (Razin et a l, 1986, 1988). Exposure to HMBA in the presence of inhibitors 
of methylation results in inhibition of MELC differentiation (Razin et al., 1988). 
However, HMBA-induced differentiation is inhibited in the presence of cycloheximide 
even though hypomethylation occurs normally, thus although DNA hypomethylation 
appears to be essential for HMBA-induced MELC differentiation, it is not sufficient per 
se.
There is evidence that PKC is a component of the HMBA-induced differentiation 
pathway. HMBA and DMSO cause an initial increase, followed by a decrease in 
diacylglycerol, one of the triggers of PKC activity (Michaeli et al., 1992; Durkin et al.,
1992). Phorbol esters which mimic diacylglycerol, inhibit differentiation (Melloni et al., 
1987; Falleto et al., 1985). Isoform-specific translocation of PKC8 and PKCe from the 
cytosol to the membrane occurs early during differentiation, and failure to do so is 
associated with resistance to HMBA-induced differentiation (Leng et al., 1993).
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Recent molecular studies on the induction of MELC differentiation have focused on 
the control of the cell cycle (Kiyokawa et a l, 1994; Marks et a l, 1994). MELCs exposed 
to HMBA exhibit a prolonged Gi-phase (Gambari et a l, 1978, 1979). Researchers have 
suggested that the prolongation of the Gi-phase by HMBA enables a larger proportion of 
the cells to leave the cell cycle and undergo differentiation (Marks et a l, 1994). HMBA- 
treatment results in a 20-fold decrease in cdk4 protein levels, a 3-fold increase in cyclin 
D3 levels and a 3-4-fold increase in levels of underphosphorylated pRB (Richon et a l, 
1992; Kiyokawa et a l, 1994). The inhibition of cdk4 activity appears to be a crucial step 
in differentiation, since over-expression of cdk4 in transfected cells leads to an inhibition 
of HMBA-induced differentiation (Kiyokawa et a l, 1994). Cdk4 may be required for 
phosphorylation of pRB and p i07, which in their phosphorylated forms are unable to 
complex with and inactivate transcription factors such as E2F. The transcription factor 
E2F transactivates genes required for progression into the cell cycle, such as c-myc, c- 
myb and DNA polymerase a . Thus HMBA leads to underphosphorylation of proteins 
such as pRB and pl07, thereby resulting in prolonged Gi-phase and differentiation rather 
than entry into S-phase and mitosis. Consistent with the hypothesis that HMBA acts by 
altering the cell cycle, HMB A-treament of MELCs causes a loss of E2F DNA-binding 
activity, an increase in levels of p i07 protein and the emergence of a new form of E2F 
(Richon and Ventaperez, 1996).
Reactivation of HSV in animal models is stimulated by HMBA and DMSO (section 
1.3.8 .2.; Harbour et a l, 1983; Whitby et a l, 1987; Bernstein and Kappes, 1988; Leib et 
a l, 1989). Since other hypomethylating substances such as 5-azacytidine and L-ethionine 
also facilitate reactivation (Whitby et a l, 1987; Stephanopoulos et a l, 1988), the ability 
of HMBA and DMSO to facilitate reactivation was attributed to their hypomethylating 
activity. However, HMBA and DMSO dramatically overcome the defective phenotype of 
m l814 in tissue culture, whereas 5-azacytidine does not (McFarlane et a l, 1992), thus 
the mode of action of these substances on reactivation of HSV from latency has been 
brought into question.
The particle / PFU ratio of m l814 is close to that of wild type virus during infection 
in the presence of HMBA (McFarlane et a l, 1992). Previous exposure of cells to HMBA 
is unable to stimulate m l814 titre, thus the changes on the cell induced by HMBA are 
transient, 1814 titre gradually becomes insensitive to HMBA over the first 6 hours of 
infection, since after approximately 6 hours infection HMBA does not stimulate the titre 
above that which occurs in its absence. HMBA therefore has an effect on ml814 similar 
to that of Vmw65, since Vmw65 is also unable to stimulate ml814 titre at 6 hours post­
infection (Harris and Preston, 1991). The concentration of HMBA required for maximal 
stimulation of ml814 titre (5 mM) is similar to the concentration which causes maximal 
induction of MELC differentiation. In addition, other inducers of MELC differentiation
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are also capable of stimulating the titre of ml814 (McFarlane and Preston, 1992; C.M. 
Preston, unpublished data), suggesting a common mechanism of action between the 
induction of MELC differentiation and the stimulation of ml814 titre.
HMBA increases levels of viral IE mRNAs in HFL cells infected with ml814 by 
approximately 2-fold, suggesting that HMBA exerts its effect on m l814 by stimulating IE 
gene expression (McFarlane et al., 1992). The effect on viral IE mRNA levels occurs in 
the presence of cycloheximide, thus HMBA acts transiently on pre-existing factors rather 
than by inducing the expression of cellular genes.
The particle / PFU ratio of the Vmwl 10 deletion mutant d/1403 is not restored to 
that of wild type by HMBA (McFarlane et al., 1992), neither are Vmwl75-defective 
mutants able to forms plaques in the presence of HMBA (McFarlane et al., 1992; 
McFarlane, 1993), thus it is unlikely that HMBA acts by inducing factors that functionally 
substitute for Vmwl 10 or Vmwl75.
The ability of HMBA to stimulate gene expression is dependent on the location of 
the template DNA. HMBA stimulates gene expression from IE, E and L HSV promoters 
and from the HCMV major IE and SV40 promoters when in transfected plasmids, thus 
the effect of HMBA on gene expression appears relatively non-sequence-specific 
(McFarlane, 1993). However, when introduced into the cell genome, the HSV IE and E 
promoters are unresponsive to HMBA but remain responsive to transactivation by 
Vmw65 and the viral IE proteins. The non-sequence-specific action of HMBA suggests 
that it stimulates gene expression by altering a global process involved in gene 
expression, possibly by enhancing transcription initiation (McFarlane, 1993).
One possible mechanism by which HMBA could increase the accumulation of viral 
EE mRNAs, is to promote the formation of a transactivation complex at TAATGARAT 
elements. HMBA might either modify cell components enabling them to transactivate via 
TAATGARAT or enable the mutated Vmw65 to form the viral transactivation complex 
with Oct-1 and HCF. However, an investigation into the formation of complexes at 
TAATGARAT using gel-retardation experiments did not reveal any difference in 
TAATGARAT binding complexes in untreated and HMBA-treated cells (McFarlane,
1993), thus HMBA does not appear to stimulate HSV IE gene expression by inducing a 
TAATGARAT-binding transactivation complex.
Although it seems possible that HMBA increases levels of viral IE mRNAs by 
stimulating transcription, McFarlane was unable to demonstrate that HMBA stimulated 
transcription mediated by RNA pol II or RNA pol III in in vitro transcription assays 
(McFarlane, 1993). It was suggested that the inability to detect a stimulation of 
transcription was due to the highly transient nature of the alterations induced by HMBA.
In summary, HMBA is known to alter gene expression in cells and at least some of 
these alterations have been uncovered, however, the mechanism by which it stimulates 
HSV IE gene expression and overcomes the defect in m l814 is not yet fully understood.
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1.5. THE INTERFERONS AND THEIR  
ANTIVIRAL ACTION AGAINST HSV.
IFN was first identified as a soluble factor released by chick egg chorioallantoic 
membrane upon exposure to heat-inactivated influenza virus (Isaacs and Lindenman, 
1957). The soluble factor conferred resistance to virus infection when used to treat to 
other cells.
The IFNs are produced by a wide variety of cells and have marked effects on 
cellular gene expression leading to modulation of growth and differentiation and an 
antiviral state (Samuel, 1991; Sen and Lengyel, 1992).
Two types of IFN exist, type I includes IFNa and EFNp and type II is IFNy. 
Almost all cell types are capable of producing the type I IFNs, whereas type II is 
produced solely by T lymphocytes and natural killer cells. Type I IFNs are induced by 
virus infection, bacteria, mycoplasma and exposure to certain lymphokines such as 
colony-stimulating factor-1, interleukin (IL)-l, IL-2 and tumour necrosis factor. Inducers 
of type II include EL-2 and any antigen to which the organism is sensitised.
All of the type I IFN genes are clustered on the short arm of human chromosome 9 
(Weissmann and Weber, 1986). There are over 20 copies of IFNa and just one copy of 
IFNp. All of the type I IFN genes lack introns, whereas the single gene encoding IFNy 
contains 3 introns and is located on the long arm of chromosome 12.
IFNs a  and p share the same receptor, whereas IFNy uses a separate receptor 
(Merlin et al., 1985). However, expression of the human IFNa receptor on mouse cells 
confers responsiveness to certain subtypes of human IFNa but not to human EFNp, 
inferring that additional receptor molecules might be involved in the binding of EFNp 
(Uze e ta l ,  1990).
Induction of the IFN genes occurs at the transcriptional level and does not require 
protein synthesis (Hiscott et a l, 1995). The EFN genes contain cis-acting sequences at 
their 5' ends which bind transcriptional activators which are activated in response to the 
appropriate stimuli. The 5' regulatory region of the IFNp gene is the best characterised of 
the EFN promoters, containing a 110 nucleotide regulatory element with multiple binding 
site for both activators and repressors. In the uninduced state, the EFNp promoter is 
bound by numerous transcriptional repressors, whereas upon virus infection a large array 
of activators bind to their specific sites, replacing the repressors. The activators include 
IRF (EFN-regulated factor)-1, the NFkB / Rel family of transcription factors, the ATF-2 / 
CREB family and HMG 1/Y. The signal for the activators to bind to the IFNp gene 
regulatory regions are not fully understood in most cases, however NFkB binding can be 
induced by the action of PKR (Williams, 1995). In response to activation by dsRNA 
produced in virus-infected cells and possibly by other virus-induced stimuli, PKR
61
Introduction
phosphorylates IkB which in its dephosphorylated state complexes with and represses 
NFkB. Thus phosphorylation of IkB releases NFkB enabling transcriptional activation of 
NFkB-dependent genes.
The binding of IFNa to its receptor activates latent transcriptional activators termed 
Stats (signal transducers and activators of transcription; Levy, 1995). In uninduced cells, 
Statl and Stat2 are located in the cytoplasm, whereas upon IFNa-treatment they are 
tyrosine phosphorylated by a member of the JAK family of receptor-bound kinases 
(Janus kinases), assemble into multimeric complexes and translocate to the nucleus. Statl 
and Stat2 form a complex termed ISGF3 (IFN-stimulated gene factor 3) by binding to the 
constitutively expressed DNA-binding IRF p48. ISGF3 binds to the ISREs (IFN- 
stimulated response elements) upstream of all IFNa-induced genes and stimulates their 
transcription. The individual biological responses generated by each individual IFN can 
be explained by the functional overlap and complex regulation of their signal transducers 
and the interferon-stimulated gene regulatory elements, for example phosphorylated Statl 
alone can also activate IFNy-induced genes containing the gamma-activated site (GAS), 
thus GAS-containing promoters are activated by both IFNa and IFNy.
The IFNs are known to induce the synthesis of more than 30 proteins, some of 
which are undetectable in untreated cells and some of which are increased only slightly in 
response to IFN. A proportion of the IFN-induced genes are only induced by one IFN, 
whereas others are induced by all 3 types.
The molecular basis for the antiviral state induced by the IFNs has been extensively 
studied and has revealed 3 major mechanisms of resistance to virus replication so far, the 
Mx system, the 2',5'-A oligoadenylate synthetase-induced pathway and the dsRNA- 
dependent IFN-induced protein kinase pathway. These 3 mechanisms will be reviewed 
briefly.
The human MxA protein accumulates in the cytoplasm of type I IFN-treated cells. 
MxA possess antiviral activity against influenza (Pavlovic et a l, 1995), measles (Schnorr 
et a l, 1993), VSV (Pavlovic et a l, 1995; Schwemmle et a l,  1995) and Thogoto virus 
(Pavlovic et a l, 1995). All mammalian species examined synthesise one or more Mx 
proteins in response to the type I IFNs, however the mechanism of action of the Mx 
proteins differs between species and the action of any single Mx protein differs between 
the target viruses. Mx proteins are believed to exert their antiviral functions by binding to 
and inactivating polymerase proteins of negative-stranded RNA viruses. The MxA protein 
inhibits different steps of the multiplication cycles of influenza A virus, VSV and measles 
virus. In the case of VSV, primary transcription of the input genome is inhibited (Staehli 
and Pavlovic, 1991; Schnorr et a l, 1993). Influenza A virus is inhibited at an unknown 
step between primary transcription and genome amplification (Pavlovic e ta l ,  1992). 
MxA appears to affect measles virus glycoprotein synthesis, rather than transcription or
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genome replication (Schnorr et a l, 1993). Mx proteins are GTP-binding proteins with 
GTPase activity that is essential for their function (Pitossi et al., 1993). Although the 
mechanism that GTP binding and hydrolysis plays in the activity of the Mx proteins is not 
fully understood, a recent study indicated that the binding of GTP to MxA, and not GTP 
hydrolysis, was necessary for antiviral activity against VSV (Schwemmle et al., 1995).
The enzyme 2',5'-oligoadenylate synthetase is induced by type I and type II IFNs 
(Samuel, 1991). When activated by dsRNA, 2',5'-oligoadenylate synthetase catalyses the 
formation of 2',5'-oligoadenylates (abbreviated to 2,5-A), a family of oligonucleotides 
with the structure ppp(A2'p5')nA, where n > 2. In turn, 2,5-A binds to and activates 
RNase L, which proceeds to cleave single stranded viral and cellular RNAs, thereby 
inhibiting viral replication. The enzyme 2',5'-phosphodiesterase performs a regulatory 
role by catalysing the conversion of 2,5-A to AMP and ATP. The 2,5-A system acts 
selectively against the picomaviruses.
PKR is induced by type I IFNs and activated by the binding of dsRNA. Activation 
of PKR leads to autophosphorylation, and when in the activated state PKR 
phosphorylates the a  subunit of the translation initiation factor eIF-2a, thereby leading to 
inhibition of translation (Samuel, 1993). Viruses including adenovirus, EBV, HIV, 
influenza, poliovirus, reovirus and vaccinia have evolved intriguing and varied 
mechanisms for preventing the antiviral function of PKR (Katze, 1993). Mechanisms of 
inhibition of PKR include the production of RNAs which specifically bind to and 
inactivate PKR (adenovirus, EBV and HIV), the activation of cellular pathways which 
repress PKR activity (influenza and poliovirus), and the production of viral proteins 
which bind and sequester the dsRNA activator molecules (reovirus and vaccinia).
Viruses with DNA genomes, including HSV, are relatively resistant to the action of 
the IFNs compared to the RNA viruses. The production of infectious HSV progeny is 
reduced by approximately 100-fold in IFN-pretreated cells in culture. However, the 
mechanism of action of the IFNs against HSV appears not to occur via one of the well 
characterised IFN-induced pathways described above, but by a specific inhibition of IE 
transcription (Mittnacht etal., 1988; Oberman and Panet, 1988; LaMarco andMcKnight, 
1989; DeStasio and Taylor, 1990). Researchers have consistently found that adsorption, 
penetration and uncoating of HSV is unaffected in IFN-pretreated cells (Mittnacht et al., 
1988; Oberman and Panet, 1989; DeStasio and Taylor, 1990), but that levels of IE and E 
transcripts are reduced (Mittnacht et a l, 1988; Oberman and Panet, 1988; DeStasio and 
Taylor, 1990). The reduction in HSV IE mRNA levels occurs as the result of an 
inhibition of transcription initiation rather than a slowing down transcript-elongation or 
degradation of the RNA (Mittnacht et a l, 1988; DeStasio and Taylor, 1990). However, 
while viral genes in the context of the viral genome are affected by IFN, cellular genes are 
insensitive (Mittnacht et a l, 1988; Oberman and Panet, 1989; DeStasio and Taylor,
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1990). In addition, the ability of a plasmid expressing Vmw65 to stimulate transcription 
from a cotransfected plasmid containing an HSV IE promoter was circumvented by IFN 
pretreatment, thus it was proposed that IFN inhibits HSV by specifically disrupting 
transactivation by Vmw65 (DeStasio and Taylor, 1990).
The observation that the Vmw65 mutant m l814 is more sensitive to IFNa than its 
revertant 1814R is apparently inconsistent with the hypothesis that IFN acts by disrupting 
Vmw65 (Jamieson et al., 1995), since if IFN acts solely on the Vmw65-containing 
complex one would expect m l814 to be insensitive to IFN. It is of importance that IFN 
acts against SV40 (Brennan and Stark, 1983) and MCMV (Gribaudo et al., 1993) by 
inhibiting IE transcription, and that the HCMV promoter is sensitive to IFN when in the 
HSV genome (C.M. Preston, unpublished data). In the case of MCMV, the major EE 
promoter is largely dependent upon pre-existing cellular transcription factors, including 
NFkB, ATF, AP-1 and IRFs, thus it is unlikely that IFN acts by disrupting viral 
transactivators. In addition, the HCMV promoter is devoid of TAATGARAT elements but 
is sensitive to IFN when in the HSV genome (C.M. Preston, unpublished data). Recent 
data suggests that IFN acts specifically on an IE promoter in the viral genome, but that the 
same promoter in the cell genome is insensitive (C.M. Preston, unpublished data). Thus, 
IFN prevents transcription specifically from EE promoters in the viral genome by a 
mechanism that is not just specific for Vmw65. One possible model which might explain 
the specific action of IFN on viral IE genes proposes that IFN treatment results in the 
inactivation of cellular transcription factors specifically within the compartments of viral 
transcription.
The objectives of the study described in the thesis presented here were to further 
analyse the in vitro latency system of Jamieson et al. (section 1.3.4.3.; Jamieson, 1993; 
Jamieson et a l, 1995), in other words to investigate the structure of HSV genomes after 
latency was established in HFL cells pretreated with IFNa and infected with the double 
mutant m l820, which contains a non-transactivating Vmw65 and is virtually devoid of 
Vmwl 10 expression in this cell type. In addition to the structural studies, investigations 
were also made into the possibility that virus structural components modify HFL cells 
thereby facilitating the establishment of latency, and into the possibility that delayed virus 
uncoating mimics infection of neurons in vivo and leads to latency.
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Materials
2.1. Tissue culture cells.
HFL Flow 2002 cells (ICN Flow) were normally supplied at passage 16 and 
renewed after 8-15 further passages. HFL cells were used for in vitro latency 
experiments.
BHK-C13 cells obtained from C.M. Preston and originally described by 
MacPherson and Stoker (1962) were used for growth and titration of virus stocks. 
WS-HeLa and CV-1 cells were supplied by the Institute cytology facility.
2.2. Tissue culture media.
All cell types were propagated in Glasgow Modified Eagle’s Medium (GMEM) 
(Busby et al., 1964). GMEM was diluted from a lOx concentration and supplemented to 
a final concentration of 0.26% (w/v) sodium bicarbonate, lx  MEM non-essential amino 
acids, 100 units/ml penicillin, 100 (ig/ml streptomycin, 4 mM L-glutamine. Further 
modification depended on the cell type for which the medium was to be used, as is shown 
below.
EFjq 10% (v/v) foetal calf serum.
ETC jo 10% (v/v) tryptose phosphate broth, 10% (v/v) newborn calf serum.
EFjo was used for propagation of HFL, WS-HeLa and CV-1 cells.
ETC jo was used for propagation of BHK cells.
During titrations of HSV-1, secondary plaque formation was prevented by 
overlaying cell monolayers with one of the following media.
CMC/EFjq (HFL only) EFjq containing 1.5% (w/v) carboxymethylcellulose
sodium salt.
CMC/ETCjo (BHK) ETC10 containing 1.5% (w/v) carboxymethylcellulose
sodium salt.
EHU5 (HFL and BHK) Eagle’s medium containing 5% (v/v) pooled human serum.
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Agar overlay containing 
X-gal (BHK)
Eagle’s medium containing 10% (v/v) newborn calf serum, 
0.5% (w/v) Noble agar and 225 p.g/ml X-gal. X-gal was 
dissolved in DMSO at a concentration of 150 mg/ml and 
added just before use.
The remaining media are listed below.
Tryptose phosphate broth 2% (w/v) bactotryptose, 0.2% (w/v) bactodextrose,
0.5% (w/v) NaCl, 0.25% (w/v) Na2H P04.
Tris-saline
Trypsin 
Versene 
PBS A
PBS B 
PBS C 
PBS A+B+C
140 mM NaCl, 30 mM KC1, 280 mM Na2H P04, 1 mg/ml 
glucose, 5 mM Tris-HCl (pH 7.4), 0.001% (w/v) Phenol 
red, 100 u/ml penicillin, 100 |ig/ml streptomycin.
0.25% (w/v) trypsin dissolved in Tris-saline.
600 mM EDTA in PBS A, 0.0015% (w/v) phenol red.
170 mM NaCl, 3.4 mM KC1, 1 mM Na2H P04,
2 mM KH2P 0 4. pH 7.2.
6.8 mM CaCl2.
4.9 mM MgCl2.
8 parts PBS A: 1 part PBS B : lpart PBS C.
2.3. Reagents used in tissue culture.
ACG, Ara-C, Brefeldin-A, cycloheximide, HMBA, human lymphoblastoid IFNa 
and PAA were all obtained from Sigma Chemical Company Ltd.
2.4. Virus stocks.
HSV-1 viruses were derived from wild-type strain 17 (syn+).
The table overleaf summarises properties of the 1814 based viruses used for the
research presented in this thesis.
TsK  (Marsden et al., 1976), d/1403 (Stow and Stow, 1986), d/1403/p-gal 
(d/1403 with an E.coli lac Z marker gene recombined into U l 43, constructed by 
C.M. Preston, unpublished data) and all of the viruses described in table 2.1. were
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Virus Vmw65 transactivation IE-1 promoter HCMV-L4C Z Reference
ml814 — wild type — Ace etal. (1989).
1814R + wild type — Ace etal. (1989).
ml 853 — wild type TK locus
C.M.Preston,
unpublished
data.
ml 863 + wild type TK locus
C.M.Preston,
unpublished
data.
ml 820 — MMLV LTR —
Jamieson et al. 
(1995).
ml 825 + MMLV LTR —
Jamieson et al. 
(1995).
ml 883 — MMLV LTR TK locus
Jamieson et al. 
(1995).
ml 830 — MMLV LTR UL43
C.M.Preston,
unpublished
data.
Table 2.1. Summary of in 1814 and i/i 1820-based viruses.
supplied by C.M. Preston.
The temperature sensitive uncoating mutant ts\2\2> was supplied by V.G. Preston 
(V.G. Preston, unpublished data).
7«1850 is in 1814 with a 600 bp Pvul fragment from the HSV-1 LAT promoter 
upstream of the E.coli lacZ gene inserted into the TK locus (C.M. Preston, unpublished 
data).
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2.5. Isolation of nuclei from tissue culture cells.
TK lysis buffer 10 mM Tris HC1 pH 7.5, 2 mM MgC^, 150 mM NaCl,
0.5% (v/v) Nonidet P-40.
Sucrose wash 10 mM Tris HC1 pH 7.5, 2 mM MgCl2, 10% (w/v)
sucrose. Protein contamination was removed by the 
addition of DEP to 0.1% (v/v) with vigorous shaking 
followed by autoclaving. Tris HC1 was added after DEP 
treatment and autoclaving.
2.6. Digestion of cell nuclei with nucleases.
DNase I storage buffer 10 mM Tris HC1 pH 7.5, 5 mM MgC^, 50% (v/v)
glycerol.
MN was stored in sterile distilled water.
The reaction buffers for digestion of nuclei with DNase I and MN were as 
follows.
DNase I 0.25 M sucrose, 10 mM PIPES, 10 mM NaCl, 3 mM
MgCl2, 5 mM 2-mercaptoethanol, 0.1 mM PMSF.
MN 0.25 M sucrose, 20 mM PIPES, 10 mM NaCl,
1 mM MgCl2, 1 mM CaCl2, 5 mM 2-mercaptoethanol, 
0.1 mM PMSF.
2.7. Purification of DNA from tissue culture cells.
SDS / Proteinase K buffer 20 mM Tris HC1 pH 7.5, 2.5 mM EDTA pH 7.5,
0.5% SDS, 100 |ig/ml proteinase K.
Phenol: chloroform 1 volume redistilled phenol: 1 volume chloroform.
2.8. Purification of polv/Al-containing RNA from tissue culture cells.
Lysis/binding buffer 100 mM Tris HC1 pH 8.0, 500 mM LiCl, 10 mM EDTA
pH 8.0, 1% (w/v) LiDS, 5 mM DTT.
68
Materials
Wash buffer with LiDS 10 mM Tris HC1 pH 8.0, 0.15 M LiCl, 1 mM EDTA,
0.1% LiDS.
Elution solution 2 mM EDTA pH 8.0.
2.9. Enzvmes.
Restriction endonucleases were supplied by Boehringer Mannheim or New England 
Biolabs.
Klenow enzyme was supplied by Boehringer Mannheim.
T4 DNA ligase was from New England Biolabs.
2.10. Electrophoresis of DNA.
1 Ox TBE buffer 90 mM Tris, 1 mM EDTA, 90 mM boric acid. pH 8.3.
Ficoll loading buffer 10% (w/v) ficoll, 5x TBE, 0.1% (w/v) bromophenol blue.
2.11. Electrophoresis of RNA.
lOx MOPS buffer 0.4 M MOPS, 0.1 M CH3COONa, 10 mM EDTA. pH 7.2.
Sample loading buffer 50% (v/v) deionised formamide, lx  MOPS buffer,
7% (w/v) formaldehyde, 0.1% (w/v) bromophenol blue.
2.12. Southern transfer and hybridisation.
Alkaline transfer solution 0.4 M NaOH, 0.6 M NaCl.
Neutralising solution 0.5 M Tris HC1, 1 M NaCl. pH 7.0.
0.8M Sodium phosphate 0.7 M Na2H P04, 0.1 M NaH2P 0 4.
buffer pH 7.4
Southern pre- / 0.5 M sodium phosphate buffer pH 7.4, 7% SDS.
hybridisation buffer
20x SSC 3M NaCl, 0.3 M sodium citrate.
Membrane wash buffer 0.2x SSC, 0.1% SDS.
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2.13. Northern transfer and hybridisation.
20x SSPE 3 M NaCl, 0.2 M NaH2P 0 4, 20 mM EDTA. pH 7.4.
50x Denhardt’s 1% (w/v) BSA, 1% (w/v) ficoll 400, 
1 % (w/v) polyvinylpyrrolidone.
Northern pre- / 
hybridisation buffer
5x SSPE, 50% (v/v) deionised formamide,
1% (w/v) SDS, 5x Denhardt’s, 10 |ig/ml sheared 
denatured calf thymus DNA (northern pre-hybridisation 
buffer only).
2.14. Purification of DNA from agarose gels.
Sephaglas Sephaglas BP 20% (w/v) suspended in 6 M Nal, 
50 mM Tris HC1 pH 8.0, 0.05% Na2S 0 3, 
lOmMCDTA.
Gel solubiliser 6 M Nal, 50 mM Tris HC1 pH 8.0, 0.05% Na2S 0 3, 
10 mM CDTA.
Wash buffer 20 mM Tris HC1 pH 8.0, 1 mM CDTA, 0.1 mM NaCl, 
60% (v/v) ethanol.
Elution buffer 10 mM Tris HC1, 1 mM EDTA.
2.15. Radiochem icals.
a - [32P] labelled dNTPs at a specific activity of 10 mCi/ml were supplied by 
Amersham International pic.
2.16. Labelling of probes bv random primer extention.
Oligo reaction mix 250 mM Tris HC1 pH 8.0, 25 mM MgCl2,
50 mM 2-mercaptoethanol, 1 M HEPES pH 6.6, 
30 OD units/ml random sequence 
hexadeoxyribonucleotides.
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2.17. Plasmids.
Plasmids containing cloned DNA fragments were supplied by C.M. Preston.
2.18. Bacterial strains and culture media.
E.coli. strain K12 DH-1 (Hanahan, 1983) was grown in L-broth.
For isolation of single bacterial colonies, L-broth containing 1.5% agar was used to 
give a solid substrate.
When required, bacterial growth media was supplemented with 100 |lg/ml 
ampicillin (SmithKline Beecham Pharmaceuticles).
2.19. Small scale preparation of plasmid DNA from E .coli.
L-broth 1% (w/v) NaCl, 1% (w/v) bactopeptone, 
0.5% (w/v) yeast extract.
STET 5% (v/v) Triton X-100, 50 mM EDTA pH 8.0, 
50 mM Tris HC1 pH 8.0, 10% (w/v) sucrose.
2.20. Large scale preparation of plasmid DNA from E .coli.
Buffer PI 100 jig/ml RNase A, 50 mM Tris HC1, 10 mM EDTA. 
pH 8.0.
Buffer P2 200 mM NaOH, 1% SDS.
Buffer P3 3 M CH3COOK pH 5.5.
Equilibration buffer 0.15 % (v/v) Triton X-100. pH 7.0.
Wash buffer 1 M NaCl, 50 mM MOPS, 15% (v/v) ethanol. pH 8.5.
Elution buffer 1.25 M NaCl, 50 mM Tris HC1, 15% (v/v) ethanol. pH 8.5.
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2.21. Transfection of DNA into tissue culture cells.
2x HEBS - 40 mM HEPES NaOH pH 7.05, 0.28 M NaCl,
2 mg/ml D-glucose, 10 mM KC1, 1.4 mM Na2HPC>4.
2.22. Staining of tissue culture monolayers for plaque assay.
Giemsa’s stain improved R66 solution was supplied by BDH Chemicals.
2.23. Staining of tissue culture monolayers for ft-galactosidase.
p-galactosidase stain PBS A containing 5 mM K4Fe(CN)6, 5 mM K^FeCCN)^,
2 mM MgCl2, 0.01% (v/v) Nonidet P-40 and 1 mg/ml X-gal. 
X-gal was dissoved in DMSO at a concentration of 40 mg/ml 
and added just before use.
2.24. Suppliers.
Reagents were obtained from the companies listed below.
Amersham International pic, BDH Chemicals, Boehringer Mannheim, Fisons 
Scientific Equipment, Gibco BRL, ICN Flow, Pharmacia Chemicals, Sigma Chemical 
Company, SmithKline Beecham Pharmaceuticals.
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Methods
3.1. Tissue culture.
HFL cells were grown in tissue culture flasks at 37° in an atmosphere of 5% CO2 
: 95% air. When grown to full confluence, usually after 2 or 3 days at 37°, the cells were 
used immediately or moved to 31° and used after a further 1-4 days. Each tissue culture 
flask had a growth surface of 175 cm2 and contained approximately 2 x 107 cells at full 
confluence. Passage of HFL cells was carried out as follows.
Medium was poured from a flask of confluent HFL cells and the cell monolayer 
washed with 20 ml versene. The versene was poured away and 25 ml 1 volume trypsin : 
4 volumes versene was added to the flask. After briefly rinsing the cells in the trypsin / 
versene approximately 23 ml was poured from the flask leaving 2 ml remaining. When 
the majority of cells were visibly dislodged from the growth surface 10 ml EFjq was 
added and the cells aspirated and split 1 : 4 to seed other tissue culture flasks, or used to 
seed tissue culture dishes. One flask yielded a sufficient number of cells to seed 25 35 
mm diameter tissue culture dishes.
WS-HeLa and CV-1 cells were propagated in the same way as HFL cells, with the 
only difference that trypsin was diluted with versene in the ratio 1 volume trypsin : 1 
volume versene.
BHK-C13 cells were grown in tissue culture roller bottles at 37° in an atmosphere 
of 5% CO2 : 95% air. At full confluence, usually after 2 or 3 days at 37°, the cells were 
used immediately or moved to 31° and used after a further 1-4 days. Each tissue culture 
roller bottle had a growth surface of 850 cm2 and at full confluence contained 
approximately 2 x 108 cells. Passage of BHK cells was carried out as follows.
Medium was poured from a roller bottle of confluent BHK cells and the cell 
monolayer washed with 40 ml versene. The versene was poured away and 40 ml 1 
volume trypsin : 1 volume versene was added. After briefly rinsing the cells in the trypsin 
/ versene, approximately 37 ml was poured off leaving 3 ml remaining. The monolayer 
was observed until the majority of cells were dislodged and the cells immediately 
aspirated in 10 ml ETC 10 and split 1 : 10 to seed other roller bottles, or used to seed tissue 
culture dishes. One roller bottle yielded a sufficient number of cells to seed 250 35 mm 
diameter tissue culture dishes.
Monolayers seeded in tissue culture dishes were ready for use after incubation at 
37° for 16-30 hrs. All cell types grew to similar densities hence the number of cells 
present on any given size dish was the same for all cell types.
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diameter of dish number of cells upon volume of medium per dish 
confluence
35 mm 
60 mm 
90 mm
1 x 106 
3 x  106 
7.5 x 106
2 ml 
6 ml 
15 ml
Each well on 24-well tissue culture plates was seeded with cells suspended in 1 ml 
of medium and contained 2 x 105 cells after growth to full confluence.
3.2. Preparation of HSV-1 stocks.
Virus seed stocks used for inoculating BHK cells in tissue culture roller bottles 
were prepared by inoculating a plaque isolate onto a BHK monolayer in a 60 mm diameter 
tissue culture dish and incubating at the appropriate temperature. When severe CPE was 
evident the cells were harvested, sonicated and the virus titre was determined.
Tissue culture roller bottles seeded with BHK cells and grown to 80-100% 
confluence were each inoculated with 2 x 106 PFU of seed stock in 50 ml ETCjo and 
incubated at the appropriate temperature. During the growth of ml814-based viruses 3 
mM HMBA was included in the growth medium for the first 16-24 hrs of infection, after 
which the medium was replaced with 40 ml ETCjq* During growth of m l820 based 
viruses and HSV-1 viruses which did not contain the Vmw65 mutation of ml814, the 
presence of HMBA was not necessary hence the cells were maintained in the 50 ml 
inoculum throughout infection.
When the infected cells exhibited severe CPE they were dislodged into the growth 
medium and distributed into centrifuge bottles. The cellular material was removed by 
centrifugation in a Sorvall GSA rotor at 2000 rpm for 15 minutes at 4°. Sorvall GSA 
rotors were centrifuged in a Sorvall RC5-B centrifuge. The resulting pellets were 
processed to release the cell-associated virus and the supernatants centrifuged to 
concentrate the extracellular virus.
The cell pellets were resuspended in ETCjq (0.5 ml for each roller bottle of BHK 
cells infected), pooled, and bath sonicated thoroughly to release the cell-associated virus. 
The cellular debris was pelleted by centrifugation at 2500 rpm for 10 minutes at 4° in a 
Sorvall RT6000B benchtop centrifuge and the supernatant stored at -70° for future use as 
a virus stock.
The extracellular virus particles were concentrated by centrifugation in a Sorvall 
GSA rotor at 12000 rpm for 2 hrs at 4°. The pellets were gently resuspended in ETCjq 
(0.5 ml for each roller bottle of BHK cells infected), pooled, bath sonicated to disperse 
aggregated virus and cell debris and stored at -70° for future use as a virus stock.
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3.3. Purification of HSV-1 light particles.
The technique used for purification of extracellular light particles (L-particles) was 
modified from the method first described by Szilagyi and Cunningham (1991).
Tissue culture roller bottles seeded with BHK cells were inoculated with HSV-1 
as described in section 3.2. When severe CPE was evident the cells were removed from 
the growth surface by shaking the roller bottle and the medium containing the cells 
distributed in centrifuge bottles. The cellular material was removed by centrifugation in a 
Sorvall GSA rotor at 5000 rpm for 15 minutes at 4°. In order to concentrate the 
extracellular L-particles and virions the supernatants were centrifuged in a Sorvall GSA 
rotor at 12000 rpm for 2 hrs at 4°. After centrifugation the supernatants were discarded 
and the pellets overlaid with 1 ml Eagle’s medium without phenol red for every three 
infected roller bottles of BHK cells processed. The pellets were left to soften on ice with 
gentle agitation for 6 hrs, gently aspirated and left on ice with gentle agitation for a further 
16 hrs. Gradual resuspension of the viral particles over a 22 hr period negated the need 
for vigorous aspiration or bath sonication and hence minimised damage to the fragile L- 
particles. The resuspended pellets were layered onto 35 ml pre-formed 5-15% gradients 
of ficoll 400 dissolved in Eagle’s medium without phenol red. The resuspended pellets 
were distributed on the gradients such that each gradient took L-particles and virions from 
3 or 4 roller bottles. The L-particles and virions were separated in the gradients by 
centrifugation in a Sorvall AH629 rotor at 12000 rpm for 2 hrs at 4°. AH629 rotors were 
centrifuged using a Sorvall OTD50B ultracentrifuge. L-particles were removed by side 
puncture and extraction with a surgical needle and syringe and pelleted by centrifugation 
in a Sorvall AH629 rotor at 12000 rpm for 16 hrs at 4°. The pellets were resuspended by 
overlaying with 100 |il Eagle’s medium without phenol red for each roller bottle of 
infected BHK cells processed and incubating on ice for 6 hrs with occasional agitation. L- 
particles were stored at -70°.
3.4. Titration of HSV-1 stocks.
Titres of HSV-1 stocks were determined by plaque assay on BHK cells. HSV-1 
stocks were serially diluted 10-fold and 200 jil of each dilution used to infect a BHK 
monolayer in a 35 mm diameter tissue culture dish. Usually each dilution was titrated in 
duplicate. After 1 hr adsorption with rocking every 20 minutes to prevent drying of the 
monolayers the inocula were removed and the cells overlaid with 2 ml per dish of EHU5 
or CMC/ETC 10. Monolayers were incubated at the appropriate temperature until plaques 
were easily visible under a low magnification light microscope. The medium was 
removed and approximately 1 ml Giemsa stain added to each dish. After staining for a 
minimum of 30 minutes at room temperature the cells were washed with water and the 
plaques counted under a dissection microscope.
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Titres of HSV'-l mutants containing the Vmw65 mutation of m l814 were 
standardised by titration on BHK cell monolayers with 3 mM HMBA in the culture 
medium. The presence 3 mM HMBA during the early stages of infection has previously 
been shown to restore the particle / PFU ratio of ml814 close to that of wild type HSV-1 
(McFarlane et al., 1992). After the 1 hr adsorption period the inocula were removed and 
the monolayers overlaid with 2 ml per dish of EHU5 containing 3 mM HMBA or 2 ml per 
dish of CMC/ETC jo containing 3 mM HMBA. Cells were incubated, stained and counted 
as described in the paragraph above.
HSV-1 mutants containing the m l814 mutation and which expressed p- 
galactosidase were titrated on HFL monolayers in the absence of HMBA. Because 
mutants with the in 1814 phenotype titrate in a nonlinear manner in the absence of HMBA, 
3-fold rather than 10-fold dilutions were used for titrations. HFL monolayers seeded on 
24-well dishes were infected with 100 fxl of dilution per well. After 1 hr adsorption with 
rocking every 15 minutes the inocula were removed and the monolayers overlaid with 1 
ml per well of EHu5 or 1 ml per well of CMC/EFio- After incubation for 20-24 hrs the 
monolayers were fixed and stained for p-galactosidase activity.
3.5. Inactivation of HSV-1 bv irradiation with UV light.
When cell released HSV-1 preparations were to be UV-irradiated, it was first 
necessary to replace the ETC 10 in which the virus was suspended with Eagle’s medium 
without phenol red, since phenol red in ETC 10 absorbs UV light and reduces the 
efficiency of UV-inactivation.
0.8 ml of a cell released HSV-1 preparation was added to 10 ml Eagle’s medium 
without phenol red in a 30 ml glass corex tube and centrifuged in a Sorvall SS34 rotor at 
15000 rpm for 1 hr at 4°. Sorvall SS34 rotors were centrifuged in a Sorvall RC-5B 
centrifuge. The supernatant was discarded and the virus pellet washed briefly with 5 ml 
Eagle’s medium without phenol red. The pellet was resuspended in 0.8 ml Eagle’s 
medium without phenol red and bath sonicated to disperse aggregated virus particles. The 
sample was ready for UV-irradiation. Gradient purified HSV-1 L-particle or virion 
preparations were UV-irradiated without previous treatment.
A 40 pi fraction of the sample to be irradiated was removed, foetal calf serum was 
added to a final concentration of 10% and the fraction stored at -70°. The remainder of 
the sample was distributed into 35 mm diameter tissue culture dishes, <0.4 ml being 
applied to each dish. The dishes were placed in a UV Stratalinker 1800 (Stratagene) with 
the lids off and subjected to 5 exposures of 80 mJ of UV radiation. The dishes were 
removed from the Stratalinker between each exposure and rocked to distribute the virus 
preparation and prevent drying. After the final exposure, foetal calf serum was added to a 
final concentration of 10% and the samples mixed and stored at -70°. Subsequently, the
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UV-irradiated sample and the untreated fraction were titrated in parallel to assess the drop 
in virus titre caused by the UV-irradiation. A reduction in titre of >105-fold was 
consistently observed.
3.6. In vitro la tency .
In this thesis is described the analysis of an in vitro latency system for HSV-1 
which was designed and characterised by D.R.S. Jamieson and C.M. Preston 
(Jamieson., 1993; Jamieson e ta l,  1995). The in vitro latency system is modified from an 
earlier system of Harris and Preston (1991).
Latency of m l820 in HFL cells was established as follows.
HFL cells which had been seeded in a 35 mm tissue culture dish 16-24 hrs 
previously were treated with IFNa by replacing the growth medium with 2 ml EF^q 
containing 1000 u/ml IFNa and incubating at 37° for 16-20 hrs. The IFNa was removed 
thoroughly and the cells given 2 x 2 ml washes with EF^- An inoculum of m l820 in 200 
|il EF10 was applied to the monolayer and the virus allowed to adsorb to the cells by 
incubation at 37° for 1 hr with rocking every 20 minutes. When the adsorption period 
was complete, 2 ml EFjo containing 50 pg/ml Ara-C was added and incubation continued 
at 37° for 2 or 3 days, during which time the virus entered the state referred to in this 
thesis as ‘m vitro latency’. When latency was established in HFL cells grown on 60 mm 
plates, volumes were scaled up accordingly. The technique used to establish in vitro 
latency is summarised in figure 3.1.
In 1820 was reactivated from in vitro latency by superinfection with HSV-1. The 
EFjo containing Ara-C was removed from a latently infected HFL cell monolayer in a 35 
mm dish and the superinfecting virus in 200 p.1 EFjq containing 50 jLig/ml Ara-C was 
applied. After 1 hr adsorption at 37° with rocking every 20 minutes, 2 ml EFjq containing 
50 Jig/ml Ara-C was added and incubation continued at 37° for a further 6 or 7 hrs.
3.7. Isolation of nuclei from tissue culture cells.
i
During the isolation of nuclei from tissue culture cells, aggregation of nuclei and 
the activity of endogenous nucleases was minimised by storing the samples on ice 
between manipulations and by chilling the buffers on ice for >45 minutes before use.
Culture medium was removed from a monolayer of cells grown in a 35 mm or 60 
mm diameter tissue culture dish and the cells washed with 2 ml or 6 ml respectively of 
PBS A+B+C. The cells were harvested in 1 ml PBS A+B+C using a rubber policeman, 
transferred to a 1.5 ml vial and pelleted by centrifugation at 13000 rpm for 45 seconds in 
a benchtop microfuge. The supernatant was removed with a Pasteur pipette and the cell 
pellet resuspended in the residual PBS A+B+C by vortex mixing. 1 ml TK lysis buffer 
was added, the cells distributed by vortex mixing and left on ice for 5 minutes to allow
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Seed tissue culture dish with HFL cells.
16-24 hours
Replace culture medium with medium containing IFNa.
16-20 hours
Remove IFNa, infect with in 1820.
Incubate for 2 or 3 days +Ara-C.
Isolate nuclei Reactivate by superinfection in 
presence of Ara-C.
Chromatin analysis.
Incubate nuclei 
with MN.
Examination of circularity/ 
linearity of the latent genome.
t
Isolate DNA.
Examination of the 
sensitivity of specific 
restriction fragments to 
MN or DNase I.
I
I
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MN or DNase I.
I
Isolate DNA. Incubate DNA with Bam HI. Isolate DNA.I
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restriction 
endonuclease.
Electrophorese resulting DNA fragments in an agarose gel, 
perform Southern blot analysis.
Figure 3.1. Summary of the in vitro latency system and the techniques 
used to examine the structure of the latent / reactivated genomes.
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lysis of the cells. Nuclei were pelleted by centrifugation at 13000 rpm for 45 seconds, the 
lysis buffer containing the cytoplasmic material was removed and either discarded or the 
DNA purified for Southern blot analysis. The nuclei were resuspended in the residual TK 
lysis buffer by vortex mixing and 1 ml sucrose wash was added followed by further 
vortex mixing to distribute the nuclei. Nuclei were pelleted through the sucrose wash by 
centrifugation at 13000 rpm for 45 seconds, the sucrose wash was removed and the 
nuclei resuspended in the residual sucrose wash by vortex mixing. The nuclei were ready 
for incubation with MN or DNase I; alternatively the nucleic acid was purified 
immediately, as described below and summarised in figure 3.1.
3.8. Digestion of tissue culture cell nuclei with nucleases.
Nuclei isolated from cells cultured in a 35 mm or 60 mm diameter tissue culture 
dish were resuspended in 150 pi MN or DNase I reaction buffer and vortex mixed 
thoroughly. The reaction was started by the addition of MN dissolved in sterile distilled 
water or DNase I dissolved in storage buffer without glycerol to various concentrations 
followed by brief vortex mixing and incubation in a 37° waterbath for various times. The 
reaction was stopped by placing the nuclei on ice and immediately adding EDTA pH 7.5 
to a final concentration of 12 mM.
3.9. Digestion of naked viral DNA with MN.
Purified m l850 DNA was supplied by C. M. Preston. 2 pg m l850 DNA in 7 pi 
H20  was added to 50 pi MN reaction buffer. 10 pi of various concentrations of MN 
dissolved in H20  was added and the sample placed in a 37° waterbath for 5 minutes. The 
reaction was stopped by adding EDTA pH 7.5 to a final concentration of 17 mM and the 
sample made to a volume of 500 pi with H20. The sample was phenol : chloroform 
extracted and the DNA purified as described in section 3.10. The purified DNA pellet was 
resuspended in 20 pi H20  and half the sample electrophoresed in a 1.5% agarose gel in 
order the assess the extent of nuclease digestion.
3.10. Purification of DNA from tissue culture cells.
Nuclei isolated from cells cultured in a 35 mm or 60 mm diameter tissue culture 
dish were incubated in 0.5 ml SDS / proteinase K buffer at 37° overnight or at 45° for 3 -  
5 hrs. After MN or DNase I digestion, 350 pi SDS / proteinase K buffer made at a 1.43x 
concentration was added to the nuclei suspended in 150 pi reaction buffer to give the final 
concentration of SDS / proteinase K buffer specified in section 2.7.
After digestion with SDS / proteinase K buffer, the sample was extracted twice 
with phenol : chloroform and once with chloroform. Extractions were carried out by
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adding 0.5 ml phenol : chloroform or chloroform, followed by vigorous mixing. The 
phases were separated by centrifugation at 13000 rpm for 10 minutes in a benchtop 
microfuge and the aqueous phase containing the nucleic acid was removed to a separate 
vial. After the chloroform extraction, CI^COONa pH 7.0 was added to a final 
concentration of 0.3 M and the nucleic acid was precipitated by adding 1 ml ethanol and 
vigorously mixing the sample. Precipitated nucleic acid was pelleted by centrifugation at 
13000 rpm for 10 minutes. After removal of the supernatant, the pellet was washed by 
adding 0.5 ml 70% (v/v) ethanol and gently mixing. The pellet was collected at the bottom 
of the vial by centrifugation at 13000 rpm for 5 minutes, the supernatant removed and the 
pellet allowed to dry by lying the vial on the bench with the lid open for >45 minutes. The 
dried pellet was subject to restriction endonuclease cleavage or for chromatin analysis was 
resuspended in sterile distilled water containing 10 JLLg/ml RNase A and incubated at 37° 
for 30 minutes. DNA was stored at -20°.
To purify DNA from the cytoplasmic fraction, the lysate from cells cultured in a 
35 mm or 60 mm diameter tissue culture dish was made up to the concentration of SDS / 
proteinase K buffer shown in section 2.7 and divided into 2 x 0.5 ml fractions. DNA was 
purified as with nuclear DNA. The resuspended purified DNA pellets from the two halves 
of the sample were pooled.
3.11. Purification of polv(A)-containing RNA from tissue culture cells.
Poly(A)-containing RNA was purified from tissue culture cells using the 
Dynabeads Oligo d(T)25 (Dynal) kit. The use of Dynabeads Oligo d(T)25 relies on base 
pairing between poly(A) residues at the 3' end of most mRNA and the oligo (dT) residues 
covalently coupled to the surface of magnetic polystyrene beads. The beads can be 
separated from solution with a magnetic particle concentrator (MPC).
Culture medium was removed from a monolayer of cells cultured in a 90 mm 
diameter tissue culture dish and the cells washed with 15 ml PBS A+B+C which had 
previously been cooled to 4°. The cells were harvested in 5 ml PBS A+B+C with a 
rubber policeman, transferred to a 50 ml polypropylene conical tube and pelleted by 
centrifugation at 1500 rpm for 10 minutes at 4° in a Sorvall RT6000B benchtop 
centrifuge. The supernatant was removed and the pellet resuspended in 1 ml PBS A+B+C 
and transferred to a 1.5 ml vial. The cells were pelleted by centrifugation at 13000 ipm for 
45 seconds in a benchtop microfuge, the supernatant removed and the cell pellet stored at 
-70°. Without prior thawing, the pellet was resuspended in 0.5 ml lysis / binding buffer 
and passed through a 21 gauge syringe needle 3 times to shear the DNA and reduce the 
viscosity of the solution. Dynabeads Oligo d(T)25 from 260 p.1 of a 10 mg/ml suspension 
in PBS A were concentrated in an MPC and washed once with 200 p.1 lysis / binding 
buffer. The lysis / binding buffer was discarded, the vial removed from the MPC and the 
Dynabeads Oligo d(T)25 resuspended in the cell lysate. Binding of poly(A)-containing
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RNA to the Dynabeads Oligo d(T)25 was allowed by incubation at room temperature for 5 
minutes with occasional agitation. The vial was placed in the MPC, the lysate removed 
from the Dynabeads Oligo d(T)25 /  RNA and the Dynabeads Oligo d(T)25 /  RNA given 3 
washes with 0.5 ml wash buffer with LiDS. The final wash was removed thoroughly and 
the poly(A)-containing RNA eluted from the Dynabeads Oligo d(T)25 by removing the 
vial from the MPC and resuspending the Dynabeads Oligo d(T)25  ^RNA in 20 p.1 elution 
solution followed by incubation in a 65° waterbath for 2 minutes. The vial was placed in 
the MPC and the supernatant containing the eluted poly(A)-containing RNA removed to a 
separate vial and stored at -70°.
3.12. Cleavage of DNA with restriction endonucleases.
Pellets of nuclear or cytoplasmic nucleic acid isolated from tissue culture cells 
cultured in a 35 mm or 60 mm diameter tissue culture dish were resuspended in 40-100 
jil of a suitable buffer containing 10 units of restriction enzyme and 10 |ig/ml RNase A. 
Reaction conditions were optimised according to the suppliers recommendations. Digests 
were usually incubated at 37° overnight.
Cleavage of plasmid DNA was carried out according to the manufacturers 
instructions, incubation at 37° for 3-5 hrs being sufficient. The inclusion of RNase A 
was only necessary for cleavage of plasmid DNA from small scale preparations.
For cleavage of DNA with more than one restriction endonuclease which required 
buffers that were incompatible, the DNA was incubated with one enzyme, adjusted to a 
volume of 0.5 ml with sterile distilled water, extracted with phenol : chloroform and 
subject to the DNA purification procedure described in section 3.10. The cleaved, purified 
DNA pellet was ready for incubation with another restriction endonuclease.
3.13. Electrophoresis of DNA.
Agarose gels for Southern blotting or separation of cleaved plasmid DNA 
fragments had the dimensions 260 mm x 160 mm and a volume of 300 ml. Gels 
consisted of 0.7-1.5% (w/v) agarose, lx  TBE buffer, 0.5 fig/ml ethidium bromide and 
were electrophoresed horizontally in lx  TBE buffer with 1 cm of buffer above the gel. 
DNA was electrophoresed at 16 mA overnight or at 6 mA over 2 days, or until the 
bromophenol blue had migrated approximately 13 cm.
Before loading on the gel, ficoll loading buffer was added to each DNA sample to 
a lx final concentration.
Electrophoresed DNA was visualised by transillumination with UV light. Short 
wavelength UV light was used for gels which were to be blotted. Gels used to separate 
fragments for cloning or to be radiolabelled for use as probes were transilluminated with 
long wavelength UV light. Agarose gels were photographed using Polaroid 667 film.
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3.14. Electrophoresis of RNA.
Agarose gels for northern blotting had the dimensions 260 mm x 160 mm and a 
volume of 200 ml. Gels consisted of 1.2% (w/v) agarose, lx  MOPS buffer, 2% (w/v) 
formaldehyde and were electrophoresed horizontally in lx  MOPS buffer with 1 cm of 
buffer above the gel. RNA was electrophophoresed at 30 mA overnight or until the 
bromophenol blue had migrated approximately 13 cm. Gel tanks used for electrophoresis 
of RNA were previously treated overnight with 0.1% (v/v) DEP and were used solely for 
electrophoresis of RNA. The glass plate on which the gel was cast and which supported 
the gel during electrophoresis was also used exclusively for RNA.
Before loading on the gel, sample loading buffer was added to each sample in the 
ratio 5 volumes RNA sample : 11 volumes sample loading buffer and the RNA denatured 
by heating to 100° for 1 minute followed by incubation on ice for 10 minutes.
A sample of whole cell RNA was electrophoresed alongside poly(A)-containing 
RNA to enable positions of the rRNAs to be visualised after staining with ethidium 
bromide.
After electrophoresis, the gel was cut as required and placed in a container with 
1500 ml distilled water. After gentle agitation for 10 minutes at room temperature, the 
water was poured away and another 1500 ml distilled water added followed by gentle 
agitation for a further 10 minutes at room temperature. Agitation with distilled water 
removed formaldehyde from the gel. The water was poured away, 500 ml distilled water 
containing 2 Jig/ml ethidium bromide was added and agitation continued for 10 minutes at 
room temperature to allow the ethidium bromide to enter the gel and bind the RNA. The 
RNA was visualised by transillumination with short wavelength UV light and 
photographed using Polaroid 667 film.
3.15. Southern transfer and hybridisation.
The method used to transfer DNA onto hybridisation membranes was the alkaline 
transfer capillary blotting technique adapted by Reed and Mann (1985) from the technique 
described by Southern (1975).
The electrophoresed, photographed gel was cut to the required size and the DNA 
denatured by immersion in 400 ml alkaline transfer solution for 15-30 minutes 
immediately prior to blotting. Gels used for the analysis of chromatin (sections 4.10-
4.12.) were depurinated before soaking in alkaline transfer solution. Depurination was 
achieved by soaking the gel in 400 ml 0.25 M HC1 for 5 minutes with occasional agitation 
followed by a brief rinse in deionised water.
A bijou rack was placed in an enamel tray and a glass plate 190 mm x 157 mm 
placed onto the rack. A strip of Whatman 3 mm thick chromatography paper cut to 320 
mm x 157 mm was placed across the length of the plate and a strip 187 mm x 190 mm
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across the breadth. Alkaline transfer solution was poured over the chromatography papers 
to soak them, leaving the two ends hanging over the plate to act as wicks. The gel was 
placed onto the chromatography papers and any air pockets between the gel and the paper 
were removed by rolling a clean pipette over the gel. A piece of GeneScreen Plus 
hybridisation transfer membrane (NEN Research Products) cut to the exact size of the gel 
was placed in alkaline transfer solution, allowed to soak up the solution by capillary 
action and placed onto the gel ensuring that the correct side of the membrane contacted the 
gel. Air spaces between the hybridisation membrane and the filter papers were removed 
and six pieces of Whatman filter paper cut to the exact size of the gel and saturated in 
alkaline transfer solution were placed onto the membrane. Dry paper hand towels cut to 
the size of the sandwich were placed onto the filter papers and the sandwich weighted 
with a glass plate and a 500 ml bottle filled with water. Finally, 300 ml alkaline transfer 
solution was added to the enamel tray and the apparatus left overnight to allow transfer of 
the DNA onto the membrane.
When transfer was complete, the membrane was placed in 100 ml neutralising 
solution for 15 minutes with occasional agitation. The membrane was daubed with 
absorbent tissue to remove excess neutralising solution and the DNA immediately cross- 
linked to the damp membrane by exposure to 120 mJ of UV light in a UV Stratalinker 
1800. The membrane was hybridised immediately, or stored on the bench for future use.
During hybridisation, constant mixing and temperature control was maintained by 
use of a Hybaid oven. All buffers and the Hybaid hybridisation tubes were heated to 70° 
in the oven before use. The temperature was kept at 70° as stringently as possible 
throughout the following procedure.
The membrane was rolled in a Hybaid nylon support membrane, placed inside a 
hybridisation tube and pre-hybridised in 50 ml Southern pre-hybridisation buffer for 1-2 
hrs. After removal of the Southern pre-hybridisation buffer, 20 ml Southern hybridisation 
buffer was added to the tube and agitation continued for 3-5 hrs. Purified, denatured 
[32P]-labelled probe was added to the Southern hybridisation buffer and agitation 
continued for 16-24 hrs.
The membrane was washed for 45 minutes in 50 ml of a solution equivalent to the 
Southern pre-hybridisation buffer, followed by 3 x 30 minute washes with 100 ml 
membrane wash buffer.
The hybridised membrane was removed from the tube, daubed with an absorbent 
tissue to remove excess liquid and exposed to autoradiographic film.
3.16. Northern transfer and hybridisation.
The method used to transfer RNA onto hybridisation membranes and to hybridise 
the bound RNA with DNA probes was described in the GeneScreen Plus transfer and 
detection protocols booklet (NEN Research Products).
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The photographed gel was blotted onto GeneScreen Plus using the technique 
described for Southern transfer but with lOx SSPE as the transfer solution.
After transfer, the membrane was rinsed briefly in 2x SSPE, dried at room 
temperature and baked at 80° for 2 hrs to remove traces of formaldehyde.
Hybridisation was at 42° in a Hybaid oven. The oven, buffers and hybridisation 
tubes were warmed to 42° -before hybridisation. The membrane was pre-hybridised in 50 
ml northern pre-hybridisation buffer for 2-4 hrs at 42°, the northern pre-hybridisation 
buffer was removed and 20 ml northern hybridisation buffer was added and incubation 
continued for 1-3 hrs. The purified, denatured [32P]-labelled DNA probe was added and 
agitation continued for 16-24 hrs.
The membrane was washed in 50 ml 2x SSPE for 15 minutes at 42°, removed 
from the hybridisation tube, transferred to a plastic container and subsequently washed 
by agitation in 200 ml 2x SSPE for 15 minutes at room temperature, 400 ml 2x SSPE / 
2% SDS in a 65° water bath for 45 minutes and finally in 200 ml 0.1 x SSPE at room 
temperature for 15 minutes.
The membrane was dried by daubing with an absorbent tissue and exposed to 
autoradiographic film.
3.17. Labelling of probes bv random primer extension.
DNA was radiolabelled with a-[32P] dNTPs by extension of hybridised random 
sequence hexadeoxyribonucleotides with Klenow DNA polymerase (Feinberg and 
Vogelstein, 1983).
The DNA fragment to be radiolabelled was made to a volume of 22 jllI in a 1.5 ml 
vial and denatured by placing in a boiling water bath for 2 minutes followed by incubation 
on ice for 10 minutes. The solution was collected at the bottom of the vial by brief 
centrifugation and 10 |il oligo reaction mix was added followed by 2 |il 0.1% BSA, 2.5 
jil each of two 4 mM dNTPs, 5 jxl each of the remaining two a -[32P]-labelled dNTPs 
(specific activity 10 mCi/ml) and 1 j l l I  Klenow enzyme (2 units/fil). The labelling reaction 
mixture was incubated at room temperature overnight or at 37° for 2 hrs.
The proportion of [32P] incorporated into DNA was assessed as follows. 0.5 ji.1 
of the labelling reaction was diluted in 10 jil H2O and 3 fil of the dilution spotted onto 
each of 2 Whatman grade 1 2.5 cm diameter filter papers. One of the filters papers was 
placed in 100 ml 10% TCA for 10 minutes at room temperature with occasional agitation, 
the remaining filter paper was left untreated. During the wash in 10% TCA, fragments of 
DNA remain bound to the filter paper, whereas unincorporated dNTPs are soluble in acid. 
The 10% TCA was discarded, 50 ml ethanol was added and the filter paper rinsed by 
swirling the solution. The ethanol was discarded and the filter paper rinsed again in 50 ml 
ethanol. Both filter papers were dried under a 275 Watt infra-red reflector lamp, placed in 
scintillation vials with 5 ml Ecoscint A (national diagnostics) and the radioactivity was
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determined in a scintillation counter. The incorporation was determined as the percentage 
of radioactivity on the 10% TCA-washed filter paper compared to the total (100%) 
radioactivity on the untreated filter paper. Only labelling reactions with incorporation 
>30% were used.
[32P]-labelled DNA was separated from unincorporated [32P]-labelled dNTPs by 
passage through a 10 ml column of swollen medium sephadex G-50 (Pharmacia 
Chemicals).
The purified DNA probe was denatured by adding NaOH to a final concentration 
of 0.15 M and incubating at room temperature for 15 minutes.
3.18. Purification of DNA from agarose gels.
DNA was purified from agarose gel slices using the Sephaglas BandPrep Kit 
(Pharmacia Chemicals).
The band containing the DNA to be purified was excised from the agarose gel 
during visualisation with long wavelength UV light and transferred to a 1.5 ml vial. 
250 p.1 gel solubiliser was added and the vial placed in a 60° water bath until the gel slice 
had dissolved completely. If the gel slice had not dissolved after 15 minutes, a further 200 
|il gel solubiliser was added and incubation continued. The container of Sephaglas was 
shaken to produce an even suspension and 5 |il added to the dissolved agarose gel slice 
for each pg of DNA to be purified. The DNA was allowed to bind to the Sephaglas by 
incubation at room temperature for 5 minutes with agitation every minute. The Sephaglas 
with bound DNA was pelleted by centrifugation at 13000 rpm for 10 seconds in a 
benchtop microfuge and the supernatant discarded. The pellet was washed by 
resuspending the Sephaglas in a volume of wash buffer 8x the volume of Sephaglas 
added above and pelleted again by centrifugation at 13000 rpm for 10 seconds. The 
washing procedure was repeated twice to give a total of three washes. After the final wash 
had been removed, the vial was flicked to partially disperse the Sephaglas and the pellet 
dried by lying the vial on the bench for >45 minutes. DNA was eluted from the Sephaglas 
by resuspending in a volume of elution buffer 2x the volume of Sephaglas used and 
incubating at room temperature for 5 minutes with agitation every minute. The suspension 
was centrifuged at 13000 rpm for 1 minute and the supernatant containing the DNA 
removed to a fresh vial. The elution step was repeated to maximise the yield of DNA.
3.19. DNA Probes.
The diagrams in figures 3.2. and 3.3. indicate the positions of DNA probes to 
detect sequences within the LAT / LEI and TK regions respectively.
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Figure 3.2. Location of probe fragm ents a t the LAT /  IE1 region of the 
genome. (A) Representation of the HSV-1 genome showing the location of the unique 
long and unique short regions. (B) The internal copy of the long repeat region expanded 
with the the location of the restriction endonuclease sites relevant to the studies in the 
thesis presented in the thesis presented here indicated. The replacement of the wild type 
IE1 promoter with the MMLV LTR, yielding the ml820-based viruses, is depicted 
(details on the construction of m l820 are published in Jamieson et al. 1995). (C) 
Transcripts arising from the LAT / EE 1 region and their positions relative to the restriction 
sites.
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Figure 3.3. Location of the EcoR I restriction endonuclease cleavage sites 
at the TK locus and its modification by the insertion of the HCMV IE 
prom oter controlling lacZ. (A) Representation of the HSV-1 genome showing the 
location of the unique long and unique short regions. (B) The EcoRl fragment 
encompassing Ul23, encoding the TK gene, expanded from U l region. (C) The position
of insertion of the HCMV IE promoter controlling transcription of the E.coli lacZ gene 
with the SV40 termination signal. With viruses wild type at the TK locus, EcoRI 
digestion yields a single fragment of 2.42 kbp, viruses containing the HCMV / lacZ 
insertion produce 2 EcoRI fragments, one of 1.03 kbp and one of 1.80 kbp.
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3.20. Autoradiography.
Hybridised membranes were exposed at -70° to X-omat S film (Kodak) with a 
DuPont Cronex Lightning Plus intensifying screen.
3.21. Stripping of DNA probes from hybridisation membranes.
Membranes were boiled for 30 minutes in a solution of 10 mM Tris HC1 pH 7.5,
1 mM EDTA and 1% SDS. To assess the efficiency of stripping, the membrane was 
exposed to autoradiographic film.
3.22. Quantification of hybridisation.
Hybridisation was quantified using a Molecular Dynamics Phosphorlmager with 
Molecular Dynamics ImageQuant software.
To calculate the relative proportions of nonlinear and linear molecules of latent 
m l820, the relative band peak areas of hybridisation to the joint and terminal fragments 
were determined for latent ( J l a t  and T l a t  respectively) and virion ( J v i r  and T v i r  
respectively) DNA. The ratio of joint / terminus for latent DNA was adjusted for the 
hybridisation bias observed in virion DNA.
J l a t  / T l a t  x  T v i r / J v i r  = x
As each nonlinear molecule has two joints, and each linear molecule contributes 
one joint, the number of nonlinear genomes per linear genome was 0.5(x-l).
The number of m l820 genomes per cell was calculated by comparing 
hybridisation to the joint fragments of the latent sample to hybridisation to the virion DNA 
standards, which were of known mass. The method used to calculate the number of 
in 1820 genomes per cell was as follows.
Because the majority of virion genomes contain 1 copy of the joint fragment and 
most latent genomes contained 2 copies, it was first necessary to adjust the band peak 
areas of hybridisation to the joint of latent DNA to that which would have occurred from 
an equivalent mass of virion DNA.
The contribution of hybridisation to the joint from linear genomes in the latent 
DNA sample (Jlinear) was calculated from the J : T ratio of hybridisation to virion DNA. 
The hybridisation to the joint from the latent sample was then adjusted to give the 
hybridisation that would have occurred from an equivalent mass of virion DNA.
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(Total hybridisation to joint -  J linear) + 2 = Adjusted hybridisation to the joint from
the nonlinear genomes
Total hybridisation to joint of latent sample, from an equivalent mass of virion DNA =
J linear + adjusted hybridisation to the joint from the nonlinear genomes
The value of hybridisation to the joints of the virion DNA samples which were of 
known mass, were used to calculate the mass (M) of latent DNA represented by the 
adjusted hybridisation to the joint from an equivalent mass of virion DNA.
The number of genomes in the sample was then calculated using M, the molecular 
mass of HSV-1 DNA (96 x 106 g/mol) and Avagadro’s constant (6 x 1023 /mol).
6 x 1023(M) 96 x 106 = number of genomes.
The number of genomes per cell = number of genomes in the sample number 
of cells from which the DNA sample was extracted.
3.23. Ligations.
Ligation reactions with a total volume of 5 pi consisted of various ratios of vector 
: insert, lx  ligase buffer and 0.5 units of T4 DNA ligase. The ingredients were kept 
chilled on ice while the reactions were being set up. Ligations were incubated at 15° for 
20-24 hrs before being used to transform E.coli. For each ligation experiment, a control 
ligation of vector without insert was performed in parallel to determine the background of 
vector ligated to itself.
3.24. Preparation of competent E.coli.
1 ml of an E.coli K12 DH-1 culture which had been grown in L-broth overnight 
was added to 1 ml 80% (v/v) glycerol and stored at - 20° for use as a seed stock.
10 ml L-broth was inoculated with 20 pi seed stock and shaken overnight at 37°. 
The following day, 90 ml L-broth was inoculated with 2.5 ml of the overnight culture and 
shaken at 37° until the bacteria had grown to an OD590 of 0.2, usually after 1.5-2 hrs. 
The cells were pelleted by centrifugation at 5000 rpm for 10 minutes at 4° in a Sorvall 
SS34 rotor, resuspended in 40 ml 100 mM CaCl2 which had previously been cooled to 4° 
and incubated on ice for 1-2 hrs. The DH-1 bacteria were pelleted by centrifugation at 
5000 rpm for 10 minutes at 4° in a Sorvall SS34 rotor, resuspended in 800 pi 100 mM 
CaCl2 and stored on ice. The DH-1 bacteria were then competent and could be stored at 
4° for up to 20 hrs before transformation.
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3.25. Transformation of E.coli.
50 |LLl of a competent E.coli K12 DH-1 preparation was added to a ligation reaction 
and incubated on ice for 1-3 hrs. The bacteria were heat shocked by placing the vial in a 
42° waterbath for 1 minute 15 seconds, added to 0.5 ml L-broth and shaken at 37° for 1 
hrs 15 minutes to enable the transformed cells to express p-lactamase. 150 (il was spread 
in triplicate on the surface of 1.5% agar / L-broth / ampicillin set in 8.5 cm diameter 
Sterilin Petri dishes (Bibby Sterilin Ltd) and incubated at 37° overnight.
3.26. Small scale preparation of plasmid DNA from E.coli.
Colonies were picked with a sterile plastic pipette tip, inoculated into 2 ml L-broth 
containing ampicillin and shaken at 37° overnight. The plasmid copy number was 
amplified by adding chloramphenicol to a concentration of 20 |Xg/ml and shaking at 37° 
overnight. 1.5 ml of a chloramphenicol-treated culture was transferred to a 1.5 ml vial and 
the bacteria pelleted by centrifugation at 6500 rpm for 2 minutes in a benchtop microfuge. 
After the supernatant had been discarded, 100 jil 9 volumes STET : 1 volume 10 mg/ml 
lysozyme was added and the sample vortex mixed. Lysis of the E.coli was completed by 
incubation in a boiling water bath for 1 minute 15 seconds. The bacterial debris was 
pelleted by centrifugation at 13000 rpm in a benchtop microfuge and the supernatant 
containing the plasmid DNA was added to a vial containing 400 |il 0.3 M C ^C O O N a 
pH 7.0. DNA was precipitated by adding 0.5 ml isopropanol and incubating at -20° for 
>1 hr. The precipitated DNA was pelleted by centrifugation at 13000 rpm for 10 minutes 
in a benchtop microfuge, the supernatant removed and the pellet washed by adding 0.5 ml 
70% (v/v) ethanol and gentle mixing. The pellet was collected at the bottom of the vial by 
centrifugation at 13000 rpm for 5 minutes, the 70% ethanol removed and the pellet 
allowed to dry by lying the tube on the bench with the lid open for >45 minutes. The 
plasmid DNA pellet was resuspended in 33 |il of H2O and 5 (il was used for incubation 
with the required restriction enzyme(s) in the presence of 10 |ig/ml RNase A, followed by 
agarose gel electrophoresis.
3.27. Large scale preparation of plasmid DNA from E.coli.
Large scale preparation of plasmid DNA from E.coli was achieved with the 
Quiagen Plasmid Midi kit (Quiagen Inc.).
A glycerol stock of DH-1 bacteria harbouring the plasmid to be purified was 
streaked onto the surface of 1.5% agar / L-broth / ampicillin using a platinum loop. 
Colonies were grown by incubation at 37° overnight. A single colony was picked, 
inoculated into 10 ml L-broth containing ampicillin and shaken at 37° overnight. 100 ml 
L-broth containing ampicillin was inoculated with 1ml of the overnight culture and shaken
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at 37° overnight. The plasmid content of the bacteria was amplified by adding 
chloramphenicol to 20 Hg/ml and shaking at 37° overnight.
The bacterial cells were pelleted by centrifugation in a GSA rotor at 8000 rpm for 
5 minutes, the pellet was resuspended thoroughly in 4 ml buffer PI and transferred to a 
40 ml plastic centrifuge tube. 4 ml buffer P2 was added, the sample mixed by gently 
inverting the tube 6 times and incubated at room temperature for 5 minutes. 4 ml buffer 
P3 which had previously been cooled to 4° was added and the sample mixed gently and 
incubated on ice for 15 minutes with occasional gentle agitation. Debris from the lysed 
bacteria was pelleted by centrifugation in a Sorvall SS34 rotor at 16000 rpm for 15 
minutes at 4° and the supernatant containing the plasmid DNA promptly transferred to a 
Quiagen-tip 100 which had been previously equilibrated with 4 ml buffer QBT. After the 
supernatant had passed through the column, the resin plus bound plasmid DNA was 
given 2 x 10 ml washes with buffer QC and the DNA eluted with 5 ml buffer QF into a 
30 ml glass Corex centrifuge tube. Plasmids were precipitated by adding 3.5 ml 
isopropanol and mixing. The plasmid DNA was pelleted by centrifugation in an SS34 
rotor at 10000 rpm for 30 minutes at 4°. After removal of the supernatant, the pellet was 
washed briefly with 5 ml 70% (v/v) ethanol and dried by lying the tube on the bench for 
>45 minutes. The dried pellet was resuspended in 2 x 250 jil of sterile distilled H2O and 
stored at - 20°.
3.28. Determination of DNA concentration.
Concentration and purity of plasmid preparations was determined by measuring 
the absorbence at wavelengths of 260 nm and 280 nm in a Beckman Du-62 
spectrophotometer. An OD of 1 at 260 nm was taken as corresponding to a concentration 
of 50 jig/ml. The ratio of the OD at 260 nm : OD at 280 nm gives an indication of purity 
and is 1.8 for an ideal aqueous solution of dsDNA.
3.29. Transfection of DNA into tissue culture cells.
DNA was transfected into tissue culture cells by the calcium phosphate 
precipitation method adapted from the technique described by Stow and Wilkie (1976).
HSV-1 DNA for transfections was prepared as follows. 100 p.1 of a cell released 
virus preparation was incubated at 37° overnight with SDS / proteinase K buffer in a total 
volume of 500 jil. The sample was extracted with phenol / chloroform and the DNA 
isolated as described in section 3.10. The purified viral DNA pellet was resuspended by 
adding 50 p.1 H2O and incubating at 4° overnight.
HSV-1 DNA was cotransfected with plasmid DNA into BHK cells in 35 mm 
diameter tissue culture dishes.
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BHK cells used for transfections were seeded the previous day and had grown to 
80-100% confluence.
The transfection mix was made and stood at room temperature for 5 minutes 
before use.
Transfection mix. ~
calf thymus DNA 2.75 \Lg
HSV-1 DNA 0.1-0.3 jig
linear plasmid DNA 0.2-0.6 jig
HEBS lx
CaCl2 136 mM
Total volume 132 jil
The transfection mix was dripped onto a BHK cell monolayer in a 35 mm dish 
and the cells incubated at 37° for 40-45 minutes with rocking every 10 minutes to prevent 
drying. 2 ml ETCjq was added and incubation continued at 37° for 3-4 hrs.
The medium was poured from the dish and the monolayer washed with 2 ml 
ETC jo- The ETC^q was removed thoroughly and the monolayer overlaid with 0.3 ml 
25% DMSO / lx  HEBS and incubated at room temperature for 4 minutes with frequent 
rocking. The DMSO / HEBS was removed thoroughly and after 2 x 2 ml washes with 
ETCiQ, 2 ml ETCjo was added and the cells incubated at the appropriate temperature until 
plaques were visible under a low magnification light microscope.
3.30. Construction of HSV-1 recombinants.
HSV-1 recombinants were constructed by cotransfection of purified viral DNA 
with a linearised plasmid encoding the mutation or insertion flanked by viral sequences. 
Plasmids were linearised by cleavage with a restriction enzyme, usually at a cleavage site 
within the vector sequences. Recombination between the viral sequences flanking the 
mutation and the homologous sequences in the viral DNA yielded the desired recombinant 
virus.
The temperature sensitive uncoating mutant m l815 was constructed by 
cotransfection of m l814 DNA with pLRl which had been linearised with HindllI. After 
plaques had appeared, the cells were harvested, bath sonicated, diluted serially in 10-fold 
steps and 200 |il of each dilution was used to infect a BHK cell monolayer in a 35 mm 
tissue culture dish. After the 1 hr adsorption period the inocula were removed and the 
cells overlaid with 2 ml per dish of ETCjq containing 3 mM HMBA and incubated at 31° 
for 16 hrs. The ETCjq containing 3 mM HMBA was removed and the cells overlaid with
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2 ml per dish of agar overlay without X-gal and incubated at 31 ° until plaques were 
visible under a low magnification light microscope. Plaques were picked in a volume of 
15 pi with a micropipette, transferred to 500 pi ETC^q and bath sonicated. The virus in 
each plaque isolate was screened for temperature sensitivity by inoculating 100 pi onto 
each of two BHK cell monolayers in a single well of two replicate 24-well tissue culture 
plates. After the 1 hr adsorption period the inocula were removed and the cells overlaid 
with 1 ml per well of CMC/ETC jq containing 3 mM HMBA. One of the plates was 
incubated at 31° and the other at 39.5°. The monolayers at 31° were incubated for 4 days 
and the monolayers at 39.5° were incubated for 2 days before staining with Giemsa. A 
plaque isolate which contained temperature sensitive virus was subject to 2 further plaque 
purifications before being grown as a seed stock.
To ensure that the virus in the positive plaque isolate contained the same 
temperature sensitive lesion as ts 1213, it was subject to the coinfection / recombination 
experiment with teK and ttl213 described in section 4.29. To ensure ml815 had a defect 
in uncoating at 39.5°, it was subjected to the Southern blot assay described in section
4.30.
The temperature sensitive mutation in m l815 was rescued by cotransfection of 
ml815 DNA with a plasmid containing the Kpnl C fragment from wild type HSV-1. 
After plaques had appeared, the cells were harvested, bath sonicated, diluted serially into 
10-fold dilutions and 200 pi of each dilution was used to infect a BHK cell monolayer in 
a 35 mm diameter tissue culture dish. After the 1 hr adsorption period the inocula were 
removed and the cells overlaid with 2 ml per dish of CMC/ETCjq containing 3 mM 
HMBA and incubated at 39.5° for 2 days. Plaques were picked and subjected to 2 plaque 
purifications at 39.5°. To ensure that the Vmw65“  phenotype was retained, the response 
of the viral titre to HMBA during infection of BHK cells was assessed (section 4.31.). 
The rescuant of /«1815 was named ml816.
To construct HSV-1 mutants expressing (3-galactosidase, DNA isolated from the 
virus in which the insertion was to be made was cotransfected with a linearised plasmid 
containing the lacZ gene with desired controlling elements and flanking sequences. After 
plaques had appeared, the cells were harvested, bath sonicated, diluted serially into 10- 
fold dilutions and 200 pi of each dilution was used to infect a BHK cell monolayer in a 35 
mm diameter tissue culture dish. After the 1 hr adsorption period the inocula were 
removed and the cells overlaid with 2 ml per dish of ETCjq containing 3 mM HMBA and 
incubated at the appropriate temperature for 16 hrs. The ET C ^ containing 3 mM HMBA 
was removed and the cells overlaid with 2 ml per dish of agar / X-gal overlay and 
incubated at the appropriate temperature until plaques were visible under a low 
magnification light microscope. Replicating plaques formed by viruses expressing P~ 
galactosidase were visualised as staining blue in the presence of X-gal. Blue plaques were 
picked in a volume of 15 pi with a micropipette, transferred to 1 ml ETCiq,
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sonicated and subjected to plaque purifications until approximately 50% of plaques were 
stained blue by the agar / X-gal overlay.
Plaque isolates containing virus which expressed p-galactosidase were screened 
by Southern blotting to ensure the correct sizes of restriction endonuclease fragments at 
the region of modification. 500 pi of plaque isolate was added to a monolayer of BHK 
cells in a well of a 24-well tissue culture plate and the cells incubated at the appropriate 
temperature for 1 hr. After the adsorption period, 500 p,l ETCiq containing 6 mM HMBA 
was added to the well and incubation continued until the cells exhibited severe CPE. The 
medium was removed, 200 pi SDS / proteinase K buffer was added to the monolayer and 
the cells incubated at 37° overnight. The following day, 150 pi of the cell extract was 
placed in a 1.5 ml vial. The cell extract was made to a final concentration of 0.3 M 
CH3COONa pH 7.0 and a total volume of 500 pi. The sample was extracted with phenol 
/ chloroform and the DNA purified as described in section 3.10.
The purified DNA pellet was resuspended by adding 25 pi of H20  and incubating 
at 4° overnight. The resuspended pellet was incubated at 37° overnight with 5 units of the 
appropriate restriction endonuclease(s) and 10 pg/ml RNase A in a total volume of 50 pi. 
The next day, 5 pi of the digested infected cell DNA was further digested with 5 units of 
the restriction endonuclease(s) for 3 hrs at 37° in a total volume of 20 pi. 6 pi of 5x ficoll 
loading buffer was added and 10 pi electrophoresed in an agarose gel and subjected to 
Southern blotting and hybridisation.
3.31. Staining of tissue culture monolayers for p-galactosidase.
Medium was removed from a cell monolayer in a 35 mm diameter tissue culture 
dish and the cells washed with 2 ml PBS A. To fix the cells, the monolayer was overlaid 
with 1 ml PBS A containing 1% glutaraldehyde and incubated at room temperature for 
45-60 minutes. The glutaraldehyde was removed and after two 2 ml washes with PBS A,
1 ml p-galactosidase stain was added and the monolayer incubated at 37° until blue foci 
were easily visible under a low magnification light microscope (usually after 3-5 hrs). 
The P-galactosidase stain was removed, the monolayer washed with 2 ml distilled water 
and blue foci counted under a dissection microscope.
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4. RESULTS.
OBJECTIVES.
The objectives of the study described here were to extend previous structural 
analysis of the viral genomes in the in vitro latency system described by Jamieson et al. 
(described in section 1.3.4.3.; Jamieson, 1993; Jamieson et a l, 1995), and to investigate 
important early events in the establishment of in vitro latency.
CHAPTER 1. 
Structural studies on HSV-1 during latency in IFNoc-treated HFL cells.
4.1. Z/il820 genomes were retained in a nonlinear form.
The HSV-1 genome is a nonlinear episome during latency in neurons (Rock and 
Fraser, 1983; Rock and Fraser, 1985; Efstathiou et al. , 1986). In order to determine 
whether m l820 DNA was nonlinear in the in vitro latency system, IFNa-treated HFL 
cells were infected with 75 particles of m l820 per cell and incubated for 3 days in the 
presence of Ara-C. Nuclear DNA was purified, cleaved with BamHI, electrophoresed 
alongside known amounts of virion DNA, blotted and hybridised to radiolabelled DNA 
fragment from a region of the MMLV LTR (figure 3.2.). Use of the MMLV LTR probe 
enabled detection of the joint and L-terminal Bam HI restriction fragments and also 
minor species caused by variation in the number of copies of the a sequence.
Hybridisation showed a predominance of the viral Bam HI restriction fragments 
joining the long and short regions of the genome and a reduction in the L-terminal 
BamHI fragments, indicating that the ends of the genomes were joined together (figure 
4.1., lanes 3, 7 and 11). The degree of conversion to a nonlinear form was quantified by 
comparison with hybridisation to purified virion DNA (lanes 1-2, 5-6 and 9-10). Table
4.1. shows results of quantification of the degree of non-linearity of latent m l820 
obtained from two separate experiments, the autoradiographs of which are shown in 
figures 4.3. and 4.5. The values for the 6 latent m l820 samples ranged between 75% 
and 92% nonlinear, the average was 84% nonlinear.
Table 4.1. also shows the results of calculations to determine the average 
number of genomes retained per cell. In 1820 genomes were retained between a range of
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Figure 4.1. Configuration of viral genomes during in vitro latency. IFNa-treated 
HFL cells in 60 mm diameter tissue culture dishes were infected with 75 particles of 
m l820 per cell (lanes 3, 7 and 11) or mock infected (lanes 4 and 8) and overlaid with 
EFio containing 50 fxg/ml Ara-C. After incubation at 37° for 3 days the nuclei were 
isolated and the DNA purified. DNA was cleaved with Bam HI and half of each sample 
electrophoresed in a 0.7% agarose gel alongside 1.5 ng (lanes 1, 5 and 9) and 5.0 ng 
(lanes 2, 6 and 10) m l825 virion DNA standards. Electrophoresed DNA was blotted 
onto a hybridisation membrane and hybridised to a [32P]-labelled 455 bp Bam HI / Bfr I 
fragment from the MMLV LTR (figure 3.2.). Positions of the joint and L-terminal 
BamHI restriction fragments are indicated. L: latently infected sample; M: mock 
infected sample; V: virion DNA.
Results
F ig u re 4.3 4.5
Lane 4 11 1 2 3 7
% Nonlinear 84 90 86 76 92 75
Average % 
nonlinear 84
Copy num ber 
(genom es 
/ce ll)
6.3 5.6 14.7 12.0 15.6 18.8
A verage copy 
num ber 
(genom es 
/ce ll)
12.2
Table 4.1. Configuration and copy number of latent ml820 genomes. Hybridisation 
to the latent m l820 DNA samples and virion DNA standards in figures 4.3. and 4.5. 
was quantified. The percentage of latent in 1820 genomes which were converted to a 
nonlinear form and the number of genomes retained per cell were calculated by 
comparison to the virion DNA standards .
6.3 and 18.8 genomes per cell with an average of 12.2 genomes per cell. The data in 
table 4.1. are derived from experiments in which the input MOI was 110 particles per 
cell, thus it is probable that approximately 90% of the input DNA was lost. For an 
accurate determination of the percentage of viral DNA which was retained during 
latency, a direct comparison with DNA isolated from the virus inoculum was required. 
Jamieson et al. showed that input in 1820 genomes not retained in the cell nuclei were 
undetectable in the cytoplasm or culture medium and were presumably degraded, 
although the nonlinear DNA was stable for up to 4 days after infection (Jamieson et al., 
1995).
Retention of nonlinear HSV genomes in in vitro latency systems using HFL 
cells has been observed previously (Harris and Preston, 1991). In 1814 was retained as a
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nonlinear molecule after infection of HFL cells at low MOI and maintenance in the 
presence of Ara-C or aphidicolin. The experiments described in this thesis confirm the 
observation made by‘Jamieson that nonlinear ml 820 genomes are retained in IFNa- 
treated HFL cells after infection at high MOI and maintenance in the presence of Ara-C 
(Jamieson,, 1993). Previous studies showed that most m l883 genomes retained after 3 
days infection were competent for reactivation, as measured by P-galactosidase 
expression after superinfection (Jamieson et a l , 1995). Most of the retained m l820 
genomes were converted to a nonlinear form and retained in virtually all of the cells in a 
state resembling latency.
Approximately 16% of latent m l 820 DNA was linear (table 4.1.). A 
characterisation of the structural differences between the linear and nonlinear DNA is 
described later in this chapter.
4.2. In 1820 genomes reactivated from in vitro latency bv superinfection were more 
sensitive to nucleases than the superinfecting genomes.
Jamieson demonstrated an increase in MN sensitivity of the m l820 TK gene as 
the virus proceeded to latency (Jamieson, 1993). To examine whether insensitivity to 
MN or DNase I was restored after superinfection and reactivation with in 1863 (m l863 
encodes a wild-type Vmw65 and has the HCMV major IE promoter controlling the 
E.coli lacZ gene at the TK locus), IFNa-treated HFL cells were infected with 75 
particles of in 1820 per cell and incubated for 3 days in the presence of Ara-C. The 
cultures were superinfected with 5 PFU of in 1863 per cell and incubated in the presence 
of Ara-C. At 8 hours post-superinfection the nuclei were isolated and incubated with 
various concentration of MN or DNase I for various times or were untreated. The DNA 
was purified, cleaved with EcoRI, electrophoresed, blotted and hybridised to a 
radiolabelled EcoRI n fragment spanning the HSV-1 TK gene. The HCMV IE promoter 
/ lacZ insert in the TK gene of in 1863 enabled the EcoRI restriction fragments to be 
resolved from the wild-type restriction fragment of m l820 (figure 3.3.; figure 4.2.; 
positions of in 1820 and m l863 TK gene restriction fragments are indicated).
The TK gene of in 1820 was more sensitive to MN and DNase I than the TK 
gene of in 1863 (lanes 2-4 and 8-10), therefore resistance to nucleases was not restored 
by reactivation. As both m l820 and m l863 were transcriptionally active, the difference 
in nuclease sensitivity of their genomes was not caused by a difference in 
transcriptional activity but was most likely to have been caused by the difference in the 
total period of time that the viruses had been infecting the cells, 3 days in the case of
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Figure 4.2. Relative nuclease sensitivities of viral genomes reactivated from latency 
and genomes of a superinfecting virus. IFNa-treated HFL cells in 60 mm diameter 
tissue culture dishes were infected with 75 particles of m l820 per cell (lanes 1-4 and 7 - 
10) or mock infected (lanes 5 and 6) and overlaid with EFio containing 50 |Hg/ml Ara- 
C. After incubation at 37° for 3 days the cells were superinfected with 5 PFU of in 1863 
per cell (lanes 1-4 and 6-10) or mock superinfected (lane 5) and incubated at 37° in the 
presence of 50 Jig/ml Ara-C. At 7 hours post-superinfection, the nuclei were isolated 
and digested with MN (lanes 2-4) or DNase I (lanes 8-10) or were untreated (lanes 1 
and 5-7). DNA was purified, digested with E coR l and half of each sample 
electrophoresed in a 1% agarose gel. Electrophoresed DNA was blotted onto a 
hybridisation membrane and hybridised to a [32P]-labelled 2.4 kbp EcoRI n fragment 
from the HSV-1 TK gene (figure 3.3.). MN digestion was as follows: 1 unit for 3 
minutes (lane 2), 3 units for 5 minutes (lane 3) or 22 units for 10 minutes (lane 4). 
DNase I digestion was as follows: 1 unit for 3 minutes (lane 8), 2 units for 5 minutes 
(lane 9) or 5 units for 20 minutes (lane 10). Positions of m l 820 and ml 863-specific 
restriction fragments are indicated. indicates the positions of partial FcoRI digestion 
products. Lsi: latent / superinfected sample; M: mock infected / mock superinfected 
sample; Msi: mock infected / superinfected sample.
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m l820 and 8 hours with m l863. There was a small proportion of m l820 DNA in the 
nuclei which remained intact after extensive exposure to nucleases (lanes 4 and 10).
4.3. Nonlinear viral genomes were more sensitive to nucleases than linear genomes.
Jamieson observed that m l820 genomes became more sensitive to MN as the 
virus proceeded to latency and that transcriptionally active genomes did not enter the 
nuclease-senstive state (Jamieson, 1993). The nuclease-sensitive state was attributed to 
a structure specific for the latent genomes. The finding in section 4.2. that differences in 
nuclease sensitivity was dependent on the time of infection suggested that sensitivity to 
nucleases may be determined by uncoating of the viral genomes. There was a 
proportion of latent DNA which was highly resistant to nucleases, indicative of two 
separate populations of genomes. A comparison of the nuclease sensitivities of the 
nonlinear and linear latent viral DNA populations was undertaken in order to determine 
if they represented the two separate nuclease sensitive and nuclease resistant types. 
IFNa-treated HFL cells were infected with 110 particles of m l820  per cell and 
incubated for 3 days in the presence of Ara-C. Nuclei were isolated and digested with 
various concentrations of MN or DNase I for various times or were untreated. The DNA 
was purified, electrophoresed alongside virion DNA, blotted and hybridised to a 
radiolabelled fragment from the MMLV LTR.
The nonlinear DNA was the nuclease sensitive fraction and the linear DNA was 
nuclease resistant (figure 4.3. lanes 5-7 and 12-14; table 4.2.). The nuclease resistant 
linear viral DNA was probably from nonuncoated genomes associated with the nuclear 
pores or membranes which co-purified with the nuclei. It was clear, however that a 
significant proportion of the genomes (84%) were stably retained as nonlinear, 
uncoated, transcriptionally repressed, reactivatable molecules and were thus 
biologically relevant. The data of Jamieson (1993) can now be interpreted in light of the
f
finding that differences in nuclease sensitivity are caused by differences in uncoating. 
Experiments which examined the nuclease sensitivity of viral DNA after infection with 
Vmw65+ viruses were limited to the short term due to cytotoxicity (Jamieson, 1993), 
but it seems likely that transcriptionally active viruses would become nuclease sensitive 
if long term experiments were possible.
The experiment presented in figure 4.3. and table 4.2. examined the nuclease 
sensitivity of the MMLV LTR in the in 1820 long repeats. To examine whether the joint 
regions were in a structure distinct from the rest of the genome, rendering them more 
sensitive to nucleases, the hybridisation membrane depicted in figure 4.3. was stripped 
and re-hybridised to a radiolabelled 2.4 kbp EcoRI n fragment from the HSV-1 TK
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Figure 4.3. Relative nuclease sensitivities of nonlinear and linear viral genomes.
IFNa-treated HFL cells in 60 mm diameter tissue culture dishes were infected with 110 
particles of m l820 per cell (lanes 4-7 and 11-14) or mock infected (lanes 3 and 10) and 
overlaid with EFio containing 50 p.g/ml Ara-C. After incubation at 37° for 3 days the 
nuclei were isolated and digested with MN (lanes 5-7) or DNase I (12-14) or were 
untreated (lanes 3-4  and 10-11). DNA was purified, digested with Bam HI and half of 
each sample electrophoresed in a 0.7% agarose gel alongside 1.5 ng (lanes 2 and 9) and 
5.0 ng (lanes 1 and 8) in 1825 virion DNA standards. Electrophoresed DNA was blotted 
onto a hybridisation membrane and hybridised to a [32P]-labelled 455 bp Bam HI / BfrI 
fragment from the MMLV LTR. MN digestion was as follows: 1 unit for 3 minutes 
(lane 5), 3 units for 5 minutes (lane 6) or 22 units for 10 minutes (lane 7). DNase I 
digestion was as follows: 1 unit for 3 minutes (lane 12), 2 units for 5 minutes (lane 13), 
or 5 units for 20 minutes (lane 14). Positions of joint and L-terminal BamHI restriction 
fragments are indicated. L: latently infected sample; M: mock infected sample; V: virion 
DNA.
Results
N uclease MN DNase I
Enzyme units 0 1 3 0 1 2 5
Incubation 
time (mins) 0 3 5 0 3 5 20
. %
hybrid isation  
to jo in t
100 62 12 100 32 9.8 8.5
%
hybrid isation  
to L terminus
100 124 114 100 132 56 72
Table 4.2. Nuclease sensitivities of ml820 joint and L-terminal BamHI restriction 
fragments. Hybridisation to the nuclease treated and untreated latently infected nuclear 
DNA samples in figure 4.3. was quantified and the relative amounts of hybridisation to 
the joint and L-terminal restriction fragments determined. The non-nuclease treated 
samples represent 100% DNA.
gene, resulting hybridisation is presented in figure 4.4. Quantification revealed that the 
nuclease sensitivity of the TK gene, which is located in the unique long region of the 
genome, did not significantly differ from the joint region (table 4.3.). Sensitivity to 
nucleases was presumable a property of the entire nonlinear genomes and was not 
confined to the joints.
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Figure 4.4. Nuclease sensitivity of the in 1820 TK gene. The hybridisation membrane 
from the experiment described in section 4.3. (figure 4.3.) was stripped and re ­
hybridised to a [32P]-labelled 2.4 kbp FcoRI n fragment from the HSV-1 TK gene. L: 
latently infected sample; M: mock infected sample; V: virion DNA.
Results
Nuclease MN DNase I
Enzyme
units 0 1 3 0 1
Incubation
time(mins) 0 3 5 0 3
% TK 
gene 100 62 9 100 27
Table 4.3i Nuclease sensitivity of the m l820 TK gene. Hybridisation to the nuclease 
treated and untreated latently infected nuclear DNA samples shown in figure 4.4. was 
quantified and the relative amounts of hybridisation determined. The non-nuclease 
treated samples represent 100% DNA.
4.4. Nonlinear viral genomes were templates for reactivation.
Superinfection of latently infected HFL cells with viruses expressing Vmwl 10 
resulted in activation of the HCMV enhancer and the Vmwl 10 promoter in the latent 
genomes, and resumption of viral replication (Jamieson, 1993; Jamieson et a l, 1995). 
To investigate whether a change in configuration of the nonlinear genomes occurred 
after reactivation, the configuration of the m l820 genomes were determined after 
superinfection with ml863, a virus which expresses Vmwl 10, or dl 1403, an IE1 
deletion mutant which does not reactivate viruses from in vitro latency. IFNa-treated 
HFL cells were infected with 110 particles of m l820 per cell and incubated for 3 days 
in the presence of Ara-C. Cultures were superinfected with 5 PFU per cell of m l863 or 
dl 1403 and incubated for 7 hours in the presence of Ara-C. Nuclei were isolated and the 
DNA purified, electrophoresed alongside virion DNA, blotted and hybridised to a 
radiolabelled fragment from the MMLV LTR.
No significant change in configuration occurred after superinfection with either 
virus (figure 4.5.; table 4.1.). The nonlinear genomes were templates for reactivation 
and did not require previous conversion to the linear form to allow viral gene 
expression. Presumably the linear molecules would have been converted to the
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Figure 4.5. Configuration of viral genomes after reactivation. IFN a-treated HFL 
cells in 60 mm diameter tissue culture dishes were infected with 110 particles of in 1820 
per cell (lanes 1-3 and 7-10) or mock infected (lane 6) and overlaid with EFio 
containing 50 |ig/m l Ara-C. After incubation at 37° for 3 days, the cultures were 
superinfected with 5 PFU per cell of m l863 (lanes 2-3) or d/1403 (lanes 8-10) or were 
mock superinfected (lanes 1 and 7) and incubated at 37° in the presence of 50 |ig/ml 
Ara-C. At 7 hours post-superinfection the nuclei were isolated and the DNA was 
purified. DNA was cleaved with Bam HI and half of each sample electrophoresed in a 
0.7% agarose gel alongside and 5.0 ng (lane 4) and 1.5 ng (lane 5) in 1825 virion DNA 
strandards. Electrophoresed DNA was blotted onto a hybridisation membrane and 
hybridised to a [32P]-labelled 455 bp BamHI / BfrI fragment from the MMLV LTR. 
Positions of joint and L-terminal Bam HI restriction fragments are indicated. L: latently 
infected sample; M: mock infected sample; V: virion DNA.
Results
nonlinear form if superinfection induced uncoating. The linear molecules remained 
linear, therefore uncoating was not induced by superinfection.
4.5. HFL cells contained fewer nonlinear, uncoated viral genomes than BHK. 
HeLa and CV-1 cells at a set time after infection.
• The presence of linear, nonuncoated viral genomes after 3 days infection of HFL 
cells indicated that uncoating was unexpectedly slow. To investigate whether slow viral 
uncoating was a peculiar property of HFL cells, the rate of conversion to the nonlinear 
form, sensitivity to DNase I and amount of total nuclear viral DNA was compared after 
infection of HFL, BHK, HeLa and CV-1 cells. HFL, BHK, HeLa or CV-1 cells were 
infected with 75 particles of in 1820 per cell and incubated in the presence of Ara-C. At 
7 hours post-infection, nuclei were isolated and treated with DNase I or were untreated, 
DNA was purified, digested with Bam HI, electrophoresed alongside virion DNA, 
blotted and hybridised to a radiolabelled fragment from the MMLV LTR. Resulting 
hybridisation is shown in figure 4.6. Hybridisation was quantified and the relative 
proportions of nonlinear and linear viral genomes calculated by comparison to the 
virion DNA standards. The relative proportions of nonlinear and linear viral genomes in 
the non-nuclease treated samples between the cell types is presented in figure 4.7. The 
proportions of nonlinear viral genomes within each cell type and the percentage of 
genomes remaining after DNase I digestion is presented in table 4.4.
HFL cells contained a lower proportion of nonlinear molecules than the other 
cell types, 28% of the genomes in HFL cells being nonlinear compared with 88% in 
BHK cells, 52% in HeLa cells and 52% in CV-1 cells (figure 4.6.; figure 4.7). A 
comparison of numbers of nonlinear genomes between the cell types revealed that the 
number of nonlinear genomes present in HFL cells was approximately 7-fold lower 
than in BHK cells, 6-fold lower than in HeLa cells and 4-fold lower than in CV-1 cellsv
(figure 4.7.). A lower proportion of nonlinear molecules in HFL cells indicated that 
uncoating or conversion to the nonlinear form occured more slowly in HFL cells than in 
the other three cell types. The genomes in HFL cell nuclei were more resistant to DNase 
I digestion than in the other cell types, supporting the view that differences in the 
number and proportion of nonlinear molecules was due to differences in rates of 
uncoating (table 4.4.).
The lower proportion of nonlinear genomes in HFL cells could have been 
caused by the a slower rate of virus penetration across the cell membrane or migration 
to the nuclei. If entry into the nuclei was limited by slower penetration across the cell 
surface and migration to the nuclei, then the viral genomes would have had less time to
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Figure 4.6. Comparison of the configuration of viral genomes after infection of 
HFL, BHK, HeLa and CV-1 cells. HFL, BHK, HeLa or CV-1 cells in 35 mm diameter 
tissue culture dishes were infected with 75 particles of m l820 per cell (samples in lanes 
2-3, 6-7, 10-11 and 14-15 were from infected HFL, BHK, HeLa and CV-1 cell nuclei 
respectively) or mock infected (samples in lanes 1, 5, 9 and 13 were from mock infected 
HFL, BHK, HeLa and CV-1 cell nuclei respectively), overlaid with medium containing 
50 Jig/ml Ara-C and incubated at 37°. At 7 hours post-infection the nuclei were isolated 
and digested with 10 units of DNase I for 20 minutes (lanes 3, 7, 11 and 15) or were 
untreated (lanes 1-2, 5-6, 9-10 and 13-14). DNA was purified, digested with Bam HI 
and half of each sample electrophoresed in a 0.7% agarose gel alongside standards of 
m l825 virion DNA (lanes 4, 8 and 12). Electrophoresed DNA was blotted onto a 
hybridisation membrane and hybridised to a [32P]-labelled 455 bp Bam HI / Bfr I 
fragment from the MMLV LTR. Positions of joint and L-terminal BamHI restriction 
fragments are indicated. D: infected, DNase I digested sample; INF: infected, untreated 
sample; M: mock infected sample; V: virion DNA.
Results
Relative proportions of nonlinear and linear viral genomes in 
the nuclei of infected HFL. BHK. HeLa and CV-1 cells.
■ % total genomes
□ % nonlinear genomes
■ % linear genomes
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Cell type
Figure 4.7. Relative proportions nonlinear and linear viral genomes in the nuclei of 
different infected cell types. Hybridisation in figure 4.6. was quantified and the 
relative proportions of nonlinear and linear viral genomes in the non-nuclease treated 
samples determined by comparison with the purified virion DNA standards. The total 
number of genomes in HeLa cell nuclei, which contained the greatest total number of 
genomes compared to the other three cell types, represents 100%.
Results
Cell type HFL BHK HeLa CV-1
% genomes nonlinear 28 88 52 52
% genomes remaining 
after DNase I digestion 47 4.8 24 21
Table 4.4. Configuration and DNase I sensitivity of viral genomes in different 
infected cell types. Hybridisation in figure 4.6. was quantified and the percentage of 
nonlinear genomes in the non-nuclease treated samples calculated by comparison to the 
purified virion DNA standards. The percentage of genomes remaining after DNase I 
digestion was determined by comparison with the untreated samples.
uncoat and a lower proportion of nonlinear molecules would be expected. If a reduced 
rate of penetration and migration to the nuclei was the case, HFL cells should contain a 
greater number of genomes in the cytoplasm. To test the possibility that penetration and 
migration to the nuclei occurred more slowly in HFL cells than in BHK, HeLa and CV- 
1 cells, a comparison of viral DNA in the cytoplasm at a set time after infection was 
performed. HFL, BHK, HeLa or CV-1 cells were infected with 75 particles of m l820 
per cell in triplicate and incubated in the presence of Ara-C. At 7 hours post-infection 
nuclei were isolated and the DNA in the TK lysis buffer purified, digested with Bam HI, 
electrophoresed, blotted and hybridised to a radiolabelled fragment from the MMLV 
LTR. Hybridisation showed that levels of viral DNA in the cytoplasm of HFL cells was 
not greater than in the other cell types (figure 4.8.), thus slower rate of penetration and 
migration to the nuclei was unlikely to be the cause of the lower proportion of nonlinear 
molecules in HFL cells.
In summary, HFL cells contained significantly fewer nonlinear, uncoated viral 
genomes than BHK, HeLa and CV-1 cells at a set time point after infection and this 
difference might be caused by differences in rates of virus uncoating.
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Figure 4.8. Comparison of the numbers of viral genomes in the cytoplasm after 
infection of HFL, BHK, HeLa and CV-1 cells. HFL, BHK, HeLa or CV-1 cells in 35 
mm diameter tissue culture dishes were infected with 75 particles of in 1820 per cell 
(samples in lanes 1-3, 5-7, 19-11 and 13-15 were from infected BHK, HeLa and CV-1 
cells respectively) or mock infected (samples in lanes 4, 8, and 12 were from mock 
infected BHK, HeLa and CV-1 cells respectively), overlaid with medium containing 50 
p.g/ml Ara-C and incubated at 37°. At 7 hours post-infection, the cells were lysed with 
TK lysis buffer, DNA was purified from the resulting lysate, digested with BamHI and 
electrophoresed in a 1.2% agarose gel. Electrophoresed DNA was blotted onto a 
hybridisation membrane and hybridised to a [32P]-labelled 455 bp Bam HI / B frl 
fragment from the MMLV LTR. Positions of joint and L-terminal BamHI restriction 
fragments are indicated. M: mock infected sample.
Results
4.6. The m!814 mutation and HMBA did not exert their effects bv inhibiting virus
uncoating.
The data in section 4.5. suggested that virus uncoating was unusually slow in 
HFL cells, hence in this and the next three sections experiments are described which 
investigate the relationship between virus uncoating and in vitro latency. Mutants of 
HSV-1 defective in expression of Vmwl 10 exhibit a particularly high particle /  PFU 
ratio in HFL cells (Stow and Stow, 1986; Ace et al., 1989; Everett, 1989). After 
infection of neurons in vivo , viral nucleocapsids are transported along the nerve axons 
leading to a delay between infection at the neuronal cell surface and release of the viral 
genomes into the nuclei (Cook and Stevens, 1973), hence it was tempting to postulate 
that slow uncoating in HFL cells was mimicking the situation in vivo. An investigation 
to determine if the ml814 mutation, HMBA, IFN a or Ara-C act by altering the rate of 
virus uncoating is described in this and the next three sections..
The virus protein Vmw65 is a major component of the virion tegument and as 
such might play a role in virus uncoating. It seemed possible that the mutation in in 1814 
affects virus replication by blocking uncoating in addition to preventing transactivation 
of IE genes and that HMBA might overcome the defect in zti 1814 by facilitating 
uncoating. An investigation was undertaken to examine the effect of the m l814 
mutation and HMBA on virus uncoating by comparing the rates of conversion of the 
genomes of in 1814 and its revertant 1814R to the nonlinear form after infection in the 
presence or absence of HMBA. HFL cells were infected with 0.5 PFU of m l814 or 
1814R per cell and incubated for 7 hours in the presence of Ara-C with or without 5 
mM HMBA. Nuclei were extracted and were digested to a sufficient extent with DNase 
I to degrade most of the cell DNA visualised on the agarose gel, or were untreated. 
DNA was purified, digested with BamHI, electrophoresed, blotted onto a hybridisation 
membrane and hybridised to a radiolabelled DNA fragment from the HSV-1 IE1 
promoter (figure 3.2.). Resulting hybridisation is presented in figure 4.9. Quantification 
of the relative proportions of nonlinear and linear genomes in the non-nuclease treated 
samples is presented in figure 4.10. The percentage of nonlinear molecules within the 
non-nuclease treated samples and the percentage of genomes remaining after DNase I 
digestion is presented in table 4.5.
If the rate of uncoating was stimulated in the presence of HMBA the proportion 
of nonlinear molecules would be increased and the DNase I sensitivity of the genomes 
increased. The proportion of nonlinear molecules was not increased by HMBA, neither 
was the DNase I sensitivity of the genomes increased (figure 4.10.; table 4.5.), thus it is 
unlikely that HMBA facilitated uncoating. A comparison of the total number of 
genomes in HMBA treated samples with the total number of genomes in the untreated 
samples showed that HMBA did not significantly alter virus adsorption, penetration or
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Figure 4.9. Effect of the ml814 mutation and HMBA on virus uncoating. HFL cells 
in 35 mm diameter tissue culture dishes were infected with 0.5 PFU per cell of m l814 
(lanes 1-6) or 1814R (lanes 7-11), overlaid with EFio containing 50 Jig/ml Ara-C with 
(lanes 1-3 and 7-8) or without (lanes 4-6  and 9-11) 5 mM HMBA, and incubated at 
37°. At 7 hours post-infection the nuclei were isolated and digested with 5 units of 
DNase I for 20 minutes (lanes 3, 6, 8 and 11) or were untreated (lanes 1-2, 4 -5 , 7 and 
9-10). DNA was purified, digested with Bam HI, electrophoresed in a 1.2% agarose 
gel, blotted onto a hybridisation membrane and hybridised to a [32P]-labelled fragment 
specific for the 960 bp Bam HI / Sstl fragment spanning the promoter of IE1 (figure 
3.2.). Positions of joint and L-terminal Bam HI restriction fragments are indicated. The 
difference in mobility of the joint fragments between DNase I treated and untreated 
samples was caused by differences in the total amounts of DNA electrophoresed. D: 
DNase I digested sample.
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Figure 4.10. Effect of the m l814 mutation and HMBA on virus uncoating.
Hybridisation shown in figure 4.9. was quantified and the relative proportions of 
nonlinear and linear genomes in the non-nuclease treated samples determined. The 
hybridisation bias for virion DNA used to calculate the relative proportions of nonlinear 
and linear genomes was taken from hybridisation shown in figures 4.3. and 4.5. The 
total number of genomes in the nuclei from cells infected with 1814R in the absence of 
HMBA, which contained the greatest total number of genomes compared to the other 
samples, represents 100%.
Results
Virus ±HMBA ml814 +HMBA m 1814-HMBA 1814R+HMBA 1814R-HMBA
% nonlinear 30 22 21 27 7 16 15
Average % 
nonlinear 26 24 7 16
% genomes 
remaining 
after DNase I 
digestion
43 41 36 33
Table 4.5. Effect of m l814 mutation and HMBA on virus genome configuration 
and DNase I sensitivity. Hybridisation in figure 4.9. was quantified and the percentage 
of nonlinear genomes in the non-nuclease treated samples calculated by comparison to 
the purified virion DNA standards. The percentage of genomes remaining after DNase I 
digestion was determined by comparison with the untreated samples. The slow 
mobilities of the joint fragments in the DNase I-digested samples compared to the non- 
nuclease treated samples was caused by differences in the total amounts of DNA loaded 
on the gel.
migration of the genomes to the nuclei. If the in 1814 mutation inhibited uncoating, the 
proportion of nonlinear genomes in ml814 infected samples would have been smaller 
than in 1814R infected samples. The data presented in table 4.5. demonstrated that the 
proportion of nonlinear genomes was not smaller in ml814 infected samples compared 
to 1814R infected samples: m l814 was 24% nonlinear in the absence of HMBA 
whereas 1814R was 16% nonlinear . The total number of viral genomes in the nuclei of 
1814R infected samples was approximately 2.5-fold higher than in m l814 infected 
samples (table 4.5.). Ace etal. demonstrated that the m l814 mutation had no significant 
effect on entry of the viral genomes into the nuclei of infected cells (Ace et a l , 1989), 
thus the difference described in the study described here may be explained by 
experimental error in dilution or titration of the virus preparations. It should be noted 
that MOI was calculated in terms of PFU / cell rather than particles / cell and that the 
m l814 preparation was titrated in the presence of 3 mM HMBA to overcome the 
particle / PFU defect. An accurate determination of the effect of the in 1814 mutation on
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entry of viral genomes into nuclei would require the cells to be infected with equal 
numbers of particles of ml814 or 1814R. Lower proportions of nonlinear DNA in the 
1814R infected samples might be related to cytotoxicity caused by expression of IE 
proteins. In the 1814R samples infected in the presence of HMBA IE gene expression 
would have been stimulated by both Vmw65 and HMBA, only 7% of the genomes were 
nonlinear, supporting the theory that cytotoxicity reduced the number of nonlinear 
molecules. The data presented in this thesis supports previous work by others who 
demonstrated that HMBA and the Vmw65 mutation of ml814 exert their effects by 
directly altering levels of IE transcription (Ace et al. , 1989; McFarlane et al. , 1992).
4.7. The antiviral state caused bv IFNa-treatment did not act via an alteration of 
virus uncoating.
It has been reported previously that the antiviral action of IFN a  on HS V-1 is via 
a specific inhibition of IE transcription (Mittnach et al., 1988; Oberman and Panet, 
1989; DeStasio and Taylor, 1990). To determine whether IFNa-treatment causes 
inhibition of virus adsorption, penetration, migration to the nucleus, uncoating or 
conversion of the genomes to the nonlinear configuration, the total number of genomes 
and proportion of nonlinear viral genomes after infection of IFNa-treated and mock- 
treated HFL cells was compared using the Southern blot assay. HFL cells were treated 
with 1000 u/ml of IFNa in the culture medium for 24 hours, or were mock-treated. The 
cells were infected with 75 particles of m l820 per cell and incubated in the presence of 
Ara-C. At 24 hours post-infection the nuclei were extracted and digested with DNase I 
or untreated. DNA was purified, digested with ZtomHI, electrophoresed, blotted and 
hybridised to a radiolabelled DNA fragment from the MMLV LTR. Resulting 
hybridisation is presented in figure 4.11. Relative proportions of nonlinear genomes and 
linear genomes in the non-nuclease treated samples were quantified and presented in 
figure 4.12. The percentage of nonlinear molecules in the non-nuclease treated samples 
and percentage of genomes remaining after DNase I digestion was quantified and 
presented in table 4.6.
If IFNa-treatment reduced adsorption, penetration or uncoating, a smaller 
proportion of total numbers of genomes and a smaller proportion of nonlinear genomes 
would be expected in IFNa-treated cells. Quantification presented in figure 4.12. 
showed that the total number of genomes was increased by 1.4-fold and the proportion 
of nonlinear genomes was increased by 1.5-fold in the nuclei of IFNa-treated cells. The 
antiviral action of IFNa was not on adsorption, penetration, migration to the nucleus,
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Figure 4.11. Effect of IFNa pretreatm ent on virus uncoating. HFL cells in 35 mm 
diameter tissue culture dishes were treated overnight with 1000 u/ml of IF N a in the 
culture medium (lanes 6-8) or were mock treated (lanes 2-4). The monolayers were 
infected with 75 particles of m 1820 per cell (lanes 3-4 and 7-8) or mock infected (lanes 
2 and 6), overlaid with E F jo containing 50 p.g/ml Ara-C and incubated at 37°. At 24 
hours post-infection the nuclei were isolated and digested with 10 units of DNase I for 
20 minutes (lanes 4 and 8) or were untreated (lanes 3 and 7). DNA was purified, 
digested with BamHI and electrophoresed in a 0.8% agarose gel alongside 1.5 ng 
standards of m l825 virion DNA (lanes 1 and 5). Electrophoresed DNA was was blotted 
onto a hybridisation membrane and hybridised to a [32P]-Iabelled 455 bp Bam HI / Bfr I 
fragment from the MMLV LTR. Positions of joint and L-terminal Bam HI restriction 
fragments are indicated. D: DNase I digested sample; M: mock infected sample; V; 
virion DNA.
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Figure 4.12. Relative proportions of nonlinear and linear viral genomes in the 
nuclei of IFN a-treated and mock-treated infected HFL cells. Hybridisation in figure 
4.11. was quantified and the relative proportions of nonlinear and linear viral genomes 
in the non-nuclease treated samples quantified by comparison to the virion DNA 
standards.The total number of genomes in the nuclei from the IFNa-treated cells, which 
contained the greatest total number of genomes compared to the non-IFNa-treated 
sample, represents 100%.
Results
± IF N a -IFNa +IFNa
% nonlinear 61 67
% genomes remaining 
after DNase I digestion 27 9.5
Table 4.6. Configuration and DNase I sensitivity of viral genomes in IFN a-treated 
and mock treated HFL cells. Hybridisation in figure 4 .11. was quantified and the 
percentage of genomes which were nonlinear in the non-nuclease treated samples 
calculated by comparison to the purified virion DNA standards. The percentage of 
genomes remaining after DNase I digestion was determined by comparison with the 
untreated samples.
uncoating or conversion of the genomes to the nonlinear configuration, but was on IE 
transcription, as reported by others. The increase in total numbers of genomes and 
proportion of nonlinear genomes in IFNa-treated cells might have been caused by the 
protective effect of IFNa reducing the number of cells dying from viral CPE and 
floating into the culture medium. Viral genomes in the dead cells would not have been 
detected in the assay, leading to a lower signal in the untreated samples.
4.8. Conversion of viral genomes to the nonlinear configuration did not require de 
novo protein synthesis.
Little is known about the mechanism by which HSV-1 genomes are converted to 
the nonlinear configuration after infection. To examine whether uncoating and 
conversion of viral genomes to the nonlinear configuration was dependent on viral or 
cellular gene products synthesised de novo or was caused by pre-existing cell or viral 
factors, the rate of conversion to the nonlinear configuration was compared after 
infection of HFL or BHK cells in the presence of Ara-C or cycloheximide. HFL or 
BHK cells were infected with 75 particles of m l820 per cell and incubated in the 
presence of Ara-C or cycloheximide. At 7 hours post-infection nuclei were isolated and
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Figure 4.13. Effect of inhibition of protein synthesis on virus genome uncoating 
and conversion to the non-linear form. HFL or BHK cells in 35 mm diameter tissue 
culture dishes were infected with 75 particles of m l820 per cell (samples in lanes 1-6 
and 7-11 were from infected HFL and BHK cells respectively), overlaid with medium 
containing 50 Jig/ml Ara-C (lanes 1-3, 7 and 8) or 50 Jig/ml cycloheximide (lanes 4-6  
and 9-11) and incubated at 37°. At 7 hours post-infection the nuclei were isolated and 
digested with 5 units of DNase I for 20 minutes (lanes 3, 6, 8 and 11) or were untreated 
(lanes 1-2, 4 -5 , 7, and 9-10). DNA was purified, digested with BamYQ., 
electrophoresed in a 1.2% agarose gel alongside a 1.5 ng in 1825 virion DNA standard 
(lane 12), blotted onto a hybridisation membrane and hybridised to a [32P]-labeIled 455 
bp Bam HI / Bfrl fragment from the MMLV LTR. Positions of joint and L-terminal 
Bam HI restriction fragments are indicated. D: DNase I digested sample; V: virion DNA.
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Figure 4.14. Relative proportions of nonlinear and linear viral genomes after 
infection in the presence or absence of protein synthesis. Hybridisation shown in 
figure 4.13. was quantified and the relative proportions of nonlinear and linear viral 
genomes in the non-nuclease treated samples quantified by comparison to the virion 
DNA standards. The total number of genomes in the BHK cell nuclei infected +Ara-C, 
which contained the greatest total number of genomes compared to the other samples, 
represents 100%.
Results
Cell type / 
inhibitor HFL +Ara-C HFL+CH BHK + Ara-C BHK + CH
Average % 
nonlinear 38 43 91 92
Average % 
genomes 
remaining after 
DNase I 
digestion
53 60 5.2 3.5
Table 4.7: Configuration and DNase I sensitivity of viral genomes after infection in 
the presence or absence of protein synthesis. Hybridisation in figure 4.13. was 
quantified and the percentage of genomes which were nonlinear in the non-nuclease 
treated samples calculated by comparison to the purified virion DNA standards. The 
percentage of genomes remaining after DNase I digestion was determined by 
comparison with the untreated samples.
digested with DNase I or untreated. DNA was purified, digested with ZtomHI, 
electrophoresed in an agarose gel, blotted and hybridised to a radiolabelled DNA 
fragment from the MMLV LTR. Resulting hybridisation is presented in figure 4.13. The 
relative proportions of nonlinear and linear viral genomes in the non-nuclease treated 
samples was quantified and presented in figure 4.14. The percentage of nonlinear 
genomes in the non-nuclease treated samples and genomes remaining after DNase I 
digestion is presented in table 4.7.
The proportion of nonlinear genomes within the nuclei of both cell types was 
not significantly altered when protein synthesis was inhibited by cycloheximide (figures 
4.13. and 4.14.). The proportion of genomes remaining after DNase I digestion was 
similar after infection in the presence of Ara-C or infection in the presence of 
cycloheximide, indicating that the number of uncoated genomes was unaffected by 
inhibition of protein synthesis (table 4.7.). It was concluded that uncoating and 
conversion of the viral genomes to the nonlinear form was not dependent on de novo 
protein synthesis but was caused by factors pre-existing in the cell or associated with 
incoming virus particles. It was noted again that BHK cells contained approximately 9-
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fold more uncoated, nonlinear viral genomes than HFL cells (figure 4.14.) and that the 
viral genomes in BHK cells were approximately 13-fold more sensitive to DNase I 
(table 4.7.), supporting the concept that rate of uncoating differs greatly between the 
two cell types.
4.9. r s!2 1 3  genomes were not uncoated or converted to the nonlinear 
configuration at the NPT.
Temperature sensitive uncoating mutants of HSV-1 have been characterised by 
their inability to release viral DNA from nucleocapsid cores, to produce any virus - 
specific products or to be fully complemented by other mutants at the NPT (Knipe et 
al., 1981; Batterson et al., 1983). The HSV-1 mutant tel213 contains a ts lesion which 
has been mapped to the major tegument protein encoded by U l36 and has a phenotype 
consistent with that of an uncoating mutant (V.G. Preston, personal communication). In 
order to confirm that ^1213 is an uncoating mutant and assess the validity of the 
Southern blot assay for uncoating utilised in sections 4.5.-4.8., ts 1213 was examined in 
the assay. BHK cells were infected with 0.5 PFU of tel213 or 1814R per cell and 
incubated at 31° or 39.5° in the presence of Ara-C. At 7 hours post-infection nuclei were 
isolated and digested with DNase I or untreated. DNA was purified, digested with 
BamHl, electrophoresed alongside purified virion DNA, blotted and hybridised to a 
radiolabelled DNA fragment from the 5' coding sequences of IE1 (figure 3.2.). 
Resulting hybridisation is presented in figure 4.15. The relative proportions of nonlinear 
and linear viral genomes in the non-nuclease treated samples was quantified and is 
presented in figure 4.16. The percentage of nonlinear genomes in the non-nuclease 
treated samples and the percentage of genomes remaining after DNase I digestion is 
presented in table 4.8.
At 31°, ts 1213 DNA was converted to the nonlinear configuration at a similar 
rate to 1814R (figure 4.15., lanes 2 and 4; figure 4.16.). At 39.5°, the NPT for tal213, 
1814R DNA was converted to the nonlinear configuration with comparable efficiency 
to that at 31°, but ts 1213 showed no evidence of conversion to the nonlinear 
configuration (figure 4.15., lanes 8 and 10; figure 4.16.). The total numbers of genomes 
in the nuclei after infection with ts\2\3  at the NPT was about 30% of the total numbers 
of genomes after infection at 31°, indicating that the ability of the linear genomes to co- 
purify with the nuclei was related to uncoating. The percentage of genomes remaining 
after DNase I treatment was approximately 1.7-fold greater in the sample infected with 
ts\2\2> at the NPT than in samples infected under permissive conditions implying that 
the genomes were more resistant to DNase I but retained a degree of sensitivity. The
105
Results
31°C 39.5° C
1814R fs1213 1814R fs1213
I 1 i 1 i 1 I i
V D D M V  D D M V
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3
Joint -
L t e r m i n u s  ~ S
Figure 4.15. Configuration of tel213 genomes after infection at the NPT. BHK cells 
in 35 mm diameter tissue culture dishes were infected with 0.5 PFU per cell of 1814R 
(lanes 2-3 and 8-9) or ts 1213 (lanes 4-5 and 10-11) or mock infected (lanes 6 and 12), 
overlaid with EF io containing 50 Jig/ml Ara-C and incubated at 31° (lanes 2-6) or 39.5° 
(lanes 8-12). At 7 hours post-infection the nuclei were isolated and digested with 10 
units of DNase I for 20 minutes (lanes 3, 5, 9 and 11) or were untreated (lanes 2, 4, 8 
and 10). DNA was purified, digested with ZtamHI and half of each sample 
electrophoresed in a 0.7% agarose gel alonside 1.0 ng m l825 virion DNA standards 
(lanes 1, 7 and 13). Electrophoresed DNA was blotted onto a hybridisation membrane 
and hybridised to a [32P]-labelled 640 bp Bam HI / N co\ fragment from the 5' coding 
sequences of IE1 (figure 3.2.). Positions of joint and L-terminal Bam HI restriction 
fragments are indicated. D: DNase I digested sample; M: mock infected sample; V: 
virion DNA.
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Figure 4.16. Effect of the ts 1213 mutation on the relative proportions of nonlinear 
and linear viral genomes after infection at the permissive and non-permissive 
temperatures. Hybridisation in figure 4.15. was quantified and the relative proportions 
of nonlinear and linear viral genomes in the non-nuclease treated samples quantified by 
comparison to the virion DNA standards. The total number of genomes in nuclei from 
cells infected with 1814R at 39.5°, which contained the greatest total number of 
genomes compared to the other samples, represents 100%.
Results
Temperature (“) 31 39.5
Virus 1814R ttl213 1814R t s l l t t
% nonlinear ' 34 38 30 - 1
% genomes 
remaining after 
DNase I digestion
ND 38 26 55
Table 4.8. Configuration and DNase I sensitivity of tel213 genomes after infection 
at the permissive and non-permissive temperatures. Hybridisation in figure 4.15. 
was quantified and the percentage of genomes which were nonlinear in the non­
nuclease treated samples calculated by comparison to the purified virion DNA 
standards. The percentage of genomes remaining after DNase I digestion was 
determined by comparison with the untreated samples. ND; not determined due to 
interfering background.
ts 1213 genomes exhibited a phenotype at 39.5° expected of an uncoating mutant, they 
were not converted to the nonlinear form, did not associate with nuclei as efficiently as 
in normal infection and were resistant to DNase I, giving credibility to the Southern blot 
assay for uncoating and confirming that ts\2\3  is an uncoating mutant.
4.10. Non-nucleosomal pattern of MN digestion of the TK gene was not altered bv 
the specificity of the DNA replication inhibitor.
Partial digestion of eukaryotic chromatin with MN produces a series of DNA 
fragments with sizes multiples of about 200 bp (figure 4.17., lower panel). HSV-1 DNA 
in the brainstems of latently infected mice was digested by MN into a series of 
fragments chracteristic of cell chromatin (Deshmane and Fraser, 1989). Previous work 
demonstrated that the viral TK gene produced heterogeneously sized DNA fragments 
after partial MN digestion of nuclei from latently infected HFL cells (Jamieson, 1993; 
Jamieson et a l, 1995). The TK gene was bound by regularly spaced nucleosomes when 
in the cell genomes of a stably transfected cell line, demonstrating that the HSV-1 TK
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Figure 4.17. MN digestion of the viral TK gene during latency in the presence of 
Ara-C, ACG or PAA. IFNa-treated HFL cells in 35 mm diameter tissue culture dishes 
were infected with 75 particles of m l820 per cell (lanes 1-3, 7-9 and 13-15) or mock 
infected (lanes 4-6 and 10-12) and overlaid with EFio containing 50 pg/ml Ara-C 
(lanes 1-3), 5 jiM ACG (lanes 4-9) or 50 pg/ml PAA (lanes 10-15). After incubation at 
37° for 3 days the nuclei were extracted and digested with MN (lanes 2-3, 5-6, 8-9, 
11-12 and 14-15) or were untreated (lanes 1, 4, 7, 10 and 13). DNA was purified, 
electrophoresed in a 1.5% agarose gel, blotted onto a hybridisation membrane and 
hybridised to a [32P]-labelled 2.4 kbp FcoRI n fragment from the HSV-1 TK gene. MN 
digestion was as follows: 5 units for 10 minutes (lanes 2, 5, 8, 11 and 14) or 10 units for 
10 minutes (lanes 3, 6, 9, 12 and 15). Upper panel shows the autoradiograph, lower 
panel shows the ethidium bromide-stained gel. L: latently infected sample; M: mock 
infected sample.
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DNA sequences did not preclude the formation of chromatin (Jamieson et al., 1995). It 
appeared that during latency in vitro, in 1820 genomes were either bound by irregularly 
spaced nucleosomes or were in a completely different structure from the majority of cell 
chromatin.
Cellular histone synthesis is tightly coupled to DNA replication. To examine the 
possibility that a reduction in cell histone pools by Ara-C treatment prevented a normal 
pattern of nucleosome spacing on the latent viral genomes, the pattern of MN digestion 
was examined after latency in the presence of ACG or PAA, which have more specific 
action on viral DNA replication. IFNa-treated HFL cells were infected with 75 particles 
of in 1820 per cell and incubated in the presence of Ara-C, ACG or PAA. At 3 days 
post-infection, nuclei were extracted and partially digested with MN or were untreated. 
DNA was purified, electrophoresed, blotted onto a hybridisation membrane and 
hybridised to the HSV-1 EcoRl n fragment spanning the TK gene. The cell DNA was 
digested into a characteristic ‘ladder’ of nucleosome-associated DNA fragments, as 
visualised in the ethidium bromide-stained gel (figure 4.17., lower panel). Resulting 
hybridisation demonstrated that the latent genomes were not bound by regularly spaced 
nucleosomes during latency in the presence of Ara-C, ACG or PAA (figure 4.17., upper 
panel). Inhibition of cell DNA replication and intracellular histone pools by Ara-C did 
not preclude a regular nucleosome arrangement. The absence of regularly spaced 
nucleosomes on the m l820 genomes was therefore not a secondary consequence of 
inhibition of histone synthesis.
4.11. A chromatin-like pattern of MN digestion was detected at the region of the 
genome encoding VmwllO and LAT.
Only the TK gene had been examined in previous studies using MN digestion to 
detect chromatin on viral genomes in the in vitro latency. An investigation was
r
undertaken to determine if the region of the genome which is transcriptionally active 
during latency in vivo formed a chromatin structure during in vitro latency. IFN a- 
treated HFL cells were infected with 120 particles of m l820 per cell and incubated in 
the presence of Ara-C. At 3 days post-infection nuclei were extracted and partially 
digested with MN or were untreated. DNA was purified, electrophoresed, blotted onto a 
hybridisation membrane and hybridised to a radiolabelled 3.8 kbp Pstl / Kpril fragment 
from the IE1 / LAT region (figure 3.2.).
The IE1 / LAT region was digested into DNA fragments which produced a 
ladder characteristic of cell chromatin (figure 4.18., left panel). The presence of 
chromatin at the region of the genome transcriptionally active in vivo and the inability
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Figure 4.18. MN digestion of the LAT /  DEI encoding region. IFNa-treated HFL 
cells in 35 mm diameter tissue culture dishes were infected with 120 particles of in 1820 
per cell (lanes 3-5) or mock infected (lanes 1 and 2) and incubated at 37° in the 
presence of 50 fig/ml Ara-C. At 3 days post-infection the nuclei were isolated and 
digested with MN (lanes 2, 4 and 5) or were untreated (lanes 1 and 3). DNA was 
purified, half of each sample electrophoresed in a 1.5% agarose gel, blotted onto a 
hybridisation membrane and hybridised to a [32P]-labelled 3.8 kbp P stl/ Kpnl fragment 
from the LAT / IE1 region (figure 3.2.). MN digestion was as follows: 5 units for 2 
minutes (lanes 2 and 4) or 10 units for 10 minutes (lane 5). Left panel shows an 
autoradiograph, right panel shows the ethidium bromide-stained gel. Positions of DNA 
fragments which were associated with 1, 2 or 3 nucleosomes are indicated. M: mock 
infected sample; L: latently infected sample.
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to detect chromatin at the TK gene implied that specific regions of the genome were 
forming chromatin more readily than others. Differential formation of chromatin might 
reflect transcriptional regulation of the genome during latency. The bands on the 
autoradiograph (figure 4.18., left panel) did not correspond exactly with the 
nucleosomal bands from the bulk of cell DNA observed in the ethidium bromide- 
stained gel (figure 4.18., right panel). The viral nucleosome-associated DNA fragments 
migrated faster than the nucleosome-associated fragments from the cell DNA, noticable 
particularly with the di- and tri- nucleosome-associated fragments. A possible 
explanation for the difference in migration speeds between viral DNA fragments and 
cell nucleosome-associated DNA fragments was that nucleosomes on the viral genomes 
were more closely spaced than on the cell DNA. Other possible causes of the difference 
in migration speeds between viral cell nucleosome-associated DNA might be high G+C 
content or unusual structural properties of the HSV sequences, or alternatively by an 
alteration, of their positions during transfer from the gel onto the hybridisation 
membrane. A control of hybridisation to a cell gene performed in parallel with 
hybridisation to the EE 1 / LAT region was required to confirm a genuine difference in 
migration speeds between viral and cellular protein-associated DNA fragments.
4.12. Chromatin was detected on the TK gene and the IE1 / LAT region when 
examined in parallel.
The apparent difference in chromatin organisation between the TK gene and the 
IE 1 / LAT region may have been caused by differences between experiments. The TK 
gene and the IE / LAT region were examined in parallel. In addition, naked viral DNA 
digested with MN was examined alongside samples probed for IE1 / LAT in order to 
assess whether the ladder of DNA fragments observed in figure 4.18. was due to 
chromatin or sequence-specific nuclease digestion. IFNa-treated HFL cells were
t
infected with 120 particles of in 1820 per cell and incubated in the presence of Ara-C. At 
2 days post-infection nuclei were extracted and partially digested with MN or were 
untreated. DNA was purified, electrophoresed alongside partially MN-digested or non­
digested naked virion DNA and blotted onto a hybridisation membrane. The 
hybridisation membrane was divided into two parts, one part was hybridised to a 
radiolabelled 3.8 kbp PstI / Kpnl fragment from the IE1 / LAT region and the the 
remaining part of the membrane was hybridised to a radiolabelled 2.4 kbp EcoRI n 
fragment from the TK gene.
A regular pattern was apparent in the samples probed for the TK gene and the 
samples probed for the IE1 / LAT region, indicating that the arrangement of
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Figure 4.19. MN digestion of the TK gene and LAT /  IE1 encoding region. IFN a-
treated HFL cells in 35 mm diameter tissue culture dishes were infected with 120
particles of in 1820 per cell (lanes 4, 6, 7, 8, 10 and 11) or mock infected (lanes 5 and 9)
and incubated at 37° in the presence of 50 pg/ml Ara-C. At 2 days post-infection the
nuclei were isolated and digested with MN (lanes 5, 6, 7, 9, 10 and 11) or untreated
(lanes 4 and 8). DNA was purified, electrophoresed in a 1.5% agarose gel alongside
untreated (lane 1) or MN digested (lanes 2 and 3) naked m l850 virion DNA, blotted
onto a hybridisation membrane and hybridised to a [32P]-labelled 3.8 kbp Kpnl / Pstl
fragment from the region of the HSV-1 genome encoding LAT / IE1 (lanes 1-7) or a
2.4 kbp ZscoRI n DNA fragment from the HSV-1 TK gene (lanes 8-11). MN digestion
was as follows: 0.08 units for 5 minutes (lane 2), 0.1 units for 5 minutes (lane 3), 10
units for 2 minutes (lanes 5, 6, 9 and 10) or 10 units for 10 minutes (lanes 7 and 11).
Upper panel shows the autoradiograph, lower panel shows the ethidium bromide-/
stained gel. *; positions of DNA fragments which were associated with 1, 2 or 3 
nucleosomes. M: mock infected sample; L: latently infected sample; V: virion DNA.
Results
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nucleosomes was similar on both regions and presumably on the entire genome (figure; 
4.19., upper panel). As in the experiment described in section 4.11., the virall 
nucleosome-associated DNA fragments migrated faster than the nucleosome-associatedl 
DNA fragments from the cell DNA, indicating that nucleosomes on the viral genomes; 
might be more closely spaced than on the cell DNA. The presence of discrete bands ini 
the MN-digested naked virion DNA samples indicated that sequence-specific digestioni 
was occurring in the assay. As the products of sequence-specific MN-digestion did not: 
exactly correspond to the apparent nucleosome-associated fragments observed in the 
IE 1 / LAT probed samples and as the nucleosomal bands in the TK-hybridised samples 
and the IE 1 / LAT-hybridised samples were superimposable, the banding pattern in the 
MN-digested latently infected samples was probably caused by nucleosome positioning. 
Previous apparent differences in chromatin organisation of the TK gene and the IE1 /' 
LAT region were caused by differences in chromatin arrangement between experiments 
or differences in the ability to detect the nucleosomal ladder of DNA fragments.
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CHAPTER 2.
The inhibition of HSV-1 infectivitv in HFL cells pretreated 
with UV-inactivated /h!814.
4.13. Infectivitv of iwl853 was reduced in HFL cells pretreated with UV- 
inactivated /w!814.
The study described in section 4.5. demonstrated that at a set time after infection 
HFL cell nuclei contained fewer uncoated, nonlinear viral genomes than most other cell 
types, possibly as a result of slower virus uncoating. An investigation to determine 
whether the ml814 mutation, HMBA or IFNa exert their effects on in vitro latency by 
altering virus uncoating was described, the results of which were negative. It was 
considered possible that the slow uncoating in HFL cells was related to the more efficient 
establishment of latency in these cells (Wigdahl et al., 1981, 1982b, 1984b; Russell and 
Preston, 1986; Stow and Stow, 1986; Ace et al., 1989; Everett, 1989; Harris and 
Preston, 1991). One possible mechanism by which slow virus uncoating could lead to 
latency is if components of the virus particle alter the intracellular environment, thus 
converting the cell to a state in which latency is the outcome of infection. The delay 
between fusion of the virion with the cell surface and release of the genome into the nuclei 
of HFL cells might allow more time for the components of the virion to modify the cell 
than in other cell types, and this hypothesis is possibly similar to the situation during 
establishment of latency after infection of the mouse via the footpad, where the delay 
between infection of nerve axons at the periphery and entry into the neuronal cell nuclei 
was estimated to be between 20 and 24 hours (Cook and Stevens, 1973). Slow virus 
uncoating in HFL cells might therefore mimic establishment of latency in vivo. In the 
chapter presented here, a study is described which was aimed at investigating the 
possibility that virus structural components modify HFL cells to a state in which latency 
is the outcome of infection.
To test the hypothesis that a structural component of virus particles modifies cells to 
make them more liable to be latently infected, HFL cells were treated with a preparation of 
ini 814 which had been UV-irradiated to eliminate its capacity to express genes, and the 
effect on the ability of the cells to support plaque formation upon subsequent infection 
with m l853 was examined. 7«1853 expresses P-galactosidase under the control of the 
HCMV major IE promoter, enabling the rapid and sensitive assay of plaque formation by 
staining the monolayers for P-galactosidase activity. Previous UV-irradiation of the
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Figure 4.19. Inhibition of in 1853 infectivity in HFL cells pretreated with 
UV-inactivated inl814. HFL cells in 24-well tissue culture dishes were treated with 
UV-inactivated ml814 at various MOIs or mock-treated, overlaid with EFio and 
incubated at 37°. At 6 hours post-treatment the monolayers were superinfected with 100 
PFU of m l853 per well (MOI was determined from the titre in HFL cells in the absence 
of HMBA), overlaid with EHU5 and incubated 37°. At 24 hours post-infection with 
m l853 the monolayers were fixed, stained for P-galactosidase activity and the number of 
blue foci per well was determined. The value for the mock-pretreated sample is the 
average of 8 samples, the remaining values are the averages of duplicates.
Results
ml 814 was necessary to prevent the expression of IE genes which would complement the 
superinfecting m l853.
HFL cell monolayers were treated with various amounts of UV-irradiated m l814 or 
mock-treated and incubated at 37°. At 6 hours post-treatment the cells were infected with 
100 PTO of m l853 per monolayer of 2 x 105 cells. The titre of ml814-based viruses in 
HFL cells in the absence of HMBA is far less than in BHK cells in the presence of 
HMBA, therefore to ensure that an easily countable number of plaques were produced, 
m l853 was previously titrated in HFL cells in the absence of HMBA. The infected 
monolayers were incubated for a further 24 hours and then fixed, stained for p- 
galactosidase activity and the resulting numbers of blue foci of virus replication per well 
was determined. The average numbers of blue foci per monolayer is presented in figure 
4.19.
In 1853 infectivity was inhibited by previous treatment with UV-ml814, in a 
manner which was dependent on the initial input of UV-irradiated particles. An 8-fold 
inhibition was observed after infection with 660 particles of UV-ml814 per cell.
The ability of UV-ml814 to inhibit m l853 infectivity suggested that components of 
virus particles modified the cells to a state in which latency was the outcome of infection. 
In the chapter described here, a characterisation of the inhibition of infectivity by UV- 
m!814 is described.
4.14. UV-m l814 lipht-particles retained the ability to cause inhibition of 
iw l853 infectivitv.
Novel HSV-1-related particles termed light-particles (L-particles) have been 
described (Szilagyi and Cunningham, 1991; McLauchlan and Rixon, 1992; Rixon etal., 
1992; Szilagyi and Berriman, 1994). L-particles are similar in structure to HSV-1 virions 
but lack the nucleocapsid and DNA, thus they consist only of tegument and envelope and 
are non-infectious (Szilagyi and Cunningham, 1991; Szilagyi and Berriman, 1994). The 
protein composition of L-particles is similar to that of virions except that the nucleocapsid 
proteins are absent, however it has been reported that Vmwl75 in extracellular virus 
preparations is located exclusively in the L-particles and not the virions (Szilagyi and 
Cunningham, 1991; McLauchlan and Rixon, 1992). In addition, L-particles frequently 
contain inclusion vesicles which consist of a low electron density material surrounded by 
an envelope with no obvious glycoprotein spikes (Szilagyi and Berriman, 1994). The role 
of L-particles in the HS V life cycle, if any, is unknown and their production in vivo has 
never been demonstrated.
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F igure 4.20. Inhibition of in 1853 infectivity in HFL cells p re trea ted  with 
UV-m l814 L-particles. HFL cells in 24-well tissue culture dishes were treated with 
UV-m 1814 L-particles at various MOIs or mock-treated, overlaid with EFio and 
incubated at 37°. At 6 hours post-treatment the monolayers were superinfected with 75 
PFU of m l853 per well (MOI was determined from the titre in HFL cells in the absence 
of HMBA), overlaid with EHus and incubated 37°. At 24 hours post-infection with 
ml853 the monolayers were fixed, stained for p-galactosidase activity and the number of 
blue foci per well was determined. The value for the mock-pretreated sample is the 
average of 8 samples, the remaining values are the averages of duplicates.
Results
If components of the virus membrane or tegument were responsible for the 
inhibition of m l853 infectivity by UV-m 1814, then L-particles would retain the ability to 
cause the inhibition. The effect on ml 853 infectivity of pretreating HFL cells with ml 814 
L-particles was examined in the same way as described for UV-m 1814. L-particle 
preparations are contaminated with virions at a level of 0.1 -0.5% (Szilagyi and 
Cunningham, 1991), thus prior UV-irradiation of the L-particles was required to prevent 
viral gene expression, especially of Vmwl 10, from complementing m l853.
HFL cell monolayers were treated with various MOIs of UV-ml814 L-particles or 
mock-treated and incubated at 37°. At 6 hours post-treatment the cells were infected with 
75 PFU of ml 853 per monolayer (MOI was determined from the titre in HFL cells in the 
absence of HMBA), incubated for a further 24 hours and then fixed, stained for P- 
galactosidase activity and the numbers of blue foci per monolayer were determined. The 
average numbers of blue foci of virus replication per monolayer were counted and are 
presented in figure 4.20.
In 1853 infectivity was inhibited in HFL cells pretreated with UV-m 1814 L-particles 
to a greater extent than the inhibition caused by pretreatment with UV-m 1814. After 
treatment with 675 UV-ml814 L-particles per cell, m l853 infectivity was inhibited by 
approximately 140-fold, almost reaching levels undetectable in the assay. In section 
4.13., 660 UV-m 1814 particles per cell gave an 8-fold inhibition, whereas in the section 
described here an 8-fold inhibition was estimated to occur after treatment with 
approximately 70 UV-m 1814 L-particles per cell, thus UV-m 1814 L-particles caused a 
stronger inhibition than UV-ml814 and reached maximal inhibitory activity at lower 
MOIs. The observation that L-particles gave greater inhibition of infectivity than the virus 
preparation suggested that components of the tegument or envelope are responsible for 
their inhibitory activity. Alternatively, the greater inhibition by L-particles may have been 
caused by the lower proportion of virions in the L-particle preparation compared to the 
virus preparation, leading to a lower proportion of treated cells expressing viral proteins 
and complementing the infectivity defect of ml 853. Although UV-irradiation eliminated 
the titre of virus and L-particle preparations, residual gene expression cannot be 
discounted.
4.15. Infectivities of in 1863. fwl830 and f/71403 were reduced in HFL 
cells pretreated with UV-t/il814 or UV-ml814 L-particles.
If Vmw65 overcomes the inhibition of infectivity in HFL cells pretreated with UV- 
m l814 L-particles or virus, then a virus containing wild-type Vmw65 would be 
insensitive to the inhibition. The sensitivity of m l863 (an essentially wild-type virus with
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Figure 4.21. Inhibition of i/il863 , z/zl830 and d /1403 /p -gal infectivity in 
HFL cells p re trea ted  with UV-znl814 or UV-z/il814 L -particles. HFL cells 
in 24-well tissue culture dishes were treated with UV-ml814 or UV-ml814 L-particles at 
various MOIs or mock-treated, overlaid with EFio and incubated at 37°. At 6 hours post- 
treatment each monolayer was infected with 100 PFU of ml863, ml830 or d/1403 per 
well (MOI was determined from the titres in HFL cells in the absence of HMBA) overlaid 
with EHus and incubated 37°. At 24 hours post-infection with the the non-UV-inactivated 
viruses the monolayers were fixed, stained for p-galactosidase activity and the number of 
blue foci per well was determined. The value for the mock-pretreated sample is the 
average of 4 samples, the remaining values are from single determinations. (A) Effect of 
UV-m 1814 on infectivity; (B) effect of UV-m 1814 L-particles on infectivity.
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Results
the HCMV enhancer controlling transcription of lacZ at the TK locus), m l830 (m l820 
with the HCMV enhancer controlling transcription of lacZ at the U l43 locus) and 
d/1403/p-gal (<7/1403 with the HCMV enhancer controlling transcription of lacZ at the 
U l43 locus) to the inhibition of infectivity in HFL cells pretreated with UV-ml814 or 
UV-ml814 L-particles was examined.
HFL monolayers were treated with various MOIs of UV-ml814 or UV-ml814 L- 
particles or were mock-treated and incubated at 37°. At 6 hours post-treatment the cells 
were infected with 100 PFU of one of the lacZ-containing viruses per monolayer (MOI 
was determined from the titre in HFL cells in the absence of HMBA), incubated for a 
further 24 hours and then fixed, stained for p-galactosidase activity and the resulting 
numbers of blue foci of virus replication per well were counted. The numbers of blue foci 
of virus replication is presented in figure 4.21.
Infectivity of all of the viruses was inhibited in HFL cells pretreated with UV- 
ml814 virus or L-particles. 7«1863 was inhibited approximately 6-fold in HFL cells 
pretreated with 675 UV-ml814 L-particles per cell, thus Vmw65 did not overcome the 
inhibition. D/1403 was especially sensitive to the inhibition, with a greater than 40-fold 
inhibition occurring in monolayers pretreated with UV-ml814 L-particles at MOIs above 
225 particles per cell. 7«1830 was inhibited only 2.5-fold in monolayers pretreated with 
225 UV-ml814 L-particles per cell. Mutant ml830 is effectively VmwllCh under EE 
conditions in HFL cells, thus it is unclear why m l830 was more resistant to the inhibition 
than d/1403. As in previous experiments described in the chapter presented here, UV- 
ml814 L-particles caused greater inhibition of all three viruses than did UV-ml814 
(comparison of graphs A and B).
4.16. Inhibition of in 1853 infectivity in HFL cells pretreated with UV- 
f/il814 L-particles or virus reached a maximum at 6 hours post-treatment 
with the UV-inactivated viral particles.
To examine how the inhibition of infectivity in HFL cells pretreated with UV- 
ml814 virus or L-particles varied over time, HFL monolayers were treated with 65 UV- 
ml814 particles or L-particles per cell, or were mock infected and incubated at 37°. At 
various times post-treatment the monolayers were infected with 100 PFU of m l853 per 
monolayer (MOI was determined from the titre in HFL cells in the absence of HMBA) 
and incubated at 37°. To allow for the drop in titre of the m l853 inoculum over time, 
mock-treated monolayers were infected with the m l853 dilution at each time point and the 
dilution was stored on ice between time points. At 24 hours post-infection with the final 
time point of m l853 infection, the monolayers were fixed and stained for P-galactosidase
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Table 4.9. Time course of the inhibition of //il853 infectivity in HFL cells 
pretreated with UV-i'/tl814 virus or L-particles. HFL cells in 24-well tissue 
culture dishes were treated with 65 particles per cell of UV-ml814 or UV-ml814 L- 
particles, either alone or co-infected with 100 PFU of ml853 per well (MOI was 
determined from the titre in HFL cells in the absence of HMBA), or were mock-treated, 
overlaid with EFio and incubated at 37°. At various times post-treatment the monolayers 
were infected with 100 PFU m l853 per well (MOI was determined from the titre in HFL 
cells in the absence of HMBA), overlaid with EHus and incubated 37°. To allow for the 
drop in titre of the.ml853 inoculum over time, mock-infected monolayers were infected 
with the in 1853 dilution at each time point and the dilution was stored on ice between time 
points. At 24 hours post-infection with the final time point of m l853 infection, the 
monolayers were fixed, stained for p-galactosidase activity and the number of blue foci 
per well was determined. The value for the mock-pretreated samples is the average of 
duplicates, the remaining values are the from single determinations. (A) Samples 
pretreated with UV-ml814 L-particles. (B) Samples preinfected with UV-ml814.
Results
A
Time of infection of the cells with in 1853, 
post-treatment with U V-i/i 1814 L-particles 
(hours)
0 2 4 6 9
Pretreatment
Mock (number of 
plaques) 400 253 169 151 154
U V -inl814 L- 
particle (number of 
plaques)
153 12 6 2 5
Fold-inhibition o f  i/i!853 infectivity 2.6 24 22 52 31
B
Time of infection of the cells with in 1853, 
post-treatment with UV-i/il814 (hours) 0 2 4 6 9
Pretreatment
Mock (number of 
plaques) 400 253 169 151 154
UV-i/i1814 (number 
of plaques) 158 28 14 6 14
Fold-inhibition of i/i 1853 infectivity 2.5 9 12 25 11
Results
activity. The resulting numbers of blue foci of virus replication per well were counted and 
the average values and the fold-inhibition at each time point presented in table 4.9.
The inhibitory effect on m l853 infectivity increased over time and reached a 
maximum at 6 hours post-treatment with the UV-inactivated particles. The observation 
that the inhibition increased after infection suggested that a gradual rather than immediate 
change occurred in the cells after treatment with UV-inactivated viral particles.
4.17, The components of UV-twl814 L-particles responsible for the 
inhibition of t/i!853 infectivity were removed bv centrifugation.
The inhibition of m l853 infectivity in HFL cells treated with UV-ml814 L-particles 
or virus might have been caused by soluble factors in the UV-inactivated preparations 
rather than viral particles. To assess whether the inhibition was caused by viral particles, 
an L-particle preparation was centrifuged and the resulting supernatant and resuspended 
pellet were tested for their ability to inhibit m l853 infectivity. As a control for any loss of 
inhibitory activity due to loss of infectivity of the particles over time, an aliquot was 
stored at 4° during the centrifugation and tested for the ability to inhibit m l853 infectivity.
HFL cells were treated with 3 p,l of the supernatant, pellet or 4°-stored L-particles 
per monolayer of 2 x 105 cells (corresponding to an MOI of 6600 particles per cell of the 
original preparation) and incubated at 37°. At 7 hours post-treatment the cells were 
infected with 100 PFU of m l853 per monolayer (MOI was determined from the titre in 
HFL cells in the absence of HMBA) and incubated at 37°. At 24 hours post-infection with 
m l853, the monolayers were fixed, stained for p-galactosidase activity and the number of 
blue foci per well was determined. The average values for each treatment is presented in 
figure 4.22.
The resuspended pellet and the sample stored at 4° caused a 10-fold inhibition of 
m l853 infectivity, whereas the supernatant caused no significant inhibition, thus the 
inhibitory factors were pelleted during centrifugation and were almost certainly associated 
with the viral particles.
It is notable in this experiment that the inhibitory activity of the L-particles was 
lower than in previous experiments, an MOI of 6600 L-particles per cell giving a 10-fold 
inhibition of infectivity compared to the experiment described in section 4.14. where an 
MOI of 100 L-particles per cell was sufficient to cause an equivalent inhibition. The 
differences in inhibitory activity between experiments was probably caused by differences 
in the qualities of the L-particle preparations.
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Figure 4.22. Removal of the inhibitory factors in a U V -i/il814 L-particle 
preparation by centrifugation. 100 pi of an UV-ml814 L-particle preparation was 
centrifuged at 12000 rpm for 16 hours in an AH629 rotor. The resulting pellet was 
resuspended in 100 pi Eagle’s A+B without phenol red and both the supernatant, the 
resuspended pellet and an aliquot of the L-particle preparation which were stored at 4° 
during the centrifugation were examined for their ability to inhibit m l853 infectivity when 
used to pretreat HFL cells. HFL cells in 24-well tissue culture plates were treated with 3 
pi per well (corresponding to an MOI of 6600 particles per cell of the original 
preparation) of the supernatant, pellet or 4°-stored light particles, overlaid with EFio and 
incubated at 37°. At 7 hours post-treatment, the cells were superinfected with 100 PFU 
m l853 per well (MOI was determined from the titre in HFL cells in the absence of 
HMBA), overlaid with CMC/EFio and incubated at 37°. At 24 hours post-infection with 
m l853, the monolayers were fixed, stained for p-galactosidase activity and the number of 
blue foci per well was determined. The value for the mock-pretreated samples is the 
average of 4 samples, the remaining samples are the averages from triplicates.
Results
4.18. HMBA only partially overcame the inhibition of in !853 infectivity  
in HFL cells pretreated with U V -inl814.
The particle / PFU ratio of ini 814 preparations are restored to levels similar to those 
of wild-type HSV-1 in the presence of 3 mM HMBA, thus when present at the initial 
stages of infection, HMBA can almost completely overcome repression of in i814 
genomes (McFarlane et al., 1992). The restoration of in 1814 infectivity by HMBA is the 
result of a stimulation of IE transcription, substituting for Vmw65 transactivation 
however, during the first 6 hours of infection the defect in in 1814 cannot be overcome by 
HMBA or Vmw65, thus once established, the latent state is unresponsive to HMBA or 
Vmw65. One possible interpretation of the observation that latent virus is unresponsive to 
HMBA is that in 1814 infection leads to an antiviral state in the cells which leads to latency 
and that this antiviral state cannot be overcome by HMBA. This interpretation is 
supported by the observation that UV-inactivated viral particles induce an antiviral state 
and that the antiviral state acts against in 1863, suggesting that it is not overcome by 
Vmw65.
In order to assess whether the repression of in 1853 infectivity in HFL cells treated 
with UV-inl814 can be overcome by HMBA, HFL cells were treated with 65 UV-inl814 
particles per cell or mock-treated and incubated at 37°. At 6 hours post-treatment the 
monolayers were infected with various amounts of in 1853 (input PFUs shown were 
determined from the titre in HFL cells in the presence of HMBA) and overlaid with EHU5 
or EHU5 containing 5 mM HMBA. At 24 hours post-infection with in 1853 the 
monolayers were fixed, stained for p-galactosidase activity and the number of blue foci 
per well was determined. Values are presented in table 4.10(A). In addition, to determine 
the inhibition that occurred in the absence of HMBA it was necessary to perform an 
experiment in parallel in which the input PFU of in i853 was determined using the titre in 
the absence of HMBA (table 4.10.(B)).
In the presence of HMBA, in 1853 infectivity was inhibited by at least 5-fold in 
HFL cells pretreated with UV-inl814 (A). In the absence of HMBA the inhibition was 
19-fold (B), thus HMBA was not able to overcome fully the inhibition of infectivity by 
the UV-viral particles. Like latency of in 1814 in untreated cells, the antiviral state induced 
by the UV-viral particles dominates over HMBA and Vmw65.
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Table 4.10. HMBA partia lly  overcame the inhibition of infectivity in HFL 
cells p re treated  with UV-i/il814. (A) HFL cells in 24-well tissue culture dishes 
were treated with 65 particles of UV-ml814 per cell or mock-treated, overlaid with EFio 
and incubated, at 37°. At 6 hours post-treatment the monolayers were superinfected with 
various amounts of m l853 per well (PFUs shown were determined from the titres in 
HFL cells in the presence of HMBA), overlaid with EHU5 or EHU5 containing 5 mM 
HMBA and incubated 37°. At 24 hours post-infection with m l853 the monolayers were 
fixed, stained for P-galactosidase activity and the number of blue foci per well was 
determined. Values are the results of single determinations. (B) Monolayers were pre­
treated as indicated in the table and described above with the only difference that the input 
PFU was as determined from the titre in HFL cells in the absence of HMBA. Values are 
the averages of triplicates.
Results
A
Input PFU of in 1853 (+HMBA titre) 200 67 33 20
Treatment
-HM BA 0 0 0 0
+HMBA 200 66 27 21
+ U V -in l814  
/  +HMBA 35 13 2 1
Fold-inhibition 5 5 14 21
B
Input PFU of in 1853 100
Pretreatment
Mock 95
+ U V -in l814 5
Fold-inhibition 19
Results
4.19. The inhibition of infectivity in HFL cells pretreated with UV-/wl814  
was only partially overcome bv co-infection with tsK.
The particle / PFU ratio of m l814 is restored to levels similar to those of wild-type 
, . . virus in cells co-infected with teK or UV-irradiated tsK (Ace et ah, 1989; Harris and 
Preston, 1991). Almost all input m l820 infectivity in the in vitro latency system is 
competent for reactivation by superinfection with f.sK (Jamieson et al., 1995).
To assess whether the inhibition of infectivity in HFL cells pretreated with UV- 
m l814 can be overcome by co-infection with taK at a NPT for tsK, HFL cells were 
treated with 65 particles of UV-ml814 per cell or mock-treated. After incubation for 6 
hours, the monolayers were superinfected with 500 or 1000 PFU of m l853 per 
monolayer (MOI was determined from the titre in BHK cells in the presence of HMBA) 
and immediately superinfected with 0.5 PFU of tsK per cell or mock-superinfected. At 24 
hours post-infection with m l853 the monolayers were fixed, stained for P-galactosidase 
; activity and the number of blue foci per well was determined. Values are presented in
table 4.11.
j Superinfection with taK reactivated only a proportion of the m l853 which was
inhibited in the UV-ml814 particle pretreated cells, thus in this respect the apparently 
; latent state induced in UV-viral pretreated cells appeared to differ from latency of ml 814-
based viruses in untreated cells.
ij
I
i
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Input PFU of in !8 5 3 500 1000
Treatm ent
znl853 alone 2 2
+taK TNTC TNTC
+U V -znl814 / 
+teK 150 200
Table 4.11. The inhibition of infectivity in HFL cells p retreated  with UV- 
zral814 was only partia lly  overcome by co-infection with tsK. HFL cells in 
24-well tissue culture dishes were treated with 65 particles of UV-ml814 per cell or 
mock-treated, overlaid with EFio and incubated at 37°. At 6 hours post-treatment the 
monolayers were superinfected with 500 or 1000 PFU of m l853 per well (PFUs shown 
were determined from the titres in BHK cells in the presence of HMBA) and immediately 
superinfected with 0.5 PFU of tsK per cell or mock-superinfected, overlaid with EHus 
and incubated 37°. At 24 hours post-infection with m l853 the monolayers were fixed, 
stained for |3-galactosidase activity and the number of blue foci per well was determined. 
Values are the results of single determinations. Mock-infected samples are values for 
single determinations, all other values are the averages of duplicates. TNTC: too 
numerous to count.
4.20. 7/zl853 infectivity inhibited in UV-t/zl814 L -partic le-p re trea ted  HFL 
cells was not reactivated  bv superinfection with tsK  a t 2 davs post­
in fec tio n .
The inability of co-infection with tsK to restore the infectivity of m l853 to wild- 
type levels in UV-viral particle-treated HFL cells might have been caused by the 
inhibitory activity of the UV-viral particle treatment acting on toK and hindering the 
efficiency of complementation. An experiment was carried out to assess whether the 
m l853 genomes which were inhibited in UV-viral particle-treated HFL cells could be 
reactivated by superinfection after 2 days infection, when the inhibitory ’activity of the 
UV-viral particle treatment might have subsided.
HFL cells were treated with 65 UV-ml814 L-particles per cell or mock-treated. At
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Treatm ent m l853 alone +tsK +UV-ml814L- particles +teK
Average num ber 
of plaques 0 32 7
Table 4.12. 7/il853 infectivity inhibited by UV-i'/il814 L-particles was not 
reactivated by superinfection with tsK  a t 2 days post-infection. HFL cells in 
24-well tissue culture dishes were treated with 65 UV-ml814 L-particles per cell or 
mock-treated, overlaid with EFio and incubated at 37°. At 6 hours post-treatment the 
monolayers were superinfected with 100 PFU m l853 per well (PFU was determined 
from titres in BHK cells in the presence of HMBA), overlaid with EFjo containing 50 
pg/ml Ara-C and incubated 37°. At 2 days post-infection with m l853 the monolayers 
were superinfected with 0.5 PFU of taK per cell or mock-superinfected, overlaid with 
EHus and incubated at 37°. After incubation for a further 24 hours the cells were fixed, 
stained for P-galactosidase activity and the number of blue foci per well was determined. 
Values are the averages of triplicates.
6 hours post-treatment the monolayers were infected with 100 PFU of m l853 per 
monolayer (MOI was determined from the titre in BHK cells in the presence of HMBA) 
and incubated in the presence of Ara-C. At 2 days post-infection with m l853 the 
monolayers were superinfected with 0.5 PFU of /jK per cell or mock superinfected. 
After incubation for a further 24 hours the cells were fixed, stained for p-galactosidase 
activity and the number of blue foci per well was determined. The average values are 
presented in table 4.12.
The infectivity which was inhibited by UV-ml814 L-particle pretreatment was not 
fully reactivated to give a number of plaques equal to the number of plaques in 
monolayers mock-pretreated. It appeared that the m l853 inhibited in HFL cells pretreated 
with UV-ml814 L-particles was at least partially permanently lost and could not be 
reactivated by ttK.
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4.21. The inhibition of twl853 infectivity in HFL cells treated with UV- 
in 1814 remained for at least 2 davs.
In section 4.20. it was found that m l853 inhibited in HFL cells pretreated with UV- 
m l814 L-particles was not reactivated by superinfection with tsK at 2 days post­
infection. In the section described here, the possibility that the inhibition of infectivity in 
HFL cells remained after 2 days, thereby hindering the ability of tsK  to cause 
reactivation, is examined.
HFL cells were treated with various MOIs of UV-ml814 or mock-treated. At 6 
hours, 1 day or 2 days post-treatment the cells were infected with 100 PFU of m l853 per 
well (MOI was determined from the titre in HFL cells in the absence of HMBA). At 24 
hours post-infection with m l853 the monolayers were fixed, stained for P-galactosidase 
activity and the number of blue foci per well was determined. The average values are 
presented in figure 4.23.
The inhibition of m l853 infectivity remained for 1 and 2 days in HFL cells treated 
with UV-ml814. It is probable, therefore, that the inability to reactivate m l853 fully by 
superinfection with tsK. was caused by the previous UV-ml814 viral particle treatment 
inhibiting tsK, thus superinfection with toK was not a reliable method of reactivating 
m l853 from HFL cells pretreated with UV-ml814. Alternatively, the inability of 
superinfection with toK to fully reactivate the m l853 could have been explained if a 
proportion of the m l853 genomes in the UV-ml814 pretreated cells were degraded or 
converted to a form unresponsive to taK superinfection.
4.22. Tissue culture medium taken from HFL ce lls ' treated with UV- 
fn !8 1 4  L-particles did not confer significant inhibition of i n i  85  3 
infectivity when used to treat other HFL cells.
HFL cells treated with UV-inactivated viral particles might release soluble factors, 
such as IFNa, which could cause the reduced ability of the cel Is to support HSV 
infection. As IFNa acts by reducing viral IE transcription, the hypothesis that repression 
of m l814 genomes in HFL cells occurs via an IFNa-induced pathway was considered 
possible.
HFL cells were treated with 800 UV-ml814 L-particles per cell or mock-treated, 
washed with EFio to remove any un-adsorbed L-particles, and overlaid with EFjo- After 
incubation for 6 hours the medium was removed and. stored and the cells were infected 
with 100 PFU of m l853 per monolayer (MOI was determined from the titre in HFL cells 
in the absence of HMBA). At 24 hours post-infection with m l853 the cells were fixed,
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Inhibition of in  1853 infectivity in HFL cells treated  with 
UV-in 1814 6 hours. 1 dav. and 2 davs previously.
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F igure 4.23. Inhibition of in 1853 infectivity after infection of HFL cells 6 
hours, 1 day and 2 days post-treatm ent with UV-inl814. HFL cells in 24-well 
tissue culture dishes were treated with various MOIs of UV-ml814 or mock-treated, 
overlaid with EFio and incubated at 37°. At 6 hours, 1 day or 2 days post-treatment the 
cells were superinfected with 100 PFU of m l853 per well (MOI was determined from the 
titre in HFL cells in the absence of HMBA), overlaid with EHus and incubated at 37°. At 
24 hours post-infection with m l853 the monolayers were fixed, stained for p- 
galactosidase activity and the number of blue foci per well was determined. Values for the 
mock-pretreated samples are the averages of 6 samples, the remaining samples are the 
averages from duplicates.
Figure 4.24. Tissue culture medium taken from HFL cells treated with 
U V -/ti1814 L-particles did not confer significant inhibition of i n l 8 5 3  
plaque initiation when used to treat other HFL cells. (A) HFL cells in 24-well 
tissue culture.dishes were treated with 800 UV-ml814 L-particles per cell or mock- 
treated, washed once with 1 ml of EFio per well, overlaid with EFio and incubated at 
37°. At 6 hours post-treatment the medium was removed, stored, and the cells infected 
with 100 PFU of m l853 per well (PFU was determined from the titre in HFL cells in the
1
absence of HMBA), overlaid with CMC/EFio and incubated at 37°. At 24 hours post­
infection with m l853 the cells were fixed, stained for p-galactosidase activity and the 
blue foci of virus replication counted. (B) The medium from the mock-treated or L- 
particle-treated HFL cells was immediately applied to HFL cell monolayers in a separate 
24-well tissue culture plate and the cells incubated at 37° overnight. The cells were 
infected with 100 PFU of m l853 per well (MOI was determined from the titre in HFL 
cells in the absence of HMBA), overlaid with CMC/EFio and incubated at 37°. At 24 
hours post-infection with m l853 the cells were fixed, stained for p-galactosidase activity 
and the blue foci of virus replication counted. Values presented are the averages numbers 
of foci of virus replication per well from 4 samples.
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Absence of soluble factors released bv HFL cells treated 
with UV-i/i 1814 L-particles.
A  Initial inhibition
■ Number of plaques
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Results
stained for P-galactosidase activity and the blue foci of virus replication counted. The 
medium from the mock-treated or UV-L-particle treated HFL cells were immediately 
applied to separate HFL cell monolayers and incubation was continued overnight. The 
medium-treated cells were infected with 100 PFU of m l853 per monolayer and at 24 
hours post-infection the cells were fixed, stained for p-galactosidase activity and the blue 
foci of virus replication counted. The average numbers of plaques per monolayer are 
presented in figure 4.24.
In the initial inhibition experiment (figure 4.24. A) m l853 infectivity was inhibited 
10-fold in the UV-L-particle treated HFL cells. However, when other HFL cells were 
exposed overnight to medium taken from the UV-ml814 L-particle treated HFL cells, no 
significant inhibition was conferred to those cells (figure 4.24. B), thus a soluble factor 
released from HFL cells in response to infection with UV-ml814 L-particles was not 
detected.
4.23. Pretreatment of HFL cells with UV-/nl814 L-particles did not exert 
its affect on iw!853 infectivity bv altering virus adsorption, penetration, 
migration to the nuclei, uncoating or DNA stability.
The observation that cells become nonpermissive to superinfection after treatment 
with high MOIs of UV-inactivated virus has been made in previous studies by other 
research groups (Vahlne et al., 1979; Johnson and Ligas, 1988). After one study, it was 
suggested that gD brought into the cell with the UV-inactivated particles caused the 
nonpermissive state by sequestering receptors required for fusion of the virus with the 
cell, thus preventing penetration of superinfecting viruses (Johnson and Ligas, 1988). 
The hypothesis that gD inhibits superinfection is supported by the observation that cell 
lines constitutively expressing gD are nonpermissive (Campadelli-Fiume et al., 1988; 
Johnson and Spear, 1989; Campadelli-Fiume et al., 1990). In addition, a cell line 
constitutively expressing the viral structural component encoded by Us 11 was 
nonpermissive due to a blockage in virus penetration (Roller and Roizman, 1994). The 
inhibition of virus replication in the Us 11 expressing cell line also appeared to be via an 
interaction with gD. It is a possibility that the blockage to virus infection in UV-ml814 
viral particle treated HFL cells observed in the preceding sections was occurring before 
viral EE transcription, possibly as a result of sequestration of gD receptors by gD brought 
into the cell with the UV-inactivated viral particles. Thus the effect of pretreating HFL 
cells with UV-ml814 on the levels of viral DNA in the nuclei after infection with m l853 
was examined using the Southern blot assay described in chapter 1 of the results section 
of the thesis described here.
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F igure  4.25. A dsorp tion , p en e tra tio n , m igration  to the  nuclei and  
uncoating of /«1853 in HFL cells pretreated  with UV-*/zl814 L -partic les.
HFL cells in 35 mm diameter tissue culture dishes were treated with 225 UV-ml814 L- 
particles per cell (lanes 3, 5 and 7) or mock-treated (lanes 2, 4 and 6), overlaid with EFio 
and incubated at 37°. At 6 hours post-treatment, the cells were superinfected with 1 PFU 
of m l853 per cell (lanes 4-7) or mock superinfected (lanes 2 and 3) and incubated at 37° 
in the presence of 50 fig/ml Ara-C. At 24 hours post-treatment, the cell nuclei were 
isolated and the DNA purified, cleaved with Bam  HI and half o f each sample 
electrophoresed in a 0.7% agarose gel alongside 1.0 ng of m l814 (lane 1) and m l825 
(lane 8) DNA. Electrophoresed DNA was blotted onto a hybridisation membrane and 
hybridised to a [32P]-labelled 640 bp BamHl  / Ncol  fragment from the 5' coding 
sequences of IE1 (figure 3.2.). Positions of joint and L-terminal BamHl  fragments are 
indicated. The slower migration of the L-terminal fragment from m l825 is due to the 
replacement of the IE1 promoter with the MMLV LTR (lane 8). LP: UV -m l814 L- 
particle pretreated sample; M: mock-pretreated sample; V: virion DNA.
Results
Effect of U\ - i n  1814 L-particle pretreatm ent on virus 
adsorption, penetration, m igration to nuclei and uncoating.
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Figure 4.26. Relative proportions of nonlinear and linear viral genomes in 
the nuclei a fter infection of UV-i/il814 L -particle p re trea ted  or mock- 
pretreated HFL cells. Hybridisation in figure 4.25. was quantified and the relative 
proportions of nonlinear and linear genomes determined by comparison with the purified 
virion DNA standards. The total number of genomes in the U V -m l814 L-particle 
pretreated HFL cell nuclei, which contained the greatest total number of genomes 
compared to mock-pretreated cells, represents 100%.
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HFL cells were treated with 225 UV-ml814 L-particles per cell or mock-treated. At 
6 hours post-treatment the cells were superinfected with 1 PFU of m l853 per cell or 
mock superinfected and incubated in the presence of Ara-C. At 24 hours post­
superinfection, cell nuclei were isolated and the DNA purified, cleaved with BamHl and 
half of each sample electrophoresed alongside virion DNA. Electrophoresed DNA was 
blotted onto a hybridisation membrane and hybridised to a radiolabelled fragment from 
the 5' coding sequences of IE1 which detects the joint and L-terminal BamHl restriction 
fragments. Resulting hybridisation is shown in figure 4.25. Quantification of the relative 
proportions of nonlinear and linear genomes is presented in figure 4.26.
UV-ml814 L-particle pretreatment did not decrease the amount of m l853 DNA in 
the nuclei, neither was the degree of nonlinearity significantly altered. Thus the 
mechanism of inhibition of superinfection did not, therefore, appear to be via an 
inhibition of adsorption, penetration, migration to the nuclei, uncoating or DNA stability. 
In the experiments described in this thesis, the nonpermissive state induced by UV-virus 
pretreatment appeared to differ from that observed by Johnson and Ligas (1988).
4.24. Levels of viral IE  mRNAs were reduced bv 2-fold in HFL cells 
p re trea ted  with U V -i/il814 L-particles. and  the reduction in IE mRNA 
levels did not require de novo protein synthesis.
As virus adsorption, penetration, migration to nuclei or DNA stability was not 
significantly altered in UV-ml814 L-particle pretreated cells (section 4.23.), it follows 
that the inhibition of plaque initiation in such cells was caused by an alteration of viral 
gene expression. Inhibition of HSV IE transcription causes a reduced ability to initiate 
plaque formation, as demonstrated by the phenotype of ml814 and the action of IFNa, 
thus one possible mechanism by which the UV-inactivated viral particles might exert their 
effects is to cause an inhibition of viral IE gene expression. Levels of viral IE mRNAs 
after infection with m l853 were compared in HFL cells pretreated or mock-pretreated 
with UV-ml814 L-particles. The effect of inhibiting protein synthesis during the UV- 
ml814 L-particle pretreatment was also examined.
HFL cells were treated with 265 UV-ml814 L-particles per cell or mock-treated and 
overlaid with medium with or without cycloheximide. At 5 hours post-treatment the cells 
were infected with 10 PFU of m l853 per cell or mock superinfected in the presence of 
cycloheximide. At 5 hours post-infection with m l853, poly(A)-containing RNA was 
extracted, each sample was divided into 2 portions, electrophoresed in an agarose gel and 
blotted onto a hybridisation membrane. The hybridisation membrane was divided in two,
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Figure 4.27. V iral IE  mRNAs in HFL cells p retreated  with UV-i/i1814 L- 
particles. HFL cells in 90 mm diameter tissue culture dishes were treated with 265 UV- 
ml814 L-particles per cell (lanes 2-4) or mock-treated (lanes 1 and 5), overlaid with 
EFio with (lanes 3-5) or without (lanes 1 and 2) 50 pg/ml cycloheximide and incubated 
at 37°. At 5 hours post-treatment the cells were superinfected with 10 PFU of m l853 per 
cell (lanes 1-3) or mock superinfected (lanes 4 and 5) in the presence of 50 pg/ml 
cycloheximide, overlaid with EFio containing 50 (ig/ml cycloheximide and incubated at 
37°. At 5 hours post-infection with m l853, poly(A)-containing RNA was extracted. Each 
sample was divided into 2 halves, electrophoresed in a 1.2% agarose gel and blotted onto 
a hybridisation membrane. The hybridisation membrane was divided in two, one half was 
hybridised to a [32P]-labelled 670 bp EcoRI / PvwII DNA fragment from a plasmid 
containing the cloned Xhol C fragment from HSV-1, specific for the mRNA encoding 
Vmwl75, a 700 bp A sp llS  / BamHl fragment from the plasmid pJR3, specific for 
Vmwl 10 mRNA and a 1.2 kbp BamHl / SaH fragment from plasmid HpaSV, specific for 
Vmw63 mRNA (left panel). The remaining half of the membrane was hybridised to a 500 
bp ZscoRI / HindlH fragment from plasmid B47#19, specific for P-galactosidase mRNA 
and an 840 bp BglU / Xbal fragment from plasmid pMGl, specific for y-actin mRNA 
(right panel). The positions of mRNAs are indicated. CH: pretreatment was in the 
presence of cycloheximide; LP: sample pretreated with UV-ml814 L-particles; M: mock 
infected sample.
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Results
and one half was hybridised to radiolabelled DNA fragments specific for Vmwl75, 
Vmwl 10 and Vmw63 mRNAs (figure 4.27., left panel), while the remaining half of the 
membrane was hybridised to radiolabelled DNA fragments specific for p-galactosidase 
and y-actin mRNAs (figure 4.27., right panel). Hybridisation to y-actin in parallel enabled 
accurate quantification by allowing adjustment of viral IE mRNA levels for the total 
amount of RNA loaded in each track. The resulting autoradiographs are presented in 
figure 4.27.
Levels of all of the viral IE mRNAs were reduced by approximately 2-fold in HFL 
cells pretreated with UV-ml814 L-particles (comparison of lanes 1 and 2), but the 
reduction in IE mRNA levels was not significantly altered when protein synthesis was 
inhibited by cycloheximide during the pretreatment (comparison of lanes 2 and 3), thus 
the inhibition was presumably mediated through pre-existing factors. The reduction in 
levels of viral IE mRNAs might account for the reduced ability of HSV to form plaques in 
cells pretreated with UV-ml814 L-particles, however, whether levels of IE mRNA were 
reduced by an alteration of transcription or mRNA stability cannot be distinguished by 
northern blotting. It was noted that levels of p-galactosidase mRNA transcribed from the 
HCMV major IE promoter were reduced by a similar extent to those of the HSV mRNAs, 
and since the HCMV major IE promoter does not contain TAATGARAT elements (C.M. 
Preston, personal communication), the reduction in IE mRNA levels was not caused 
solely by TAATGARAT-specific inhibition of transcription.
4.25. A version of in 1814 defective in the vhs function was constructed.
A possible explanation for the reduced levels of viral IE mRNA after infection of 
HFL cells pretreated with UV-ml814 L-particles was that vhs proteins carried into the 
cells by the UV-ml814 L-particles were causing degradation of viral mRNA. To test the 
hypothesis that vhs was responsible for the ability of UV-viral particles to induce the 
uninfectious state, a vhs~ version of in 1814 was constructed and in section 4.26. was 
examined for the ability to cause inhibition of ml 853 infectivity when UV-irradiated and 
applied to HFL cells.
Plasmid pMJ78, containing a fragment encompassing the region of the HSV-1 
genome encoding Ul41 (encoding the vhs protein) with a 935 bp fragment of Ul41 
replaced by the HCMV major IE promoter controlling the E.coli lacZ gene (figure 4.28.), 
was constructed and recombined into the m l814 genome by cotransfection (pMJ78 was 
kindly constructed and supplied by M.J. Nicholl and C.M. Preston). Fourteen plaque 
isolates from plaques stained blue by X-gal were screened for the presence of the HCMV 
/ lacZ  insert by Southern blotting (figure 4.29.). All but one of the plaque isolates
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Figure 4.28. Construction of a vhs~ version of z/il814. An 8.1 kbp E coR l / 
Xhol fragment of the HSV-1 EcoA fragment, encompassing Ul41, was cloned yielding 
plasmid pMJ74 (all plasmids used to construct vhs~ ml814 were constructed by M.J. 
Nicholl and C.M. Preston). Plasmid pMJ74 was digested with BamHl and Pstl and an 
Xhol / BglH / Xbal linker was inserted yielding plasmid pMJ75 which has a 935 bp 
deletion in U l41. A 3.8 kbp Xbal (partial) / Xhol fragment from plasmid pMJIOl 
(Jamieson et al., 1995) consisting of the HCMV major IE promoter controlling the E.coli 
lacZ gene was ligated between the Xbal and Xhol sites in pMJ75, yielding pMJ78. 
Plasmid pMJ78 was cotransfected with ml814 DNA and P-galactosidase containing 
plaques were isolated and screened for the presence of the modification in pMJ78. A: the 
HSV-1 genome; B: the region of the genome cloned into pMJ74 and the probe used for 
screening recombinants; C: positions of the deletion in Ul41 and the insertion of HCMV / 
lacZ in pMJ78. The orientation of insertion of the HCMV / lacZ fragment was unknown.
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Figure 4.29. Screening of plaque isolates for the lacZ  insertion in Ul 41.
//z 1814 DNA and pMJ78 were cotransfected into BHK cells and the monolayers were 
incubated at 37°. After plaques had appeared the cells were harvested, bath sonicated and 
titrated in 10-fold serial dilutions in the presence of X-gal. Blue plaques were picked, 
subjected to 4 rounds of plaque purification each selecting for p-galactosidase expression 
by staining with X-gal, and then screened for the presence of the deletion in Ul41 and the 
HCMV / lacZ  insert. Fourteen plaques were picked, inoculated onto BHK cell 
monolayers in 24-well tissue culture plates and incubated in the presence of HMBA. 
When severe CPE was evident the medium was removed and the DNA extracted from the 
cells, digested with Fa?RI and HindUl, and a proportion was electrophoresed in a 0.8% 
agarose gel, blotted onto a hybridisation membrane and hybridised to a radiolabelled 6.6 
kbp £a?RI / HindUl fragment spanning the wild-type HSV-1 Ul41 gene (figure 4.28.). 
Lane 1: plasmid pMJ74 containing the wild-type FcoRI / HindUl fragment spanning 
Ul41 digested with FcoRI and HindUl; lane 2: plasmid pMJ78 containing the HCMV / 
lacZ insert digested with ZscoRI and HindUl; lanes 3-16: plaque isolates digested with 
FcoRI and HindUl. A scanned autoradiograph is presented. The positions of the wild- 
type and recombinant EcoRl / HindUl fragments are indicated. All of the plaque isolates 
contained virus with the HCMV / lacZ insert. Isolate 9 was a mixture of wild-types and 
recombinants. The exact sizes of the fragments of the recombinants depended upon the 
orientation of the HCMV / lacZ insert in pMJ78, which was unknown. If the HCMV 
enhancer was in the left orientation, the FcoRI / HindUl fragments would have been 4.6 
kbp and 1.5 kbp, if in the right orientation the fragments would have been 4.2 kbp and 
1.9 kbp. Isolate 3 was grown as a virus stock and used for further experimentation.
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contained pure recombinant virus. Details on the construction of vhs~ m l814 is presented 
in the legends to figures 4.28. and 4.29.
4.26. The vhs function did not cause the reduced infectivitv of iw l853 in 
H FL cells pretreated with UV-t/il814 L-particles.
If vhs caused the inhibition of infectivity in HFL cells pretreated with UV-ml814, 
then the vhs~ m l814 mutant would be unable to cause the inhibition.
To examine whether UV-v/ir m l814 L-particles retained the ability to modify HFL 
cells and convert them to a state less able to be infected with m l853, HFL cells were 
treated with UV-ml814 L-particles or UV-v/zj-  m l814 L-particles at various MOIs or 
mock-treated. At 6 hours post-treatment the monolayers were infected with 100 PFU of 
m l853 per well (MOI was determined from the titre in HFL cells in the absence of 
HMBA) and incubated at 37°. At 24 hours post-infection with m l853 the monolayers 
were fixed, stained for p-galactosidase activity and the number of blue foci per well was 
determined. The results of the inhibition experiment are presented in table 4.13.
UV-inactivated L-particles from vhs~in\%\A gave inhibition of ml853 infectivity at 
a level comparable to that of UV-ml814 L-particles in pretreated HFL cells (table 4.13., 
comparison of inhibition in HFL cells pretreated with 3000 particles per cell), thus vhs 
did not cause the inhibition of infectivity in HFL cells pretreated with UV-ml814 L- 
particles. It should be noted that this is the result from a single experiment and the L- 
particle preparations appear less effective than in previous experiments, giving only a 4- 
fold inhibition with 104 particles per cell.
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Pretreatm ent MOI (particles / cell)
Number of 
p laques Fold inhibition
Mock - 52 -
UV-ml814L-
particles
3000 18.5 2.8
U V-■vhs~ in 1814 L- 
particles
10 36 1.4
300 34 1.5
3000 15 3.5
10000 13 4
Table 4.13. Inhibition of in 1853 infectivity in HFL cells p re trea ted  with 
UV-v/is“ inl814 L-particles. HFL cells in 24-well tissue culture dishes were treated 
with UV-ml814 L-particles or UV-v/z.y m l814 L-particles at various MOIs or mock- 
treated, overlaid with EFjo and incubated at 37°. At 6 hours post-treatment the 
monolayers were infected with 100 PFU of in 1853 per well (MOI was determined from 
the titre in HFL cells in the absence of HMBA), overlaid with CMC/EFjo and incubated 
at 37°. At 24 hours post-infection with in 1853 the monolayers were fixed, stained for (3- 
galactosidase activity and the number of blue foci per well was determined. The value for 
the mock-pre-infected samples is the average of 4 samples, the values from the samples 
pretreated with UV-ml814 L-particles is the average of duplicates, the remaining values 
are from single determinations.
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CHAPTER 3.
Studies on in vitro latency with a temperature sensitive 
uncoating mutant.
4.27. A restriction fragment encompassing the temperature sensitive 
uncoating mutation in t s l l l Z  was cloned yielding plasmid pLRl.
The hypothesis that delayed uncoating leads to latency in HFL cells can be tested by 
inserting a ts uncoating mutation into the genome of ml 814 and controlling uncoating by 
temperature shift. If delayed uncoating leads to latency, the virus would be expected to be 
repressed more efficiently at the NPT than at the permissive temperature. The ts mutant 
te l213 has a phenotype consistent with that of an uncoating mutant and, like its 
counterpart teB7, its mutation is located within the tegument protein encoded by U l36 
(V.G. Preston, unpublished data; Batterson e ta i,  1983). In this chapter the construction 
of a version of ml 814 containing the ts lesion of tel213, and an assessment of whether it 
is repressed during infection at the NPT, is described.
Plasmid pUC18lacZ (Jamieson et al., 1995) was digested with BamHl and Xbal to 
remove the lacZ insert and the pUCl 8 fragment was purified for use as a vector. A 17.25 
kbp BglR / SpeIDNA fragment from the te 1213 genome, encompassing the ts mutation, 
was ligated into the pUC18 vector, yielding plasmid pLRl. Colonies were screened by 
digestion with EcoKl. From 48 colonies screened one contained the correct plasmid. A 
summary of the construction of pLRl and its EcoKL digestion profile is shown in figure 
4.30.
4.28. Plasmid pLRl did not rescue the temperature sensitive lesion in 
t s !2 1 3 .
To examine whether pLRl contains the te 1213 te lesion, the ability of pLRl to 
rescue te 1213 was assessed by cotransfection of pLRl with tel213 DNA.
Ts\2\3> DNA was cotransfected into BHK cells together with pGX122 digested 
with Kpnl or pLRl digested with HindHL. Plasmid pGX122 contains the Kpnl C 
fragment from wild-type HSV-1, which encompasses the corresponding region mutated 
in tel213. After incubation at 31° for 6 days, the cells were harvested in the culture
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Figure 4.30. Cloning of the tem perature sensitive mutation in tel213 yielding 
plasm id p L R l. (A) Strategy for cloning of the temperature sensitive mutation in 
tel213. A 17.25 kbp BgH l/ Spel fragment from tel213 spanning the ts lesion in U l36 
was ligated between the Bam HI and Xbal sites of the pUC18 vector from pUC18/acZ 
(Jamieson eta l. , 1995). The vector sequences were obtained from pUC18/acZ because 
the juxtaposition of the BamHl and Xbal sites in the native form of pUC18 would 
hinder efficient restriction endonuclease cleavage. Note that the Smal site was removed 
during the construction of pUC18lacZ (Jamieson et al., 1995). (B) EcoBl digestion 
profile of pLRl. A scanned photograph of an ethidium bromide-stained 0.7% agarose 
gel is presented. M; plasmid pTKl digested with BamHl and Smal as size markers. 
Sizes of the expected DNA restriction fragments are indicated in kbp.
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H indlll
Sphl
Pstl
Sail
Xbal M- 
BamlU
Xhol (Smal) 
Kpnl 
Sacl 
EcoRl
Spe I 
'80722
BglU
63472
EcoRl 64121 
sites 64133
17.25 kbp Bglll / Spel fragment from ts 1213
68206 69697 74916
B
3.50
0.76
pLRl
EcoRl
digest
Results
E xperim ent Plasm id Titre at 31° (PFU per ml)
T itre a t 39.5° 
(PFU p er ml)
1
pGX122 3.7 x 107 3.2 x 106
pLRl 5.2 x 106 <50
None 2.3 x 107 50
2
pGX122 5.6 x 106 3.0 x 105
pLRl 7.2 x 106 <50
None 1.5 x 107 <50
Table 4.14. M arker rescue of tel213 with pL R l or pGX122. BHK cells in 35 
mm diameter tissue culture dishes were cotransfected with 0.2 pg of tel213 DNA plus 4 
jig (experiment 1) or 8 pg (experiment 2) of pGX122 digested with Kpnl or pLRl 
digested with HindLH. After incubation at 310 for 6 days, the cells were harvested in the 
culture medium, bath sonicated and the virus titres were determined in BHK cells in the 
presence of 3 mM HMBA at 31° or 39.5°.
medium, bath sonicated and the virus titres were determined at 31° or 39.5°. The average 
titres are presented in table 4.14.
Plasmid pGX122 rescued the mutation in te l213, as demonstrated by the 
observation that approximately 10% of the viruses produced from the cotransfection were 
capable of forming plaques at 39.5°. However, pLRl DNA did not rescue te l213 at 
levels above the background represented by te 1213 DNA transfected alone, therefore 
pLRl probably contains the tel213 mutation.
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4.29. The ts  uncoating mutation encoded bv pLRl was recombined into 
the tnl814 genome, yielding i/ i l8 1 5 .
To recombine the ts mutation of tel213 into the //1I8 14 genome, pLRl which had 
been linearised by digestion with HindJJI was cotransfected with ml814 DNA into BHK 
cells. After incubation at 31° for 4 days the cells were harvested, bath sonicated and 10- 
fold serial dilutions were used to infect BHK cell monolayers. After incubation at 31° in 
the presence of HMBA for 4 days, 36 plaques were picked. The plaque isolates were 
screened for temperature sensitivity by inoculating a proportion onto BHK cells in 
duplicate 24-well tissue culture plates and incubating one of the plates at 310 and the other 
at 39.5°. After plaques had appeared, the monolayers were stained and the numbers of 
plaques were determined. One of the plaque isolates contained ts virus and was subjected 
to 2 plaque purifications and grown as a seed stock. The ts virus in the plaque isolate was 
examined by coinfection with tsK or ts 1213 to ensure that its ts lesion was the same as 
that in ts\2 \3 . If the seed stock contained the same mutation as ts\2 \3  it would
recombine with teK but not ts\2\2>.
BHK cells were infected with 2.5 PFU per cell of various combinations of the
plaque isolate (PI), tsK or tal213 and incubated at 31° for 24 hours. The cells were
harvested, bath sonicated and the titres determined at 31° and 39.5° in the presence of 
HMBA. The titres are presented in table 4.15.
The plaque isolate rescued the mutation in toK, but not ts 1213, therefore it contains 
the mutation in r -^1213. The virus in the plaque isolate, which is m l814 with the ts lesion 
of ts 1213, was named ml815.
Results
V irus Titre at 31° T itre a t 39.5°
PI alone 1.1 x 107 <500
Tsl213 alone 1.6 x 108 <500
TyK alone 4.8 x 107 <500
PI + tel213 1.8 x 107 <500
PI + tsK 2.7 x 107 5.8 x 105
Ts\2\3  + teK 3.4 x 107 8.6 x 105
Table 4.15. Coinfection / recom bination of i/il815  with ts l2 1 3  o r t s K . 
BHK cells in 35 mm diameter tissue culture dishes were infected with 2.5 PFU per cell of 
various combinations of the plaque isolate (PI), teK or te1213 and incubated at 31° for 24 
hours. The cells were harvested into the culture medium, bath sonicated, and the virus 
titres at 31° and 39.5° were determined in the presence of 3 mM HMBA.
4.30. In  1815 exhibited a phenotype expected of an uncoating m utant, as 
determ ined in the Southern blot assay.
In order to confirm that ml815 is an uncoating mutant, m l815 was examined in the 
Southern blot assay described in chapter 1. BHK cells were infected with 0.5 PFU of 
m l814 or ml815 per cell and incubated at 31° or 39.5° in the presence of Ara-C. At 7 
hours post-infection nuclei were isolated and digested with DNase I or were untreated. 
DNA was purified, digested with BamHI, electrophoresed alongside purified virion 
DNA, blotted, and hybridised to a radiolabelled DNA fragment from the 5’ coding 
sequences of LEI. Resulting hybridisation is presented in figure 4.31. The relative 
proportions of nonlinear and linear viral genomes in the non-nuclease treated samples 
were quantified and are presented in figure 4.32. The percentages of nonlinear genomes 
in the non-nuclease treated samples and genomes remaining after DNase I digestion are 
presented in table 4.16.
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Figure 4.31. Configuration of ml815 genomes after infection at the NPT. BHK cells 
in 35 mm diameter tissue culture dishes were infected with 0.5 PFU per cell of m l814 
(lanes 3-4  and 9-10) or ml815 (lanes 5-6 and 11-12) or mock infected (lanes 2 and 8), 
overlaid with EFio containing 50 Jig/ml Ara-C and incubated at 31° (lanes 2-6) or 39.5° 
(lanes 8-12). At 7 hours post-infection nuclei were isolated and digested with 5 units of 
DNase I for 20 minutes (lanes 4, 6, 10 and 12) or were untreated (lanes 3, 5, 9 and 11). 
DNA was purified, digested with Bam HI and half of each sample was electrophoresed 
in a 0.7% agarose gel alongside 1.0 ng m l814 virion DNA standards (lanes 1 and 7). 
Electrophoresed DNA was blotted onto a hybridisation membrane and hybridised to a 
[32P]-labelIed 640 bp ZtamHI / N col fragment from the 5' coding sequences of IE 1. 
Positions of joint and L-terminal Bam HI restriction fragments are indicated. D: DNase I 
digested sample; M: mock infected sample; V: virion DNA.
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Demonstration that in 1815 is an uncoating m utant using the
Southern blot assay.
in 1814 in 1815 inl814 inl815
/ 31 / 31 / 39.5 / 39.5
Virus / temperature (°C)
■ % total genomes
□ % nonlinear genomes
■ % linear genomes
Figure 4.32. Relative proportions of nonlinear and linear in lS 1 5  genomes 
a f te r  infection a t the perm issive and non-perm issive tem p era tu re s .
Hybridisation in figure 4.31. was quantified and the relative proportions of nonlinear and 
linear viral genomes in the non-nuclease treated samples quantified by comparison to the 
virion DNA standards. The total number of genomes in nuclei from cells infected with 
m l815 at 31°, which contained the greatest total number of genomes compared to the 
other samples, represents 100%.
Results
Temperature (°C) 31 39.5
Virus ml814 z>z 1815 ml 814 ml815
% nonlinear 45 52 46 30
% genomes 
remaining after 
DNase I digestion
23 21 33 60
Table 4.16. Configuration and DNase I sensitivity of in 1815 genomes 
after infection at the permissive and non-permissive tem peratures.
Hybridisation in figure 4.15. was quantified and the percentage of genomes which were 
nonlinear in the non-nuclease treated samples calculated by comparison to the purified 
virion DNA standards. The percentage of genomes remaining after DNase I digestion was 
determined by comparison with the untreated samples.
At 31°, in 1815 DNA was converted to the nonlinear configuration at a similar rate to 
m l814 DNA (figure 4.31., lanes 3 and 5; figure 4.32.). At 39.5°, the NPT for m l815, 
ml814 DNA was converted to the nonlinear configuration with comparable efficiency to 
that at 31°, but conversion of ml815 DNA to the nonlinear configuration was impaired 
(figure 4 . 3 1 lanes 9 and 11; figure 4.32.). The total numbers of genomes in the nuclei 
after infection with ml815 at the NPT was about 30% of the total numbers of genomes 
after infection at 31°. The percentage of genomes remaining after DNase I treatment was 
over 2-fold greater in the sample infected with m l815 at the NPT than in samples infected 
under permissive conditions, implying that the genomes were more resistant to nucleases. 
The ml815 genomes exhibited a phenotype at 39.5° expected of an uncoating mutant: 
they were not converted to the nonlinear form, did not associate with nuclei as efficiently 
as in normal infection and were resistant to DNase I. Mutant m l815 thus exhibited a 
similar phenotype to ttl213 in the uncoating assay.
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4.31. 7/tl815 did not become insensitive to HMBA at the NPT as
efficiently as its revertant i'm1816. or m l 814 .
During the first 6 hours of infection in HFL cells, m l814 genomes gradually enter a 
latent state which cannot be overcome by activators of transcription such as HMBA or 
Vmw65, but if either of these two activators are added at the beginning of infection the 
defect in in 1814 is overcome and the virus forms plaques with normal efficiency (Harris 
and Preston, 1991; McFarlane et a l,  1992). If delayed uncoating leads to latency, then 
ml815 might be expected to become unresponsive to HMBA at 39.5° more rapidly than 
ml814. A series of 7 experiments were carried out to determine whether ml815 
establishes latency more efficiently at 39.5° than ml814. In addition to comparing ml815 
with in 1814, m l815 was compared with its rescuant, m l816, which has the ts mutation 
restored but retains the mutation in Vmw65. The ts uncoating mutation in ml815 was 
restored by cotransfecting ml815 DNA with linearised plasmid pGX122 which contains 
the Kpnl C fragment from wild type HSV-1, encompassing region of the mutation in 
tel213. Plaques were selected at 39.5° and plaque purified to yield the rescuant ml816 
which should be equivalent to ml814. To enable virus titres to be determined by staining 
monolayers for P-galactosidase activity, the lacZ gene under the control of the HCMV 
major IE enhancer was recombined into a nonessential region of the ml815 genome 
yielding m l817 (a detailed description of the construction of ml817 is described below), 
and the repression of ml817 at 39.5° was compared to that of ml853 (ml814 with the 
lacZ gene under the control of the HCMV major IE enhancer inserted into the TK gene).
HFL cell monolayers were infected at 39.5° with 10-fold serial dilutions of an 
ml815, ml814, ml816, ml817 or ml853 preparation. Immediately after the 1 hour 
adsorption period or after 7 or 24 hours at 39.5° the culture medium was replaced with 
medium containing 3 mM HMBA and the monolayers were shifted to 31°. The 
monolayers were left at 31° for 4-6 days and stained with Giemsa or for 2 days and 
stained for p-galactosidase activity, plaques were counted and virus titres were 
determined. The results from 7 separate experiments are presented in table 4.17.
The purpose of these experiments was to assess whether ml 815 became repressed 
more rapidly than m l814 during incubation at 39.5°. If uncoating leads to latency, then 
during incubation at 39.5° the titre of ml815 would be expected to drop more rapidly than 
ml814.
At 39.5°, viruses containing the uncoating mutation were not repressed as 
efficiently as viruses not containing the uncoating mutation, as was demonstrated by the 
smaller decrease in the titre of ml815 compared to ml814 or ml816 after incubation at 
39.5° for 7 hours or 24 hours (table 4.17.), thus delayed uncoating did not lead to 
latency.
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Table 4.17. Repression of i/il815 during infection of HFL cells a t 39.5°. HFL cell 
monolayers were infected at 39.5° with 10-fold serial dilutions of an ml815, ml814, 
m l816, in 1853 or m l817 preparation. Either immediately after the adsorption period, or 
after incubation at 39.5° for 7 hours or 24 hours the culture medium was removed and 
replaced with medium containing 3 mM HMBA and the monolayers were shifted to 
31°. The monolayers were left at 31° for 4-6 days and stained with Giemsa 
(experiments 1-5) or for 2 days and stained for p-galactosidase activity (experiments 6 
and 7), plaques were counted and the virus titres were determined. Results are presented 
from 7 separate experiments. * indicates titre was determined entirely at 31°. ND; not 
determined.
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Table 4.18. Repression of inl815 upon downshift to 31° after 1 hour or 7 hours 
incubation a t 39.5°. HFL cells in 35 mm diameter tissue culture dishes were infected at 
39.5° with 10-fold serial dilutions of an m l814, ml816, or m l815 preparation and 
overlaid with EF5 containing 2% pooled human serum. Monolayers were immediately 
shifted to 31° (A) or were maintained at 39.5° for a further 6 hours before being 
downshifted (B). At 0 hours, 3 hours or 6 hours after downshift the culture medium was 
removed and the monolayers overlaid with CMC/EF10 containing 3 mM HMBA. After 
incubation at 31° for 4 days the plaques were counted and the virus titres were 
determined.
Results
A . Downshift to 31° after 1 hour at 39.5*.
Virus Time HMBA added Titre
after downshift to (PFU / ml)
31° (hours)
0 7.7 x 108
i//1814 3 5.4 x lO 7
6 2.6 x lO 7
0 8.1 x 109
i/I 1816 3 3.1 x 108
6 1.7 x 108
0 1.3 x lO 10
ml815 3 7.0 x lO 8
6 1.9 x lO 8
B . Downshift to 31* after 7 hours at 39.5'.
Virus Time HMBA added Titre
after downshift to (PFU /  ml)
31" (hours)
0 3.5 x 107
i/il814 3 3.0 x lO 7
6 3.5 x 107
0 2.2 x 108
iti1816 3 2.4 x 108
6 1.7 x 108
0 3.3 x 109
i/il815 3 1.4 x lO 9
6 4.8 x 108
Fold decrease in 
titre
0
14
30
0
26
48
0
19
68
Fold decrease in 
titre (compared to 
+HMBA after 1 
hour at 39.5°)
22
26
22
37
34
48
4
9
27
Results
If delayed uncoating facilitates the establishment of latency, but the action of HMBA 
dominates over the repression of the viral genomes when present immediately after 
uncoating, then the assay described above might not have detected an increased rate of 
repression of ml815 at 39.5°. To determine whether an increased rate of repression 
occurs after downshift to 31°, HFL cells were infected with ml814, ml816, or m l815 at 
39.5° and the rate of repression of the viruses after downshift to 31° was compared by 
adding HMBA at various times after downshift.
HFL cells were infected at 39.5° with 10-fold serial dilutions of an ml814, ml816, 
or m l815 preparation and overlaid with EF5 containing 2% pooled human serum. 
Monolayers were immediately shifted to 31° or were maintained at 39.5° for a further 6 
hours before being downshifted. At 0 hours, 3 hours or 6 hours after downshift the 
culture medium was removed and the monlolayers were overlaid with CMC/EF10 
containing 3 mM HMBA. After incubation at 31° for 4 days the plaques were counted and 
the virus titres were determined. The resulting titres are presented in table 4.18.
Upon downshift immediately after the adsorption period, m 1815 was repressed at a 
similar rate to ml814 and ml816, thus ml815 had retained the ml814 mutation during its 
construction (table 4.18.A). After incubation at 39.5° for 7 hours, ml815 had become 
less repressed than m l814 or ml816, 4-fold as compared to 22-fold and 37-fold 
respectively. While the repression of m l814 and ml816 was completed after incubation at 
39.5° for 7 hours, repression of ml816 was not complete (table 4.18.B). If delayed 
uncoating leads to latency, then the rate of repression of ml815 upon downshift after 7 
hours at 39.5° would be greater than after downshift immediately after adsorption. The 
rate of repression of ml815 upon downshift to 31° after incubation at 39.5° for 7 hours 
was not greater than upon downshift after 1 hour at 39.5°. No evidence was found in this 
study to suggest that delayed uncoating leads to latency.
4.32. Treatment of HFL cells with UV-i/il815 L-particles made the cells 
less permissive for m !853 plaque initiation.
The observation that ml815 does not become repressed at 39.5° is difficult to 
reconcile with the finding that cells treated UV-inactivated viral particles become less 
permissive for plaque initiation. One possible explanation was that ml815 had acquired a 
mutation during its construction which prevents its ability to induce the nonpermissive 
state. In order to ensure that ml815 retained the ability to inhibit plaque initiation when 
UV-irradiated and used to treat HFL cells, UV-ml815 L-particles were tested for their 
ability to inhibit plaque initiation.
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Inhibition of in 1853 infectivity in HFL cells 
pretreated with UY-in 1815 L-particles.
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Figure 4.33. Inhibition of infectivity in HFL cells pretreated with UV- 
in l815 L-particles. HFL cell monolayers were treated with various MOIs of UV- 
ml815 L-particles or mock-treated, overlaid with EFio and incubated at 37°. At 6 hours 
post-treatment the cells were infected with 100 PFU of m l853 per monolayer (MOI was 
determined from the titre in HFL cells in the absence of HMBA), overlaid with EHU5, 
incubated for a further 24 hours and then fixed, stained for p-galactosidase activity and 
the average number of blue foci per monolayer was determined. The value for the mock 
infected sample is the average of 4 samples the remaining values are the averages of 
duplicates.
Results
HFL cell monolayers were treated with various MOIs of UV-ml815 L-particles or 
mock-treated and incubated at 37°. At 6 hours post-treatment the cells were infected with 
100 PFU of m l853 per monolayer (MOI was determined from the titre in HFL cells in the 
absence of HMBA), incubated for a further 24 hours and then fixed, stained for p- 
galactosidase activity and the number of blue foci per monolayer was determined. The 
average numbers of blue foci of virus replication per monolayer is presented in figure
4.33.
/«1853 plaque initiation was inhibited up to 7-fold in HFL cells pretreated with UV- 
ml815 L-particles, thus m l853 does not have a unique characteristic which prevents its 
ability to induce the nonpermissive state.
4.33. Pretreatment of HFL cells with non-UV-inactivated inlS15 L- 
particles at the NPT stimulated fwl853 plaque initiation.
A possible explanation for the observation that HFL cells treated with UV- 
inactivated viral particles become less permissive for plaque initiation, but that ml815 did 
not become repressed at 39.5°, is that the inhibitory activity of the particles is a product of 
UV-irradiation. In previous studies viral particles required UV-irradiation to prevent IE 
gene expression complementing m l853, however the requirement of prior UV-irradiation 
of the particles might be circumvented by pretreating the cells with ml815 at the NPT, 
under circumstances where the virus cannot uncoat and express its genome. The effect of 
pretreating HFL cells with non-UV-irradiated ml815 L-particles at 39.5° on m l853 
plaque initiation was investigated.
HFL cell monolayers were treated with various MOIs of non-UV-inactivated ml815 
L-particles or mock-treated and incubated at 39.5°. After incubation for a further 5 hours 
the cells were infected with 100 PFU of m l853 per monolayer (MOI was determined 
from the titre in HFL cells in the absence of HMBA), incubated for a further 24 hours and 
then fixed, stained for (3-galactosidase activity and the average number of blue foci per 
monolayer was determined. Values are presented in figure 4.34.
At MOIs of up to about 5 particles per cell there was a slight inhibition of m l853 
infectivity, but infectivity was stimulated by higher MOIs. The stimulation of m l853 
plaque initiation in HFL cells pretreated with non-UV-irradiated ml815 L-particles 
indicated that the nonpermissive state induced by the UV-irradiated particles was the result 
their UV irradiation. Alternatively, tal213 might have ‘leaked’ during incubation at the 
NPT at sufficient levels to complement m l853.
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Stimulation of in  1853 infectivity in HFL cells p retreated  
with non-UV-inactivated in 1815 L-particles a t the NPT.
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F igure 4.34. Stim ulation of infectivity in HFL cells p re trea ted  a t 39.5° 
with non-UV-inactivated in 1815 L-particles. HFL cell monolayers were treated 
with various MOIs of non-UV-inactivated m l815 L-particles or mock-treated and overlaid 
with EFio- After incubation for a further 5 hours the cells were infected with 100 PFU of 
m l853 per monolayer (MOI was determined from the titre in HFL cells in the absence of 
HMBA), overlaid with CMC/EFio, incubated for a further 24 hours and then fixed, 
stained for p-galactosidase activity and the average number of blue foci per monolayer 
was determined. All incubations were at 39.5°, media were preheated to 39.5° before use 
and all manipulations were carried out in an atmosphere maintained at 37°. The value for 
the mock infected sample is the average of 4 samples the remaining values are the 
averages of triplicates.
Results
4.34. Infection of HFL cells with iwl815 at the NPT resulted in the 
induction of an IFNa-induced cellular gene.
Infection with HSV results in the overall inhibition of host protein synthesis 
(Fenwick, 1984; Roizman and Sears, 1993), however transcription of a small number of 
cell genes is induced (Kemp et al., 1986; Latchman et al., 1987; Jang and Latchman, 
1989; Jang etal., 1991; Latchman, 1991; Smiley etal., 1991). The majority of cell genes 
induced by HSV are stimulated by viral gene products synthesised de novo, but at least 
some do not require protein synthesis hence their induction is triggered by the binding of 
virus to the cell surface, entry into the cell or uncoating (Kemp et al., 1986; Preston, 
1990). Previously it was reported that a 56 kDa protein (p56) was induced in HFL cells 
by HSV infection, and that induction occurred in the absence of viral protein synthesis 
(Preston, 1990). A protein of the same apparent molecular weight is induced by the IFNs 
(Rubin etal., 1988). Since IFN-induced genes are activated in response to virus infection 
it seemed possible that the 56 kDa protein induced by IFN was identical to that induced by 
HSV. A cDNA encoding the IFN-induced 56 kDa protein has been isolated (c56; Chebath 
et al., 1983) and was used as a probe to investigate whether c56 RNA is induced by HSV 
and whether w l 815 retains the ability to cause the induction. As IFN a pretreatment 
facilitates the establishment of latency in HFL cells, IFNa-induced factors are candidates 
as possible mediators of the repression of ml 814.
HFL cells were infected with 10 PFU per cell of ml814 or ml815 and incubated at 
39.5° in the presence or absence of cycloheximide. In parallel, a monolayer was overlaid 
with medium containing cycloheximide and 1000 u/ml of IFNa and incubated at 39.5°. 
At 6 hours post-infection poly(A)-containing RNA was extracted, electrophoresed in an 
agarose gel, blotted onto a hybridisation membrane and hybridised to radiolabelled c56 
(supplied by V.G. Preston, Chebath et al., 1983) and a DNA probe specific for Vmwl75 
RNA. Resulting hybridisation is presented in figure 4.35.
RNA complementary to c56 was induced by both ml814 and ml815 at 39.5°, in 
the presence or absence of protein synthesis. The observation that ml815 induced c56 
RNA at the NPT indicated that induction was triggered by a stage of infection prior to 
uncoating of the genome, such as adsorption or entry into the cell. C56 RNA was 
strongly induced by IFNa treatment and the induction occurred in the absence of protein 
synthesis, thus the induction of c56 by HSV appeared to be via an intermediate signal and 
not via the release of IFNa. As expected, Vmwl75 RNA was reduced in cells infected 
with ml815 at the NPT compared to ml814 at the same temperature however, small 
amounts of Vmwl75 were present suggesting that m l815 had leaked.
The observation that m l815 activates an IFNa-induced pathway at the NPT, 
combined with the fact that it did not become repressed efficiently at 39.5° argues against
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Figure 4.35. Induction of an IFN a-induced cellular gene during infection with 
in 1815 a t the NPT. HFL cells in 90 mm diameter tissue culture dishes were infected at 
39.5° with 10 PFU per cell of ml814 (lanes 4 and 5) or ml815 (lanes 6 and 7) or were 
mock infected (lanes 2 and 3) in the presence (lanes 3, 5 and 7) or absence (lanes 2, 4 
and 6) of 50 |Lig/ml cycloheximide, overlaid with EFio with or without cycloheximide 
and incubated at 39.5°. In parallel, a monolayer was overlaid with EF io containing 1000 
u/ml IFNa and incubated at 39.5° (lane 1). At 6 hours post-infection poly(A)-containing 
RNA was extracted, half of each sample was electrophoresed in a 1.2% agarose gel, 
blotted onto a hybridisation membrane and hybridised to a [32P]-labelled 330 bp BglU / 
Sspl fragment from plasmid c56 which contains a cDNA of the IFN-induced 56 kDa 
protein (supplied by V.G. Preston, Chebath etal., 1983), and to a Vmw 175-specific 670 
bp EcoRl / Pvull fragment from plasmid XI, containing the HSV-1 Xhol C fragment. 
The positions of c56 and Vmw 175 RNAs are indicated. * indicates the position of ai
large c56 or Vwm 175-specific RNA produced in the presence of de novo viral protein 
synthesis.
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the possibility that the repression is mediated by the IFN-induced 56 kDa protein, or 
probably any other IFNa-induced factor.
It is tempting to speculate that the 56 kDa protein observed to be induced by HSV in 
previous studies (Preston, 1990) is identical to a protein of the same apparent molecular 
weight that is induced by IFNa (Chebath et al., 1983; Rubin et al., 1988). Both proteins 
have the same apparent molecular weight, are induced by IFNa and do not require de 
novo protein synthesis for their induction.
4.35. The E.coli  lacZ gene under the control of the HCMV maior IE 
promoter was inserted into a nonessential region of the tn!815 genom e, 
yielding i n l S l l .
To facilitate studies with //z 1815 and assess the extent to which it leaks at the NPT, 
a version which expresses (3-galactosidase under the control of the HCMV major IE 
promoter was constructed.
The lacZ gene was inserted into the Ul43 gene, mutants of which have no 
demonstrable phenotype in vitro or in vivo (MacLean et al., 1991), by cotransfecting the 
plasmid B3#76 with 1815 DNA. Twenty-four plaque isolates from plaques stained blue 
by X-gal were screened for the presence of the HCMV I lacZ insert by Southern blotting 
(figure 4.37.). All of the plaque isolates contained pure recombinant virus. Details on the 
construction of m l817 are presented in the legends to figures 4.36. and 4.37.
4.36. Z/il817 leaked at the NPT.
In the experiment described in section 4.33., an attempt was made to demonstrate 
the inhibition of plaque initiation in HFL cells pretreated with non-UV-irradiated L- 
particles by using m l815 L-particles at the NPT; it was found that the non-UV-irradiated 
L-particles stimulated plaque initiation. However, it is possible that the ts uncoating 
mutation in m l815 leaks at the NPT, leading to the expression of viral IE proteins that 
would complement a superinfecting virus. Staining ml817-infected cell monolayers with 
X-gal enabled an assessment of the proportion of PFU which leak at the NPT, thus 
although plaques are not formed by viruses containing the riyl213 mutation at the NPT the 
mutation might also act at a late stage of replication, enabling expression of viral proteins 
but preventing the virus from spreading from cell to cell and forming plaques. Staining 
ml817-infected monolayers with X-gal enabled single lytically infected cells to be
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Figure 4.36. Insertion of lacZ into the i/il815 genome. An Xhol / Bgill / Xbal linker 
was ligated into the unique Nsil site within the Ul43 coding sequences of clone p35 
(MacLean e ta l., 1991), yielding A994#29. Clone p35 consists of a 5.1 kbp ZtomHI 
(position 91608 in the HSV-1 genome) / EcoBl (96749) fragment of the HSV-1 genome 
cloned into the BamHl / EcoBl sites of pUC19 (MacLean et a l , 1991). An X bal/X ho l 
fragment from plasmid pMJIOl (Jamieson et a l , 1995) consisting of the HCMV major 
IE promoter controlling the lacZ gene with SV40 terminator sequences was ligated into 
the Xbal / Xhol sites of A994#29 to yield B3#76 (B3#76 was constructed and kindly 
supplied by C.M. Preston). Plasmid B3#76 was cotransfected into BHK cells with 
m l815 DNA and P-galactosidase expressing plaques were screened for the presence of 
the insertion in U l43. A: The HSV-1 genome. B: The region of the genome cloned in 
p35. C: The position of insertion of HCMV / lacZ in B3#76.
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Figure 4.37. Screening of in 1815 plaque isolates for the lacZ  insertion in U l43.
7nl815 DNA and B3#76 were cotransfected into BHK cells and incubated at 31°. After 
plaques had appeared the cells were harvested, bath sonicated and titrated in 10-fold 
serial dilutions in the presence of X-gal. Blue plaques were picked, subjected to 4 
rounds of plaque purification (each selecting for |3-galactosidase expression by staining 
with X-gal), and then screened for the presence of the HCMV / lacZ insert in Ul43. 
Twenty-four plaques were picked, inoculated onto BHK cell monolayers in 24-well 
tissue culture plates and incubated at 31 ° in the presence of HMBA. When severe CPE 
was evident the medium was removed and the DNA was extracted from the cells, 
digested with EcoRI, HindHI and BamHl. A proportion was electrophoresed in a 0.8% 
agarose gel, blotted onto a hybridisation membrane and hybridised to radiolabelled 
plasmid p35 containing the wild-type HSV-1 U l43 gene (figure 4.36.). Lane 1: Plasmid 
p35 containing the wild-type Ul43 digested with EcoRI, HindHI and BamHl. Lane 2: 
Plasmid B3#76 containing the HCMV / lacZ insert digested with EcoRl HindHI and 
BamHl. Lanes 3-26: Blue plaque isolates digested with ZscoRI, HindHI and BamHl. The 
positions of the wild-type and recombinant fragments and the pUC19 vector are 
indicated. All of the plaque isolates contained virus with the HCMV / lacZ insert. There 
is no hybridisation to isolates 13 and 23, probably due to loss of the DNA pellets during 
extraction. Isolate 3 was grown as a virus stock and used for further experimentation. A 
scanned autoradiograph is presented.
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Tem perature Inpu t PFU
Num ber of blue cells
(°C)
Alone +HM BA
103 0 1398
31
104 ~ 4 ND
105 300 ND
106 ND ND
103 0 95
39.5
104 2 784
105 24 ND
106 329 ND
Table 4.19. Assessment of the leakiness of in 1817 a t the NPT. HFL cells 
in 35 mm diameter tissue culture dishes were infected at 31° or 39.5° with 106, 105« 104 
or 103 PFU of in 1817 per monolayer. The infected cells were overlaid with EFio 
containing 2.5 |ig/ml Brefeldin A or EFio containing Brefeldin A and 3 mM HMBA and 
incubated at 31° or 39.5°. At 19 hours post-infection the monolayers were stained for p- 
galactosidase activity and the number of blue cells per monolayer was determined.
counted.
HFL cells were infected at 31° or 39.5° with various MOIs of in 1817, overlaid with 
medium containing Brefeldin A or medium containing Brefeldin A and HMBA and 
incubated at 31° or 39.5°. At 19 hours post-infection the monolayers were stained for P~ 
galactosidase activity and the number of blue cells per monolayer was determined and
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presented in table 4. 19.
In the presence of HMBA, the number of ml817-infected cells expressing viral 
genes in monolayers infected at 39.5° was approximately 6% of the number of cells 
expressing viral genes at 31°. In the absence of HMBA 15% of the ml817 leaked, thus 
up to 15% of m l817 leaked at the NPT. 7/21817 does not form plaques at 39.5°, thus the 
ts uncoating mutation presumably also acts at a late stage of replication thereby preventing 
the production of infectious virus in cells infected with leaky virus.
In light of the finding that ml815 leaked at the NPT, is seems probable that the 
stimulation of m l853 in HFL cells pretreated with non-UV-inactivated ml815 L-particles 
at 39.5° (section 4.33.) was caused by contaminating virions in the L-particle preparation 
leaking, expressing IE genes and complementing the m l853.
. In the experiments examining the ability of in 1815 to enter the repressed, latent state 
at 39.5° (section 4.31.), the small proportion of virus which became repressed at 39.5° 
might have been caused by leaking virus entering the latent state. The fact remains that 
ml815 did not enter the latent state at 39.5° as efficiently as ml814 or ml816, hence the 
interpretation that delayed uncoating did not lead to latency remains unaffected.
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5. DISCUSSION.
It was previously reported that viral genomes entered a latent state in tissue culture 
cells when viral IE transcription was abrogated (Harris and Preston, 1991; Jamieson, 
1993). In the first chapter of the results section of the thesis presented here, a study is 
described which was aimed at delineating the structure of HSV-1 genomes during latency 
in HFL cells after viral IE transcription and cytotoxicity had been reduced by pretreating 
the cells with 3FNa, and by use of the mutant ml 820. 7^1820 has two modifications, an 
insertion in Vmw65 rendering it unable to transactivate IE genes, and a modification in 
the promoter controlling transcription of DEI, resulting in a Vmwl 10“ phenotype under 
IE conditions in HFL cells.
An investigation into the possibility that virus structural components 
biochemically modify HFL cells to a state which makes latency the outcome of infection 
is described in the second chapter, and in the final chapter an attempt was made to 
determine whether slow virus uncoating leads to latency.
As with related in vitro latency systems using HFL cells (Harris and Preston, 
1991; Preston and Russell, 1991), and during latency in vivo (Rock and Fraser, 1983, 
1985; Efstathiou et a l , 1986) the predominant population of retained viral genomes were 
in a nonlinear form (sections 4.1, 4.3 and 4.4.). The nonlinear viral genome 
configuration observed in the in vitro latency system described in the thesis presented 
here is in contrast to the system of Wigdahl et al. who established latency of wild type 
HSV-1 in HFL cells by pretreating the cells with IFNa and BVDU for 24 hours prior to 
infection with up to 2.5 PFU of virus per cell (Wigdahl et al., 1984a). After incubation at 
37° for 7 days the virus was maintained in the latent state in the absence of the inhibitors 
if the cells were shifted to 39.5-40.5°. Reactivation was induced by superinfection with 
HCMV or by downshift to 37°. The predominant population of latent viral genomes in 
the system of Wigdahl et a l was linear (Wigdahl et a l, 1984a), suggesting that the basis 
for repression of viral replication fundamentally differs from latency described by Preston 
and co-workers (Russell and Preston, 1986; Harris and Preston, 1991; Jamieson et a l, 
1995). In the system studied here (Jamieson et a l, 1995), the linear population of viral 
genomes resulted from incomplete uncoating of input virus particles, thus it is tempting to 
speculate that the block to viral replication in the systems utilising inhibitors and high 
temperature occurs as a result of inhibition of uncoating of input genomes or by inhibition 
of a stage of the replicative cycle post-cleavage or encapsidation of de novo synthesised 
DNA. As has been suggested previously (Shiraki and Rapp, 1986; Preston and Russell, 
1991), two populations of genomes might exist in the system of Wigdahl et a l,  one 
which is blocked by incubation at 39.5-40.5° and reactivated by downshift to 37° and 
one which is reactivated by superinfection with HCMV. It seems possible that the
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HCMV-reactivated genomes in the system of Wigdahl et al. are in a nonlinear state 
resembling the latent genomes in the system of Jamieson et al., but that the nonlinear 
population is of such low abundance relative to the linear population that their detection in 
Southern blots is prevented. The HCMV-reactivated genomes in the systems using 
inhibitors and elevated temperature remain stable over time, but the 37°-reactivated 
genomes decrease in number (Shiraki and Rapp, 1986), thus the hypothesis that these 
two populations of genomes represent nonlinear and linear DNA respectively is supported 
by the observation that nonlinear genomes in the system of Jamieson et al. are stable and 
the linear genomes are preferentially degraded (Jamieson et al., 1995).
Virtually all of the genomes detected in the in vitro latency system were competent 
for reactivation by superinfection (Jamieson et al., 1995). That virtually all the detectable 
genomes were competent for reactivation enabled the demonstration that the nonlinear 
population are templates for reactivation and that conversion to a linear form is not 
required as a prerequisite for the genomes to express genes and resume replication 
(section 4.4.), thus nonlinearity per se is not responsible for repressing the latent 
genomes. It seems likely that nonlinearity plays an important role in preventing 
degradation by exonucleases and may be required to enable other changes to occur which 
stabilise or repress the genomes.
A striking finding which arose from the structural studies was that HFL cells 
contained a greater proportion of non-uncoated genomes than other cell types at a set time 
after infection, and a smaller total amount of DNA (sections 4.5. and 4.8.). Use of the in 
vitro latency system enabled experiments to be carried out in which infections proceeded 
for 3 days, however non-uncoated genomes were still present at 3 days post-infection, 
thus uncoating appeared particularly slow in HFL cells. Alternatively, the high proportion 
of non-uncoated genomes might be explained if linear DNA is degraded particularly 
efficiently in HFL cells before it is stabilised by conversion to the nonlinear configuration 
and associated with nucleosomes. Specific degradation of linear DNA has been observed 
previously (Jamieson et al., 1995), and might itself be a result of inefficient uncoating. 
The hypothesis that degradation of virus DNA occurs more efficiently in HFL cells than 
in other cell types was supported by the observation that infected HFL cells contained 
fewer viral genomes in both the nuclei and cytoplasm than the other cell types tested 
(section 4.5.).
In previous studies by Jamieson it was observed that latent genomes were more 
sensitive to MN when compared to m l820 shortly after infection or to genomes 
transcribing in the presence of Ara-C (Jamieson, 1993). It was suggested that latent 
genomes were sensitive to MN as a specific result of their latent state and that transcribing 
viruses remained MN-resistant because they did not have such changes conferred upon 
them. In the study described in the thesis presented here, the linear portion of genomes in
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the in vitro latency system were resistant to nucleases and were thus defined as resulting 
from non-uncoated input genomes (section 4.3.), thus the nuclease-sensitive state was a 
result of uncoating rather than conversion to the latent form. The interpretation of 
Jamieson was probably confused by the unusually high proportion of non-uncoated virus 
genomes which remain in the nuclei of infected HFL cells. Another possible cause of the 
high resistance of transcribing viral genomes to MN was that the ability of the cells to 
uncoat incoming virus particles was reduced by the cytotoxicity of viral gene expression, 
and had long-term experiments been possible with transcribing viruses, they too would 
have entered a nuclease-sensitive state.
Infectivity of HSV-1 in HFL and BHK cells is similar but HFL cells contained up 
to 9-fold fewer nonlinear, uncoated viral genomes (sections 4.5 and 4.8.). It follows that 
a large proportion of viral genomes in HFL cells do not undergo replication and are 
degraded, but in BHK cells these genomes are converted to the nonlinear configuration 
and retained, whereas input genomes destined to undergo replication are stable in both 
HFL and BHK cells. The observation that only a small proportion of input viral genomes 
undergo replication has been made previously (Jacob and Roizman, 1977).
Virus uncoating was assayed by hybridising Southern blots to probes which 
detected the joint and L-terminal BamHl restriction fragments of the genome (sections 
4.5.-4.9., 4.23. and 4.30.). Conversion to the nonlinear configuration was expected to 
occur rapidly after uncoating, therefore the amount of nonlinear genomes was indicative 
of the rate of uncoating. The sensitivity of the nuclear viral DNA to digestion with DNase 
I was also used to assess the degree of uncoating. Genomes of the temperature sensitive 
uncoating mutant ts 1213 exhibited a phenotype at the NPT expected of an uncoating 
mutant: they were not converted to the nonlinear configuration, did not associate with 
nuclei as efficiently as in normal infection and were relatively resistant to DNase I (section 
4.9.). The Southern blot assay was thus a valid and useful method of assessing the effect 
on uncoating of treatments which alter HSV-1 replication, such as IFNa and HMBA.
Uncoating and conversion to the nonlinear configuration was found to result from 
the action of pre-existing cell factors or factors brought in with virus particles (section 
4.8.), as has been observed in other laboratories (Poffenberger and Roizman, 1985). 
Uncoating was unaffected by the ml 814 mutation (section 4.6.), IFN a pretreatment 
(section 4.7.) or HMBA (section 4.6.), thus while uncoating possibly varies between cell 
types, no evidence was found that rate of uncoating is a target for treatments which 
modify virus infectivity.
In agreement with studies by Jamieson, initial data indicated that the TK gene was 
not associated with regularly spaced nucleosomes (section 4.10.; Jamieson, 1993). In 
addition, using replication inhibitors with a specific action on viral DNA replication, it 
was demonstrated that the absence of regularly spaced nucleosomes on the latent genomes
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was not a secondary consequence of Ara-C inhibiting histone synthesis. The data in the 
thesis presented here is in agreement with those of Daniell et a l who demonstrated that 
the regular nucleosome arrangement on parental adenovirus DNA during infection was 
not prevented when histone synthesis was inhibited with butyrate (Daniell et al., 1981), 
thus even when de novo histone synthesis is prevented, cells contain sufficient pools of 
histones to bind incoming virus genomes and form a regularly spaced structure.
A chromatin-like pattern of MN digestion was detected on the LAT / DEI region of 
m l820 genomes in the in vitro latency system (section 4.11.), indicating that the latent 
genomes were in a similar structure to the bulk of latent HSV-1 DNA in the brainstems of 
mice (Deshmane and Fraser, 1989). To the knowledge of the author of the thesis 
presented here, there are no published reports to date of regular nucleosome arrangement 
on the viral genomes in any other in vitro latency system. In order to convert to the 
nonlinear configuration and associate with nucleosomes, the viral genomes must be free 
from components of the nucleocapsid and available to components of the cell. Association 
with nucleosomes may increase the stability of the latent genomes and might also 
contribute to their transcriptional repression. Nucleosome-associated DNA fragments 
from latent viral DNA partially digested with MN appeared to have migrated faster in 
agarose gels than nucleosome-associated DNA fragments from cell DNA, an observation 
which was also made with latent viral DNA from mice (Deshmane and Fraser, 1989). 
One interpretation of the discrepancy between the migration speeds of viral and cellular 
nucleosome-associated DNA fragments is that nucleosomes were more closely spaced on 
viral DNA than on the cell DNA, however there are other possible technical reasons for 
the discrepancy which render this interpretation speculative, such as alteration of 
electrophoretic mobility caused by high G+C content or alteration of the positions of the 
nucleosome-associated DNA fragments during transfer from the agarose gels onto the 
hybridisation membranes.
The detection of a regular nucleosome arrangement at the LAT / IE1 region of the 
genome when no such pattern had been previously detected at the TK loeus, indicated that 
the LAT / IE1 region formed a structure bound by regularly spaced nucleosomes in 
preference to other regions of the genome; an exciting possibility because the LAT / IE1 
region is the only region of the viral genome to be transcriptionally active during latency 
in vivo, thus nucleosome positioning might play a crucial role in transcriptional regulation 
of this region. However, in the final experiment, when the LAT / IE1 region and the TK 
gene were examined in parallel, a regular arrangement was found on both regions 
indicating that the regular pattern is present on the entire genome and that the previous 
inability to detect chromatin on the TK gene was caused by differences in chromatin 
arrangements between experiments or by differences in the ability to detect the ladder of 
DNA fragments (section 4.12.). In experiments using Southern blotting and hybridisation 
of MN-digested DNA to detect chromatin, small variations in the arrangement of
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nucleosomes and variations in the ability to resolve the heterogeneously sized 
nucleosome-associated DNA fragments have a large bearing on the interpretation of the 
data. Chromatin was detected on the TK gene only once, and it is possible that the effects 
seen in figure 4.19. lane 11 are due to unfortunate background on the autoradiograph.
There are two possible reasons why chromatin was not detected on the latent viral 
genomes in previous studies and in some of the experiments described here. One possible 
cause was that the ability to detect the ladder of DNA fragments in Southern blots varied 
between experiments. Another possibility was that the state of the cells varied between 
experiments in such a way as to alter the ability of nucleosomes to form a regular binding 
pattern, perhaps as a result of variations in levels of histone pools. In light of the previous 
finding that in a parallel experiment chromatin was detected on the TK gene when in the 
cell genome but not when in the latent genome (Jamieson et al., 1995), the latter 
hypothesis is most likely to be the true explanation. As explained above, small variations 
in nucleosome positioning on the genomes and in the techniques used to detect chromatin 
have a large bearing on the interpretation of the data. Although inhibition of histone 
synthesis by Ara-C did not affect the inability the detect chromatin on the TK gene in the 
latent genome, Ara-C was added at 1 hour post-infection and might not have had time to 
exert a large enough effect on the levels of histone pools to alter the nucleosomal 
arrangement.
Since neurons are nondividing, do not undergo DNA synthesis and therefore 
contain low histones pools, the formation of a regular nucleosome arrangement on HSV 
genomes during the initial stages of latency in neurons might also be expected to occur 
slowly.
It has been observed that m l814 and other mutants defective in Vmwl 10 have 
exceptionally high particle / PFU ratios in HFL cells (Stow and Stow, 1986; Ace et a l, 
1989; Everett, 1989). In addition, other in vitro latency systems have utilised HFL cells 
(Wigdahl et al., 1981; 1982b, 1984b; Russell and Preston, 1986; Harris and Preston, 
1991) thus HFL cells seem particularly suited to in vitro latency experiments. One 
possible interpretation of the observation that HFL cells contained fewer nonlinear, 
uncoated genomes after infection than other cell types, is that virus uncoating occurs more 
slowly in HFL cells than in the other cell types. During establishment of latency in mouse 
dorsal root ganglia after infection in the footpad, transport of the virus nucleocapsids 
along the nerve axons results in a 20-24 hour delay between binding of the virus to the 
cell surface and entry of the virus nucleocapsid into the neuronal cell body (Cook and 
Stevens, 1973), thus slow uncoating of HSV in HFL cells might mimic establishment of 
latency in ganglia in vivo. Researchers in other laboratories have hypothesised previously 
that axonal transport facilitates the establishment of latency by resulting in the loss of 
Vmw65 (Roizman and Sears, 1987). In the latter two chapters of the results section in the
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thesis presented here, investigations were carried out to determine whether a virus 
structural component modified cells and induced latency, and to determine whether slow 
virus uncoating gives the antiviral state an advantage over viral replication, thereby 
leading to latency.
The observation that HFL cells treated with UV-inactivated m l814 were less 
permissive for plaque initiation upon subsequent infection with HSV-1 appeared to 
support the concept that components of viral particles modify cells, causing the 
establishment of latency (sections 4.13-4.15.).
The inhibition of plaque initiation in HFL cells pretreated with UV-ml814 L- 
particles did not occur via an inhibition of adsorption, penetration, migration to the nuclei 
or uncoating (section 4.23.), thus the nonpermissive state appeared to be the result of an 
inhibition of viral IE gene expression. Levels of the viral EE mRNAs were reduced in 
UV-ml814 L-particle-pretreated HFL cells by a mechanism which did not require protein 
synthesis (section 4.24.), whether as a result of inhibition of transcription or RNA 
stability is unclear at present. The vhs function of HSV-1 was a possible component of 
the viral particles which could have reduced the viral IE mRNA levels by causing their 
degradation, however, UV-inactivated L-particles from a vhs~ version of m l814 retained 
the ability to induce the nonpermissive state in HFL cells (section 4.26.), demonstrating 
that vhs was not responsible for the inhibition.
The observation that the antiviral state induced by the UV-ml814 viral particles 
was not overcome by HMBA (section 4.18.) and acted against a virus expressing wild- 
type Vmw65 (section 4.15.) suggested that the antiviral state induced by the UV- 
inactivated particles was similar to that which occurs during latency of ml814 in normal 
cells, where the virus becomes unresponsive to these activators during the first 6 hours of 
infection. However, the apparently latent state induced in HFL cells pretreated with UV- 
inactivated viral particles appeared to differ from latency of m l814 in untreated HFL 
cells, in that reactivation of all the input virus was not induced by superinfection with tsK 
(sections 4.19.-4.21.). One possible explanation for the inability to reactivate the latent 
virus in UV-ml814 treated HFL cells was that the inhibitory activity of the UV- 
inactivated particles was acting against the tsK , lowering the efficiency of reactivation 
(section 4.21.).
Adsorption, penetration, migration to the nuclei and uncoating were unaffected in 
HFL cells pretreated with UV-ml814 L-particles (section 4.23.), thus the inhibition of 
plaque initiation appeared to differ from that observed by Johnson and Ligas who 
reported that gD brought into the cells with the UV-inactivated particles caused a 
nonpermissive state by sequestering gD receptors required for fusion of the virus with the 
cells (Johnson and Ligas, 1988).
In the experiments of Johnson and Ligas, human R970 cells were treated with 
UV-inactivated gD-containing or gD~ virus at 4° and whilst being maintained at 4° were
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infected with HSV-1 or HSV-2 (Johnson and Ligas, 1988). The infected cells were 
shifted to 37° and the infectivity assayed by labelling with [35S]m ethionine, 
immunoprecipitating TK and examining the amount of labelled TK after electrophoresis. 
TK was undetectable in cells pretreated with over 5000 particles of the gD-containing 
virus per cell, but not in cells pretreated with the gD-  virus. Infectivity was not inhibited 
when the UV-inactivated gD-containing virus was added after the infectious virus, thus it 
was concluded that pretreatment of the cells with UV-inactivated gD-containing virus 
inhibited subsequent infection with HSV by sequestering gD receptors, and that treatment 
of the cells with the gD“ virus failed to bring about the nonpermissive state because of 
their lack of gD. The interpretation that gD inhibits superinfection was supported by the 
observation that cell lines constitutively expressing gD are nonpermissive (Campadelli- 
Fiume et al., 1988; Johnson and Spear, 1989; Campadelli-Fiume et al., 1990). It is of 
interest to speculate why the inhibitory activity of the UV-inactivated viral particles 
observed by Johnson and Ligas differed from the nonpermissive state reported in the 
thesis presented here. If the inhibition was caused by gD brought into the cell with the 
UV-inactivated viral particles, the inhibitory activity would be expected to have reached 
maximum activity immediately after the adsorption period. In the study described in the 
thesis presented here, the inhibitory nonpermissive state in the UV-inactivated viral 
particle treated HFL cells increased over the first 6 hours after treatment (section 4.16.), 
indicating that a gradual biochemical change was occurring in the cells. The difference 
between the experiments described by Johnson and Ligas and those presented in the 
thesis described here may lie in the fact that in the experiments by Johnson and Ligas 
penetration of the cells by the UV-inactivated viral particles was prevented by incubation 
at 4°, thus at the time of adding the infectious virus the UV-inactivated particles were still 
present on the cell surface, whereas in the experiments in the study described here 
penetration of the UV-inactivated particles was expected to have been completed by the 
time the infectious virus was added. After adsorption of the UV-inactivated viral particles 
with the cells, gD would remain on the cell surface and might retain the ability to inhibit 
further infection of the cells, as demonstrated by the nonpermissivity of the gD- 
expressing cell lines (Campadelli-Fiume et a l,  1988; Johnson and Spear, 1989; 
Campadelli-Fiume et a l, 1990). However, in most of the experiments described in the 
thesis presented here the infectious virus was added 6 hours after treatment with the UV- 
inactivated particles, thus levels of gD on the cell surface might have decreased to levels 
below that required to give inhibition of adsorption. In addition, MOIs of UV-inactivated 
viral particles used in the experiments presented here were less than those used by 
Johnson and Ligas, contributing further to the difference in amount of gD brought into 
the cells. It is possible that UV-inactivated viral particles inhibit infection by two 
mechanisms, one which involves the inhibition of penetration by gD and one which 
occurs after fusion of the UV-inactivated particles with the cells. Whether gD caused the
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nonpermissive state in the study described here could be tested using a UV-inactivated 
gD“ version of in 1814.
When uncoating of m l815 was prevented by infection at 39.5°, the viral titre 
remained responsive to HMBA (section 4.31.). In addition, the rate at which the genomes 
became unresponsive to HMBA after downshift to 31° was not increased compared to 
infected cells downshifted to 31° immediately after the 1 hour adsorption period at 39.5° 
(section 4.31.), thus delayed uncoating did not lead to latency in HFL cells.
The inability of m l815 to become unresponsive to HMBA at 39.5° might be 
explained if the components of the viral particles which induce the repressed state were 
not released at 39.5°. It was demonstrated that the uncoating mutant tsB l released 
Vmw65 after infection at 39.5° (Batterson and Roizman, 1983), but did not release a 
gene product of Ul26 which raises the mutation frequency of cells (Shillitoe et a l , 1993; 
Das et al., 1994), thus components of the tegument can be released during infection at 
39.5° but the nucleocapsid and its contents remain intact, as would be expected if 
uncoating is prevented. If the repression of the viral genome was induced by components 
of the nucleocapsid or components associated with the virus DNA, then latency would 
not have been induced at 39.5°. However, delayed uncoating caused by the mutation in 
ml 815 was expected to be a reliable representation of the delay in uncoating in HFL cells, 
thus it is unlikely that slow uncoating in HFL cells facilitates the establishment of latency. 
The possibility that the repression is induced by a viral transcript synthesised de novo has 
been discounted by the finding that viral defectives containing only an origin of 
replication, a packaging signal and the lacZ gene are shut-off (C.M. Preston, unpublished 
data), thus the basis for repression of Vmw65 mutants remains elusive.
The observation that delayed uncoating did not induce latency, combined with the 
finding that virus inhibited in UV-ml814 viral particle treated HFL cells was not fully 
reactivated by superinfection with tsK, indicates that the apparent latent state induced in 
UV-ml814-pretreated cells differs from latency of m l814 in normal infection. The ability 
of UV-ml814 viral particles to induce the nonpermissive state may be a by-product of 
UV-irradiation, possibly resulting from UV-damaged DNA or proteins inducing a stress 
response in the cells, making them more resistant to infection.
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Future work.
Now that it has been demonstrated that at least some specific regions of the latent 
genomes are associated with regularly spaced nucleosomes, a characterisation of the role 
of chromatin in latency should be performed. To what extent do nucleosomes repress the 
latent genomes, and is the chromatin detected on the viral genomes identical to the usual 
chromatin found on the majority of cell DNA? It is of interest to know whether 
nucleosomes need to be removed from the viral genomes for reactivation to occur and if 
so, which viral or cell gene products mediate their removal. Another important issue is the 
mechanism of action of the DNA element proposed to overcome the repression of the 
latent genomes and drive LAT expression in vivo (Lokensgard et al., 1994). Although 
LAT is not expressed in the in vitro latency system (Anderson, 1991), the long-term 
expression element might exist as a hypersensitive-site, or other alteration of chromatin. 
Thus it should be determined whether the nucleosomes are arranged uniformly on the 
genomes or whether there are differences in chromatin organisation between different 
regions.
The mechanism by which the latent genomes are silenced in HFL cells is of 
crucial importance. If the factors responsible for repressing the latent genomes are 
induced by HSV infection, they could be identified by cloning cDNAs from HSV- 
infected cells and performing differential screening using radiolabelled cDNA from 
infected and uninfected cells as probes. However, the work described in the thesis 
presented here and work by others (C.M. Preston, unpublished data) suggest that the 
repression of ml814 in HFL cells does not require protein synthesis, and therefore is 
caused by pre-existing factors. One possible method of identifying the pathway by which 
the repression occurs, might be to isolate a version of ml814 which is unable to enter 
latency, to map the location of the mutated gene within the viral genome and characterise 
its product.
The location of the latent genomes within the cell nuclei might cause their 
repression by preventing the access of transcription factors. HSV DNA localises in ND10 
domains during the early stages of lytic infection (Maul et al., abstract 133, 20th 
International Herpesvirus Workshop, Groningen, The Netherlands, 1995; R.D. Everett, 
personal communication), thus it is of interest to know whether the viral DNA is located 
in ND10 domains during latency. The finding that treatments which cause reactivation, 
such as expression of Vmwl 10 (Harris et a l , 1989; Harris and Preston, 1991; Cai et al., 
1993; Minigawa et al., 1994), administration of CdS04  (Fawl and Roizman, 1993) and 
hyperthermia (Sawtell and Thompson, 1992) cause redistribution of ND10 (Maul et a l, 
1993; Maul, 1995; Maul et al., abstract 133, 20th International Herpesvirus Workshop, 
Groningen, The Netherlands, 1995) implicates a role for ND10 domains in latency.
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Until the inhibition of infectivity in HFL cells pretreated with UV-ml814 viral 
particles is demonstrated with non-UV-irradiated particles, the inhibition cannot be 
unequivocally considered a bona fide  property of the viral particles rather than a by­
product of their UV-irradiation. UV-irradiation might be avoided by using PREP 
particles, viral particles similar to L-particles which are produced during infection in the 
presence of viral DNA replication inhibitors or by DNA replication mutants at the NPT 
(Dargan et a l , 1995). The particle / PFU ratio of PREPs ranges from 6 x 105 to 3.8 x 
108 particles per PFU, thus interference from residual viral IE gene expression 
complementing superinfecting viruses might be low enough to obviate the need for UV- 
irradiation.
Despite the Finding that delayed uncoating did not lead to latency in HFL cells, it 
remains tempting to postulate that the delay between infection at the cell surface and entry 
of the viral DNA into the nuclei of sensory neurons in vivo plays a role in the 
establishment of latency. It would be interesting to determine the effect of delaying 
uncoating in neuronal cells.
Clearly an investigation of the role of LAT is not possible with the in vitro latency 
system as it stands, since LAT is not expressed (Anderson, 1991). The absence of LAT 
expression might be explained by the absence of the appropriate neuronal transcription 
factors in HFL cells. However, LAT expression might be induced if the LAT controlling 
elements are replaced with elements active during latency in HFL cells. To date no such 
element has been found (C.M. Preston, unpublished data). A subset of VZV RNAs have 
been demonstrated in satellite cells of latently infected human sensory ganglia (Croen et 
al., 1988; Croen and Straus, 1991), suggesting that VZV is capable of latency in non­
neuronal cells and that the promoters of these genes are active when the rest of the 
genome is repressed. A valid experiment would be to insert one of the latency-active 
genes of VZV into the genome of m l820 and examine whether expression occurs during 
latency in HFL cells.
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Quiescent viral genomes in human fibroblasts after infection with 
herpes simplex virus type 1 Vmw65 mutants
D. R. Stuart Jamieson, Laurence H. Robinson, Jasmine I. Daksis,| Mary Jane Nicholl and 
Chris M. Preston*
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The development and utilization of a tissue culture 
system for the analysis of quiescent, nonreplicating 
herpes simplex virus type 1 (HSV-1) genomes is 
described. It was demonstrated previously that the HSV- 
1 Vmw65 mutant ml 814, which is impaired for im­
mediate early (IE) transcription, was retained for many 
days in human fetal lung (HFL) fibroblasts in a quiescent 
‘latent’ state. Molecular analysis of the viral genome was 
not possible, however, due to residual expression of IE 
proteins and consequent cytotoxicity at high m.o.i. In 
the study reported here, IE transcription was reduced 
further by pretreatment of cells with interferon-a (IFN- 
a) and by the the use of mutant m l820, a derivative of 
ml 814 in which the Vmwl 10 promoter was replaced by 
the Moloney murine leukaemia virus (Momulv) en­
hancer. The Momulv enhancer was not expressed under 
IE conditions; thus m l820 was more impaired for 
replication than m l814 and behaved as if deficient for 
both Vmw65 and Vmwl 10. In cells pretreated with IFN- 
a and subsequently infected with m l820 cytotoxicity
was overcome, enabling a tissue culture system to be 
developed in which all cells stably retained at least one 
quiescent viral genome. To assist the analysis of gene 
expression, m l820 was further modified by insertion of 
the E s c h e r ic h ia  c o l l  l a c Z  gene controlled by the human 
cytomegalovirus enhancer (mutant m l883) or the HSV- 
1 immediate early Vmwl 10 promoter (m l884). Ex­
pression of /?-galactosidase was not detected after 
infection of IFN-a-pretreated cells with m l883 or ml 884 
but could be induced in almost all cells containing a viral 
genome, by superinfection of cultures. 7«1820-derived 
viruses - were retained for at least 9 days and were not 
reactivated by subculture of cells. A regular arrangement 
of nucleosomes, as found in cellular chromatin, was not 
detected on the viral genome at the thymidine kinase 
locus. The' non-linear genome was a template for 
reactivation With no requirement for prior conversion to 
a linear form. A small number of remaining linear 
genomes resulted from incomplete uncoating of input 
virus.
Introduction
Transcription of herpes simplex virus type 1 (HSV-1) 
immediate early (IE) genes is stimulated by the virus 
structural protein Vmw65 (also known as VP16 or a- 
TIF), resulting in efficient production of five IE proteins 
shortly after infection (Post e t  a l ., 1981; Campbell e t  a l., 
1984). Vmw65 forms a complex at the IE-specific 
sequence TAATGARAT (R is a purine) with at least two 
cellular proteins, Oct-lvand HCF, thereby bringing the 
C-terminal activating region of Vmw65 into proximity 
with cellular factors required for initiation of tran­
scription (McKnight e t  a l ., 1987; O’Hare & Goding,
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t  Present address: Department of Microbiology, Immunology and 
Cancer Research, The Hospital for Sick Children, 555 University 
Avenue, Toronto, Canada M5G 1X8.
1988; Preston e t  a l . , 1988; Triezenberg e t  a l ., 1988; 
Sadowski e t  a l ., 1988; Stern e t  a l ., 1989; Katan e t  a l., 
1990; Kristie & Sharp, 1990; Wilson e t  a l., 1993). Three 
of the IE proteins, Vmwl75 (ICP4), Vmwl 10 (ICPO) and 
Vmw63 (ICP27), are known to be important regulators 
of viral gene expression. Vmwl75 and Vmw63 are 
essential for virus replication, exerting effects at the 
transcriptional and post-transcriptional levels, respect­
ively (Preston, 19796; Watson & Clements, 1980; Dixon 
& Schaffer, 1980; Sacks e t  a l., 1985; Everett, 1987; 
Sandri-Goldin & Mendoza, 1992), whereas Vmwl 10 is 
not essential but enables virus replication to be initiated 
efficiently, especially after infection at low m.o.i. (Stow & 
Stow, 1986; Sacks & Schaffer, 1987; Everett, 1989). 
Vmwl 10 is a potent activator of gene expression which 
acts on a wide variety of virus- or plasmid-bome 
promoters in a manner that is apparently not sequence- 
specific (Everett, 1984; O’Hare & Hayward, 1985; Cai & 
Schaffer, 1992; Chen & Silverstein, 1992).
At present, three properties of Vmw65 have been
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documented. The protein is a major structural com­
ponent of the virus tegument and is therefore required 
for the formation of mature virions (Heine e t  a l ., 1974; 
Ace e t  a l ., 1988; Weinheimer e t  a l . , 1992). More recently, 
Vmw65 has been shown to associate with the virion host 
shutoff (vhs) protein (Smibert e t  a l ., 1994). The third 
function, activation of IE transcription, has been studied 
in great detail at the molecular level but only one virus 
mutant defective in this process, z«l 814, has been 
described to date (Ace e t  a l., 1989). The Vmw65 protein 
specified by ml814 is deficient in transactivation of IE 
transcription due to the presence of a four-amino-acid 
insertion within a domain required for binding to Oct-1 
and HCF (Ace e t  a l., 1988; Greaves & O’Hare, 1990; 
Hayes & O’Hare, 1993). As a consequence of reduced IE 
transcription, ml814 is unable to initiate productive 
infection efficiently and thus, at low m.o.i., only a small 
proportion (01-1% , depending jn the cell type) of 
virus-cell interactions result in virus replication (Ace 
e t  a l ,  1989; Daksis & Preston, 1992). The vast majority 
of infected cells harbour the m l814 genome in a stable 
quiescent state that has been termed 6in  v itr o  latency’ 
(Harris & Preston, 1991). By 1 day after infection, m l814 
genomes become insensitive to activation by Vmw65 or 
hexamethylene bisacetamide (HMBA), even though 
these agents effectively complement the defect in virus 
replication if applied at the time of infection (Ace e t  a l., 
1989; Harris & Preston, 1991; McFarlane e t  a l., 1992). It 
is possible, however, to recover m l814 from cultures 
several days after initial infection by superinfection with 
HSV-1, provided the superinfecting virus expresses 
functional Vmwl 10 (Harris & Preston, 1991). Entry of 
m l814 into the quiescent state is probably due mainly to 
reduced synthesis of Vmwl 10, since mutants deleted for 
the Vmwl 10 gene have a phenotype similar to that of 
ml814 (Stow & Stow, 1986, 1989; Everett, 1989).
HSV latency in the peripheral nervous system of 
animals and humans is characterized by repression of all 
regions of the genome except for that encoding the 
latency-associated transcripts (LATs) (Croen e t  a l., 1987; 
Spivack & Fraser, 1987; Stevens e t  a l., 1987; Fraser e t  
a l., 1992). It has been suggested that a block to IE 
transcription, possibly imposed by inhibitory 
TAATGARAT-binding proteins, is primarily respon­
sible for the abortion of lytic replication and hence the 
establishment of latency (Roizman & Sears, 1987; Kristie 
& Roizman, 1988; Kemp e t  a l ., 1990; Lillycrop e t  a l.,  
1991, 1994; Sears e t  a l., 1991). In support of this 
hypothesis, m l814 establishes latency after inoculation 
into mice even though productive infection in neurons is 
impaired, suggesting that IE gene expression is not 
required for latency (Steiner e t  a l., 1990; Valyi-Nagy e t  
a l., 1991; Ecob-Prince e t  a l., 1993). The phenotype of 
m l814 in tissue culture cells is therefore apparently
similar to that observed in mice: productive replication is 
reduced and virus retention in a latent state is favoured. 
7«1814 is the only virus mutant currently available to 
investigate the effects of reducing IE gene expression in 
tissue culture cells; therefore studies on the structure and 
function of the quiescent ml 814 genomes are relevant to 
an understanding of the suppression of gene expression 
that occurs during latency.
At present, the structural basis for the inactivity, and 
insensitivity to inducers, of quiescent m l814 genomes 
retained in fibroblasts is unclear. It is known that viral 
DNA is sequestered in a non-linear, probably circular, 
form analogous to that found during latency in  v ivo  
(Rock & Fraser, 1983; Efstathiou e t  a l ,  1986; Harris & 
Preston, 1991), but information is lacking on the nature 
of viral nucleoprotein complexes, either at specific 
promoters or the entire genome. Analysis of this problem 
presents technical difficulties because although the 
predominant outcome of infection is failure of m l814 to 
replicate, the small number of productive interactions 
can form a significant background, especially if viral 
DNA replication occurs, thereby obscuring detection of 
the quiescent genomes. Furthermore, at high m.o.i. 
m l814 is cytotoxic due to expression of IE proteins 
(Johnson e t  a l ., 1994). We describe here methods which 
reduce IE transcription from viruses containing the 
m l814 mutation, enabling the establishment of viable 
human fibroblast cultures containing at least one viral 
genome per cell. The methodology has been used to 
obtain novel information on the structure and expression 
of the quiescent genome.
Methods
Cells. Flow. 2002 human fetal lung (HFL) fibroblasts (Flow 
Laboratories) were propagated in Eagle’s medium supplemented with 
fetal calf serum at 10 % (EF10) or 5 % (EF5) or with 5 % human serum 
(EHu5). BHK-21 (clone 13) cells were grown in Eagle’s medium 
supplemented with 10% new born calf serum and 10% tryptose 
phosphate. Human 143 thymidine kinase deficient (TK“) cells, 
transformed to a TK+ phenotype by transfection of plasmid pTKl 
(encoding the HSV-1 TK gene; Wilkie et al., 1979), were kindly 
provided by M. McFarlane (University of Glasgow, Molecular Biology, 
UK) and grown in EF10 containing 01 mM-hypoxanthine, 16|im- 
thymidine, 0-4 pM-aminopterin and 3 pM-glycine. All cell culture media 
contained penicillin (100 units/ml) and streptomycin (100 pg/ml).
Plasmids. To prepare HSV recombinants containing the Escherichia 
coli lacZ gene inserted within the TK gene, plasmid pMJ27 was first 
constructed. The Hindlll site within the vector sequences of pGX166 
(pTKl modified by the insertion of an Xhol linker at the Sacl site 
within the TK coding sequences; kindly provided by V. G. Preston) 
was destroyed by cleavage, end-filling with Klenow enzyme and 
religation, to yield pGX166AH3. The E.coli lacZ gene plus simian virus 
40 (SV40) promoter and enhancer was excised from plasmid pFJ3 
(Rixon & McLauchlan, 1990) as a 4073 bp BamHl-Xbal fragment and 
cloned between the BamHI and Xbal sites of pUC18 (previously 
modified by insertion of an Xhol linker into the Smal site) to yield 
pUC181acZ. The lacZ gene, together with the SV40 promoter and
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polyadenylation signals, was excised from pUC181acZ as a S a ll-X h o l 
fragment and cloned into the Xhol site o f  pG X 166A H 3. A  plasm id in 
which the direction o f  lacZ  transcription was opposite to that o f  TK  
was selected and designated pM J27. Plasm id pM J27 contains unique 
Xhal and ///m il 11 sites flanking the SV40 prom oter plus enhancer, and 
has a unique Xhol site downstream  o f  the SV40 polyadenylation signal.
The human cytom egalovirus (H C M V ) Tow ne strain enhancer was 
cloned as a 760 bp Sau3AI fragment (Stinski & Roehr, 1985) from  
plasmid p H D lO l-4  (kindly provided by E. Blair, W ellcom e Research 
Laboratories, Beckenham , U K ) into the B am H l site o f  pU C 18 {from  
which the Sphl site had been removed by treatment with Klenow  
enzym e and religation), excised as an £coR I (end-filled)-//m dIII  
fragment and cloned between the Xhal (end-filled) and H in d lll  sites o f  
pMJ27 to replace the SV40 enhancer, yielding plasmid pM JIO l. The 
HSV-1 V m w l 10 prom oter was excised as an 836 bp BhvI (end- 
filled )-Sd d  fragment from pJR3 (Everett, 1984) and cloned between 
the Sphl (K lenow -treated) and S a d  sites o f  pU C 18. The prom oter was 
then removed as an EcoR ! (en d -filled )-//m d lll fragment and cloned  
between the X bal (end-filled) and / /m d ll l  sites o f  pM J27 to yield 
plasmid pM J102. The structures o f pM J27, pMJIOl and pM J102 are 
show'n in Fig. 1.
Viruses. The HSV-1 strain 17 m utant /«1814 contains a 12 bp 
insertion in the coding sequences for Vmw65 (A ce et al., 1989). Mutant 
in 1820 was derived from in 1814 essentially by replacing both copies o f  
a 971 bp N co l-S a c l  region containing the prom oter for Vm w l 10 
[nucleotide positions 124105 125076 in the inverted long repeat (IRQ  
copy; Perry & M cG eoch, 1988] with a 760 bp D N A  fragment 
containing the M oloney murine leukaemia virus (M om ulv) enhancer 
and prom oter (Lang et al., 1983). A  detailed description o f  the 
construction o f  m l 820 will be presented elsewhere. 1814R was 
constructed by rescue o f  the Vmw65 m utation o f  m 1814 (A ce et al., 
1989) and m l825 was similarly produced by rescue o f  the Vmw65 
m utation o f  m l820.
T o construct m utants m l883 and m l884, m l820 D N A  was 
cotransfected into BHK cells with .Sacl-cleaved pMJIOl and pM J102, 
respectively. Progeny viruses expressing /J-galactosidase (/9-gal) were 
identified by the developm ent o f  blue plaques in the presence o f  X -G al 
and purified by three rounds o f  enrichment for /acZ-containing viruses. 
Final plaque isolates were grown as smalt scale cultures and D N A  was 
purified from infected cells, cleaved with £coR I and analysed by 
Southern transfer and hybridization, using 32P-radiolabelled 2-4 kbp  
£ co R l n fragment, spanning the TK gene, as probe. Insertion o f  lacZ  
disrupts £cuR I n, yielding species o f  1 0  kbp and either 2-0 kbp or 
5 0 kbp. Virus isolates showing the correct pattern, and lacking 
detectable hybridization to the parental 2-4 kbp fragment after long  
autoradiographic exposures, were grown as virus stocks.
The genotypes o f  the viruses used can be summarized as follow s: 
m l814, Vmw65", m l820: V m w65~/1 lO pronw M om ulv; m l825, 
Vm w 65+/1  lOprom s-Momulv; m l883, Vm w65~/1 10prom -*M om ulv/ 
T K “[HCMV-/?-gai]; m i884, V m w 657 1 1 0 p ro m ^ M o m u lv /T K ~ [l 10- 
prom-/?-gal].
The H SV-j mutant tsK  contains a temperature-sensitive lesion in 
the immediate early protein Vm w l 75 (ICP4) (Preston, 19796; D avison  
et al., 1984).
Virus preparations were standardized by titration on BHK cells in 
the presence o f  3 ium-HM BA (M cFarlane et al., 1992) and, in addition, 
virus particle concentrations were determined (A ce et al., 1989). 
Preparations o f  m l820-based viruses used in this study contained  
approximately 100 particles per p.f.u.
Infection o f  cells. H FL cell m onolayers, initially consisting o f  
approximately 6 x l 0 5 cells per 35 mm diameter Petri dish, were 
pretreated for 16—20 h with 103 units o f  human lym phoblastoid  
interferon-a (IF N -a , S igm a)/m l, after which time the cell number had 
risen to 8 x 105 per plate. Culture medium was removed thoroughly,
cells were washed by addition o f  2 ml EF5 and infected in 0-2 ml EF5. 
After 1 h at 37 °C, 2 ml EF5 containing 50 p g /m l cytosine arabinoside 
(AraC) was added and incubation continued at 37 °C for 2 or 3 days. 
For superinfection, culture medium was removed thoroughly and 2 ml 
EF5 added. Cells were incubated at 37 °C for 1-2 h, culture medium  
was again removed carefully and 0 2 ml EF5 containing 8 x 10s p.f.u. o f  
/sK  was added. After incubation at 37 °C for 1 h 2 ml EHu5, or 2 ml 
EF5 containing 2-5 p g /m l Brefeldin A (Sigma), was added. M onolayers  
were incubated for 22 -24  h and stained for /?-gal activity, or for 2 days 
and stained with Giemsa,
Analysis o f  D N A . The ‘nuclear’ fraction was prepared by lysis o f  
cells with N onidet P40 (N P40) and centrifugation through 10%  
sucrose, and D N A  was extracted by proteinase K treatment and  
phenol-chloroform  extraction (Preston, 1979a; Harris & Preston, 
1991). Equilibrium buoyant density gradient centrifugation o f  D N A  
was carried out as described previously (Harris & Preston, 1991). 
Precipitated D N A  from individual 35 mm diameter plates or pooled  
gradient fractions was digested with BamYH and electrophoresed on 
0-6% or 0-7% (w /v ) agarose gels in TBE (90 mM-Tris, 90 mM-boric 
acid, 1 m xi-EDTA pH 8-3). D N A  fragments were capillary transferred 
to GeneScreen Plus membrane (N E N , D u Pont) in 0 4 M-NaOH, 0 6 M- 
N aC l and UV-crosslinked to the matrix by irradiation in a Stratalinker 
(Stratagene). M embranes were incubated at 70 °C in hybridization  
solution (0-5 M -NaH2P 0 4- N a 2H P 0 4 buffer, 7%  SD S pH 7-4) for 
2-3  h prior to addition o f  denatured D N A  fragments, radiolabelled  
with 32P by random primer extension (Feinberg & Vogelstein, 1983), in 
hybridization solution. The probes used were: purified HSV-1 ZcoRI n, 
spanning the TK gene; Bam H l k, spanning the joint; or a 500 bp 
B frl-S m a l fragment from the M om ulv enhancer (Lang et al., 1983). 
H ybridization was continued at 70 °C for 2 0 -24  h and membranes were 
washed once at 70 °C with hybridization solution follow ed by tw o  
washes at 70 °C with 0-2 x S S C /0 1  % SD S (1 x S S C  is 0-15 M-NaCl, 
0-015 M-sodium citrate), each wash taking 45 min. M embranes were 
washed briefly with deionized water, dried and exposed to X -om at S 
film (K odak) for autoradiography using an intensifying screen. 
Standard D N A  for hybridization was extracted from partially purified 
n il820 virus particles released into culture medium. A portion was 
digested with Bam H l and ribonuclease A , extracted with phen ol-  
chloroform , ethanol precipitated and dissolved in deionized water. The 
D N A  concentration was determined spectrophotom etrically, and the 
measured value confirmed by electrophoresis o f  uncleaved m l820 
D N A  with linearized plasmids o f known concentrations.
Quantification o f  hybridization was achieved by phosphorim age 
analysis, using M olecular D ynam ics Im ageQuant software. T o calcu­
late genom e copy numbers and the relative proportions o f  linear and 
non-linear D N A , measured values o f  band peak areas were first 
corrected for variations in transfer and hybridization efficiencies 
o f  joint and terminal fragments by com parison with m l820 D N A  
standards. If .v and y  are the corrected values for joint and terminal 
fragments, respectively, the relative number o f  linear genom es was y  
and non-linear genom es 0'5(x->). The total number o f  genom es was 
given by the sum o f  linear and non-linear m olecules.
Nuclease digestion o f  nuclei. Nuclei prepared as described above were 
resuspended in 10 mM-Tris HC1 pH 7-5, 2 mM-MgCl2, 10% (w /v )  
sucrose, and m icrococcal nuclease (M N ; Pharmacia P-L) or D N ase I 
(D N -E P ; Sigma) added at various concentrations. M N  digestion was 
carried out in 20 mM-PIPES pH 7-0, 0-25 M-sucrose, lOmM -NaCl, 
1 mM-MgCl2, 1 niM-CaCl2, 5 mM-/?-mercaptoethanol, 01  mM-PMSF. 
D N ase I digestion was carried out in 10 mM-PIPES pH 7-0, 0-25 M- 
sucrose, 10 mM-NaCl, 3 mM-MgCl2, 5 mM-/?-mercaptoethanol, 0 1  mM- 
PM SF. After incubation at 37 °C for fixed times o f  2 -30  min, reactions 
were stopped by addition o f  ice-cold E D T A  to a final concentration o f  
12 mM. Samples were digested by addition o f  0-4 ml 20 mM-Tris-HCl 
pH 7-5, 2-5 mM -EDTA, 0-5% SD S and 100 p g /m l proteinase K and
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Fig. 1. Structures o f  pM J27, pM JIOl and pM J102.
incubation at 37 °C for 5 -1 6  h. D N A  was extracted and either 
electrophoresed directly on 2%  agarose gels or, after cleavage with 
B am H l, on 0-6% agarose gels. Southern transfer and hybridization w as 
carried out as described above. D N A  analysed on 2 % gels was partially  
depurinated by incubation o f  the gel in 0-25 m-HCI for 15 min prior to  
transfer.
Analysis o f  IE R N A . M onolayers o f  H F L  cells were infected with  
10 p.f.u. o f  virus per cell in the presence o f  50 /rg o f  cyclohexim ide/m l. 
After incubation at 37 °C for 5 h in the continuous presence o f  
cycloheximide, R N A  was extracted and analysed by dot-b lot hybrid­
ization using radiolabelled probes specific for the IE genes or y-actin, 
as described previously (D aksis & Preston, 1992).
H istochemical staining fo r  f-ga lactosidase. Culture m edium  was 
removed and m onolayers fixed by addition  o f  1 % glutaraldehyde, 
dissolved in PBS, for 1 h at room  tem perature. A fter rem oval o f  
glutaraldehyde, m onolayers were washed twice with PBS, and reaction  
mixture (5 mM-potassium ferricyanide, 5 mM -potassium ferrocyanide, 
2 mM-MgCl2, 0 01 % N P40, 1 m g /m l X -G al, all d issolved in PBS) was 
added. After incubation for an appropriate time (usually 3 -5  h) at 
37 °C, m onolayers were washed with water. M onolayers were counter­
stained by addition o f  Carmalum stain [25 g/1 carm ine; 25 g/1 
aluminium potassium  sulphate; 2-5%  (v /v )  glacial acetic acid] and 
incubation at 4 °C for 1-2 days, washed with water, dried and m ounted.
Results
Properties o f  m utan ts  m l 820, m l883 an d  m l884
A s described in the In troduction , w e w ished  to exam ine  
the quiescent viral gen om es w hich are retained in H F L  
cells after infection w ith m l814. W e considered  that it
Probe
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Fig. 2. IE R N A  synthesis. H F L  cells were infected with 10 p.f.u. o f  
virus/ce ll or m ock-infected, and incubated at 37 °C for 5 h in the 
presence o f  50 pg o f  cyclohexim ide/m l. R N A  w as extracted, 1 pg was 
applied to n itrocellulose m em branes and hybridization with gene- 
specific probes was carried out.
w as essentia l to m eet tw o criteria: first, for structural 
studies the viral gen om e m ust, realistically, be present at 
on e or m ore cop ies per c e ll; and, second, evidence m ust 
be provided  that the gen om es detected  were b io log ica lly  
relevant. In practice, the latter p rop osition  dem anded the 
d em on stration  that m ost o f  the quiescent gen om es  
detected  were capable o f  resum ing gene expression  in 
response to  an appropriate stim ulus. Since there w as no  
m od el in w hich  these objectives had been attem pted  or 
ach ieved , it w as necessary to develop  a new  cell culture 
system  for the study o f  quiescent gen om es. E xtend ing  
our unpublished  observation s, w hich  were in agreem ent 
w ith  those reported by Joh nson  e t al. (1992, 1994), that 
p rod u ction  o f  IE proteins resulted in cell degeneration , 
w e attem pted  further to reduce IE transcription  after 
in fection  o f  H F L  cells w ith  in 1814. T he first step involved  
specifically reducing V m w l 10 synthesis, since m utants  
deleted  on ly  for this gene can  also  persist in a quiescent 
state (S tow  & S tow , 1989). M utant m l820 w as derived  
from  m l8 1 4  by replacem ent o f  the V m w l 10 gene 
p rom oter w ith  the M om u lv  prom oter and enhancer. 
A d d ition a l insertion, at the T K  locus, o f  the E. coli la c Z  
gene con tro lled  by either the H C M V  enhancer or the 
H SV -1 V m w l 10 prom oter yielded m l8 8 3  and m l8 8 4 , 
respectively. W hen titrated on  H F L  cells, m l820 and its 
d erivatives were m ore im paired for replication  than  
m l8 1 4 , w ith virus stock s exh ib iting an ap proxim ately  10- 
fo ld  higher p artic le:p .f.u . ratio (results n ot sh ow n). This 
ob servation  w as extended by analysis o f  IE R N A  
accum u lation  after in fection  o f  H F L  cells in the presence  
o f  cycloh exim id e (F ig . 2). A s sh ow n  previously  (A ce e t 
al., 1989; D ak sis & Preston, 1992), levels o f  IE R N A s  
w ere low er in in 1814-infected cells com pared  w ith  1814R - 
in fected  cells. T he am ou n ts o f  IE R N A s en cod in g  
V m w l7 5 , V m w 68 and V m w 63 w ere sim ilar in m l814 -  
and m l820 -in fected  cells, but IE R N A  en cod in g  V m w l 10
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was not detectable in ml820-infected cells. HFL cells 
infected with m l825, the rescuant of m l820 at the 
Vmw65 locus, also showed no detectable production of 
Vmwl 10 RNA. Thus, the Momulv enhancer was not 
recognized as an IE promoter, with the consequence that 
m l820 behaved as a Vmw65/Vmwll0 double mutant in 
HFL cells. A detailed description of the properties of 
m l820 and m l825 will be published elsewhere.
Viruses with mutations in Vmwl 10 or Vmw65 exhibit 
low titres in plaque assays because initiation of pro­
ductive replication is extremely inefficient at low m.o.i. 
(Stow & Stow, 1986; Sacks & Schaffer, 1987; Ace e t  a l., 
1989; Everett, 1989). This causes difficulties in accurately 
assessing the effective input m.o.i., as discussed by Cai & 
Schaffer (1992). To overcome this problem, we standard­
ized virus preparations by titration on BHK cells in the 
presence of 3 mM-HMBA, which allows ml814 and 
m l820 to be assayed essentially as wild-type viruses 
(McFarlane e t  a l., 1992). This procedure provided a 
sound basis for comparison of virus stocks but, as shown 
below, a value approximately three times higher was 
obtained by co-infection with 1 p.f.u. of the HSV-1 
mutant teK per cell and subsequent incubation at 37 °C. 
Co-infection with t s K  provides both Vmw65 and 
Vmwl 10, thereby fully complementing the defects of 
m l820. When ‘p.f.u. ’ was measured by complementation 
with t s K ,  particle:p.f.u. ratios of ml814- and ml 820- 
based mutants were equivalent to those of wild-type 
HSV-1 stocks.
U se  o f  I F N - a p r e tr e a tm e n t  to  r e d u c e  I E  g e n e  e x p r e s s io n
Although the use of m l820, instead of m l814, 
increased the number of virus particles that could be 
added to monolayers, cell degeneration still occurred 
after infection with 106 p.f.u. per plate (approximately 
1 p.f.u. per cell). Further reduction of IE gene expression 
was achieved by pretreatment of cells with IFN-a, a 
procedure known to inhibit IE transcription and reduce 
cell killing (Mittnach e t  a l., 1988; Oberman & Panet, 
1989; Johnson e t  a l., 1992).
Monolayers were pretreated with 103 units of IFN- 
a/ml for 16-20 h prior to infection with 1814R, m l814, 
ml820 or ml883 (Table 1). The titre of 1814R was 
reduced by approximately 7-fold after IFN-a pre­
treatment. The titre of m l814 was reduced to an even 
greater extent, although application of 106 p.f.u. resulted 
in cell destruction irrespective of IFN-a pretreatment. 
When infected with 106 p.f.u. of m l820, however, IFN-a- 
pretreated monolayers withstood infection and produced 
only five plaques per plate, whereas at lower m.o.i. no 
plaques were observed. The use of m l883, which 
permitted subsequent staining for /?-gal expression, 
provided a more sensitive means of detecting viral
Table 1. In h ib i t io n  o f  H S V  r e p lic a tio n  b y  IFN-a 
p r e tr e a tm e n t
Vims
Inoculum 
(p.f.u. per plate)
Plaque numbers*
-IF N -a + IFN-a
1814R 1 x 103 CPEt 196
1814R lx lO 2 98 14
ml814 lx lO 6 CPE CPE
m 1814 1x 10s 146 1
1820 1x 10® CPE 5
ml 820 3 x 105 CPE 0
ml 820 lx lO 5 38 0
ml883J 3 x 105 CPE 16
ml 883 lx lO5 72 3
ml 883 3 x 104 14 0
* Values represent the means of duplicate or triplicate deter­
minations.
t  CPE: extensive cytopathic effect prevented estimation of plaque 
numbers.
t  Plaques, or single cells, were counted after reaction of ml 883- 
infected monolayers with X-Gal.
replication or gene expression but even in this case only 
16 ‘plaques’, some of which were single cells, were 
observed on plates infected with 3 x 105 p.f.u of m l883.
Pretreatment with IFN-a thus permits the survival of 
cultures after infection with at least 1 p.f.u. of m l820 per 
cell. Since the titre of m l820 after complementation with 
t s K  was approximately 3-fold higher than the value 
measured on BHK cells in the presence of HMBA, it 
follows that an input m.o.i. of 3 x 105 p.f.u. per mono­
layer of 8 x 105 cells should deliver an average of at least 
one genome per cell. Under these circumstances, mol­
ecular analysis of the genome should be possible, 
provided the small number of potentially active genomes 
(16 after infection with 3 x 105 p.f.u. per plate; Table 1) 
was hot amplified by replication. An inhibitor of DNA  
replication, AraC, was therefore added after infection of 
IFN-a-pretreated monolayers.
To determine whether IFN-a pretreatment or the 
presence of AraC exerted significant influence on the 
retention of virus, HFL cells were infected with 30 p.f.u. 
of m l883, incubated with or without AraC for 2 days, 
then superinfected with t s K  (Table 2). Co-infection with 
toK resulted in 85 plaques on untreated cultures or 65 on 
IFN-a-pretreated monolayers. /«1883 was recovered by 
superinfection after 2 days, as expected from previous 
studies (Harris & Preston, 1991); a process referred to as 
‘reactivation’ hereafter. Treatment with AraC did not 
reduce the reactivation of m l883 and IFN-a pre­
treatment had only a small effect. Crucially, reactivation 
of m l883 from cells treated with both agents (140 
plaques) was close to that observed in untreated cells 
(178 plaques), demonstrating that the combination of 
IFN-a pretreatment and AraC addition did not sig­
nificantly affect retention and reactivation of the m l883
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Table 2. C o m p le m e n ta t io n  o f  in  1 8 8 3  b y  t s K  *
Time of 
superinfection AraC
Plaques on monolayersf
-IFN -a + IFN-a
OhJ _ 85 65
2 days — 178 113
2 days + 174 140
* Monolayers of HFL cells, either pretreated with IFN-a or mock- 
pretreated, were infected with 30 p.f.u. of ml883 and incubated at 
37 °C with or without AraC. After 2 days, monolayers were washed 
and superinfected with 8 x 105 p.f.u. of tsK per plate, overlaid with 
EHu5 and incubated at 37 °C for 24 h. Plaques were identified by 
expression of /?-gal. No plaques were detected on monolayers infected 
with ml883 alone, 
f Values represent the means of triplicate determinations.
J Monolayers were co-infected with 30 p.f.u. of ml883 and 
8 x 105 p.f.u. of tsJL.
Table 3. S ta b i l i ty  o f  th e  v ir u s - c e l l  in te r a c t io n *
Plaques per monolayerf
Treatment mock si si tsK
Superinfect day 3 0 169
Subculture 1:3 on day 3, 0 55
superinfect on day 6{
Subculture 1:3 on day 6, 0 13
superinfect on day 9§
* IFN-a-pretreated HFL cultures were infected with 40 p.f.u. of 
ml883 and maintained at 37 °C for 3 days in the presence of AraC. 
Monolayers were washed and incubation continued at 37 °C for a 
further 3 days. Cultures were mock-superinfected (mock si) or 
superinfected with 8 x 105 p.f.u. of taK per plate (si tsK) and maintained 
at 37 °C for 24 h prior to staining for /?-gal.
t  Values represent the means of between three and nine deter­
minations.
t  After 3 days in the presence of AraC, monolayers were washed, 
trypsinized and replated at one third of the original density. On day 6, 
cultures were mock-superinfected or superinfected with 8 x 105 p.f.u. of 
tsK per plate and maintained at 37 °C for 24 h prior to staining for /?- 
gal.
§ Monolayers subcultured on day 3 were again subcultured 1:3 on 
day 6 and superinfected on day 9.
genome. Analogous results were obtained when infec­
tions were initiated with m l820 or m l884 (results not 
shown). The increase in recovery of virus by super­
infection over the 2 day period is thought to be due to 
gradual uncoating of the viral genome (see below, Fig. 
5): low-level replication is unlikely since the presence of 
AraC at a concentration known to inhibit viral DNA  
synthesis did not prevent the effect and, furthermore, no 
increase in DNA levels was detectable over the 2 day 
period (Fig. 5).
The stability of retention of ml820-based viruses was 
investigated (Table 3). IFN-a-pretreated monolayers 
were infected with 40 p.f.u. of m l883 per plate and, after 
3 days in the presence of AraC, monolayers were 
superinfected with t s K  or mock-superinfected. No virus 
replication or expression of /?-gal was detected on
untreated plates, but superinfection with t s K  yielded an 
average of 169 plaques per plate. Subculture and 
reseeding at 3-fold dilution after 3 days in the presence of 
AraC did not result in reactivation of m l883. Once 
monolayers had become confluent, superinfection with 
t s K  yielded approximately one-third of the initial number 
of plaques per plate. A further cycle of subculture again 
failed to reactivate virus, and the number of plaques per 
plate reactivated by superinfection with t s K  was again 
reduced by a factor of approximately three. Therefore, 
trypsinization, subculture and regrowth of HFL cells did 
not reactivate quiescent m l883, emphasizing that re­
pression of gene expression could not be overcome by the 
changes in cell metabolism which occur during sub­
culture. There was also no evidence for co-replication 
with the host cell, since reactivation competent cells were 
diluted in approximately the same ratio as the total cell 
population. The m l883 genome remained within cells 
and could be reactivated for at least 9 days after 
infection.
R e te n t io n  o f  th e  v ir a l  g e n o m e  a f te r  in fe c tio n  a t  h ig h  
m .o .i .
The information from the previous sections was used 
to develop a system in which each HFL cell should 
contain at least one quiescent viral genome. Infection of 
IFN-a-pretreated monolayers with 30 p.f.u. of m l883 
yielded 140 plaques after superinfection with t s K  (Table 
2); thus addition of 3 x 105 p.f.u. of m l883 should result 
in almost all cells in a monolayer of 8 x 105 cells receiving, 
on average, one reactivatable genome. To demonstrate 
directly the validity of this extrapolation, IFN-a- 
pretreated monolayers were infected with 3 x 104 p.f.u. 
or greater of m l883 per plate, maintained in the presence 
of AraC for 2 days and superinfected with t s K .  To 
prevent intercellular spread of virus, Brefeldin A was 
present during superinfection (Cheung e t  a l ., 1991). 
Control experiments showed that in cells treated with 
Brefeldin A, /?-gal and its reaction product were restricted 
to individual cells (results not shown). After super­
infection, monolayers were stained for the presence of /?- 
gal (Fig. 3).
In cultures infected with 3 x 105 p.f.u. of m l883 per 
plate, very few ^-gal-expressing cells were observed on 
mock-superinfected cells (Fig. 3 a ) , whereas almost all 
cells expressed the enzyme after superinfection with t s K  
(Fig. 3 b ). When the initial inoculum was reduced to 
1 x 105 p.f.u. per plate (Fig. 3 c ), approximately 95% of 
cells expressed /?-gal after superinfection, and at 
3 x 104 p.f.u. per plate (Fig. 3 d )  the proportion of ^ -gal- 
expressing cells was approximately 33%, as determined 
by counting on colour photographs of stained cells. Very 
similar results were obtained after initial infection with
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Table 4. R e la t io n s h ip  b e tw e e n  g e n o m e  c o p y  n u m b e r  a n d  r e a c t iv a ta b le  v iru s
/«1883 
(p.f.u. per plate)
Genomes 
retained 
after 3 days*
/?-Galactosidase-expressing cellsf Genomes per 
reactivating 
cellmock si si taKt
3 x 104 3*7 x 105 (2)§ 0-6 (6)§ 2-1 x 105 1*4
lx lO 5 10 x 106 (4) 5-6 (6) 7-6 x 105 1*3
3 x 105 2-3 x 106 (2) 32-2 (6) 80 x 105 2*9
* Data from Southern blots, as shown in Fig. 4, were used to calculate genome copy number in IFN-a- 
pretreated HFL cell cultures infected with z«1883. The results were correlated with analysis of ^ -gal-expressing 
cells, as shown in Fig. 3.
t  Monolayers infected with in 1883 were stained for y?-gal after mock-superinfection (mock si) or superinfection 
with 8 x 105 p.f.u. of tsK per plate (si tsK) in the presence of Brefeldin A.
% Calculated from the percentage of cells staining for fi-gal and the measured average cell density of 8 x 105 cells 
per monolayer.
§ Mean value, number of determinations in brackets.
ml 884 (Fig. 3 e - f ) .  In addition, superinfection with 
1814R (essentially wild-type HSV-1) and incubation for 
7 h in the presence of Brefeldin A, or AraC, reactivated 
m l883 or m l884 as efficiently as superinfection with t s K  
(results not shown).
The extrapolation from results obtained at low m.o.i. 
was therefore verified directly. It was possible to produce 
cultures with each cell containing at least one reactivat­
able genome and with the background of cells harbouring 
potentially replicative genomes contributing less than 
0.01 % of the population. The results also demonstrate 
that the HCMV enhancer and Vmwl 10 promoter were 
not detectably active, except in a small number of cells.
S tr u c tu r e  a n d  c o p y  n u m b e r  o f  D N A
Previous experiments showed that viral DNA was 
sequestered as a non-linear molecule when HFL cells 
were infected with ml814 at an m.o.i. of approximately 
0-1 p.f.u. per cell and subsequently maintained in the 
presence of AraC or aphidicolin (Harris & Preston, 
1991). The configuration of viral DNA was therefore 
investigated after infection of IFN-a-pretreated HFL 
cells with 106 p.f.u. of m l820 per plate and maintenance 
in the presence of AraC. DNA was extracted from cell 
nuclei, cleaved with B a m H l  and enriched for viral 
sequences by equilibrium bouyant density gradient 
centrifugation. Hybridization with the joint-spanning 
B a m H l  k fragment from HSV-1 revealed a prepon­
derance of joint fragment after 1 day in culture (Fig. 4 a , 
lane 1) and an almost complete absence of termini after 
2 days (lane 2), demonstrating conversion to a non-linear 
form.
To obtain an estimate of viral genome copy number, 
DNA was extracted from nuclei of cells pretreated with 
IFN-a, infected with 3 x 104 or 1 x 105 p.f.u. of m l883 
and maintained in the presence of AraC for 7 h or 3 days. 
Hybridization was carried out on unfractionated DNA  
using a radiolabelled DNA fragment from the Momulv
enhancer, thereby avoiding problems of cross-hybrid­
ization with cellular sequences which can occur with 
HSV joint-spanning fragments (Fig. 4 b ) . This probe 
detected the joint-spanning fragment, the L terminus and 
minor species containing additional ‘a ’ sequences, and a 
minor band of unknown origin smaller than the L 
terminus. The results again demonstrated that the DNA  
was predominantly non-linear (Fig. 4 b ,  lanes 6 and 7). 
Quantification was carried out on the data shown in Fig. 
4 (b )  and on four independent experiments, and the total 
amount of viral DNA was compared with the number of 
reactivation competent cells as estimated from propor­
tions of /?-gal-containing cells after superinfection with 
t s K  (Table 4). After infection with 3 x 104 and 
1 x 105 p.f.u. of m l883 per plate, the situations in which 
/?-gal expression is proportional to input m.o.i., cultures 
retained, respectively, 3*7 x 105 and 1*0 x 106 ml883 DNA  
molecules per monolayer of 8 x 105 cells. The estimated 
numbers of ^-gal-expressing cells upon superinfection 
with t s K  were 2-7 x 105 (33%) and 7*6 x 105 (95%), as 
derived from experiments represented in Fig. 3; thus 
cultures contained 1-3—1*4 genomes per reactivated cell. 
Most genomes detectable at 3 days after infection were 
therefore competent for reactivation, as measured by 
expression of /?-gal after superinfection.
This conclusion is crucial because it can be stated with 
certainty that the genomes detected biochemically were 
templates for reactivation. As a consequence, studies on 
the structure of the quiescent genome in HFL cells and 
the changes that occur upon reactivation will be 
meaningful since they pertain to biologically relevant 
material. It is important, therefore, to define the limits 
within which the conclusion is based. The values 
presented rely on calculations that are individually 
subject to error, but over a number of experiments using 
1 x 105 or fewer p.f.u. of m l883 and, to a lesser extent, 
m l884, the genome copy per reactivating cell varied only 
between 1-0 and 2-0. The proportion of non-linear 
genomes at 3 days post-infection ranged between 70 %
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Fig. 3. Expression o f  /?-gal after superinfection. Cultures were pretreated with IF N -a  and infected with ?'«1883 or m 1884 for 48 h in the 
presence o f  AraC. M onolayers were stained for /?-gal 24 h after m ock-superinfection (a, e) or superinfection with 8 x 105 p.f.u. o f  tsK  
per plate (b , c, d ,J \ g, h) in the presence o f  2-5 p g /m l Brefeldin A. Cultures were initially infected with z'«1883 at 3 x 105 (a , b), 1 x 105 
(c) or 3 x 104 (d) p.f.u. per plate, or z'/?1884 at 3 x 105 (e , f ), 1 x 105 (g) or 3 x 104 (h) p.f.u. per plate. Cells expressing /?-gal on m ock- 
superinfected plates (a , e) are labelled with arrows. Bar represents 120 pm.
and >  95% , thus the num ber o f  non-linear genom es per 
reactivating cell was, in som e cases, low er than presented  
in Table 4 and closer to one.
Com parison o f  /?-gal-expressing cell num bers (Table 4)
w ith values for plaque form ation  (Table 2) revealed a 
discrepancy: after superinfection with tsK, cultures 
infected w ith 3 x 104 p.f.u . o f  /«1883 yielded approxi­
m ately 2-7 x 105 /?-gal-expressing cells yet an input o f
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L terminus
(termini)
Fig. 4. A nalysis o f  viral D N A . (a) IFN-a-pretreated cultures were infected with 1 x 106 p.f.u. o f  m 1820 per plate, AraC was added, and 
D N A  was extracted after 1 (lane 1) or 2 (lane 2) days. Viral D N A  was cleaved with Bam  HI and partially purified by equilibrium  
buoyant density gradient centrifugation prior to Southern transfer and hybridization, using radiolabelled HSV-1 Bam H \ k fragment 
as probe. M ock-infected cell D N A  o f  equivalent density (lane 3), and 1-5 ng o f  m 1820 D N A  (lane 4) were also analysed. (b) IF N -a-  
pretreated cultures were infected with 3 x 104 (lanes 6 and 8) or 1 x 105 (lanes 7 and 9) p.f.u. o f  m 1883 per plate and nuclear D N A  was 
extracted at 7 h (lanes 8 and 9) or 3 days (lanes 6 and 7) post-infection. Standards consisted o f  3 x 107 (4-5 ng, lane 2), 1 x 107 (lane 3), 
3 x 106 (lane 4) or 1 x 10® (lane 5) copies o f  m 1820 D N A . D N A  extracted from 1 x 105 p.f.u. o f  />? 1820 was applied to lane 1. The probe 
was a M om ulv-specific fragment.
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Fig. 5. Fate o f  /«1883 D N A . (a) IFN -a-pretreated cultures were infected with 3 x 105 p.f.u. o f  m 1883 per plate and D N A  was extracted  
from the nuclear fraction (lanes 1-6), N P40 supernatant plus sucrose wash (lanes 7 -12) or culture m edium  (lanes 13-17) at 2 h (lanes 
1, 7 and 13), 7 h (lanes 2, 8 and 14), 1 day (lanes 3, 9 and 15), 2 days (lanes 4, 10 and 16), 3 days (lanes 5, 11 and 17) or 4 days (lanes 
6 and 12) after infection. The probe was a M om ulv-specific fragment. (b) The signals from lanes 16 were quantified by phosphorim age  
analysis, and the am ounts o f  total (O ), linear ( □ )  and non-linear ( # )  m 1883 D N A  plotted.
30 p.f.u. per plate resulted in approxim ately 100 plaques 
(140 in the experim ent described in Table 2), instead o f  
the 270 expected. This ob servation  w as found to be due 
to a suppressive effect o f  the hum an serum  used to  
prevent virus spread during virus titration. C ultures were 
co-infected  with 30 p .f.u . o f  />? 1883 and 8 x 105 p .f.u . o f  
taK, overlaid w ith various com b in ation s o f  serum and  
Brefeldin A , and incubated at 37 °C for 24 h prior to
staining for /?-gal. M on olayers overlaid w ith E H u5 alone  
yielded 73 plaques (m ean o f  triplicate determ inations), 
whereas those overlaid with EF5 con ta in ing  2-5 p g /m l 
Brefeldin A  resulted in 151 stained cells. E H u5 con ta in ing  
Brefeldin A  gave 57 stained cells. The presence o f  hum an  
serum  low ered the ‘ titre’ by a factor o f  m ore than tw o, 
by an unknow n m echanism , thereby accoun ting for the 
differences betw een the reactivation efficiencies derived
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Fig. 6. D igestion  o f  viral D N A  with M N . IF N -a-  
pretreated cells were infected with 1x10® p.f.u. o f  
m l 820 per plate and nuclei prepared after 3 days. 
Nuclei were digested with M N , D N A  was extr­
acted and electrophoresed on a 2%  (w /v ) agarose 
gel. The probe was £coR I n, spanning the TK  
gene. In lanes 1-8, AraC was added after 
infection, whereas in lanes 13-18 5 pM-acyclovir 
was added. D N A  was from m ock-infected cells 
(lanes 1^4 and 13-15), latently infected cells (lanes 
5-8  and 16-18) or 143 T K “ cells transformed with 
p T K l (lanes 9 -12). N uclei were treated at 37 °C 
with no M N  (lanes 1, 5 ,9 , 13 and 16), 7.5 units for 
2 min (lanes 2, 6 and 10), 22 5 units for 10 min 
(lanes 3, 7 and 11), 45 units for 30 min (lanes 4, 8 
and 12), 5 units for 2 min (lanes 14 and 17), or 
10 units for 10 m in (lanes 15 and 18). Lower 
panels show  ethidium -brom ide-stained gels, 
upper panels show  autoradiographs. N ucleos- 
om al D N A  fragments are bracketed.
from plaque num bers or stained cell counts. ‘ R ea­
ctivation’, as used in T able 4, therefore strictly applies to  
activation o f  gene expression  rather than the production  
o f infectious virus.
Fate o f  input D N A
The experiment sh ow n  in Fig. 4(b )  also includes 
hybridization to D N A  from  an input inoculum  o f  
1 x 105 p.f.u. o f  m l883 (lane 1) and D N A  present at 7 h 
after infection o f  IF N -a-p retreated  cells w ith 3 x 104 and  
1 x 105 p.f.u. in the presence o f  A raC  (lanes 8 and 9). 
Over five determ inations, 1 x 105 p .f.u . corresponded to  
1-07 x 107 input D N A  m olecules, o f  w hich  2-9 x 106 were 
detected in the nuclear fraction at 7 h post-in fection . The  
7 h value thus exceeded the num ber o f  gen om es retained  
after 3 days (1 x 106), and an exp lan ation  w as sou ght for 
this unexpected finding.
IFN -a-pretreated cells were infected w ith 3 x  105 p .f.u . 
o f  m l883, washed twice w ith E F5 after 1 h at 37 °C, and  
overlaid with EF5 contain ing A raC . A t various tim es 
after addition o f  virus to cells, m onolayers were 
harvested and nucleic acids extracted from  the nuclear 
fraction, the N P40 supernatant plus 10%  sucrose w ash  
o f  crude nuclei (cytoplasm ic fraction), and from  the 
culture m edium . N ucleic acids were cleaved w ith B am H l 
plus ribonuclease A  and analysed by Southern hybrid­
ization (Fig. 5a). Viral D N A  w as predom inantly in the 
nuclear fraction at all tim es, although  som e linear 
m olecules were found in the cytop lasm ic fraction up to
1 day after in fection . N o  viral D N A  w as detected in the 
culture m edium  at any time. W hen the data from  Fig. 
5(a) were expressed graphically (Fig. 5 b), it w as found  
that the total am oun t o f  m l883 D N A  fell by approxi­
m ately 3-fold  during the first 2 days o f  in fection , but that 
the num ber o f  non-linear genom es present at 2 days 
rem ained stable. Input D N A  not converted  to the n o n ­
linear form  during the course o f  the experim ent w as 
presum ably degraded, since it cou ld  n ot be recovered in 
the cytop lasm ic fraction or grow th m edium .
R egular nucleosom e arrangem ent cannot be d e tec ted  a t 
the T K  locus
Cellular D N A  is organized into chrom atin , o f  w hich  
the n ucleosom e is the basic unit. It has been show n that 
H SV  D N A  form s a chrom atin-like structure when  
sequestered in m ouse brain stem  (D esh m an e & Fraser, 
1989). T o  investigate w hether m l820 D N A  w as organ­
ized sim ilarly in H F L  cells, nuclei from  IFN -a-pretreated  
cells infected w ith in 1820 and m aintained in the presence 
o f  A raC  were partially digested w ith M N , the fragm ents 
separated by electrophoresis, and hybridization  carried 
out using radiolabelled  F'coRI n from  the T K  gene (Fig. 
6). A s a con trol, nuclei from  hum an 143 T K “ cells stably  
transform ed to a T K + phenotype by transfection  o f  the 
H SV-1 T K  gene were analysed in parallel.
E xam ination  o f  eth idium -brom ide-stained  gels d em on ­
strated that cellular chrom atin  w as digested to the 
characteristic ‘ lad d er’ o f  D N A  fragm ents. W hen viral
Retention o f  H S V  D N A  1427
D N A  w as exam ined by hybridization, how ever, m aterial 
o f  heterogeneous sizes w as observed , w ith n o  evidence  
for the presence o f  regularly spaced n ucleosom es (F ig . 6, 
lanes 5 -8 ). T he HSV-1 T K  gene, w hen present in 143 T K - 
cells, was organized in to  chrom atin  (F ig. 6, lanes 9 -1 2 ), 
dem onstrating that there are no intrinsic features o f  the 
T K  gene w hich preclude the form ation  o f  regularly  
packaged nucleosom es.
M aintenance o f  cells in the presence o f  A raC  m ight 
have reduced cellular h istone p oo ls due to in h ib ition  o f  
D N A  synthesis, thereby preventing the form ation  o f  
properly spaced n u cleosom es on  viral D N A . IF N -a -  
pretreated, m l820-in fected  H F L  cells were therefore  
treated with 5 pM -acyclovir, w hich specifically inhibits  
H SV D N A  synthesis. N uclear D N A  w as analysed after 
digestion with M N  (F ig . 6, lanes 13-18), but again  no  
evidence was obtained  for a ch rom atin-like structure o f  
the />21820 genom e. S im ilar results were obtained  when  
p hosphonoacetic acid w as used to prevent H SV  D N A  
replication (results n ot show n).
These experim ents sh ow  that the m l820 gen om e, at 
the T K  locus, was not arranged in to  the regular structure 
characteristic o f  cellular chrom atin .
Non-linear D N A  is a tem pla te f o r  reactiva tion
Superinfection o f  cultures resulted in activation  o f  
expression from  the H C M V  enhancer (in m l883) and the 
V m w l 10 prom oter (in m l884 ) (F ig. 3). T o  investigate  
w hether reactivation was accom panied  by alteration  o f  
the non-linear genom e configuration , IF N -a-treated  
m onolayers were infected w ith m l820, m aintained  for 
2 days in the presence o f  A raC  and superinfected w ith  
1814R in the con tinu ous presence o f  A raC . A t 8 h after 
in fection , nuclear D N A  w as prepared, cleaved  w ith  
B am H l and analysed by Southern hybridization, using  
the probe specific for the M om u lv  enhancer (F ig . 7). 
R eactivation  did not result in a change in the relative 
prop ortions o f  non-linear and linear m olecules (lanes 1 
and 2), even though this process w as know n to  activate  
gene expression . The non-linear genom e w as therefore  
the tem plate for reactivation , and conversion  to a linear 
form  w as n ot a prerequisite for this event to occur. In 
ad dition , the residual linear D N A  rem ained linear 
through out the 8 h period after infection .
Linear D N A  represents non-uncoated genom es
Even after 2 -3  days in the presence o f  A raC  a sm all 
am ount o f  m l820 D N A  w as linear (F igs 4, 5 and 7). T o  
determ ine the nature o f  this m aterial, nuclear D N A  w as 
prepared from  H F L  m on olayers pretreated w ith IF N -a , 
infected w ith  m l820 and incubated  for 2 days in the 
presence o f  A raC . N u clei were incubated  w ith  M N  or
Joint
L terminus
Fig. 7. Structure o f  viral D N A  after reactivation. IFN -a-pretreated  
cultures were infected with 1-5 x 10® p.f.u. o f  m l820  per plate and after 
3 days cultures were m ock-infected or infected with 5 p.f.u. o f  1814R  
per cell and incubated at 37 °C for 8 h in the presence o f  AraC. D N A  
was extracted, cleaved with B am H l, follow ed by hybridization using a 
M om ulv-specific probe. Lane 1, m ock-superinfected cells; lane 2, cells 
superinfected with 1814R; lane 5, uninfected cells infected after 3 days 
with 1814R. Lanes 3 and 4 show  hybridization to 3 x 107 and 1 x 107 
copies o f  z/?l 820 D N A , respectively.
Joint
M  L terminus
Fig. 8. N uclease sensitivity o f  the viral genom e. IFN -a-pretreated  
cultures were infected with 1-5 x 10® p.f.u. o f  m l 820 per plate and nuclei 
were digested with M N  or D N ase I. D N A  was purified, cleaved with 
Bam H l and electrophoresed. The probe was a M om ulv-specific  
fragment. D N A  from m ock-infected cells is show n in lanes 1 and 7. 
D N A  from latently infected cells was digested with no enzym es (lanes
2 and 8), M N  at 1 unit for 3 min (lane 3) or 3 units for 5 m in (lane 4), 
or D N ase I at 1 unit for 3 m in (lane 9), 2 units for 5 min (lane 10) or 
5 units for 20 min (lane 11). Lanes 5 and 6 show  hybridization to
3 x 107 and 1 x 107 copies o f  m l820 D N A , respectively.
D N a se  I, and D N A  w as extracted, cleaved  w ith  B am H l 
and analysed by Southern hybridization, using the 
M om ulv-specific fragm ent as probe (F ig. 8). A s d igestion
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proceeded, hybridization to the joint-spanning fragment 
decreased more sharply than to the terminal fragment 
until the residual, essentially nuclease resistant, viral 
DNA (lanes 4 and 11) was composed only o f the linear 
form with joint and terminal fragments essentially 
equimolar. This result dem onstrates that the small 
amount of linear DNA remaining in cells at 2-3 days after 
infection presumably originated from particles that had 
not undergone full uncoating and therefore protected the 
DN A from the action of nucleases.
Discussion
We describe the development o f a cell culture system in 
which the HSV genome was stably retained in a quiescent 
state in hum an fibroblasts at high efficiency without cell 
destruction. The crucial feature is the incorporation of 
steps designed to reduce IE gene expression, namely the 
use of viruses with m utations in Vmw65 and the Vmwl 10 
prom oter together with pretreatm ent with IFN -a. It 
appears that cytotoxicity during nonpermissive infection 
with HSV-1 (strain 17) was due mainly to expression of 
IE proteins and that virus structural components, 
including the vhs factor, were not deleterious at the 
multiplicities used. This conclusion agrees with that 
reached in studies by Johnson et al. (1992, 1994), who 
also reported that pretreatm ent with IF N -a reduced 
cytotoxicity by HSV-1. Reactivation by superinfection 
was almost as efficient in IFN -a-pretreated cultures as in 
untreated cultures (Table 2). For investigation of genome 
structure, which realistically demands the presence of at 
least one genome per cell, it was necessary to include an 
inhibitor o f D N A  synthesis to prevent replication, and 
hence amplification, of the low background of potentially 
replicative virus. The origin of this virus is unclear: a 
small population o f cells may be inherently more 
permissive for m l820, or a proportion of cells may 
receive a larger num ber of virus particles (possibly due to 
aggregation o f virions) and thus overcome the block to 
replication. It is im portant to emphasize that the use of 
IFN -a pretreatm ent and AraC did not fundamentally 
affect the interaction of m l820 with the host cell; these 
agents merely enabled the system to be adapted for use 
at an m.o.i. of 1 p.f.u. or greater per cell and thus for 
analysis of the viral genome.
Pretreatm ent of cells with IF N -a inhibited plaque 
formation by m l814 more severely, in percentage terms, 
than 1814R (Table 1). The blocks to IE transcription 
imposed by the Vmw65 m utation and IF N -a pre­
treatment were thus additive in their effects on virus 
replication, a result apparently at variance with the view 
that IFN -a pretreatm ent inhibits transactivation by 
Vmw65 (DeStasio & Taylor, 1990). If  this were the case, 
it might be expected that ml814 and related viruses with
impaired transactivation would be resistant to the action 
of IFN -a. Two possible explanations exist. The insertion 
m utation in the ml814 genome may not completely 
inactivate Vmw65, leaving a residual activity which is the 
target for IFN -a. A lthough we have failed to detect 
activity o f the m utant Vmw65 in functional assays in vivo 
or in vitro (Ace et al., 1988, 1989), it remains possible that 
it can form an unstable complex with Oct-1 and H C F in 
the infected cell and hence activate IE transcription to 
some extent. Alternatively, IF N -a may reduce IE 
transcription in a m anner that does not involve Vmw65. 
This possibility is implied by the observation that 
expression from the HCM V enhancer, which is active 
under IE conditions, is also inhibited by IF N -a pre­
treatm ent (Johnson et al., 1992; C. M. Preston, un­
published observations). Perhaps IF N -a prevents the 
onset of IE transcription in a manner analogous to the 
effect o f the agent on SV40 early transcription (Brennan 
& Stark, 1983).
During the quiescent state, expression o f /?-gal from 
the HCM V enhancer and Vmwl 10 prom oter could not 
be detected in the vast majority of cells, indicating that 
these elements were not active. In contrast, enzyme was 
readily detected in the few cells which presumably had 
produced sufficient am ounts o f IE proteins. The block to 
IE gene expression could easily account for the absence 
o f transcription from the remainder o f the viral genome 
since early and late genes are inactive without IE 
proteins. The HdVTV enhancer (present in 1883) is, 
however, expressed in the absence of IE proteins and is 
not dependent upon functional Vmw65 (C. M. Preston, 
unpublished observations). The lack o f detectable /Fgal 
expression in i«1883-infected cells implies that the block 
to gene expression also applies to the HCM V enhancer 
and thus may not be strictly promoter-specific. Once 
established, repression of gene expression is stable since 
genomes remain quiescent even during cell subculture. 
The cell-cycle related factor(s) which mimic Vmwl 10 
action (Cai & Schaffer, 1991) or influence IE tran ­
scription (Daksis & Preston, 1992; Ralph e t  al., 1994) are 
thus unable to reactivate quiescent genomes from /«1820- 
based viruses.
No similar studies on the fate and structure o f HSV 
DNA  in the absence of IE transcription have been 
carried out, thus it is difficult to make detailed com ­
parisons with the work of others. B. L. W igdahl and 
colleagues pretreated H FL cells with IF N -a and found 
that infection with HSV-1 at up to 2-5 p.f.u. per cell 
could be tolerated without cell degeneration. Following 
incubation for 7 days in the presence o f an inhibitor of 
viral DNA  synthesis, virus could not be detected 
provided cultures were m aintained at a supraoptim al 
tem perature o f 39-5-40-5 °C (Wigdahl et al., 1982). 
Tem perature downshift to 37 °C resulted in virus
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replication. Linear H SV  genom es were found  in cultures  
(W igdahl e t al., 1984), in contrast to  the findings reported  
here. From  our studies, the presence o f  linear D N A  
im plies that the genom e w as present in virus particles 
that had not been fully uncoated  or had been packaged  
de novo  into nucleocapsids. The problem  in interpreting  
the data o f  W igdahl e t al. (1984) is that cultures contained  
m ore than 0.5 genom es per cell, but not m ore than 3%  
o f  cells produced virus, even w hen reactivation w as 
induced by superinfection  (W igdahl et al., 1982, 1984). It 
w as therefore n ot p ossib le to  state that the linear 
genom es were tem plates for reactivation since a sm all 
proportion  o f  non-linear m olecules w ould  n ot have been  
detected. In our experim ents, the close correlation  
betw een reactivation  and cop y  num ber dem onstrates 
that non-linear D N A  is the relevant form .
D uring latency in anim als and hum ans, H SV  D N A  in 
the peripheral and central nervous system s is non-linear  
(R ock  & Fraser 1983; E fstath iou  e t al., 1986), and  
conversion  o f  input genom es to a non-linear form  seem s 
to occur in the absence o f  viral D N A  replication  
(Slobedm an e t al., 1994). In addition , genom es extracted  
from  the brain-stem  were found  to  be packaged in to  a 
chrom atin-like structure (D esh m an e & Fraser, 1989). 
W hile these data clearly describe the structure o f  the 
m ajor form s o f  the latent genom e, the D N A  copy  
num ber per latently infected cell again  far exceeds the 
num ber o f  cells from  w hich virus can be reactivated. In 
the peripheral nervous system , it has been estim ated  that 
there are tens or hundreds o f  gen om es per latently  
infected neuron, yet virus can  be reactivated from  on ly  a 
proportion  o f  neurons (R ock  & Fraser, 1983; E fstath iou  
et al., 1986; S im m ons e t al., 1992; K osz-V nenchak  et al., 
1993; Ecob-Prince & H assan, 1994). H SV  can be 
recovered from  the central nervous system  on ly  at very 
low  efficiency (R oizm an  & Sears, 1987); thus it is not 
possib le to be certain that the chrom atin-like genom es  
are able to reactivate.
Surprisingly, full u ncoating o f  the m l 820 genom e w as 
slow , on ly  reaching com p letion  2 -3  days after infection. 
The existence o f  large num bers o f  non-un coated  genom es  
has been recognized previously (Jacob & R oizm an, 
1977), but long-term  exam ination  o f  the progression  to  
uncoating o f  all gen om es has n ot been possib le due to  
viral replication a n d /o r  cell destruction. The early b lock  
im posed  by in hib ition  o f  IE transcription has enabled us 
to  dem onstrate that alm ost all gen om es that rem ain in 
cells eventually  becom e uncoated. It should  be n oted  that 
the rate o f  u ncoating o f  strain 17-derived viruses in H F L  
cells was slow er than found in other cell types (Poffen- 
berger & R oizm an, 1985; L. H. R obinson , unpublished  
observations), but that neither IF N -a  pretreatm ent nor 
the insertion m utation  in V m w 65 affected the process  
(O berm an & Panel, 1989; L. H. R obinson , unpublished
observations). A  large proportion  (up to 80% ) o f  
genom es w hich becom e associated  w ith cells are lost, 
presum ably due to degradation  since they cou ld  n ot be 
detected in cytop lasm  or culture m edium  (Fig. 5 a, b). 
The w ay in w hich viral D N A  is degraded and the 
apparently selective resistance o f  non-linear m olecules is 
unclear at present, and w e are n ot aware o f  any  
com parable studies using different cell types and virus 
strains.
A t the structural level, our results indicate that the 
m l 820 genom e undergoes som e o f  the events that 
norm ally occur prior to D N A  synthesis. C ircularization  
o f  the genom e occurs even  in the absence o f  protein  
synthesis (Poffenberger & R oizm an, 1985). T he ac­
quisition  o f  sensitivity to  M N  and the existence o f  a 
structure unlike chrom atin  has been described previously  
during productive in fection  (L einbach &  Sum m ers, 1980; 
M uggeridge & Fraser, 1986), a lthough the m ost abun­
dant form  o f  D N A  w as resistant to nuclease d igestion . 
N on eth eless, the genom e we detect is transcriptionally  
inactive, and the basis for the block  is unclear. N o n -  
linearity p er  se w as n ot the prim ary reason for the 
absence o f  gene expression, since non-linear m olecules  
were tem plates for superinfection-induced  reactivation, 
but circularization m ay be required to in itiate further 
structural changes involved  in silencing the genom e. 
F orm ation  o f  a tight chrom atin  structure, at least at the 
T K  locus, d oes not occur and w e have found no C pG  
m ethylation  o f  the C C G G  sites in the /?-gal gene o f  
m l883 (C. M . Preston, unpublished observations). F u ­
ture studies w ill use the approaches described here to  
investigate the overall organ ization  o f  the quiescent viral 
genom e and to  exam ine specific regions in detail.
We thank J. H . Subak-Sharpe for interest in the work, N . D . Stow  
and M. S. Ecob-Prince for helpful com m ents on the m anuscript, M . 
M cFarlane for provision o f  transformed 143 T K ” cells and J. A itken  
for perform ing virus particle counts. D . R. S. Jam ieson was a recipient 
o f  a M edical Research Council Training Fellow ship. L. H. R obinson  
was supported by a M edical Research Council Research Training 
Award. J. I. D aksis w as a N ational Cancer Institute o f  C anada Fellow .
References
A c e ,  C. I., D a l r y m p l e ,  M. A ., R a m s a y , F. H ., P r e s t o n ,  V. G. & 
P r e s t o n ,  C. M. (1988). M utational analysis o f  the herpes simplex 
virus type 1 /ram -inducing factor Vm w65. Journal o f  General 
Virology 69, 2595-2605.
A c e ,  C. I., M c K e e ,  T. A ., R y a n ,  J. M „ C a m e r o n ,  J. M. &  P r e s t o n ,  C. 
M . (1989). C onstruction and characterization o f  a herpes simplex 
virus type 1 m utant unable to transinduce im mediate-early gene 
expression. Journal o f  Virology 63, 2260-2269.
B r e n n a n ,  M. B . &  S t a r k ,  G. R . (1983). Interferon pretreatment 
inhibits sim ian virus 40 infections by blocking the onset o f  early 
transcription. C ell 33, 811-816.
C a i,  W , & S c h a f f e r ,  P . A. (1991). A  cellular function can enhance gene 
expression and plating efficiency o f  a m utant defective in the gene for 
ICP0, a transactivating protein o f  herpes simplex virus type 1. 
Journal o f  Virology 65, 4078-4090.
1430 D . R .  S .  J a m ie s o n  a n d  o th e r s
C ai, W. & S c h a f f e r ,  P. A. (1992). Herpes simplex virus type 1 ICPO 
regulates expression of immediate-early, early and late genes in 
productively infected cells. Journal of Virology 66, 2904-2915.
C a m p b e ll, M. E. M., P a lfr e y m a n , J. W. & P r e s t o n ,  C. M. (1984). 
Identification of herpes simplex virus DNA sequences which encode 
a trans-acting polypeptide responsible for stimulation of immediate 
early transcription. Journal of Molecular Biology 180, 1-19.
C h e n , J. & S ilv e r s t e in ,  S. (1992). Herpes simplex viruses with 
mutations in the gene encoding ICPO are defective in gene expression. 
Journal of Virology 66, 2916-2927.
C h e u n g , P., B a n f ie ld ,  B. W. & T u f a r o ,  F. (1991). Brefeldin A arrests 
the maturation and progress of herpes simplex virus particles during 
infection. Journal of Virology 65, 1893 -1 9 0 4 .
C r o e n , K . D ., O s tr o v e ,  J. M ., D r a g o v ic ,  L. J. & S tr a u s ,  S. E. 
(1987). Latent herpes simplex virus in human trigeminal ganglia: 
detection of an immediate-early gene ‘ antisense ’ transcript by in situ 
hybridization. New England Journal o f Medicine 317 , 1427-1432.
D a k sis , J. I. & P r e s to n , C. M. (1992). Herpes simplex immediate early 
gene expression in the absence of transinduction by Vmw65 varies 
during the cell cycle. Virology 189, 196-202.
D a v iso n , M.-J., P r e s to n , V. G. & M c G e o c h ,  D. J. (1984). De­
termination of the sequence alteration in the DNA of the herpes 
simplex virus type 1 temperature-sensitive mutant tsK. Journal of 
General Virology 65 , 859-863.
D esh m an e, S. L. & F r a s e r ,  N. W. (1989). During latency, herpes 
simplex virus type 1 DNA is associated with nucleosomes in a 
chromatin structure. Journal of Virology 63, 943-947.
D e S ta s io , R. P. & T a y l o r ,  M. W. (1990). Specific effect of interferon 
on the herpes simplex virus type 1 transactivation event. Journal of 
Virology 64, 2588-2593.
D ix o n , R. A. F. & S c h a f f e r ,  P. A. (1980). Fine-structure mapping and 
functional analysis of temperature-sensitive mutants in the gene 
encoding the herpes simplex virus type 1 immediate early protein 
VP175. Journal of Virology 36 , 189-203.
E c o b -P r in c e , M. S. & H a ss a n , K. (1994). Reactivation of latent herpes 
simplex virus from explanted dorsal root ganglia. Journal of General 
Virology 75 , 2017-2028.
E c o b -P r in c e , M . S ., P r e s t o n ,  C . M ., R ix o n , F . J., H a ss a n , K . &  
K e n n e d y , P. G . E . (1993). Neurons containing latency-associated 
transcripts are numerous and widespread in dorsal root ganglia 
following footpad inoculation of mice with herpes simplex virus type 
1 mutant ini814. Journal of General Virology 74 , 985-994.
E f s t a th io u ,  S., M in so n , A. C., F ie ld ,  H. J., A n d e r s o n , J. R. & 
W ild y ,  P. (1986). Detection of herpes simplex virus-specific DNA 
sequences in latently infected mice and humans. Journal of Virology 
57, 446-455.
E v e r e t t ,  R. D. (1984). Transactivation of transcription by herpes virus 
products: requirement for two HSV-1 immediate-early polypeptides 
for maximum activity. EM BO Journal 3, 3135-3141.
E v e r e t t ,  R. D. (1987). The regulation of transcription of viral and 
cellular genes by herpesvirus immediate-early gene products. Anti­
cancer Research 7 , 589-604.
E v e r e t t ,  R. D. (1989). Construction and characterisation of herpes 
simplex virus type 1 mutants with defined lesions in immediate early 
gene 1. Journal of General Virology 70, 1185-1202.
F e in b e r g , A. P. & V o g e ls t e in ,  B. (1983). A technique for radio­
labelling restriction endonuclease fragments to a high specific 
activity. Analytical Biochemistry 132, 6-13.
F r a s e r ,  N. W., B lo c k ,  T. M. & S p iv a c k , J. G. (1992). The latency- 
associated transcripts of herpes simplex virus: RNA in search of a 
function. Virology 191, 1-8.
G r e a v e s , R. & O ’H a r e , P. (1990). Structural requirements in the 
herpes simplex virus type 1 transactivator Vmw65 for interaction 
with the cellular octamer-binding protein and target TAATGARAT 
sequences. Journal of Virology 64 , 2716-2724.
H a r r is , R. A. & P r e s t o n ,  C. M. (1991). Establishment of latency in 
vitro by the herpes simplex virus type 1 mutant z'«l 814. Journal of 
General Virology 72 , 907-913.
H a y e s , S. & O ’H a r e , P. (1993). Mapping of a major surface-exposed 
site in herpes simplex virus protein Vmw65 to a region of direct 
interaction in a transcription complex assembly. Journal o f Virology 
67, 852-862.
H ein e , J. W., H o n e ss , R. W., C a ssa i, E. & R o izm a n , B. (1974). 
Proteins specified by herpes simplex virus. XII. The virion poly­
peptides of type 1 strains. Journal of Virology 14, 640-651.
J a c o b , R. J. & R o izm a n , B. (1977). Anatomy of herpes simplex virus 
DNA. VII. Properties of the replicating DNA. Journal of Virology 
23, 394-411.
J o h n so n , P. A., M iy a n o h a r a ,  A., L ev in e , F., C a h i l l ,  T. & F r ie d ­
m an n , T. (1992). Cytotoxicity of a replication defective mutant of 
herpes simplex virus type 1. Journal of Virology 66, 2952-2965.
J o h n so n , P. A., W a n g , M. J. & F r ie d m a n n , T. (1994). Improved cell 
survival by the reduction of immediate-early gene expression in 
replication-defective mutants of herpes simplex virus type 1 but not 
by mutation of the virion host shutoff function. Journal of Virology 
68, 6347-6362.
K a t a n ,  M., H a ig h , A., V e r r d z e r ,  P. C., V a n  D e r  V l i e t ,  P. C. & 
O ’H a r e , P. (1990). Characterization of a cellular factor which 
interacts functionally with oct-1 in the assembly of a multicomponent 
transcription complex. Nucleic Acids Research 18, 6871-6880.
Kem p, L. M., D e n t ,  C. L. & L a tc h m a n , D. S. (1990). Octamer motif 
mediates transcriptional repression of HSV immediate-early genes 
and octamer-containing cellular promoters in neuronal cells. Neuron
4, 215-222.
K o s z -V n e n c h a k , M., J a c o b se n , J., C o en , D. M. & K n ip e , D. M.
(1993). Evidence for a novel regulatory pathway for herpes simplex 
virus gene expression in trigeminal ganglion neurons. Journal of 
Virology 67, 5383-5393.
K r is t ie ,  T. M. & R o izm a n , B. (1988). Differentiation and DNA 
contact points of the host proteins binding at the cis site for virion- 
mediated induction of herpes simplex virus 1 a genes. Journal of 
Virology 62, 1145-1157.
K r is t ie ,  T. M. & S h a r p , P. A. (1990). Interactions of the oct-1 POU 
subdomains with specific DNA sequences and with the HSV a-trans- 
activator protein. Genes & Development 4, 2383-2396.
L a n g , J. C., W ilk ie ,  N. M. & S p a n d id o s , D. A. (1983). Character­
ization of eukaryotic transcriptional control signals by assay of 
herpes simplex virus type 1 thymidine kinase. Journal of General 
Virology 64, 2679-2696.
L e in b a c h , S. S. & Sum m ers, W. C. (1980). The structure of herpes 
simplex virus type 1 DNA as probed by micrococcal nuclease 
digestion. Journal of General Virology 51, 45-59.
L i l ly c r o p ,  K. A., D e n t ,  C. L., W h e a t le y ,  S. C., B e e c h , N. M., 
N in k in a , N. N., W o o d , J. N. & L a tc h m a n , D. S. (1991). The 
octamer-binding protein oct-2 represses HSV immediate-early genes 
in cell lines derived from latently infectable sensory neurons. Neuron 
7, 381-390.
L i l ly c r o p ,  K. A., H o w a r d ,  M. K., E s tr id g e ,  J. K. & L a tc h m a n , D.
5. (1994). Inhibition of herpes simplex virus infection by ectopic 
expression of neuronal splice variants of the oct-2 transcription 
factor. Nucleic Acids Research 22, 815-820.
M c F a r la n e ,  M., D a k s is ,  J. I. & P r e s t o n ,  C. M. (1992). Hexa- 
methylene bisacetamide stimulates herpes simplex virus immediate 
early gene expression in the absence of trans-induction by Vmw65. 
Journal o f General Virology 73, 285-292.
M c K n ig h t ,  J. L. C., K r is t ie ,  T. M. & R o izm a n , B. (1987). Binding of 
the virion protein mediating a gene induction in herpes simplex virus 
1-infected cells to its cis site requires cellular proteins. Proceedings of 
the National Academy of Sciences, USA 84, 7061-7065.
M i t t n a c h ,  S., S tr a u b , P., K ir c h n e r ,  H. & J a co b se n , H. (1988). 
Interferon treatment inhibits onset of herpes simplex virus immedi­
ate-early transcription. Virology 164, 201-210.
M u g g e r id g e ,  M. I. & F r a s e r ,  N. W. (1986). Chromosomal organ­
ization of the herpes simplex virus genome during acute infection of 
the mouse central nervous system. Journal of Virology 59, 764-767.
O b erm an , F. & P a n e t ,  A. (1989). Characterization of the early steps of 
herpes simplex virus replication in interferon-treated human cells. 
Journal o f Interferon Research 9, 563-571.
O ’H a r e , P. & G o d in g , C. R. (1988). Herpes simplex virus regulatory 
elements and the immunoglobulin octamer domain bind a common 
factor and are both targets for virion transactivation. Cell 54, 
435-445.
O ’H a r e , P. & H a y w a r d ,  G. S. (1985). Three trans-acting regulatory 
proteins of herpes simplex virus modulate immediate-early gene
I GLASGOW
I ONIVFRSITY 
j LIBRARY __
Retention o f  H S V  DNA  1431
expression in a pathway involving positive and negative feedback 
regulation. Journal of Virology 56, 723-733.
P e r r y ,  L. J. & M c G e o c h ,  D. J. (1988). The DNA sequences of the 
long repeat region and adjoining parts of the long unique region in 
the genome of herpes simplex virus type 1. Journal of General 
Virology 69, 2831-2846.
P o f f e n b e r g e r ,  K. L. & R o iz m a n , B. (1985). A noninverting genome of 
a viable herpes simplex virus 1: presence of head-to-tail linkages in 
packaged genomes and requirements for circularization after 
infection. Journal of Virology 53, 587-595.
P o s t ,  L. E., M a c k e m , S. & R o iz m a n , B. (1981). Regulation of a genes 
of herpes simplex virus: expression of chimeric genes produced by 
fusion of thymidine kinase with a gene promoters. Cell 24, 555-565.
P r e s t o n ,  C. M. (1979a). Abnormal properties of an immediate early 
polypeptide in cells infected with the herpes simplex virus type 1 
mutant faK. Journal of Virology 32, 357-369.
P r e s t o n ,  C. M . (1919 b). Control of herpes simplex virus type 1 mRNA 
synthesis in cells infected with wild-type virus or the temperature 
sensitive mutant tsK. Journal of Virology 29, 275-284.
P r e s t o n ,  C, M., F ra m e, M. C. & C a m p b e ll, M. E. M. (1988). A 
complex formed between cell components and an HSV structural 
polypeptide binds to a viral immediate early gene regulatory 
sequence. Cell 52, 425-434.
R a lp h ,  W. M., C a b a t in g a n , M. S. & S c h a f f e r ,  P. A. (1994). 
Induction of herpes simplex virus immediate-early gene expression 
by a cellular activity expressed in vero and NB41A3 cells after 
growth arrest-release. Journal of Virology 68, 6871-6882.
R ix o n , F. J. & M c L a u c h la n ,  J. (1990). Insertion of DNA sequences 
at a unique restriction enzyme site engineered for vector purposes 
into the genome of herpes simplex virus type 1. Journal of General 
Virology 71, 2931-2939.
R o c k ,  D. L. & F r a s e r ,  N. W. (1983). Detection of HSV-1 genome in 
central nervous system of latently infected mice. Nature 302,523-525.
R o iz m a n , B . & S e a r s , A. E. (1987). An inquiry into the mechanisms of 
herpes simplex virus latency. Annual Review of Microbiology 41, 
543-571.
S a c k s ,  W. R., G r e e n e , C. C., A sch m a n , D. P. & S c h a f f e r ,  P. A. 
(1985). Herpes simplex virus type 1 ICP27 is an essential regulatory 
protein. Journal of Virology 55, 796-805.
S a c k s ,  W. R. & S c h a f f e r ,  P. A. (1987). Deletion mutants in the gene 
encoding the herpes simplex virus type 1 immediate-early protein 
ICPO exhibit impaired growth in culture. Journal of Virology 61, 
829-839.
S a d o w s k i,  I., M a , J., T r ie z e n b e r g , S. J. & P ta s h n e , M . (1988). 
GAL4-VP16 is an unusually potent transcriptional activator. Nature 
335, 563-564.
S a n d r i-G o ld in ,  R. M. & M e n d o z a , G. E. (1992). A herpesvirus 
regulatory protein appears to act post-transcriptionally by affecting 
mRNA processing. Genes & Development 6, 848-863.
S e a r s , A. E., H u k k a n e n , V., L a b o w , M. A., L e v in e , A. J. & R o izm a n , 
B. (1991). Expression of herpes simplex virus 1 a transinducing 
factor (VP 16) does not induce reactivation of latent virus or prevent 
the establishment of latency in mice. Journal of Virology 65, 
2929-2935.
Simmons, A., S lo b e d m a n , B., S p eck , P., A r t h u r ,  J. & E f s t a t h io u ,  S. 
(1992). Two patterns of persistence of herpes simplex virus DNA 
sequences in the nervous systems of latently infected mice. Journal of 
General Virology 73, 1287-1291.
S lob ed m an , B., E f s t a t h io u ,  S. & Sim m ons, A. (1994). Quantitative 
analysis of herpes simplex virus DNA and transcriptional activity in 
ganglia of mice latently infected with wild-type and thymidine 
kinase-deficient viral strains. Journal o f General Virology 75, 
2469-2474.
S m ib ert, C. A., P o p o v a , B., X ia o , P., C a p o n e , J. P. & S m iley , J. R.
(1994). Herpes simplex virus VP 16 forms a complex with the virion 
host shutoff protein vhs. Journal o f  Virology 68, 2339-2346.
S p iv a c k , J. G. & F r a s e r ,  N. W. (1987). Detection of herpes simplex 
virus type 1 transcripts during latent infection in mice. Journal o f  
Virology 61, 3841-3847.
S te in e r ,  I., S p iv a c k , J. G., D esh m an e , S. L., A c e , C. I., P r e s t o n ,  C. 
M. & F r a s e r ,  N. W. (1990). A herpes simplex virus type 1 mutant 
containing a non-transinducing Vmw65 protein establishes latent 
infection in vivo in the absence of viral replication and reactivates 
efficiently from explanted trigeminal ganglia. Journal o f  Virology 64, 
1630-1638.
S te r n ,  S., T a n a k a , M. & H e r r ,  W. (1989). The oct-1 homeodomain 
directs formation of a multiprotein-DNA complex with the HSV 
transactivator VP16. N ature  341, 624-630.
S te v e n s , J. G., W a g n e r , E. K., D e v i-R a o , G. B., C o o k . M. L. & 
F e ld m a n , L. (1987). RNA complementary to a herpesvirus alpha 
gene mRNA is predominant in latently infected neurons. Science 
235, 1056-1059.
S tin s k i, M. F. & R o e h r , T. J. (1985). Activation of the major 
immediate early gene of human cytomegalovirus by cw-acting 
elements in the promoter-regulatory sequence and by virus-specific 
trans-acting components. Journal o f  Virology  55, 431-441.
S to w ,  N. D. & S t o w ,  E. C. (1986). Isolation and characterization of a 
herpes simplex virus type 1 mutant containing a deletion within the 
gene encoding the immediate early polypeptide Vmwl 10. Journal o f  
General Virology 67, 2571-2585.
S t o w ,  E. C. & S t o w ,  N. D. (1989). Complementation of a herpes 
simplex virus type 1 Vmwl 10 mutant by human cytomegalovirus. 
Journal o f  General Virology 70, 695-704.
T r ie z e n b e r g , S. J., K in g s b u r y , R. C. & M c K n ig h t ,  S. L. (1988). 
Functional dissection of VP 16, the trans-activator of herpes simplex 
virus immediate early gene expression. Genes & D evelopm ent 2, 
718-729.
V a ly i - N a g y ,  T., D esh m a n e , S. L., S p iv a c k , J. G., S te in e r ,  I., A c e , C. 
I., P r e s t o n ,  C. M. & F r a s e r ,  N. W. (1991). Investigation of herpes 
simplex virus type 1 (HSV-1) gene expression and DNA synthesis 
during the establishment of latent infection by an HSV-1 mutant, 
wil814, that does not replicate in mouse trigeminal ganglia. Journal 
o f  Virology 72, 641-649.
W a t s o n ,  R. J. & C le m e n ts , J. B. (1980). A herpes simplex virus type 1 
function required for early and late virus RNA synthesis. N ature  285, 
329-330.
W ein h eim er, S. P., B o y d , B. A., D u r h a m , S. K., R e sn ic k , J. L. & 
O ’B o y le ,  D. R. (1992). Deletion of the VP16 open reading frame of 
herpes simplex virus type 1. Journal o f  Virology  66, 258-269.
W ig d a h l ,  B. L., S c h e c k , A. C., D e c le r c q ,  E. & R app , F. (1982). High 
efficiency latency and activation of herpes simplex virus in human 
cells. Science 217, 1145-1146.
W ig d a h l ,  B. L., S c h e c k , A. C., Z ie g le r ,  R. J., D e c le r c q ,  E. & R app , 
F. (1984). Analysis of the herpes simplex virus genome during 
latency in human diploid fibroblasts and rat sensory neurons. 
Journal o f  Virology  49, 205-213.
W ilk ie ,  N. M., C le m e n ts , J. B., B o l l ,  W., M a n te i ,  N., L o n s d a le ,  D. 
& W eissm an , C. (1979). Hybrid plasmids containing an active 
thymidine kinase gene of herpes simplex virus. Nucleic A cids  
Research  7, 859-877.
W ils o n ,  A. C., L a m a r c o , K., P e t e r s o n ,  M. G. & H e r r ,  W. (1993). 
The VP 16 accessory protein HCF is a family of polypeptides 
processed from a large precursor protein. C ell 74, 115-125.
(Received 9 November 1994; Accepted 24 January 1995)
Summary of i/il814 and inl820-based viruses
Virus Vmw65 transactivation IE-1 promoter HCMV-LAC Z Reference
ml 814 — wild type — Ace e t a l .  (1989).
1814R + wild type — Ace e ta l .  (1989).
ml 853 — wild type TK locus
C.M.Preston,
unpublished
data.
ml 863 + wild type TK locus
C.M.Preston,
unpublished
data.
ml 820 — MMLVLTR —
Jamieson e t  a l. 
(1995).
ml 825 + MMLV LTR —
Jamieson e t  a l. 
(1995).
ml 883 — MMLVLTR TK locus
Jamieson e t  a l. 
(1995).
ml 830 — MMLV LTR UL43
C.M.Preston,
unpublished
data.
